<SEC-DOCUMENT>0001275187-23-000005.txt : 20230106
<SEC-HEADER>0001275187-23-000005.hdr.sgml : 20230106
<ACCEPTANCE-DATETIME>20230106165555
ACCESSION NUMBER:		0001275187-23-000005
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20221130
FILED AS OF DATE:		20230106
DATE AS OF CHANGE:		20230106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANGIODYNAMICS INC
		CENTRAL INDEX KEY:			0001275187
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				113146460
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50761
		FILM NUMBER:		23515694

	BUSINESS ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
		BUSINESS PHONE:		5187981215

	MAIL ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ango-20221130.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:57ef1ee5-794e-4e06-bd71-294e22fc989b,g:b5d7794f-41e8-47c1-b455-924b13840c85,d:897c24ef20684c93801e686a95e6abcc--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ango="http://www.angiodynamics.com/20221130" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ango-20221130</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl80LTEtMS0xLTUzOTA2_c668e397-a872-40e3-b742-420b9e3add8e">false</ix:nonNumeric><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl82LTEtMS0xLTUzOTA2_3a4f3682-0c73-4695-b73c-b7c9b6732392">2023</ix:nonNumeric><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl83LTEtMS0xLTUzOTA2_ea15df07-1296-4f91-8c0b-4062a88907eb">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl8xMC0xLTEtMS01MzkwNg_14e3453f-5546-4f46-a2fd-5034a3f23eda">0001275187</ix:nonNumeric><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl8xMS0xLTEtMS01MzkwNg_3b3c21a5-6564-48cc-a73f-c036be79b077">--05-31</ix:nonNumeric><ix:nonNumeric contextRef="i01586c4af1694483a5923523cc5adc02_D20220601-20221130" name="dei:NoTradingSymbolFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl8xMi0xLTEtMS01MzkwNg_f9a4ce2b-1e24-4c8c-af3c-89b69fad9ceb">true</ix:nonNumeric><ix:nonNumeric contextRef="ia2cfe7c548c8479c9c72cfb258097cbf_D20220601-20221130" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0Mg_fc669142-82c7-49b8-a7a9-e8917629543b">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ango-20221130.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i990fe285074e41ffb69712be25fba343_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01586c4af1694483a5923523cc5adc02_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ango:PreferredStockPurchaseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc75a48f4c044ff4b7035f3ba66619f8_I20230105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58c4e8650d24eb487e88de28117da2a_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i91d36c036abe435992dbd27d886b81f0_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3787173c67d1467ea7ad2812b803a924_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ae2f2a17c5c4c0ab0620f6245443650_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i580a989d6bd346dea798e59360b2cf7b_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92253b30ce7448a9b04589161b7aef74_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0521e2ea5e8f4642ba511b1cf2257912_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9c3663238b141639922a3c2b6127596_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3170daaa632a47c2864c3b1cfbeabc53_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia78ac75b2327440aabe9a07d95648ed1_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d26b3b0e13245a9a8b3f331e8f3f094_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e978a8d0cbb4723afaecf79157faa08_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9339830d2a2e4fda87b3402b5dc095cb_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e97ca8dbd54428b944767243cf21fd_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5014bebe766c497ca5a518a9144f9fee_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc6ea670265410a9abcd9fe2ce25d89_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0679db975f1e442f95e34936148e0ca3_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a2219dda3a46beaaeefb85ffdbc421_D20220301-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eba7ef0b2324baba133dce806849e01_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i358df3908685483ba68ef5ce671cb276_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0773232166fe4bdfa46507e1fa96456b_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a1dadd2d8248f4a335ef455a4782f3_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e61a52d34bf4a7fa61bbf80ff3eef08_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605f35cad602428b8143074fa8c31ba8_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i761e3ac346f34f59b5db2c93ec5cd804_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c8c3dc240b49d1aa14a8e2c554f67d_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0436957f2064843bb33c8674690b54b_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6493fdf5e73404cb9c65ebd100d37ef_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b34f1c2e1346eb854653a87b2ad11f_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d7e5ff2d9d47c2aca189c481fd4cb8_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39078c2a8d3949c8b51612819ff52be6_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia231c271d6e74f54b40bb9f2c13d5442_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a4bd82406cc4389bd0da8087da40e52_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7310c5f116f7458bbf77606953070240_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5209e80cbf59403ba5b0127b54301190_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a5faedb2934ca3b6d2036bad066025_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96b6c43657d45239e312ea746267dc0_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80aa6442429842f5a354cbfbb8726ca1_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5703543d8ed4406290fe2b3d2ebe132b_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06eb3f7549e544fa998b0ee023503249_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce7f40f7e1c4f288eaa7bdae504643a_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc1376a994d14170988972c24d8d1eea_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29a2abe0d92149128c8af04916896413_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92d7755649c74466927d4c2e158305aa_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33519024438c43d7a67b370d508001cc_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fe451085baf4ea09c68e462c55b946d_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eaf8bf186364608810a8c124dd74a94_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3190940009fb48f29de007d763ca8a27_D20210601-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b58b5cab854792a4cd67d56850fb81_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08aee044abc04167ab7b46d2b3434e1f_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4134390d562f48ff9f977c2e6b84a29f_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if20cde87f3f1438582de0a6be9bfb0f0_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31a8b6318460497bae9c739e5328a31b_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46394e9b402e418b9d3d6c693d0247ce_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4675e13c50964ba0a48938de3e2ae4a4_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13178785dc1843d99d2ccce16ace2e65_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideddd48e387b42c2b942816100384d6a_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12da52958cc5404e98473dd0097af478_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dc3ec9fcfa545bd8484b6f100236204_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96f83ef275904264810bf98c69aa89aa_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia984848d280248bfbcb8e31640f1e39d_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i155c045358b34383ac3295044d6c9a6b_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdec94434c4945059845c818633407fb_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2dd77d8826427fb397445192c0bc76_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9770758c2964b64b48d180cbdf84531_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf6811aafe4e4669a27e18cdda0c54ef_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e896b21e924dea8f58a482a45a6580_D20210727-20210727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-27</xbrli:startDate><xbrli:endDate>2021-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ddfbc23984498e818686d27ec8ab38_D20210727-20210727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-27</xbrli:startDate><xbrli:endDate>2021-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4932000aa21a49cda2393c4098bd3848_D20191217-20191217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-17</xbrli:startDate><xbrli:endDate>2019-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b1ac96c05c4496cbe867dec215b61da_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibff045fe7c34428eabb45c34bd46a77b_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia05af3963048441980e5da6c628ad99e_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97cc578ba1c14c2790275846f3e88b4f_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da7d71470d046839e99da599e632e18_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03b89bf280264af8b946c348ba6191a5_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i608ce6e6291c48db9671f8baa53df352_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6552b74e0da8424b8b3f0a28d099316d_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69edc35bb61e4b13864a2034b42aa17e_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4c2fd9d28c04a93ae03769f99f5b982_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84b2cc1c77648d59e643ea5bca9cd40_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69be4f7a7d4e429f9786923e58bb233a_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e5207d4b6e44c3bb870e98f47ae464f_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fe0ea1cdf9b43cba1dc89583cfa12f4_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f3b790c7408444aa2438a6d74ccf219_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa5895dff1504af8b53362954d42a835_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9782032ec849455f9eb55bcd5238506f_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i730d6d555ca8411db383a11b9f16a087_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcdba87c68b44670aa983d442909c8c8_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f175e8bc06e4516859a922825203ed1_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i109b126be6684609964e1d738004a5f0_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b9577aad3e743eaab5f2db73438ff22_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1532603b5d5344d2b521ebca95510e2d_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i102e00650df64160ab95f91283be5671_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6fa11be4a974f91a8f83c64c4b79d43_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bbd65f28780439d8d4b3739c60451f2_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2cfe7c548c8479c9c72cfb258097cbf_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc7c9d9ebcb04ddca80d41fba203d212_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i96f682ba85b44a3598400d9868b15c05_D20220601-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="unit"><xbrli:measure>ango:unit</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>ango:segment</xbrli:measure></xbrli:unit><xbrli:context id="id1e9f928ee4349a68577d07adcc3b26f_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c31b0a2ffcb46a09974a5fc03fcb07e_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e8bf515dc504d2e93a4cef1b15e47ed_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic64f7b15ed9b474995bee41f47ae8270_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5cf0bee2d60494bb2779598e5ddb3eb_D20220602-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-02</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0e0ea76bcf04919ab502a0c59748fb9_D20220602-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-02</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a1d991006824083b8178abc9d11b0d5_D20220602-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-02</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a86996ae3f64984bc0a4ecc7bd4af54_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2d1378a1f24161b87c458f35456450_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e064f90d3da49b9a66c4ac18aad1d0d_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41e9cc6df0e4df7ac811956f8aff5e4_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4026512e869c44a08831de2435fa433a_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0933abd0902b4939a41c2a553e06b97d_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:ProductTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03538be72f0c479d88269196fae7627d_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a63b72365594c83ac835e0622876350_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i481617886ccd437181a9534ee467fcaa_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i232cbe1e1fc44360a597810368435c6e_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:ProductTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id17cfc417d92464bbedc0236cf2219c3_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38c064a30b74d81851783f9a22c7991_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51440fe9937d4880a24b852c727c72bc_I20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a6ca8a1a2a47948d181c2ddd57b60e_I20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93908ff9fa24ce8a539c1afc8be059d_I20190603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd47ebcb2afe4eab9e20c68e5a784838_D20220830-20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-30</xbrli:startDate><xbrli:endDate>2022-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac18782ad5a1446b96f8bacea0595e03_D20190603-20190603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-03</xbrli:startDate><xbrli:endDate>2019-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66d2669acf841099e3090e565eb8955_D20220830-20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-30</xbrli:startDate><xbrli:endDate>2022-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6651e0f87eed4540b11c234da6d13537_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b19051a3bf4afba6d1ee320c49fadb_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a200b6474a84a51a5841bde35741a37_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48b85744365f40d9883440cec0fe503a_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ec7dba98bb64aa7b30c01f66cec9680_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="covenant"><xbrli:measure>ango:covenant</xbrli:measure></xbrli:unit><xbrli:context id="i9c7dabef1a2548fc9b252f702944e5c6_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7eb5c10613d48cb9ebc0fe8c4cf3a93_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc15638543e04c98b695a64a354303c6_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa54aec1d4754ab481509765d96d5677_D20221103-20221103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:A2020StockAndIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-03</xbrli:startDate><xbrli:endDate>2022-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ea6dcaec304dba8c28be69f4cd1398_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:A2020StockAndIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d63329084d44df394d886d4d1bb5ee2_D20221103-20221103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-03</xbrli:startDate><xbrli:endDate>2022-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieefdf4931e024fcbba5c7e8746fb00ff_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id088a0af0c2d43b9ad0bda298d1ff754_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc69fb0bea484528bc57184c81e8345b_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i731c9ba446ab4192a1491d1c6f27c373_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i636ddb4bd5b74d3f8a431176bd1d93e5_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe2c52f725c437ab009d57429836a32_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:NetAssetsGeographicAreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85a313731ab245768b6c5d3dfb85c22a_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ad2ccb7c6b41e89084e3b945f40e64_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia25b0cac0e4a4dac8864feacd65915ec_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b1288467e0d4c2b98b2092131400cc2_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5eebdc1dda64c488bf0ee527902d32d_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48bf28259a0f48979d1480adb13bf9ec_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e7d990beb04157bf2af35e180e5437_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50932b29e3234e39be7fd89538f9ae51_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd9433e4df6a4d73bdb71c139f61a75a_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360405dac2ac408196db947950f5fcdd_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d7862e7cad34bfd8d2c83decfca3201_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ango:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86ec9e06fac9486392729b869d82f434_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ango:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i254de9e531fb4e0c9d03f1d1943e752e_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i544584d510904231bd6fd4ad6edaceed_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d99785b1194e778010f6582bcc0573_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412326f7f86f49389bc84bbcd7b983b4_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58f23a0eada416e97df8f458b27fbb9_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7c661bc93a4242beb5a3453d1917a2_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i404cfafae04d4964a4bf5b13fba7cb2a_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c51f234e672471b8e71d406f6c8a7e7_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27add22ce5d243fab019d5956cd78ed3_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aa1f09bc0264f0faa5e3f247394dddd_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie222d4925bad48388ddbb56ee9bec5a3_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac9f367db484179bc46e4196b143896_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf3a056055ed471eb130b5c3aa8d0761_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea95b9fd5b84377910bba4663837245_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4307997465a748938dd80b54c9b60cf4_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6fe7fe11684c62858764a7d401b9f1_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:CrBardIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-11</xbrli:startDate><xbrli:endDate>2012-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>ango:patent</xbrli:measure></xbrli:unit><xbrli:context id="i274e4b0db3ab4da292cee7a42340b2fd_D20150310-20150310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheDelawareActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-03-10</xbrli:startDate><xbrli:endDate>2015-03-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd57db09d954401a970450cb332edc2_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee3cc03838394279b14c503789157f07_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47bbc169a6da4a36952422f9fd58300c_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c5d45239404a43ada7157497ae9c3e_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1113d3caab5d408faab5a5f245311b15_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ee2fde770274d08a3b8af0bb66c465b_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f83e0c893cb4e7fb69e22ed93dc6a55_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61bc7936712144249aa26ca9905b3c8e_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ef1be6232914c8490f870666a771ffa_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ab1f2674fe04183b7df7f14ea9f167c_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica1aa84fb02d4395a39a7bf23b044eab_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06523c7cb754445ab38517c2cb05ce7d_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cec44cbde2244a9a355ca544f33885f_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7706a0f7dae740418007c9381795d2bd_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4dd796fd591465c8eb9c1eb60615285_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47789d4315de4707952ba298e204a6ed_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i044eeedb625141a788d4e6c857cff53e_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94bdb9b48a8f461b95594363296e37f6_D20210901-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9266e9d5e54f4e03aa9bff8df03159b5_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f28e909af74b0abe3ae31344d25373_D20210601-20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fe5b4172864faa8f8941f2d91a82a5_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8e6825fbb074aa89f3481933a0524ff_D20220901-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc3c6dba44947808123f698ace071df_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd649e5bedd943d9a3a7267d44a89998_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec41db309d8b4a96899fae9d890284b7_D20220601-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i897c24ef20684c93801e686a95e6abcc_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV84Nw_22ac79d6-b9fc-4cbe-8228-03e7cb013f7c">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6YWI5MjQ4MTVkZWI0NDFiZTljMmJhNTFjODY2Yzc3NGYvdGFibGVyYW5nZTphYjkyNDgxNWRlYjQ0MWJlOWMyYmE1MWM4NjZjNzc0Zl8wLTAtMS0xLTUzOTA2_b46ef638-7bc7-4d1d-a00b-48f4d7174a14">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8xMjY_d87088c8-e7df-4cd3-9758-2ba2a47d1e6f">November&#160;30, 2022</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NzM5OWNkMDM2MzRlNDY5NDg0MjQ5YmJiZmU0ZjViNzcvdGFibGVyYW5nZTo3Mzk5Y2QwMzYzNGU0Njk0ODQyNDliYmJmZTRmNWI3N18wLTAtMS0xLTUzOTA2_1d422969-d736-42d3-a087-7fe467a2570e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8yMjc_867f1581-9055-491c-b2f0-07390bc7e959">0-50761</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8yMzM_c3be1ee6-beea-44b3-84c8-59daf385501b">AngioDynamics, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><img src="ango-20221130_g1.gif" alt="ango-20221130_g1.gif" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:422px"/></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6ODQ4N2E4ZTZiMjJkNDI1Nzk1N2ZjMzhjODUzMTNiMWYvdGFibGVyYW5nZTo4NDg3YThlNmIyMmQ0MjU3OTU3ZmMzOGM4NTMxM2IxZl8wLTAtMS0xLTUzOTA2_19b75ec9-3972-40d0-bd66-4071e0474e39">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6ODQ4N2E4ZTZiMjJkNDI1Nzk1N2ZjMzhjODUzMTNiMWYvdGFibGVyYW5nZTo4NDg3YThlNmIyMmQ0MjU3OTU3ZmMzOGM4NTMxM2IxZl8wLTItMS0xLTUzOTA2_2f4ba706-f37b-4c9a-a775-5d9ddc0af047">11-3146460</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMDA_a1eeb92b-f618-4def-abdb-ff1d0aa0f2cd">14 Plaza Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMDQ_f652e6ee-03bd-45bf-8060-d00316311930">Latham</ix:nonNumeric>, <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMDg_bf5b93a7-47c1-49d3-ba68-029373aaaffe">New York</ix:nonNumeric> <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMTE_caae5c2d-be5e-4b31-9e34-5a729c078339">12110</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zNzA_4c5580c8-e4d4-481c-9d51-bf87403a3bb0">518</ix:nonNumeric>) <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zNzQ_73a9931a-e49e-45ef-a083-38e4a28b22c5">795-1400</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i990fe285074e41ffb69712be25fba343_D20220601-20221130" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8xLTAtMS0xLTUzOTA2_995f778b-2a71-48b2-a71f-8c0be30cf3db">Common Stock, par value $.01</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i990fe285074e41ffb69712be25fba343_D20220601-20221130" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8xLTItMS0xLTUzOTA2_06f05599-dc51-416d-b467-cdd54ed302b6">ANGO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i990fe285074e41ffb69712be25fba343_D20220601-20221130" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8xLTQtMS0xLTUzOTA2_4629f88c-050a-4f38-b553-76c19fb38889">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01586c4af1694483a5923523cc5adc02_D20220601-20221130" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8yLTAtMS0xLTUzOTA2_430e4317-f3b6-46b8-b657-2b901ba961d5">Preferred Stock Purchase Rights</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01586c4af1694483a5923523cc5adc02_D20220601-20221130" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8yLTQtMS0xLTUzOTA2_a14c9e88-8fe5-4ac8-93a3-466058a0556b">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Title of Class)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8xMjAw_3947b501-bc09-48a4-b239-49a3a9b8398f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8xNTAw_ec14863b-9b6a-4eb0-8225-9bd8d7d8ca69">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NDdlMDQ2ZWMwNGI1NGJjMDlkODNlNTNiNGUzYmU3MWYvdGFibGVyYW5nZTo0N2UwNDZlYzA0YjU0YmMwOWQ4M2U1M2I0ZTNiZTcxZl8wLTAtMS0xLTUzOTA2_268263f1-7448-4730-b5d0-617859b6a67f">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NDdlMDQ2ZWMwNGI1NGJjMDlkODNlNTNiNGUzYmU3MWYvdGFibGVyYW5nZTo0N2UwNDZlYzA0YjU0YmMwOWQ4M2U1M2I0ZTNiZTcxZl8yLTYtMS0xLTUzOTA2_9793b4f0-8916-4f18-83e7-86285881c2ff">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NDdlMDQ2ZWMwNGI1NGJjMDlkODNlNTNiNGUzYmU3MWYvdGFibGVyYW5nZTo0N2UwNDZlYzA0YjU0YmMwOWQ4M2U1M2I0ZTNiZTcxZl80LTItMS0xLTUzOTA2_aede6ef4-9c03-47f4-a786-faf65bb7ee63">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8yMTk5MDIzMjU3NjQ5_ee951776-4c76-47a0-acb2-510bad06dc21">&#9746;</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the Registrant&#8217;s classes of common stock, as of the latest practicable date.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Outstanding as of January 5, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock, par value $.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc75a48f4c044ff4b7035f3ba66619f8_I20230105" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MzY0YmJkNDY3ZTkzNDlhMjkyOTUxYWM0M2Q3OGRkMzAvdGFibGVyYW5nZTozNjRiYmQ0NjdlOTM0OWEyOTI5NTFhYzQzZDc4ZGQzMF8xLTItMS0xLTUzOTA2_df31ac1b-7836-4cb6-b917-a59d350594f7">39,134,144</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:17pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_10">Part I: Financial Information</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_16">Consolidated Statements of Operations (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_19">Consolidated Statements of Comprehensive Loss (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_19">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_22">Consolidated Balance Sheets (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_25">Consolidated Statements of Cash Flows (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_28">Consolidated Statements of Stockholders&#8217; Equity (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_28">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_31">Notes to Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_31">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_85">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_85">24</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_88">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_88">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_91">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_94">Part&#160;II:&#160;Other&#160;Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_97">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_97">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_100">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_100">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_103">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_103">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_106">Defaults on Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_106">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_109">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_109">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_112">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_112">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_115">35</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART 1. FINANCIAL INFORMATION</span></div><div id="i897c24ef20684c93801e686a95e6abcc_13"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements.</span></div><div id="i897c24ef20684c93801e686a95e6abcc_16"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of dollars, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi0yLTEtMS01MzkwNg_e76aeabf-9609-4c1f-8b91-39778da3e808">85,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi00LTEtMS01MzkwNg_d019def7-96d4-4f43-b3f1-3f08cf62466c">78,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi02LTEtMS01MzkwNg_b74b0f19-518d-415e-87c1-eb224791bf5c">166,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi04LTEtMS01MzkwNg_274b3030-ec88-4c2e-aa7d-0c9e900f5892">155,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of sales (exclusive of intangible amortization)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy0yLTEtMS01MzkwNg_ccb6c641-8fdb-4898-b3b9-5bf6fcd3f5e1">40,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy00LTEtMS01MzkwNg_15a80b9b-96c3-470f-8471-4f5192b6faf1">37,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy02LTEtMS01MzkwNg_5f95993a-ed9f-472a-89c5-a119924ddd8c">79,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy04LTEtMS01MzkwNg_2e396363-6d41-4968-a125-92b321e0613e">74,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC0yLTEtMS01MzkwNg_2cad9c61-a447-4b05-8ff4-85d8724a8fc8">45,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC00LTEtMS01MzkwNg_95143556-45ef-4e72-9849-e52bb2361b83">40,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC02LTEtMS01MzkwNg_4ecac4b3-60a1-48b3-8062-d9e2eede05e6">87,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC04LTEtMS01MzkwNg_6ee88004-ef50-43a4-a956-1951eb07900a">80,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi0yLTEtMS01MzkwNg_6379ed13-3abb-4077-a4e9-2749d0feb02f">6,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi00LTEtMS01MzkwNg_68446df7-d477-428d-af18-08d89de2393a">8,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi02LTEtMS01MzkwNg_c59f98a7-e80a-42e7-a4e8-d4c198e3d784">15,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi04LTEtMS01MzkwNg_43c332cb-4df9-43cc-ab5a-78c8a6af026a">15,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy0yLTEtMS01MzkwNg_ee3a35cb-3fa3-4d96-b7fc-4f7552fd5df0">26,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy00LTEtMS01MzkwNg_ff4af208-b1b7-4e55-bfc6-bbb26577ee47">23,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy02LTEtMS01MzkwNg_960158ae-5043-43b8-adf1-e66106031a97">52,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy04LTEtMS01MzkwNg_ee711dd6-359b-4262-8d54-e759c94a1006">48,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC0yLTEtMS01MzkwNg_b837b415-71b8-4ec2-99ea-986c4ca520b5">10,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC00LTEtMS01MzkwNg_b53e6c15-760b-4693-a45a-4291f104ea68">9,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC02LTEtMS01MzkwNg_f5efd05a-8a78-44e3-b058-40b6b9bcffd5">20,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC04LTEtMS01MzkwNg_44daa6ca-60f0-433f-b0a1-7321fd7a0be1">18,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS0yLTEtMS01MzkwNg_b278868c-5113-457a-b5f9-2e4ee03db4f7">4,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS00LTEtMS01MzkwNg_387984ef-5783-4ed9-a04d-c5cc99908017">4,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS02LTEtMS01MzkwNg_3ae5795c-90d7-49bc-bece-804d09f5b2ec">9,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS04LTEtMS01MzkwNg_2c2f4f9d-1d93-4e71-bf47-a35388357e52">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsiderationOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtMi0xLTEtNTM5MDY_9766e4ef-a252-4e2c-893e-a583f8c23913">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsiderationOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtNC0xLTEtNTM5MDY_5a874f81-c78e-4f98-9337-d61b81a7d766">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsiderationOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtNi0xLTEtNTM5MDY_16e1e8d0-0ed5-455e-bcd5-74d20b6c5807">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsiderationOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtOC0xLTEtNTM5MDY_b1928fdc-4f25-41c2-b668-0692bd5bb9c6">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, restructuring and other items, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtMi0xLTEtNTM5MDY_c40ded54-0dec-4f16-9112-9a51f0a7b47e">3,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtNC0xLTEtNTM5MDY_379f9ad9-9ab8-47a1-bd86-d7bab0c3dfac">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtNi0xLTEtNTM5MDY_e2edbcfa-eb82-4c09-83e9-6378abaa5ac7">8,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtOC0xLTEtNTM5MDY_41fb4f56-0890-493d-b55e-3ce002429098">4,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItMi0xLTEtNTM5MDY_32ad411f-00ca-4ad5-8490-9e1b7a65d79a">53,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItNC0xLTEtNTM5MDY_10a26a3c-e2af-4df7-aec0-28da10738bd5">49,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItNi0xLTEtNTM5MDY_2ae915fc-d876-4076-ad0c-8a1d27ab8e1e">108,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItOC0xLTEtNTM5MDY_76e30ee8-46d5-4dd6-b11e-f3efbc84be5f">97,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtMi0xLTEtNTM5MDY_963239ea-a880-468b-99fc-a99d6e6a08b4">8,115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtNC0xLTEtNTM5MDY_04497419-7659-4817-a3ad-a5394e656b7e">8,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtNi0xLTEtNTM5MDY_b94899f4-ced3-4185-a3cd-3f230cfacec8">21,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtOC0xLTEtNTM5MDY_d357b137-8f4f-417c-b738-0466809e4e19">16,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtMi0xLTEtNTM5MDY_f81cff14-f6ce-4b4d-b92c-c39a84d67ba8">684</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtNC0xLTEtNTM5MDY_af6f3414-2549-42f0-b4c8-45349c7e04b5">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtNi0xLTEtNTM5MDY_5e30383b-6a54-41f7-8756-33d486e2f03f">1,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtOC0xLTEtNTM5MDY_73575cfd-d8ec-4abf-815f-c37cc0337df2">330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtMi0xLTEtNTM5MDY_b8a2e51e-f8f1-4981-b17e-4d4019e8c487">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtNC0xLTEtNTM5MDY_e514c2f5-1cc9-447c-b3a0-b7f5de3c90cc">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtNi0xLTEtNTM5MDY_1c744637-c55b-403e-8c38-dbfc7ad447c0">427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtOC0xLTEtNTM5MDY_9a52c4fc-d65b-4d01-821d-79625e058fa5">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctMi0xLTEtNTM5MDY_4f61ccaf-638d-4b99-b139-41d533d35079">936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctNC0xLTEtNTM5MDY_c807e39e-65f1-4df3-b3c4-d2cc384da59e">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctNi0xLTEtNTM5MDY_36f689ef-e172-4768-8cf5-7e51cd32f8e7">1,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctOC0xLTEtNTM5MDY_d1027d8e-69e3-4999-a36a-ce893a2204c5">692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtMi0xLTEtNTM5MDY_dbe17c10-22d7-4f10-84cf-afe8536795a7">9,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtNC0xLTEtNTM5MDY_fabed2f7-5662-43db-8a58-d02f2ed4e8b0">8,863</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtNi0xLTEtNTM5MDY_b0c911e8-1b20-4a36-aa45-4ab9bff3ae3f">22,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtOC0xLTEtNTM5MDY_84a4b4b9-3d89-4b02-9db2-1684d274755d">17,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktMi0xLTEtNTM5MDY_4a1e206b-842a-419c-91ce-7eec5ba2429b">565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktNC0xLTEtNTM5MDY_200d1cbf-f6e5-4adc-bfb5-a5d68fdab587">512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktNi0xLTEtNTM5MDY_5d13416b-223e-411d-b911-90c71665a47c">1,418</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktOC0xLTEtNTM5MDY_ba8c3e68-0730-48e9-811f-a353f12a7da9">2,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58c4e8650d24eb487e88de28117da2a_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtMi0xLTEtNTM5MDY_bb4c2bd7-7b57-408a-b00b-9dfcc27517e3">8,486</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtNC0xLTEtNTM5MDY_a0109334-db1f-4a3a-b147-618cad0bf83f">8,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtNi0xLTEtNTM5MDY_db0cc0bc-305f-45c9-af03-671e7d3273b4">21,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtOC0xLTEtNTM5MDY_b1916cfb-e2c1-4dca-bda0-780cb42b2fa0">15,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtMi0xLTEtNTM5MDY_7d6611f3-3e7f-4884-9391-d8d16fd3080b">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtNC0xLTEtNTM5MDY_73389934-e843-4dc0-a480-7558e17ff531">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtNi0xLTEtNTM5MDY_c762e8f7-1e02-46a1-a83e-2de0bc43bb03">0.55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtOC0xLTEtNTM5MDY_3a230e47-7389-48c4-b26b-d1ed143a9295">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtMi0xLTEtNTM5MDY_6320648c-deaf-40d2-aa5d-96a6ece4d117">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtNC0xLTEtNTM5MDY_3e4d4a84-2f57-4f61-9854-3d1154d24bce">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtNi0xLTEtNTM5MDY_707a7d24-2340-40e5-8532-159a647d6732">0.55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtOC0xLTEtNTM5MDY_ee6ae28d-2d4f-489e-a233-2a2d90d942be">0.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtMi0xLTEtNTM5MDY_ca1c7a5a-fd5d-473c-9e81-7211891f1eee">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtNC0xLTEtNTM5MDY_5e9c3d3c-b349-4aa8-abba-8cd2cee29bd4">39,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtNi0xLTEtNTM5MDY_06d81fe5-c2da-4e64-9253-f5bc1e135d0b">39,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtOC0xLTEtNTM5MDY_c52ffd01-390b-4df4-bb10-22e23bc48194">38,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtMi0xLTEtNTM5MDY_bb4e8c79-a9cd-4837-b149-4d08bfd56373">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtNC0xLTEtNTM5MDY_811628e4-352f-474c-93bf-ecd266e39220">39,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtNi0xLTEtNTM5MDY_a2a81865-3206-4123-b3a4-958c0fe35f75">39,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtOC0xLTEtNTM5MDY_8f9614f4-9f11-48db-be8b-060fbd3c0373">38,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of dollars)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three&#160;Months&#160;Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi0yLTEtMS01MzkwNg_fd9282e8-88c1-4358-8949-5b77fd72e3e3">8,486</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi00LTEtMS01MzkwNg_dd74716b-a576-483f-b754-ac52b0ca7968">8,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi02LTEtMS01MzkwNg_73392432-b88b-419b-b436-6a52e581635d">21,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi04LTEtMS01MzkwNg_5fbd26f9-e3a7-4308-aa5e-6c0293c46ea4">15,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS0yLTEtMS01MzkwNg_6e75fe10-46f1-4173-95fa-7e4c8e3165d2">1,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS00LTEtMS01MzkwNg_84131fb2-2a7e-4eee-9452-6755ab8b4a41">819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS02LTEtMS01MzkwNg_f112e4c7-096f-4ba6-b37b-fa3249ff8986">1,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS04LTEtMS01MzkwNg_5c7420bf-aad2-4d1b-9914-2f05b8717cd2">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi0yLTEtMS01MzkwNg_ccc04caf-c555-4519-ab72-21548f0143b0">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi00LTEtMS01MzkwNg_58d8d8fc-238d-4044-99b7-68533b73f82a">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi02LTEtMS01MzkwNg_0d52001e-009b-43b6-bb44-0c3af88b7d25">1,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi04LTEtMS01MzkwNg_56ec17c5-e423-4165-92c1-76b8bccb5d97">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense related to items of other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy0yLTEtMS01MzkwNg_69f2018d-bdbe-4c88-8108-259840843042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy00LTEtMS01MzkwNg_7484b918-74e6-46f7-9e08-5a621438d180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy02LTEtMS01MzkwNg_1236796d-eb9f-41af-b343-0433331f7c34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy04LTEtMS01MzkwNg_478ca0c2-a99e-450e-95ba-42ef055c5b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC0yLTEtMS01MzkwNg_f4c6c180-a6af-449f-994b-a4853e8f6c81">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC00LTEtMS01MzkwNg_a926a994-bee3-4768-b58c-83b1767d2b61">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC02LTEtMS01MzkwNg_3f4f1023-ed80-48af-8e47-d8b9563a970a">1,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC04LTEtMS01MzkwNg_0a6b28b8-da6c-4a71-bc10-b67175d9c620">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS0yLTEtMS01MzkwNg_1fa197a7-ff5f-4ae0-bf6b-421676cf38d8">9,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS00LTEtMS01MzkwNg_44a19771-6d6d-45fa-bb7d-a75cc5f5885f">7,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS02LTEtMS01MzkwNg_e304289f-49a0-4212-84ed-4450438f3606">23,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS04LTEtMS01MzkwNg_146eeb95-4dbc-47b2-b585-40351e74e0a0">13,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_22"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of dollars, except share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMy0xLTEtMS01MzkwNg_b4ebe1d1-ecd1-4549-9548-6301d7df8076">29,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMy0zLTEtMS01MzkwNg_7aa4e167-89e2-49d0-9656-cdf98b8d67bb">28,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0wLTEtMS01MzkwNi90ZXh0cmVnaW9uOjQ0YTEwYjE0OWVlNTRmZGRhODZkYTlkMzcyZjJlNjA0XzQ2_19871434-4b8c-4a74-bd4a-ced2897e8b7e">2,110</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0wLTEtMS01MzkwNi90ZXh0cmVnaW9uOjQ0YTEwYjE0OWVlNTRmZGRhODZkYTlkMzcyZjJlNjA0XzUz_73128291-b962-4f93-b149-23c997f22b88">1,939</ix:nonFraction> respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0xLTEtMS01MzkwNg_f6f1ea24-376f-49a1-83c6-02e49515741e">52,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0zLTEtMS01MzkwNg_9aa9d18f-7f4a-4b29-8775-1aa704159064">52,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNi0xLTEtMS01MzkwNg_f858bdd1-5fc2-42f1-b9dc-20dbc53d0bc4">63,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNi0zLTEtMS01MzkwNg_6b52b462-b15f-46f9-99f1-af2e8b2164c3">51,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfOS0xLTEtMS01MzkwNg_7b3a045f-ec37-4a7c-ba13-391ec5158593">12,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfOS0zLTEtMS01MzkwNg_b940a930-2895-4a9d-9197-a9896f910fff">10,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTAtMS0xLTEtNTM5MDY_6041be9f-ce7c-435e-ac9d-76255723954e">158,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTAtMy0xLTEtNTM5MDY_0b26d473-a6a6-4824-b692-0efc12cf50a4">143,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTEtMS0xLTEtNTM5MDY_6e51ba80-9e32-4522-98fc-ac99ffc18ce7">45,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTEtMy0xLTEtNTM5MDY_e2717c30-7083-4916-ac63-108d5eaf4291">45,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTItMS0xLTEtNTM5MDY_d84401f2-1a22-4f99-8ad2-72055870f231">141,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTItMy0xLTEtNTM5MDY_b9ff41c3-2773-4539-815d-8baaaed1f2a8">152,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTMtMS0xLTEtNTM5MDY_3f1a03e4-ec00-4eca-bd1c-a7de104a5bd0">200,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTMtMy0xLTEtNTM5MDY_d2b39859-f223-46b2-9366-e1e967181c9d">201,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTQtMS0xLTEtNTM5MDY_842ebb5f-9554-4052-8714-03bb00fba4d5">10,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTQtMy0xLTEtNTM5MDY_c18895b6-e7e6-4923-b1f4-139dfa7d2150">10,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTYtMS0xLTEtNTM5MDY_c7a0922b-f2a6-4266-9a8b-f50b5a346ca3">558,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTYtMy0xLTEtNTM5MDY_2c77c90b-612b-4e1b-9e79-8650170edf36">552,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTktMS0xLTEtNTM5MDY_011d1fb5-5860-49cc-b804-fd849b125d34">34,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTktMy0xLTEtNTM5MDY_8dfe37ae-f03e-4ac8-ac34-2fa0797cb94a">28,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjAtMS0xLTEtNTM5MDY_74efb189-2c46-4882-86a3-ff84fce1ffe6">26,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjAtMy0xLTEtNTM5MDY_654ce83b-2155-4490-9464-76c776d4f0bf">34,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjMtMS0xLTEtNTM5MDY_eec3e595-cc8e-4f0c-a6ab-f856591f5db6">9,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjMtMy0xLTEtNTM5MDY_0bca1875-073f-4a15-8695-fc6a32dfcefe">8,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjQtMS0xLTEtNTM5MDY_594aef96-2f7b-430c-ae47-b3f78097f979">2,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjQtMy0xLTEtNTM5MDY_b83e0a1e-5a14-4697-8681-7866239c08ba">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjUtMS0xLTEtNTM5MDY_7b1aa0a3-24aa-48ea-a906-d4a0236113c8">73,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjUtMy0xLTEtNTM5MDY_7c273930-8d49-4da2-95b8-ad0fd2ddd8c8">74,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LongTermLoansPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjYtMS0xLTEtNTM5MDY_3d76ff87-d47f-4281-bc7e-5629ea081104">49,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:LongTermLoansPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjYtMy0xLTEtNTM5MDY_fd627d7d-9574-435b-a87c-040fc3dc5781">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjctMS0xLTEtNTM5MDY_cdf308f0-cdb7-4338-9a22-bd4f1a0728df">14,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjctMy0xLTEtNTM5MDY_9bd81101-8f6f-4fcb-a637-0f4141fc9a40">16,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjgtMS0xLTEtNTM5MDY_2c45ef13-b3d0-4ec3-a5c2-19c95b198954">9,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjgtMy0xLTEtNTM5MDY_9aedc4bd-3676-48b3-9393-40f595f2b8a4">8,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjktMS0xLTEtNTM5MDY_6efdbb4a-3744-4aea-8d97-0a3ef8e2e4a1">3,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjktMy0xLTEtNTM5MDY_832801ef-bc08-4a15-b73d-6e22893fff96">4,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzAtMS0xLTEtNTM5MDY_1b2eebee-b70b-495f-9a6e-94b8d72b588d">150,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzAtMy0xLTEtNTM5MDY_ca4c2b7a-7804-424c-8a87-45f76952f829">128,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 14)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzEtMS0xLTEtNTM5MDY_1bb9800e-0455-42b7-b25b-212958f530a4"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzEtMy0xLTEtNTM5MDY_e1dc0785-3657-455b-8fc0-e944b3d7ed5f"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl8zMg_053d1353-59d0-4964-85a9-1683e40ad9f0"><ix:nonFraction unitRef="usdPerShare" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl8zMg_5c948fc7-a292-4116-9504-39074dcb3638">0.01</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl80Ng_3902bffa-84b1-46a7-8d8b-7b951e6ce80f"><ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl80Ng_74f2dc7b-151b-4688-a0a9-5e1be71dee99">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_06def87c-6c48-44bb-8217-276c39a05484"><ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_0a544cb0-37d3-416d-ace5-ac28ef8b1ef9"><ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_14c2046d-45f3-4b18-84f1-e646a454601e"><ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_ae141732-a1be-45e4-bc3b-a6f32f67de28">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMS0xLTEtNTM5MDY_b1693f3b-fef4-4bf8-8da4-6ea3b45f2839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMy0xLTEtNTM5MDY_f90bb372-7275-4cac-aa19-4e6dfb1b63ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl8yOQ_492d283e-42c5-4fce-b30d-f805c38ec007"><ix:nonFraction unitRef="usdPerShare" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl8yOQ_e422992f-4496-4e32-8a4e-5db717715383">0.01</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl80Mw_2dc1857b-1854-4997-94d2-50922351cf9a"><ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl80Mw_a4f8950e-42f3-469c-a1cd-17705baf66d3">75,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl82NQ_a7a2e758-fd3c-4a26-9bde-8f58dfc23fd8">39,874,144</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl83Mg_b3a99c19-4962-4f82-b9b2-8668ceab8303">39,541,173</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl85Mw_1aa59863-a8b8-4293-b7db-10d6ea2ee16f">39,504,144</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl8xMDA_4114c132-9edf-46b6-ac52-61ba2e4b045b">39,171,173</ix:nonFraction> shares outstanding at November&#160;30, 2022 and May 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMS0xLTEtNTM5MDY_2dcc1cae-8497-4223-8d22-2bab707e0774">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMy0xLTEtNTM5MDY_25408268-f44e-4b5d-a886-c0f3dc570f66">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzUtMS0xLTEtNTM5MDY_366f1f92-7f6f-465f-a563-73da00fa0e96">593,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzUtMy0xLTEtNTM5MDY_d5be9788-6b98-4857-8a50-892f32738ffe">586,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzYtMS0xLTEtNTM5MDY_cd1b899e-6d55-4d55-ac17-fa6af00bff11">179,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzYtMy0xLTEtNTM5MDY_93d5e1f6-3299-4759-9509-d8406ff9d840">158,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, <ix:nonFraction unitRef="shares" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjphOGJhODdkYTIwMzY0Mjk3OTc5ODExNmE1NDg0ZmRhOV8yMA_0baf64f2-4197-4017-b906-da05263352df"><ix:nonFraction unitRef="shares" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjphOGJhODdkYTIwMzY0Mjk3OTc5ODExNmE1NDg0ZmRhOV8yMA_de4afea2-f5d4-4ac3-a1f9-2cc3217ce167">370,000</ix:nonFraction></ix:nonFraction> shares at November&#160;30, 2022 and May 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMS0xLTEtNTM5MDY_6f2716d1-76f8-4427-a062-16742edbb842">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMy0xLTEtNTM5MDY_fa832bea-9ed4-41a6-b3b2-0dd0ff303b64">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzgtMS0xLTEtNTM5MDY_da972606-a8c0-4736-8431-18b154af90b4">288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzgtMy0xLTEtNTM5MDY_fbf008c8-cf8a-43a5-98e7-f59031383239">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzktMS0xLTEtNTM5MDY_c7279d03-ee03-45ca-95d5-ae307bf2fd87">407,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzktMy0xLTEtNTM5MDY_afce0b94-0937-4d28-b1f4-258bd1a81ace">424,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Stockholders' Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNDAtMS0xLTEtNTM5MDY_f33cb188-974a-42d4-b176-b743e9969a43">558,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNDAtMy0xLTEtNTM5MDY_ad39ec15-e319-427a-a5a9-0424cb1073dc">552,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_25"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of dollars)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMy0xLTEtMS01MzkwNg_3e8c0de3-d4bc-42d2-b017-ff711a5a9ac2">21,490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMy0zLTEtMS01MzkwNg_435e1458-aad8-4e0b-9c00-267c9d7c0ff0">15,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNS0xLTEtMS01MzkwNg_fb203048-b6c1-4308-881a-2fc3db4e9fe2">15,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNS0zLTEtMS01MzkwNg_3558e592-d7cd-4ba7-9d6e-41eb67e44d3b">14,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:NonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNi0xLTEtMS01MzkwNg_e93e5b78-5e1c-4c86-8721-ca3212962a25">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="ango:NonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNi0zLTEtMS01MzkwNg_8f7d9545-c348-4cfb-a6b6-a1958ef83837">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNy0xLTEtMS01MzkwNg_b50a4180-4fdc-46a4-8c5d-c39ebc72520d">6,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNy0zLTEtMS01MzkwNg_936e13b6-9464-403d-96b4-3481114cec7c">5,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsiderationOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfOC0xLTEtMS01MzkwNg_8b71b52b-e0f2-4e19-8372-d9698c09092e">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsiderationOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfOC0zLTEtMS01MzkwNg_2859a0c2-713b-4d5c-b719-beb5377ee5a1">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTEtMS0xLTEtNTM5MDY_dfc088d4-06b5-466c-8340-fe8c372dce51">1,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTEtMy0xLTEtNTM5MDY_f2bf3548-ed33-4d17-b264-1cfde5dd261c">2,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accounts receivable allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTItMS0xLTEtNTM5MDY_46826e44-7c0f-425f-8f2c-30d100f762de">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTItMy0xLTEtNTM5MDY_9923afb7-bca7-4b8d-90cd-7ad48694cc2c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed and intangible asset impairments and disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTMtMS0xLTEtNTM5MDY_4074fc85-dba4-470c-a08c-ccddfa392d51">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTMtMy0xLTEtNTM5MDY_df392295-98f3-4aa5-bde2-990594575b7e">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTYtMS0xLTEtNTM5MDY_b283739f-fa44-47d3-858c-73cecb596a6a">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTYtMy0xLTEtNTM5MDY_1faa2ef6-68d4-4d09-b2fc-ea7159f1cdd2">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTgtMS0xLTEtNTM5MDY_3c723ef2-5dc7-4f13-88d8-66f15656fe5a">1,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTgtMy0xLTEtNTM5MDY_73e109db-340a-4749-9ddb-2ba145f03fca">2,922</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTktMS0xLTEtNTM5MDY_b4250841-a938-4c2d-9013-ff5cbf8c34cf">11,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTktMy0xLTEtNTM5MDY_0e85bef5-b6a8-46fa-a40a-e60d35940ae8">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjAtMS0xLTEtNTM5MDY_6c91b030-1a6b-4220-95f9-154340f756c3">3,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjAtMy0xLTEtNTM5MDY_c7a224a0-5b81-4852-9f9e-d8442ec327aa">4,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjEtMS0xLTEtNTM5MDY_441be31f-c58a-459c-89c2-03604f9e4858">2,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjEtMy0xLTEtNTM5MDY_cab67503-72d0-4023-a661-a26383e61f8e">4,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjItMS0xLTEtNTM5MDY_f6402a4c-7e3b-4ccd-a050-77d4302b0fbd">17,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjItMy0xLTEtNTM5MDY_3c92a917-3647-4281-af5a-cd67e5027afa">6,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjQtMS0xLTEtNTM5MDY_6c2c9a7c-eb82-42e2-95ed-d5c203458de5">2,090</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjQtMy0xLTEtNTM5MDY_73ab1c86-0aa0-4e3d-9900-0c90fd0bc2d8">2,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to placement and evaluation units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:PaymentsToAcquireEquipmentOnLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjYtMS0xLTEtNTM5MDY_553780f0-097f-4b26-944f-8ba2e3c6293b">3,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:PaymentsToAcquireEquipmentOnLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjYtMy0xLTEtNTM5MDY_b73a976b-7996-46f1-b06f-0c82618467f4">7,189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjctMS0xLTEtNTM5MDY_35d66c48-64a9-4abf-be59-5def1ed542b6">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjctMy0xLTEtNTM5MDY_bde00d50-8d85-4889-892e-7930ba7b8f3a">3,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzAtMS0xLTEtNTM5MDY_1979a616-8029-410c-ac2e-1eeebba7c07e">6,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzAtMy0xLTEtNTM5MDY_ba31066a-9939-4346-ba2a-6379b5617ba5">12,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from borrowings on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzItMS0xLTEtNTM5MDY_9a25f111-0734-4bfb-992c-5ee8186f370a">70,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzItMy0xLTEtNTM5MDY_b5b97af0-7b16-407c-8852-0949840591dc">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzMtMS0xLTEtNTM5MDY_a286d276-65a5-4c5c-a33d-310317b80715">45,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzMtMy0xLTEtNTM5MDY_b469b275-3230-4c1e-bbeb-2845645683a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzQtMS0xLTEtNTM5MDY_42ca7e96-549a-4508-b651-67b295a28aa8">751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzQtMy0xLTEtNTM5MDY_2210669c-bb12-47c6-b38a-0ec82c883db4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzctMS0xLTEtNTM5MDY_9895ed78-7eb2-426d-9760-a40edf9215f1">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="ango:ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzctMy0xLTEtNTM5MDY_df16d995-d9c0-49ca-8911-c07c8bf4093d">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzgtMS0xLTEtNTM5MDY_bb79969c-0855-4df4-95d1-ff1ee9a59e2d">24,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzgtMy0xLTEtNTM5MDY_5afdd73e-1f6b-4dc9-ad68-849129cebf9c">6,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzktMS0xLTEtNTM5MDY_7aa40871-d728-43f5-8460-10a03dd92aa1">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzktMy0xLTEtNTM5MDY_bbff0b14-1543-4b23-8f6c-c3a894feb4c1">354</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)  in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDAtMS0xLTEtNTM5MDY_13db8054-ab17-473e-9651-19518a0032a7">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDAtMy0xLTEtNTM5MDY_f2d73151-ef96-455e-9022-a15a2d10ad82">13,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDEtMS0xLTEtNTM5MDY_7d9372e1-3532-4258-937f-4bef4d63038e">28,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ae2f2a17c5c4c0ab0620f6245443650_I20210531" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDEtMy0xLTEtNTM5MDY_9ae2182a-a0bb-45ae-a7ca-392d4dae2043">48,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDItMS0xLTEtNTM5MDY_a7d2e5c8-a19f-4351-870b-341206dcc5d3">29,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i580a989d6bd346dea798e59360b2cf7b_I20211130" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDItMy0xLTEtNTM5MDY_4772a3d2-cd75-465d-9200-0e6fce6feea2">34,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual for capital expenditures incurred during the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDYtMS0xLTEtNTM5MDY_e370413e-33f0-4722-8f92-2a6c58a2ffde">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDYtMy0xLTEtNTM5MDY_6a864849-03a2-4753-9075-fae3b816083c">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of dollars, except share data)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>paid in<br/>capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at May 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92253b30ce7448a9b04589161b7aef74_I20220531" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xLTEtMS01MzkwNg_bdd59844-51d4-45c6-891f-097b293d8166">39,541,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92253b30ce7448a9b04589161b7aef74_I20220531" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0zLTEtMS01MzkwNg_3d3d0c46-252a-4124-8ecb-ae686e0984a7">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0521e2ea5e8f4642ba511b1cf2257912_I20220531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi01LTEtMS01MzkwNg_bf9e4cae-2c21-46a2-8d79-e097bcdb1778">586,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9c3663238b141639922a3c2b6127596_I20220531" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi03LTEtMS01MzkwNg_b1241af7-2d49-4d39-9371-2540b9955817">158,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3170daaa632a47c2864c3b1cfbeabc53_I20220531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi05LTEtMS01MzkwNg_776a405b-45bb-4acb-989f-f48c5875084e">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia78ac75b2327440aabe9a07d95648ed1_I20220531" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xMS0xLTEtNTM5MDY_0adda0c6-b5de-4e9a-afeb-6efe99316276">370,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia78ac75b2327440aabe9a07d95648ed1_I20220531" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xMy0xLTEtNTM5MDY_dc052105-17b9-4aef-b8fe-15b325f14a8e">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xNS0xLTEtNTM5MDY_6faa018c-fd90-4090-b5de-3dfbb4581145">424,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d26b3b0e13245a9a8b3f331e8f3f094_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMy03LTEtMS01MzkwNg_f28d5535-bb24-4458-b11c-8fae4b0c04b7">13,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMy0xNS0xLTEtNTM5MDY_c1d42dae-8c08-4a13-9f42-3dc5e325be8c">13,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNC0xLTEtMS01MzkwNg_b99c376b-a6c8-429f-8047-ebb5967b00c5">6,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNC01LTEtMS01MzkwNg_28cfedb6-3ef0-4878-858f-eb9c6bf605f1">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNC0xNS0xLTEtNTM5MDY_e0e5ba9e-d383-4da2-bf19-fd591abd9393">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/Cancellation of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e978a8d0cbb4723afaecf79157faa08_D20220301-20220531" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNS0xLTEtMS01MzkwNg_e9114ce7-6372-45a3-ab2f-6d5ce39692e4">213,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9339830d2a2e4fda87b3402b5dc095cb_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNS01LTEtMS01MzkwNg_ebdbddc7-887b-4b39-b6f1-cb17ef3a241c">648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11e97ca8dbd54428b944767243cf21fd_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNS0xNS0xLTEtNTM5MDY_fadc6241-e39c-44c5-9465-eb7a8e6cc35b">648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/Cancellation of performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5014bebe766c497ca5a518a9144f9fee_D20220301-20220531" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNi0xLTEtMS01MzkwNg_4a8fae02-c2b1-43ae-a426-21d08d74c023">29,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdc6ea670265410a9abcd9fe2ce25d89_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNi01LTEtMS01OTQ3Nw_91e956b9-c10c-4444-9adf-e64d82aaa4db">312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0679db975f1e442f95e34936148e0ca3_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNi0xNS0xLTEtNTk1MDQ_160586ed-c93f-4e10-829a-a1d7e58e07b4">312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of common stock under ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy0xLTEtMS01MzkwNg_7842756c-13a2-423e-86ec-1c09ba2d2982">56,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy0zLTEtMS01MzkwNg_e368d74d-039a-4499-88be-f41568f9733a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy01LTEtMS01MzkwNg_8fddfbce-e90f-48c9-9875-47b5afe49b04">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy0xNS0xLTEtNTM5MDY_3c626883-93b1-44bf-8510-8831ae250226">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfOC01LTEtMS01MzkwNg_18126138-fdb8-4a47-898c-459c10982076">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfOC0xNS0xLTEtNTM5MDY_6484319b-308d-4731-86ba-c3deabaccc6c">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89a2219dda3a46beaaeefb85ffdbc421_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTEtOS0xLTEtNTM5MDY_abe421cd-c712-4e67-9430-ff47ade4e30d">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTEtMTUtMS0xLTUzOTA2_1fcae9f6-8317-4f0d-ad96-055265dfa5f6">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at August 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4eba7ef0b2324baba133dce806849e01_I20220831" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMS0xLTEtNTM5MDY_1101a58b-1e13-431c-b6db-d61fc331913a">39,847,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eba7ef0b2324baba133dce806849e01_I20220831" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMy0xLTEtNTM5MDY_dec5de86-7e35-48f8-b395-7f018ad13a25">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i358df3908685483ba68ef5ce671cb276_I20220831" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItNS0xLTEtNTM5MDY_3dc1cd88-d9ec-4e53-82a9-33160179d761">589,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0773232166fe4bdfa46507e1fa96456b_I20220831" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItNy0xLTEtNTM5MDY_73fc8ea4-f587-4b0b-8ecd-5dbfb560721a">171,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a1dadd2d8248f4a335ef455a4782f3_I20220831" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItOS0xLTEtNTM5MDY_7322e98f-e7b2-4b93-8dc7-aa5daa2d1742">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5e61a52d34bf4a7fa61bbf80ff3eef08_I20220831" decimals="INF" sign="-" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMTEtMS0xLTUzOTA2_895e9a74-f749-42cb-a19c-302c84015ad0">370,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e61a52d34bf4a7fa61bbf80ff3eef08_I20220831" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMTMtMS0xLTUzOTA2_5eef293d-2fb0-4d59-a8fe-d2dcf610a698">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605f35cad602428b8143074fa8c31ba8_I20220831" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMTUtMS0xLTUzOTA2_04aa8c69-b2b6-4e80-9792-6c0dcd4c112a">414,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58c4e8650d24eb487e88de28117da2a_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjMtNy0xLTEtNTM5MDY_bb4c2bd7-7b57-408a-b00b-9dfcc27517e3">8,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjMtMTUtMS0xLTUzOTA2_94535150-0623-458d-b6bb-2ffa9b5b9736">8,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i761e3ac346f34f59b5db2c93ec5cd804_D20220901-20221130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjQtMS0xLTEtNTM5MDY_c2b6ee91-cc86-4a0a-adc1-89f9259f50d3">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c8c3dc240b49d1aa14a8e2c554f67d_D20220901-20221130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjQtNS0xLTEtNTM5MDY_b24c1132-5700-44cd-a7b3-ef6eabc99ecf">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjQtMTUtMS0xLTUzOTA2_9933092e-14ad-4e53-805e-b1fa59a5a2a8">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/Cancellation of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0436957f2064843bb33c8674690b54b_D20220901-20221130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjUtMS0xLTEtNTM5MDY_96a12ff9-c37f-4880-b749-651b1cff6735">11,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6493fdf5e73404cb9c65ebd100d37ef_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjUtNS0xLTEtNTM5MDY_378aa9a7-b9c8-4adb-9d7d-05cfd7ab87dd">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b34f1c2e1346eb854653a87b2ad11f_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjUtMTUtMS0xLTUzOTA2_22141868-ca61-4c86-91cd-7f8bd29d4ff7">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c8c3dc240b49d1aa14a8e2c554f67d_D20220901-20221130" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjgtNS0xLTEtNTM5MDY_382fe771-fb87-41df-9a10-95c4746ddf54">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjgtMTUtMS0xLTUzOTA2_fbd74a68-4de6-4d8d-94f4-d04ab83c7f26">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46d7e5ff2d9d47c2aca189c481fd4cb8_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzEtOS0xLTEtNTM5MDY_051a7a89-865d-49e9-be48-7fe051061f4e">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzEtMTUtMS0xLTUzOTA2_6066a235-22d0-48f0-9bbc-0d2e1eb763b5">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at November 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39078c2a8d3949c8b51612819ff52be6_I20221130" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMS0xLTEtNTM5MDY_5bec5821-bc53-4aed-a3ca-907a371a181f">39,874,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39078c2a8d3949c8b51612819ff52be6_I20221130" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMy0xLTEtNTM5MDY_d4a8325b-32b1-4ef9-add6-dc5d181622bd">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia231c271d6e74f54b40bb9f2c13d5442_I20221130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItNS0xLTEtNTM5MDY_e1b0ea28-7cc8-45fe-be14-181c7d349d38">593,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a4bd82406cc4389bd0da8087da40e52_I20221130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItNy0xLTEtNTM5MDY_fc9fcc68-403b-48da-a0ce-d6dc8aa08272">179,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7310c5f116f7458bbf77606953070240_I20221130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItOS0xLTEtNTM5MDY_b7c52293-7d95-48b1-b52e-8ab1027884db">288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5209e80cbf59403ba5b0127b54301190_I20221130" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMTEtMS0xLTUzOTA2_4ce3c009-aca3-40c6-9281-8c99c412a028">370,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5209e80cbf59403ba5b0127b54301190_I20221130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMTMtMS0xLTUzOTA2_feb5d5a5-a371-445a-b585-069ac0dbba5b">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMTUtMS0xLTUzOTA2_07e7272c-4b57-476c-bdd9-84c14764cc03">407,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>paid in<br/>capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at May 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71a5faedb2934ca3b6d2036bad066025_I20210531" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xLTEtMS01MzkwNg_22861526-4d3e-4898-a93a-3207c813ee9f">38,920,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a5faedb2934ca3b6d2036bad066025_I20210531" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0zLTEtMS01MzkwNg_337be325-7dfb-4fa0-98e4-ed069409f8a1">377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96b6c43657d45239e312ea746267dc0_I20210531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi01LTEtMS01MzkwNg_97a4763e-818e-4635-bd44-7833aefa6749">573,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80aa6442429842f5a354cbfbb8726ca1_I20210531" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi03LTEtMS01MzkwNg_676e6885-1b91-4885-86a8-65e6398b0739">131,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5703543d8ed4406290fe2b3d2ebe132b_I20210531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi05LTEtMS01MzkwNg_dd2a8352-cf41-47f5-a183-189fa8b94ec8">3,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i06eb3f7549e544fa998b0ee023503249_I20210531" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xMS0xLTEtNTM5MDY_9ac294d5-58a0-4c86-af51-5707ed894d16">370,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06eb3f7549e544fa998b0ee023503249_I20210531" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xMy0xLTEtNTM5MDY_cb4c401a-babf-4911-bbb3-5bdaa58e7fab">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ae2f2a17c5c4c0ab0620f6245443650_I20210531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xNS0xLTEtNTM5MDY_ab7b2962-f1fc-4fc8-83cd-97a17e91fab6">439,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ce7f40f7e1c4f288eaa7bdae504643a_D20210601-20210831" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMy03LTEtMS01MzkwNg_0cf4dc11-deb3-4df0-bf58-849f403a898a">6,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMy0xNS0xLTEtNTM5MDY_26476b64-0c52-4cde-a0ef-83122646ae23">6,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC0xLTEtMS01MzkwNg_cfaa4483-8814-4b66-a2d2-78162abf6409">80,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC0zLTEtMS01MzkwNg_6bf7691a-0814-478c-8f65-c51ed46fa356">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a2abe0d92149128c8af04916896413_D20210601-20210831" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC01LTEtMS01MzkwNg_26250505-a379-4c78-9dae-904188b65b59">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC0xNS0xLTEtNTM5MDY_09850380-f937-4834-bd22-002c3775ec73">1,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/Cancellation of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92d7755649c74466927d4c2e158305aa_D20210601-20210831" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNS0xLTEtMS01MzkwNg_202080c0-bd4e-4cd4-aedd-e7f63c7e8f45">279,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33519024438c43d7a67b370d508001cc_D20210601-20210831" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNS01LTEtMS01MzkwNg_8e703106-9854-48e2-9906-ac5132987c49">1,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fe451085baf4ea09c68e462c55b946d_D20210601-20210831" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNS0xNS0xLTEtNTM5MDY_3cbcb3ed-f194-4935-8f1b-bd58f3d15a23">1,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/Cancellation of performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6eaf8bf186364608810a8c124dd74a94_D20210601-20210831" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNi0xLTEtMS01MzkwNg_89f6ad25-3893-4680-9939-40145e7a36fc">59,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of common stock under ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy0xLTEtMS01MzkwNg_8772615c-c737-40d5-bb5e-145205a34064">49,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy0zLTEtMS01MzkwNg_256565e8-044f-4b04-91c5-18b3d9f20ff2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a2abe0d92149128c8af04916896413_D20210601-20210831" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy01LTEtMS01MzkwNg_751ac514-6a24-45fd-9a84-9a6c480198aa">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy0xNS0xLTEtNTM5MDY_07a8a0c5-3b2e-4e6d-9796-5057bc2f9fed">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a2abe0d92149128c8af04916896413_D20210601-20210831" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfOC01LTEtMS01MzkwNg_24677ee3-106f-4ac7-a079-dfb3c1fa20ef">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfOC0xNS0xLTEtNTM5MDY_19fcfa80-1331-4dc2-a61f-34f257298b08">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3190940009fb48f29de007d763ca8a27_D20210601-20210831" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTEtOS0xLTEtNTM5MDY_57ffdad4-705a-4eef-967d-999caba584df">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTEtMTUtMS0xLTUzOTA2_fe883335-867e-4d1e-8cd3-4fb06af7ab17">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at August 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24b58b5cab854792a4cd67d56850fb81_I20210831" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMS0xLTEtNTM5MDY_0a0fd9a9-7608-448e-a5df-646a6e7cacb1">39,390,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b58b5cab854792a4cd67d56850fb81_I20210831" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMy0xLTEtNTM5MDY_dc12fb51-3391-4426-bc1f-e53345e69c1e">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08aee044abc04167ab7b46d2b3434e1f_I20210831" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItNS0xLTEtNTM5MDY_c2bdc072-e23c-4c50-af82-c1beac614c57">576,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4134390d562f48ff9f977c2e6b84a29f_I20210831" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItNy0xLTEtNTM5MDY_85b66748-0c9a-4936-9036-c9490f0c38ee">138,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if20cde87f3f1438582de0a6be9bfb0f0_I20210831" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItOS0xLTEtNTM5MDY_3da03c0b-9f27-48b1-940f-f68dca15ac17">3,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31a8b6318460497bae9c739e5328a31b_I20210831" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMTEtMS0xLTUzOTA2_0d47ea93-c786-4995-bd74-2f3de650aa16">370,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31a8b6318460497bae9c739e5328a31b_I20210831" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMTMtMS0xLTUzOTA2_e53fc1c2-3db3-493b-8dad-46add3fc9ba3">5,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46394e9b402e418b9d3d6c693d0247ce_I20210831" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMTUtMS0xLTUzOTA2_1b03c718-339d-43e9-a63b-0f9191dc0f1a">435,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4675e13c50964ba0a48938de3e2ae4a4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTMtNy0xLTEtNTM5MDY_64979225-dfd9-487a-b97f-f3e37fbc0aa9">8,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTMtMTUtMS0xLTUzOTA2_0ae69c06-19c2-43a8-84c8-ecaf94b1d766">8,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13178785dc1843d99d2ccce16ace2e65_D20210901-20211130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTQtMS0xLTEtNTk0OTc_7ce4f985-66d9-484b-b09d-879b48dba774">56,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideddd48e387b42c2b942816100384d6a_D20210901-20211130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTQtNS0xLTEtNTk0OTc_cd03c384-469a-459f-bf65-0a808de81445">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTQtMTUtMS0xLTU5NDk3_286cf3e0-1297-47bb-b1a1-87d37143f54e">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/Cancellation of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12da52958cc5404e98473dd0097af478_D20210901-20211130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTUtMS0xLTEtNTM5MDY_ffc069d0-a4b2-4a21-b356-7ac462f728ed">8,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dc3ec9fcfa545bd8484b6f100236204_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTUtNS0xLTEtNTM5MDY_6d5e86d3-e648-4730-bf56-e88c4418b49b">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96f83ef275904264810bf98c69aa89aa_D20210901-20211130" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTUtMTUtMS0xLTUzOTA2_f0a63c0f-a3bb-491b-9fb0-51fb653e14ae">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of common stock under ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13178785dc1843d99d2ccce16ace2e65_D20210901-20211130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTctMS0xLTEtNTk0OTk_402472a4-37d4-454e-b887-3d6848212546">193</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideddd48e387b42c2b942816100384d6a_D20210901-20211130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTctNS0xLTEtNTk0OTk_429638a2-855f-4e28-afa3-ad6c752e712b">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTctMTUtMS0xLTU5NDk5_c4f78486-804a-49c3-a9a4-3a7db7067753">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideddd48e387b42c2b942816100384d6a_D20210901-20211130" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTgtNS0xLTEtNTM5MDY_4d323967-1382-49c6-931c-157686c806a1">3,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTgtMTUtMS0xLTUzOTA2_8d3df3b3-d11e-462a-8263-433941809e13">3,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia984848d280248bfbcb8e31640f1e39d_D20210901-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjEtOS0xLTEtNTM5MDY_a577fe7d-0ade-49d9-939e-3b74ac0ed12d">819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjEtMTUtMS0xLTUzOTA2_40cacce8-25e3-4edf-9c7c-f198f57ee4d7">819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at November 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i155c045358b34383ac3295044d6c9a6b_I20211130" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMS0xLTEtNTM5MDY_41ad0368-c98d-40ff-b1ab-e51702e8ac96">39,455,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155c045358b34383ac3295044d6c9a6b_I20211130" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMy0xLTEtNTM5MDY_9e3e6dec-c8a9-415d-b1ef-74847f764021">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdec94434c4945059845c818633407fb_I20211130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItNS0xLTEtNTM5MDY_08e781b6-0416-46e4-a16d-7542bebf3f3f">580,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a2dd77d8826427fb397445192c0bc76_I20211130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItNy0xLTEtNTM5MDY_4c98bf49-ca69-462a-a021-88f279bd23df">147,189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9770758c2964b64b48d180cbdf84531_I20211130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItOS0xLTEtNTM5MDY_8158c5e0-6663-4ba9-ac4e-70c967184bd5">4,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf6811aafe4e4669a27e18cdda0c54ef_I20211130" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMTEtMS0xLTUzOTA2_dddab86c-aadf-4964-b59d-481c1cb39087">370,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf6811aafe4e4669a27e18cdda0c54ef_I20211130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMTMtMS0xLTUzOTA2_ab9d275c-1635-4125-ac6e-9f6206f2014d">5,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i580a989d6bd346dea798e59360b2cf7b_I20211130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMTUtMS0xLTUzOTA2_f2535523-6e78-42de-a0ae-7c871be308d2">432,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div id="i897c24ef20684c93801e686a95e6abcc_34"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNC9mcmFnOmI0YzAxYTZhZmM4ZTQzMDBiOTM3N2RkNTcwYzVlY2FkL3RleHRyZWdpb246YjRjMDFhNmFmYzhlNDMwMGI5Mzc3ZGQ1NzBjNWVjYWRfMTI2MA_a7cc4234-ad2f-4fd7-81a9-67dba4e8dd7f" continuedAt="idefc91a0c2f2447883475472e5e6ba4a" escape="true">CONSOLIDATED FINANCIAL STATEMENTS</ix:nonNumeric></span></div><ix:continuation id="idefc91a0c2f2447883475472e5e6ba4a"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Loss for the three and six months ended November&#160;30, 2022 and 2021, the Consolidated Balance Sheet as of November&#160;30, 2022, the Consolidated Statements of Cash Flows for the six months ended November&#160;30, 2022 and 2021, and the Consolidated Statements of Stockholders&#8217; Equity for the six months ended November&#160;30, 2022 and 2021 have been prepared by the Company and are unaudited. The Consolidated Balance Sheet as of May&#160;31, 2022 was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to state fairly the financial position, changes in stockholders&#8217; equity and comprehensive income, results of operations and cash flows as of and for the period ended November&#160;30, 2022 (and for all periods presented) have been made.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim consolidated financial statements for the three and six months ended November&#160;30, 2022 and 2021 include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries (collectively, the "Company", "we", "our" or "us").  All intercompany balances and transactions have been eliminated.</span></div></ix:continuation><div id="i897c24ef20684c93801e686a95e6abcc_37"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfODg2_cadbc739-5fe3-4cea-b769-d6ef31ed034c" continuedAt="ib60e6af06b584216b045ee4e87fdeade" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="ib60e6af06b584216b045ee4e87fdeade" continuedAt="i3782f66aee7f43b8b9507bde6b745069">Camaro Support Catheter Asset Acquisition</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3782f66aee7f43b8b9507bde6b745069">On July 27, 2021, the Company acquired the Camaro support catheter (rebranded as Syntrax) from QX Medical, LLC for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i22e896b21e924dea8f58a482a45a6580_D20210727-20210727" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMjEw_ee0592af-17f4-4928-b413-46d730940fa5">4.0</ix:nonFraction>&#160;million, which included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMjUx_2e42278b-9982-46b0-a1e2-65ad93fbe3f6">3.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMjU4_6b2dda06-98e6-4c1d-a31b-8bc29c967d49">0.4</ix:nonFraction>&#160;million in purchase price holdbacks, along with $<ix:nonFraction unitRef="usd" contextRef="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727" decimals="-5" name="ango:RevenueRemainingPerformanceObligationVariableConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMzAx_0101cdca-6d53-4f3d-afd2-04ef4a51744a">1.0</ix:nonFraction>&#160;million of potential future contingent consideration related to revenue milestones. This acquisition supports the Auryon product family and the Company's strategic plan.  The Company accounted for this acquisition as an asset purchase.  The Company recorded the amount paid at closing as inventory and fixed assets of $<ix:nonFraction unitRef="usd" contextRef="i22e896b21e924dea8f58a482a45a6580_D20210727-20210727" decimals="-5" name="ango:AssetAcquisitionInventoryAndFixedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfNjE0_0dc7aedf-df01-4cc3-9403-b1f498d48465">0.1</ix:nonFraction>&#160;million and an intangible asset product technology of $<ix:nonFraction unitRef="usd" contextRef="ie6ddfbc23984498e818686d27ec8ab38_D20210727-20210727" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfNjYz_56d4701d-1717-4934-9584-6f57110b5a82">3.9</ix:nonFraction>&#160;million.  The intangible asset will be amortized over <ix:nonNumeric contextRef="i4932000aa21a49cda2393c4098bd3848_D20191217-20191217" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfNzEy_7d6d373a-61cb-4e9c-90a5-e952a02244a7">15</ix:nonNumeric> years.  The contingent consideration is comprised of revenue milestones and will be accounted for when the contingency is resolved or becomes probable and reasonably estimable.</ix:continuation>  </span></div><div id="i897c24ef20684c93801e686a95e6abcc_40"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMzNg_180c5915-a874-484a-bcfa-45363704718c" continuedAt="idc320535f9064b4cab3545c728f21b50" escape="true">REVENUE FROM CONTRACTS WITH CUSTOMERS</ix:nonNumeric></span></div><ix:continuation id="idc320535f9064b4cab3545c728f21b50" continuedAt="icdf2d06e5f5749338d2200da6aa4d4d6"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMyOQ_b13ed108-dff0-4f07-84e6-b1f912a4b59e" continuedAt="i7ed6e2d9ce374331881510c5f8a2913a" escape="true">Revenue Recognition</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><ix:continuation id="i7ed6e2d9ce374331881510c5f8a2913a" continuedAt="ic963c8b982b44b20941d982f6d993a15"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic963c8b982b44b20941d982f6d993a15" continuedAt="i7e5b18fcf4a0458a97c1ff83e3b65494">, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one primary revenue stream which is the sales of its products.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company has previously announced, the Company is focused on its ongoing transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company that delivers unique and innovative health care solutions. The Company believes that this transformation will enable the Company to shift the portfolio from the mature, lower-growth markets where we have competed in the past by investing in technology and products that provide access to larger and faster growing markets. As such, we believe the growth in the near to mid-term will be driven by our Med Tech segment.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMzNw_77d34daa-c544-41a7-ab28-409c5dfc6253" continuedAt="iec6b18596a0645e2a6ecde546880f168" escape="true">The following table summarizes net sales by Med Tech, Med Device and by geography:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="icdf2d06e5f5749338d2200da6aa4d4d6" continuedAt="i1d1a62bbd2294de9aefa9146358239fb"><ix:continuation id="iec6b18596a0645e2a6ecde546880f168"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended November 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended November 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1ac96c05c4496cbe867dec215b61da_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy0xLTEtMS01MzkwNg_0a20d937-fcbc-4a28-a024-cdfe46286f94">20,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff045fe7c34428eabb45c34bd46a77b_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy0zLTEtMS01MzkwNg_3c86f3c4-50db-4972-be22-42584ff72a76">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy01LTEtMS01MzkwNg_d77c45c9-a5f3-4e95-ba3b-90f5a0b6b042">24,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05af3963048441980e5da6c628ad99e_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy03LTEtMS01MzkwNg_2789fc9c-f441-410a-884a-c7b3c28e2852">16,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97cc578ba1c14c2790275846f3e88b4f_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy05LTEtMS01MzkwNg_f65f2537-af38-48dc-b52f-092d0b3aaa37">2,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy0xMS0xLTEtNTM5MDY_7ba568d6-5dc8-4b9b-a76e-8b82cf822aef">18,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b89bf280264af8b946c348ba6191a5_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC0xLTEtMS01MzkwNg_2eecf2d3-3ad3-482a-824b-73e6a8a24d8a">51,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i608ce6e6291c48db9671f8baa53df352_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC0zLTEtMS01MzkwNg_637b729b-570a-4493-b84e-36d1aa3187be">9,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC01LTEtMS01MzkwNg_d84427aa-a5e9-463b-88f9-d7be95afe708">60,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6552b74e0da8424b8b3f0a28d099316d_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC03LTEtMS01MzkwNg_ecd75c9b-8b4d-4f0b-acc5-abc1a5bdee16">49,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69edc35bb61e4b13864a2034b42aa17e_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC05LTEtMS01MzkwNg_24c4fde0-aa17-4193-b887-4aac814cce2b">10,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC0xMS0xLTEtNTM5MDY_d3784a98-ea69-4584-9727-c208bfef77ad">59,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c2fd9d28c04a93ae03769f99f5b982_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS0xLTEtMS01MzkwNg_b4757919-967e-4de5-9e3e-383dbb401f5f">71,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84b2cc1c77648d59e643ea5bca9cd40_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS0zLTEtMS01MzkwNg_c8ecf6f5-d16a-4f69-9037-c5ca173c50a1">13,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS01LTEtMS01MzkwNg_2484b603-f3ac-4e68-b5f4-121d4784d72c">85,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69be4f7a7d4e429f9786923e58bb233a_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS03LTEtMS01MzkwNg_26b2c048-ffb6-4fed-9554-65e5a45b5be5">65,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5207d4b6e44c3bb870e98f47ae464f_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS05LTEtMS01MzkwNg_66386942-c97b-4dec-913a-ccbf86c3d88a">12,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS0xMS0xLTEtNTM5MDY_c943e4c1-7658-4135-be16-b141f959718c">78,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended November 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended November 30, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fe0ea1cdf9b43cba1dc89583cfa12f4_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy0xLTEtMS01OTI1Nw_0f4b6aaa-6625-4bf7-8fe9-dd822c9271cf">40,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3b790c7408444aa2438a6d74ccf219_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy0zLTEtMS01OTI2NA_bab93aab-c423-4ba5-a18f-1a47b2c1d342">6,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy01LTEtMS01OTUyMQ_620a206d-bbfb-480f-bd59-ae0e840ec637">47,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9782032ec849455f9eb55bcd5238506f_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy03LTEtMS01OTI3MQ_eb53b0c0-260b-481d-8b5e-fec52a54f952">31,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i730d6d555ca8411db383a11b9f16a087_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy05LTEtMS01OTI3OA_bc5ece26-7564-43f6-ab4c-5a92730f79be">5,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy0xMS0xLTEtNTk1MjE_be8eeae0-8783-4481-8640-dadeab73690b">36,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcdba87c68b44670aa983d442909c8c8_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC0xLTEtMS01OTI1Nw_7c66cf5f-890a-482a-8ff5-37b71cd7e1b7">99,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f175e8bc06e4516859a922825203ed1_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC0zLTEtMS01OTI2NA_1853bc87-388e-4ead-b2d2-bb6050c1a217">19,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC01LTEtMS01OTUyMQ_c282b4e7-a4aa-4e88-b2e4-0bb11871fa54">119,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109b126be6684609964e1d738004a5f0_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC03LTEtMS01OTI3MQ_d56d7c73-0b56-48f6-ad09-001a3e29aa18">98,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9577aad3e743eaab5f2db73438ff22_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC05LTEtMS01OTI3OA_03c4d41b-fba7-4772-bcdd-592b92d6145f">20,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC0xMS0xLTEtNTk1MjE_45dd374c-aea1-4879-bfa8-f2bf60882c11">118,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1532603b5d5344d2b521ebca95510e2d_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS0xLTEtMS01OTUyMQ_511f2d90-f8ce-4902-8ac7-0165f74c8236">140,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102e00650df64160ab95f91283be5671_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS0zLTEtMS01OTUyMQ_c771e252-1a77-48de-88db-b031d166393a">26,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS01LTEtMS01OTUyMQ_d29e4755-fd21-4458-bd98-b558af155f86">166,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fa11be4a974f91a8f83c64c4b79d43_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS03LTEtMS01OTUyMQ_bfdc547f-5cab-4828-9c64-f00902c981b4">129,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbd65f28780439d8d4b3739c60451f2_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS05LTEtMS01OTUyMQ_71810640-db07-42e1-8df2-2af7daafba33">25,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS0xMS0xLTEtNTk1MjE_9c83d98b-486b-4d26-9149-7fe55ca20769">155,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Product Revenue</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products consist of a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's products are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be implanted for short or long term use. The Company sells its products to its distributors and to end users, such as interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists and critical care nurses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with its customers based on customer purchase orders, which in many cases are governed by master purchasing agreements. The Company&#8217;s contracts with customers are generally for product only, and do not include other performance obligations such as services or other material rights. As part of its assessment of each contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price and Allocation to Performance Obligations</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction prices of products are typically based on contracted rates. Product revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to a customer, net of any variable consideration as described below.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products underlying each performance obligation. The Company has standard pricing for its products and determines standalone selling prices based on the price at which the performance obligation is sold separately.</span></div><ix:continuation id="i7e5b18fcf4a0458a97c1ff83e3b65494" continuedAt="iba01fdf400cf43de8024b4678d829f93"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company&#8217;s performance obligation is satisfied), which occurs at a point in time, and may be upon shipment from the Company&#8217;s manufacturing site or delivery to the customer&#8217;s named location, based on the shipping terms of a contract.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether control has transferred, the Company considers if there is a present right to payment from the customer and when physical possession, legal title and risks and rewards of ownership have transferred to the customer.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically invoices customers upon satisfaction of identified performance obligations.  As the Company&#8217;s standard payment terms are <ix:nonNumeric contextRef="ia2cfe7c548c8479c9c72cfb258097cbf_D20220601-20221130" name="ango:RevenuePerformanceObligationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNDU2Ng_46f0df4e-c51d-422d-87f5-b531e0448a37">30</ix:nonNumeric> to <ix:nonNumeric contextRef="ibc7c9d9ebcb04ddca80d41fba203d212_D20220601-20221130" name="ango:RevenuePerformanceObligationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNDU3Mg_67d61237-b07c-49f9-a4c2-06f4103c6933">90</ix:nonNumeric> days from invoicing, the Company does not provide any significant financing to its customers.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into agreements to place placement and evaluation units (&#8220;units&#8221;) at customer sites, but the Company retains title to the units. For the duration of these agreements the customer has the right to use the unit at no upfront charge in connection with the customer&#8217;s ongoing purchase of disposables. These types of agreements include an embedded operating lease for the right to use the units. In these arrangements, revenue recognized for the sale of the disposables is not allocated </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="i1d1a62bbd2294de9aefa9146358239fb" continuedAt="ifbf5b60e63fd40aeb3617f3d4aa363d5"><ix:continuation id="iba01fdf400cf43de8024b4678d829f93" continuedAt="i9d3621ecfa57410aa021949ab8c9919e"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between the disposal revenue and lease revenue due to the insignificant value of the units in relation to the total agreement value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves: Revenue from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established for discounts, returns, rebates and allowances that are offered within contracts between the Company and its customers.  These reserves are based on the amounts earned or to be claimed on the related sales and are classified as a contra asset.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rebates and Allowances: The Company provides certain customers with rebates and allowances that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. The Company establishes reserves for such amounts, which is included in accrued expenses in the accompanying Consolidated Balance Sheets. These rebates and allowances result from performance-based offers that are primarily based on attaining contractually specified sales volumes.  The Company is also required to pay administrative fees to group purchasing organizations.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9d3621ecfa57410aa021949ab8c9919e" continuedAt="ie8bcdd417ab0459c8a7cc334f8ef0cab">Product Returns: The Company generally offers customers a limited right of return.  Product returns after <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="ango:ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNjU2Nw_14fbb069-108e-4354-a1fc-b7f7cd4c9294">30</ix:nonNumeric> days must be pre-approved by the Company and customers may be subject to a <ix:nonFraction unitRef="number" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="2" name="ango:ContractWithCustomerRightOfReturnRestockingCharge" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNjY0MA_8e2a9fec-c8cc-49ef-90ef-5388fc28cc0a">20</ix:nonFraction>% restocking charge.  To be accepted, a returned product must be unadulterated, undamaged and have at least <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="ango:ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNjc0OQ_ab29667d-6ca7-4278-b40a-969fdf192b18">twelve months</ix:nonNumeric> remaining prior to its expiration date.  The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized.  The Company currently estimates product return liabilities using its historical product return information and considers other factors that it believes could significantly impact its expected returns, including product recalls.  </ix:continuation>During the six months ended November&#160;30, 2022, such product returns were not material.  </span></div><ix:continuation id="ie8bcdd417ab0459c8a7cc334f8ef0cab" continuedAt="i445f2fe07d2c48a082df1f04b15e5b23"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances with Customers</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is generally recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer and generally coincide with revenue recognition. Accordingly, the Company does not have any contract assets associated with the future right to invoice its customers. In some cases, if control of the product has not yet transferred to the customer or the timing of the payments made by the customer precedes the Company&#8217;s fulfillment of the performance obligation, the Company recognizes a contract liability that is included in deferred revenue in the accompanying Consolidated Balance Sheets.</span></div></ix:continuation><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMzNA_2b0a5960-4a98-40bc-9afd-ed424a2db255" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the Company&#8217;s receivables, contract assets and contract liabilities with customers:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMS0xLTEtMS01MzkwNg_f6f1ea24-376f-49a1-83c6-02e49515741e">52,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMS0zLTEtMS01MzkwNg_9aa9d18f-7f4a-4b29-8775-1aa704159064">52,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMi0xLTEtMS01MzkwNg_8c5ae61a-20cd-492b-9558-7a1fb63a1e47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMi0zLTEtMS01MzkwNg_43e0f340-3883-4908-90bf-53f9afe65321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMy0xLTEtMS01MzkwNg_8b0e011c-2e55-4786-87ba-bbfcf17a5798">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMy0zLTEtMS01MzkwNg_8e6c1554-2137-449f-b74b-b89f96c15452">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended November&#160;30, 2022, the Company had additions to contract liabilities of $<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfODIwMQ_04119730-60e7-4363-b4c7-52fdfcc6b064">0.5</ix:nonFraction> million.  This was offset by $<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-5" name="ango:CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfODIyNQ_b0a597cb-f1d1-4d51-9079-fd0f9ff20906">0.5</ix:nonFraction> million in revenue that was recognized during the six months ended November&#160;30, 2022. </span></div><ix:continuation id="i445f2fe07d2c48a082df1f04b15e5b23" continuedAt="i5ae397c53563431786212f0b4859c26b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs to Obtain or Fulfill a Customer Contract </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, the Company may recognize an asset for incremental costs of obtaining a contract with a customer if it expects to recover those costs. The Company&#8217;s sales incentive compensation plans qualify for capitalization since these plans are directly related to sales achieved during a period of time. However, the Company has elected the practical expedient under ASC 340-40-25-4 to expense the costs as they are incurred within selling and marketing expenses since the amortization period is less than one year.</span></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifbf5b60e63fd40aeb3617f3d4aa363d5"><ix:continuation id="i5ae397c53563431786212f0b4859c26b">The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping and handling are recorded in net sales.</ix:continuation></ix:continuation>  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_43"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTM4_bbf695e4-955e-43b3-aeb5-397041703de7" continuedAt="i7fe2545208fb474b901bed54dc8bbf63" escape="true">INVENTORIES</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><ix:continuation id="i7fe2545208fb474b901bed54dc8bbf63" continuedAt="ice15cff5116e49adab3b32b9ac5afe54"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTM3_b29c98bb-0266-4b63-bff9-e06c6209a326" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at lower of cost and net realizable value (using the first-in, first-out method).  Inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMS0xLTEtMS01MzkwNg_8de16f1e-0da0-4611-87cd-220bbe2aeef5">33,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMS0zLTEtMS01MzkwNg_750da56d-d692-4505-b633-d8a33a2ade78">28,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMi0xLTEtMS01MzkwNg_e939df1f-b62a-4f6e-a54b-ef48bcd67cc2">8,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMi0zLTEtMS01MzkwNg_a3c3171f-ff3e-440b-93cf-517295e9d258">7,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMy0xLTEtMS01MzkwNg_72ab024b-17af-461d-93aa-0f6f4f5eab5f">21,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMy0zLTEtMS01MzkwNg_68b775ec-c825-4c9a-964e-918b00533f73">15,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfNC0xLTEtMS01MzkwNg_adf7523a-9e1e-43ea-ab0d-44a452e8bd77">63,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfNC0zLTEtMS01MzkwNg_3fbf5444-5fe3-4c5a-a8e5-e511584cbfae">51,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ice15cff5116e49adab3b32b9ac5afe54">The Company periodically reviews inventory for both obsolescence and loss of value.  The Company makes assumptions about the future demand for and market value of the inventory.  Based on these assumptions, the Company estimates the amount of obsolete, expiring and slow-moving inventory.  The total inventory reserve at November&#160;30, 2022 and May&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTAz_52551c1f-d2a9-4a33-8b7f-008af05c3a0f">3.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTEw_8345171e-fa2e-4f5b-9b75-7372f5d91c4f">3.7</ix:nonFraction> million, respectively.</ix:continuation>  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_46"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDYwNA_a4918cb1-ce8f-4c27-80eb-9c7da4118b0d" continuedAt="i35143c0fe2034dcdaa1857a9edee7123" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i35143c0fe2034dcdaa1857a9edee7123" continuedAt="i5d378bcab3c7487dbb703d14fe6c3148"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized, but rather, is tested for impairment annually or more frequently if impairment indicators arise. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in each business combination. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically performed its annual goodwill assessment during the third quarter of each fiscal year.  During the fourth quarter of fiscal year 2022, the Company changed its annual impairment assessment date from December 31 to April 30 to more closely align the impairment assessment date with the Company's long term planning and forecasting process.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's annual testing for impairment of goodwill was completed as of April 30, 2022.  Prior to the first quarter of fiscal year 2023, the Company managed its operations as <ix:nonFraction unitRef="unit" contextRef="i96f682ba85b44a3598400d9868b15c05_D20220601-20220831" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfODg3_82d53026-c381-401e-9cfb-e6c138fd8026">one</ix:nonFraction> reporting unit.  At the beginning of the first quarter of fiscal year 2023, the Company began to manage its operations as <ix:nonFraction unitRef="segment" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTAxMg_5b665c83-3829-44d5-8ed5-9332d13e6ccc">two</ix:nonFraction> operating segments and <ix:nonFraction unitRef="unit" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTAzOA_197333f1-dfcd-4b7c-8cc4-95f3ec1591ac">two</ix:nonFraction> reporting units, namely Med Tech and Med Device (see Note 11 "Segment and Geographic Information" set forth in the Notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q).  As a result of this change, goodwill was required to be allocated to each reporting unit and an interim goodwill impairment assessment was performed at the Company and reporting unit levels.  To determine the fair value of the individual reporting units and the entire company as of June 1, 2022, the Company utilized the income approach.  The income approach is based on the projected cash flows discounted to their present value using discount rates, that in the Company's judgment, consider the timing and risk of the forecasted cash flows using internally developed forecasts and assumptions.  Under the income approach, the discount rate used is the average estimated value of a market participant&#8217;s cost of capital and debt, derived using customary market metrics.  Other significant assumptions include revenue growth rates, profitability projections, and terminal value growth rates.  The market approach was also considered; however, the income approach was chosen as the Company determined it is a better representation of both the Med Tech and Med Device reporting units' projected long-term performance. The fair value of each reporting unit and the Company as a whole was assessed to determine if there was any impairment.  The Company compared each reporting unit's fair value to the adjusted carrying value to conclude that there was no impairment for either reporting unit or the Company as a whole.  The adjusted carrying value of each reporting unit was used to calculate the Company's book value to compare to its market capitalization at the assessment date.  Based on the results of this evaluation, there were no adjustments to goodwill for either reporting unit or the Company as a whole as of August 31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adjustments to goodwill for the six months ended November&#160;30, 2022 other than foreign currency translation adjustments.   </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even though the Company determined that there was <ix:nonFraction unitRef="usd" contextRef="id1e9f928ee4349a68577d07adcc3b26f_D20201231-20201231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzAyMw_6dcc70c8-699b-4c1b-b9d8-55e746d9c2a4">no</ix:nonFraction> goodwill impairment at November&#160;30, 2022, the future occurrence of a potential indicator of impairment, such as a significant adverse change in legal, regulatory, business or economic conditions or a more-likely-than-not expectation that one of the reporting units or a significant portion of either of the reporting units will be sold or disposed of, would require an interim assessment for the reporting units prior to the next required annual assessment as of April 30, 2023.  </span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="i5d378bcab3c7487dbb703d14fe6c3148"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDU5NQ_ab0f9aed-64ca-4200-b684-a94cb7799c33" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill for each reporting unit is allocated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Med Tech </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Med Device </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c31b0a2ffcb46a09974a5fc03fcb07e_I20220601" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMi0xLTEtMS01OTQ5MQ_3375956e-408d-492f-bd47-ce48e554c0e4">160,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8bf515dc504d2e93a4cef1b15e47ed_I20220601" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMi0zLTEtMS01OTQ5MQ_4bfc9507-0165-46b3-a599-07195cfb9199">40,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic64f7b15ed9b474995bee41f47ae8270_I20220601" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMi01LTEtMS01OTQ5MQ_e584d6e0-e0bd-4019-9e58-779bfd24bd45">201,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5cf0bee2d60494bb2779598e5ddb3eb_D20220602-20220831" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMy0xLTEtMS01OTQ5MQ_7f0c09f5-f678-4a4c-9837-381d7f747fc4">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0e0ea76bcf04919ab502a0c59748fb9_D20220602-20220831" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMy0zLTEtMS01OTQ5MQ_943c53a0-ebc8-45c9-aa0b-dfe5c456085c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a1d991006824083b8178abc9d11b0d5_D20220602-20220831" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMy01LTEtMS01OTQ5MQ_ea014423-8148-432c-b5f5-244388ab29b2">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, August 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a86996ae3f64984bc0a4ecc7bd4af54_I20220831" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNC0xLTEtMS01OTQ5MQ_9a1411d8-9d49-4c1c-97be-a99842158131">160,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac2d1378a1f24161b87c458f35456450_I20220831" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNC0zLTEtMS01OTQ5MQ_ef672902-e901-43c1-af30-c520653173c8">40,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605f35cad602428b8143074fa8c31ba8_I20220831" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNC01LTEtMS01OTQ5MQ_73a54436-258e-4caa-893a-476a730ee786">201,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e064f90d3da49b9a66c4ac18aad1d0d_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNS0xLTEtMS01OTQ5Mw_3afb3d62-13c8-414c-95ed-93f92286a5ed">283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41e9cc6df0e4df7ac811956f8aff5e4_D20220901-20221130" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNS0zLTEtMS01OTQ5Mw_e09a7f8c-e4b9-41be-b041-5c4249662894">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNS01LTEtMS01OTQ5Mw_4b328902-b3b4-48db-b01b-69f54b9bced1">283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026512e869c44a08831de2435fa433a_I20221130" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNi0xLTEtMS01OTQ5Mw_cbb65a79-3076-49f5-9f31-d02ee0bdb47d">160,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0933abd0902b4939a41c2a553e06b97d_I20221130" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNi0zLTEtMS01OTQ5Mw_6aa8dd09-b511-43e0-87a1-1c94dc5335e2">40,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNi01LTEtMS01OTQ5Mw_ff226151-9c91-4d0f-952f-1dfe89832325">200,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adjustments to goodwill for the six months ended November&#160;30, 2022 other than foreign currency translation adjustments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill are amortized over their estimated useful lives on a straight-line basis. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0Mg_fc669142-82c7-49b8-a7a9-e8917629543b">two</span> to <ix:nonNumeric contextRef="ibc7c9d9ebcb04ddca80d41fba203d212_D20220601-20221130" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0OA_0a58229e-be64-47e5-ba0e-f0058153c34c">eighteen years</ix:nonNumeric>.  The Company periodically reviews, and adjusts, if necessary, the estimated useful lives of its intangible assets and reviews such assets or asset groups for impairment whenever events or changes in circumstances indicate that the carrying value of the assets or asset groups may not be recoverable. If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</span></div><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="ango:ScheduleOfIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDU5Ng_d7c9e348-ee8b-4236-ae3b-6fa8cc00fe2d" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross carrying value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net&#160;carrying value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMi0xLTEtMS01MzkwNg_328a6eda-f500-42a0-8251-0d816bafa62e">237,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMi0zLTEtMS01MzkwNg_e46de334-d82b-43bd-8e7b-1f067d6ba4a9">119,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMi01LTEtMS01MzkwNg_3c48ca26-be1d-41f3-9df4-89233e83dd1c">118,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03538be72f0c479d88269196fae7627d_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMy0xLTEtMS01MzkwNg_c5699adb-fc1b-4128-a9f3-2d2bb3b89a63">60,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03538be72f0c479d88269196fae7627d_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMy0zLTEtMS01MzkwNg_d4cf3780-197f-4817-b706-0d89fae50369">39,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03538be72f0c479d88269196fae7627d_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMy01LTEtMS01MzkwNg_95bdb756-8d03-46cc-84af-0407f1b7db7d">20,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a63b72365594c83ac835e0622876350_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNC0xLTEtMS01MzkwNg_d24fd28f-5bf7-4a48-a21b-960c00de3999">9,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a63b72365594c83ac835e0622876350_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNC0zLTEtMS01MzkwNg_79e302c7-f5f4-4c55-85b7-6066ce841360">7,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a63b72365594c83ac835e0622876350_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNC01LTEtMS01MzkwNg_b3380c1a-e001-4685-a5ff-afe7e69aa535">2,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481617886ccd437181a9534ee467fcaa_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNS0xLTEtMS01MzkwNg_f3556d74-55be-471e-986d-3ae65479c66b">5,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i481617886ccd437181a9534ee467fcaa_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNS0zLTEtMS01MzkwNg_7760b179-6e21-4ce8-93f8-6890c4b659bf">4,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481617886ccd437181a9534ee467fcaa_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNS01LTEtMS01MzkwNg_395f5bfd-83ba-4628-b3a7-014722ef0e9d">653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfOC0xLTEtMS01MzkwNg_8aac24f4-b7d8-4d37-94ab-beffcb21e1e4">313,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfOC0zLTEtMS01MzkwNg_b4e50061-835d-4a81-b25a-113e4cde3557">171,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfOC01LTEtMS01MzkwNg_9c54a36a-55cd-47b9-86ba-e3679ab0483b">141,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross carrying value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net&#160;carrying value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232cbe1e1fc44360a597810368435c6e_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMi0xLTEtMS01MzkwNg_9c21af61-19b9-4e62-930c-ca6675fccc6b">239,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i232cbe1e1fc44360a597810368435c6e_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMi0zLTEtMS01MzkwNg_283b9de8-3f91-4ac3-a3ef-02fb5ed82ad0">112,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232cbe1e1fc44360a597810368435c6e_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMi01LTEtMS01MzkwNg_62f64995-e0d2-4e74-a01e-bab55be6809b">127,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id17cfc417d92464bbedc0236cf2219c3_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMy0xLTEtMS01MzkwNg_d7a20b69-3598-4ebb-a636-a9b14cc0701c">60,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id17cfc417d92464bbedc0236cf2219c3_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMy0zLTEtMS01MzkwNg_092a7622-28a4-4680-af59-65a728646e37">38,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id17cfc417d92464bbedc0236cf2219c3_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMy01LTEtMS01MzkwNg_eb14bfe1-dd06-4724-ab7b-3f6e07050106">22,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38c064a30b74d81851783f9a22c7991_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNC0xLTEtMS01MzkwNg_612b682e-9454-4466-a767-6e05d8786a78">9,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib38c064a30b74d81851783f9a22c7991_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNC0zLTEtMS01MzkwNg_ad6eda95-0256-42f2-9f45-64a5eb0d0fce">7,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38c064a30b74d81851783f9a22c7991_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNC01LTEtMS01MzkwNg_45561e45-f79b-428a-8548-907bfb2a3f92">2,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNS0xLTEtMS01MzkwNg_61c806fb-00a4-49d9-a79a-ee1e3f89385e">4,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNS0zLTEtMS01MzkwNg_c562e18b-3fe8-4aa7-98de-f74e4bebe489">4,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNS01LTEtMS01MzkwNg_985d4e22-1e08-4309-bd3a-bceedf1e9304">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfOC0xLTEtMS01MzkwNg_37ab8985-eada-4a40-962a-aed9929b21b3">314,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfOC0zLTEtMS01MzkwNg_66b09770-1bea-4e46-80a2-3d764c27dd74">161,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfOC01LTEtMS01MzkwNg_db310b38-3929-4b1f-92e7-835f9fa638fb">152,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three months ended November&#160;30, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTA5OTUxMTYzMjQ3Mg_5604a7e6-243b-43fb-9a66-16ba850ba637">4.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTA5OTUxMTYzMjU0Mw_ce2ab24a-e58d-4563-9715-7e7c75efe616">4.9</ix:nonFraction> million, respectively.  Amortization expense for the six months ended November&#160;30, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMjc0ODc3OTA3NDE4MQ_d4791fb7-b9ab-464b-9761-bfa89bb921ea">9.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTA5OTUxMTYzMjU0OQ_e769e9a3-9c91-4af4-a4dc-9cd079faaf70">9.7</ix:nonFraction> million, respectively.  </span></div><div style="text-indent:22.5pt"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDYwMg_057ec237-c244-4607-b03c-7c5bf78a27df" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization expense related to the intangible assets for each of the following fiscal years is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfMS0xLTEtMS01MzkwNg_844dd914-05a0-4e81-9444-44cfc59751e7">9,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfMi0xLTEtMS01MzkwNg_3b12aaaa-b773-405e-b803-05742fffb6a1">16,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfMy0xLTEtMS01MzkwNg_2da17c2b-904c-4849-93e7-de9b63c54cc9">16,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNC0xLTEtMS01MzkwNg_6671a414-6a05-4096-8797-f6f12ec57ef9">16,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNS0xLTEtMS01MzkwNg_168ae14d-a70d-40d9-b581-7a35d95ac1b1">16,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="ango:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNi0xLTEtMS01MzkwNg_65240a97-b584-4c26-be89-368e7c9dd626">66,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNy0xLTEtMS01MzkwNg_2678e7f9-f330-40d7-b4ae-3c0e8157bd3e">141,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RleHRyZWdpb246YTM2ZGI2ZGMwZWY5NDZiYmEzZjE4MTM0ZGNjMzM3ZDVfODI_bcde7d59-d894-4fb8-8a9d-ed55ea23e9cf" continuedAt="i2821a35808d14b86967e711e16594ecd" escape="true">ACCRUED LIABILITIES</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><ix:continuation id="i2821a35808d14b86967e711e16594ecd"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RleHRyZWdpb246YTM2ZGI2ZGMwZWY5NDZiYmEzZjE4MTM0ZGNjMzM3ZDVfNzg_b2d62a52-cf02-4592-b21b-e18984517a51" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMS0xLTEtMS01MzkwNg_40bdf9c3-c1d8-4760-915e-fcc9782b396d">10,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMS0zLTEtMS01MzkwNg_de72a7c6-1cdd-407c-ba30-b7dd032d2c6c">20,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMi0xLTEtMS01MzkwNg_cfd2bfcc-cec9-490a-b9cd-8c747e87c8f3">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMi0zLTEtMS01MzkwNg_94bc2c2b-c1a7-4948-9294-a42d249e8647">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMy0xLTEtMS01MzkwNg_7357ceba-8a48-41b3-b104-18487af7d2d1">6,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMy0zLTEtMS01MzkwNg_0346cab4-4e3d-4a97-8aad-4b07b6bd0874">3,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="ango:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNC0xLTEtMS01MzkwNg_a4c17ccb-8d2c-4bbf-aea4-e6846dbd563e">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="ango:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNC0zLTEtMS01MzkwNg_13476d62-2258-4c93-98c8-432ab0909ecc">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and franchise taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNS0xLTEtMS01MzkwNg_0bf751e7-8ed6-4d7a-8c3f-4e5cfec22d4c">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNS0zLTEtMS01MzkwNg_96b51dda-199c-43a3-ae9b-362ccae3f4d1">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:CustomerRefundLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNy0xLTEtMS01MzkwNg_a6df9e66-13a3-409f-814b-94bb5ce560e7">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:CustomerRefundLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNy0zLTEtMS01MzkwNg_488a9191-f1e6-4219-b021-686cde71fe1f">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfOC0xLTEtMS01MzkwNg_f526e9ea-2eeb-4575-8ba4-5cf83bc9c9af">5,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfOC0zLTEtMS01MzkwNg_d02ed941-22cb-446e-b375-0d29dd312368">5,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMTAtMS0xLTEtNTM5MDY_3a6c1461-c200-4f24-a2a8-2aec812acfc4">26,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMTAtMy0xLTEtNTM5MDY_dbbfeb35-c846-4486-8158-d9278994641c">34,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i897c24ef20684c93801e686a95e6abcc_52"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc2Ng_e39d09ef-5041-4e9d-b87a-44a3a1414632" continuedAt="i245ac74f3b5e4ad1b7b9741c03e85817" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="i245ac74f3b5e4ad1b7b9741c03e85817" continuedAt="i201dab8f13c14c859be6e90eced806dd"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2022, the Company repaid all amounts outstanding under its then existing credit agreement and entered into a new Credit Agreement (the "Credit Agreement") with its lenders, JPMorgan Chase Bank, N.A., as Administrative Agent, sole bookrunner, and sole lead arranger, and Bank of America, N.A. and KeyBank National Association, as Syndication Agents. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="i51440fe9937d4880a24b852c727c72bc_I20220830" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfNDI0_c2163e0d-0421-4390-8247-b4746a03607d">75.0</ix:nonFraction>&#160;million secured revolving credit facility (the "Revolving Facility") and a $<ix:nonFraction unitRef="usd" contextRef="i40a6ca8a1a2a47948d181c2ddd57b60e_I20220830" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfNDk0_73ad811c-72a8-4ebd-a8a7-004407d79679">30.0</ix:nonFraction>&#160;million delayed draw term loan (the "Delayed Draw Term Loan"), and also includes an uncommitted expansion feature that allows the Company to increase the total revolving commitments and/or add new tranches of term loans in an aggregate amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="ie93908ff9fa24ce8a539c1afc8be059d_I20190603" decimals="-5" name="ango:LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfNzQ2_f1d59a11-3d4b-4d56-87dc-8044616513c0">75.0</ix:nonFraction> million.&#160; Each exercise of such expansion feature must be drawn in $<ix:nonFraction unitRef="usd" contextRef="idd47ebcb2afe4eab9e20c68e5a784838_D20220830-20220830" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfODA4_54e6d0e5-ed8b-4de7-850f-a5399cc9be20">5.0</ix:nonFraction>&#160;million increments.  The proceeds of the Revolving Facility may be used for general corporate purposes, including permitted acquisitions.  The proceeds of the Delayed Draw Term Loan may be used for general corporate purposes, including primarily to finance the manufacturing costs of the Auryon laser capital equipment.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement has a <ix:nonNumeric contextRef="iac18782ad5a1446b96f8bacea0595e03_D20190603-20190603" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc3MA_80fa0d18-f092-45a6-a9a7-6c4249aa0741">five-year</ix:nonNumeric> maturity.  Interest on the Revolving Facility and  Delayed Draw Term Loan will be based, at the Company's option, on a rate equal to (i) the Secured Overnight Financing Rate ("SOFR") plus <ix:nonFraction unitRef="number" contextRef="ie66d2669acf841099e3090e565eb8955_D20220830-20220830" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTM0OA_b0bc2479-92a9-47dd-9486-6506968574c4">0.10</ix:nonFraction>% (subject to a floor of <ix:nonFraction unitRef="number" contextRef="ie66d2669acf841099e3090e565eb8955_D20220830-20220830" decimals="INF" name="ango:DebtInstrumentFloorInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTM3NA_239bcc8d-64df-4a07-9ae1-ef2528315200">0</ix:nonFraction>%), or (ii) if the Company elects to treat a borrowing as an ABR Borrowing, an alternate base rate based on SOFR, plus, in each case, an applicable margin of <ix:nonFraction unitRef="number" contextRef="i6651e0f87eed4540b11c234da6d13537_D20220601-20221130" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTUzMw_39c87266-8665-42f4-b46d-499dbb880cd2">1.25</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i65b19051a3bf4afba6d1ee320c49fadb_D20220601-20221130" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTUzNw_b5f81dcb-9336-4b6b-9b65-3a0a5e8c53be">1.50</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="i2a200b6474a84a51a5841bde35741a37_D20220601-20221130" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTU0Mw_ead48383-1ad5-4b97-a8fa-104e3e6a92d3">1.75</ix:nonFraction>%, depending on the leverage ratio.  If any amounts are not paid when due, such overdue amounts will bear interest at an amount generally equal to <ix:nonFraction unitRef="number" contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130" decimals="INF" name="ango:DebtInstrumentDebtDefaultInterestRateIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTY5MQ_1fd396df-b030-40dc-9341-f3141967cddd">2.0</ix:nonFraction>% plus the existing loan rate.  The Credit Agreement also carries a commitment fee in the case of the Revolving Facility, and a ticking fee, in the case of the Delayed Draw Term Loans of <ix:nonFraction unitRef="number" contextRef="i48b85744365f40d9883440cec0fe503a_D20220601-20221130" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTg3OQ_15162074-d5d3-4ca3-ad4d-6cec89fc62ca">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i0ec7dba98bb64aa7b30c01f66cec9680_D20220601-20221130" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTg4NQ_bdea048f-aaff-4df7-ae7f-19591011d198">0.25</ix:nonFraction>% per annum on the unused portion.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations under the Credit Agreement are unconditionally guaranteed, jointly and severally, by the Company's material direct and indirect domestic subsidiaries (the &#8220;Guarantors&#8221;). All obligations of the Company and the Guarantors under the Credit Agreement are secured by first priority security interests in substantially all of the assets of the Company and the Guarantors.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, <ix:nonFraction unitRef="covenant" contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130" decimals="INF" name="ango:LineOfCreditFacilityNumberOfCovenants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMjQ5MQ_fe492766-a53e-43cd-88cf-2f6546214f76">two</ix:nonFraction> quarterly financial covenants as follows:&#160;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maximum leverage ratio of consolidated total indebtedness* to consolidated EBITDA* of not greater than <ix:nonFraction unitRef="number" contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130" decimals="INF" name="ango:DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMjY0MA_84b52950-e444-4970-a984-483a00e46e8e">3.00</ix:nonFraction> to 1.00 (during certain periods following material acquisitions the ratio shall be increased to <ix:nonFraction unitRef="number" contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130" decimals="INF" name="ango:DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMjczOQ_0f756da2-1241-4d7a-a17e-da4c38f53edf">3.50</ix:nonFraction> to 1.00). </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Fixed charge coverage ratio of consolidated EBITDA minus consolidated capital expenditures* to&#160;consolidated interest expense* paid or payable in cash plus scheduled principal payments in respect of indebtedness under the Credit Agreement of not less than <ix:nonFraction unitRef="number" contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130" decimals="INF" name="ango:DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzAwOA_6c62e79b-d14e-48b8-9ad1-94c500f09d11">1.25</ix:nonFraction> to 1.00. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* The definitions of consolidated total indebtedness, consolidated EBITDA, consolidated capital expenditures and consolidated interest expense are specifically defined in the Credit Agreement included as an exhibit to Form 8-K filed on August 31, 2022.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;30, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i9c7dabef1a2548fc9b252f702944e5c6_I20221130" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzI5Ng_397b09de-efdb-48dc-98ed-666c2d204d57">25.0</ix:nonFraction>&#160;million outstanding on the Revolving Facility and $<ix:nonFraction unitRef="usd" contextRef="ia7eb5c10613d48cb9ebc0fe8c4cf3a93_I20221130" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzM0MQ_1af3ebb8-d2f2-4ac0-8d08-b5c2481586e4">25.0</ix:nonFraction>&#160;million outstanding on the Delayed Draw Term Loan and the interest rate at November&#160;30, 2022 applicable to each was <ix:nonFraction unitRef="number" contextRef="i9c7dabef1a2548fc9b252f702944e5c6_I20221130" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzQzNw_e5959d32-c8ea-49bf-b54e-549b97c5dbde">5.59</ix:nonFraction>%.  As of November&#160;30, 2022 and May&#160;31, 2022, the carrying value of long-term debt approximated its fair market value.  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="i201dab8f13c14c859be6e90eced806dd"><div><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc3MQ_10fcb119-2d23-4b98-b2fb-4edf318855e0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7dabef1a2548fc9b252f702944e5c6_I20221130" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfMS0xLTEtMS01MzkwNg_1a5a0e4c-1bb8-48b3-b3c3-b78ebcfb9212">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7eb5c10613d48cb9ebc0fe8c4cf3a93_I20221130" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfMi0xLTEtMS01MzkwNg_aad732e7-9d65-4cc9-bc41-bf864544e3f5">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfMy0xLTEtMS01MzkwNg_f45024f9-1814-46a9-8def-79e7edd2409e">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfNC0xLTEtMS01MzkwNg_bfd95022-09d7-424b-ab6c-9e76115869a6">49,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments of approximately <ix:nonFraction unitRef="number" contextRef="idc15638543e04c98b695a64a354303c6_D20220601-20221130" decimals="4" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzU3Mw_7eabf6e9-9a3b-4693-9518-6237fe67019c">3.57</ix:nonFraction>% on the Delayed Draw Term Loan will amortize in equal quarterly installments over a <ix:nonNumeric contextRef="idc15638543e04c98b695a64a354303c6_D20220601-20221130" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc3Mg_ea403f4c-887a-41e5-99b3-440913cfc562">five year</ix:nonNumeric> period beginning on the earlier of a full draw or the expiry of the draw period (March 1, 2024).</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_55"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181NS9mcmFnOjYxZjkzMzViOGUyMjRmNzZhNzg5MjU4NzQ0MDU5ODU3L3RleHRyZWdpb246NjFmOTMzNWI4ZTIyNGY3NmE3ODkyNTg3NDQwNTk4NTdfMTk1MA_dcfbf529-b237-421d-8c37-5aa9d5516ea2" continuedAt="iabcdc8918ba04342bf2e666fa724d538" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="iabcdc8918ba04342bf2e666fa724d538"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year adjusted for any discrete events, which are recorded in the period that they occur. &#160;The estimated annual effective tax rate prior to discrete items was <ix:nonFraction unitRef="number" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="3" name="ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181NS9mcmFnOjYxZjkzMzViOGUyMjRmNzZhNzg5MjU4NzQ0MDU5ODU3L3RleHRyZWdpb246NjFmOTMzNWI4ZTIyNGY3NmE3ODkyNTg3NDQwNTk4NTdfMzE0_cd53e6dc-5522-43e1-b1db-fcaea84d10eb">5.8</ix:nonFraction>% as of the second quarter of fiscal year 2023, as compared to <ix:nonFraction unitRef="number" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="3" name="ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181NS9mcmFnOjYxZjkzMzViOGUyMjRmNzZhNzg5MjU4NzQ0MDU5ODU3L3RleHRyZWdpb246NjFmOTMzNWI4ZTIyNGY3NmE3ODkyNTg3NDQwNTk4NTdfMzcy_64811a32-a830-4abd-9aae-66516c851658">12.3</ix:nonFraction>% for the same period in fiscal year 2022.  In fiscal year 2023, the Company&#8217;s effective tax rate differs from the U.S. statutory rate primarily due to the impact of the valuation allowance, foreign taxes, and other non-deductible permanent items (such as non-deductible meals and entertainment, Section 162(m) excess compensation and non-deductible share-based compensation). </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence.  Therefore, the Company has provided a valuation allowance on its federal and state net operating loss carryforwards, federal and state R&amp;D credit carryforwards and other net deferred tax assets that have a limited life and are not supportable by the naked credit deferred tax liability sourced income as of November&#160;30, 2022.  The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&#8217;s results of operations.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_58"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjU3MQ_d9444894-4b93-4d20-83ef-c3516341e319" continuedAt="i4ca0f83f28d14ab6862d65e18b20b470" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i4ca0f83f28d14ab6862d65e18b20b470" continuedAt="i1834171b31bd46bfb7a63d851abfe326"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 13, 2020, the Company's shareholders approved the 2020 Stock and Incentive Award Plan (the &#8220;2020 Plan&#8221;).  The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance share units, performance shares and other incentive awards to the Company's employees, directors and other service providers.  On November 3, 2022 the Company's shareholders approved an amendment to the 2020 Plan to increase the reserve of shares of common stock available for future grants by <ix:nonFraction unitRef="shares" contextRef="ifa54aec1d4754ab481509765d96d5677_D20221103-20221103" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjE5OTAyMzI1ODc5Mg_0965d44d-e6a1-470e-ac05-a6048451155b">1,950,000</ix:nonFraction> shares.  As of November&#160;30, 2022, there was a maximum of <ix:nonFraction unitRef="shares" contextRef="i72ea6dcaec304dba8c28be69f4cd1398_I20221130" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfNDg2_7a8735a6-d3a6-4c5b-bb10-b96bd2b8824a">2.8</ix:nonFraction>&#160;million shares of common stock available for future grant under the 2020 Plan.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of the 2020 Plan, equity awards were issued under the 2004 Stock and Incentive Award Plan (the &#8220;2004 Plan&#8221;).  The adoption of the 2020 Plan did not impact the administration of equity awards issued under the 2004 Plan but following the adoption of the 2020 Plan, equity award grants are no longer made under the 2004 Plan.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has an employee stock purchase plan.  On November 3, 2022 the Company's shareholders approved an amendment to the employee stock purchase plan to increase the reserve of shares of common stock available for future grants by <ix:nonFraction unitRef="shares" contextRef="i5d63329084d44df394d886d4d1bb5ee2_D20221103-20221103" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjE5OTAyMzI1ODgwMw_69bcdae2-aa1a-4e61-b0e0-e518228a0324">1,000,000</ix:nonFraction> shares.  As of November&#160;30, 2022, there was a maximum of <ix:nonFraction unitRef="shares" contextRef="ieefdf4931e024fcbba5c7e8746fb00ff_I20221130" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfOTk3_834498cf-e8a4-4f69-b893-f801ecc13b8c">3.3</ix:nonFraction>&#160;million shares of common stock available for future grant under the employee stock purchase plan.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended November&#160;30, 2022 and 2021, share-based compensation expense was $<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTE2NQ_aeb2283c-b147-48bd-8b6c-5685239d42b6">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTE3Mg_6d8f5100-8322-4514-a9d2-98d2ebbae2e1">3.0</ix:nonFraction> million, respectively.  For the six months ended November&#160;30, 2022 and 2021, share-based compensation expense was $<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTA5OTUxMTYzMDQ5Ng_07f82682-d945-4b2f-aa91-5409c635b19d">6.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTA5OTUxMTYzMDUxMA_1958f165-2d9b-4acf-ac51-b9a6e0314543">5.4</ix:nonFraction>&#160;million, respectively.    </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended November&#160;30, 2022 and 2021, the Company granted stock options and restricted stock units under the 2020 Plan to certain employees and members of the Board of Directors.  Stock option awards are valued using the Black-Scholes option-pricing model and then amortized on a straight-line basis over the requisite service period of the award.  Restricted stock unit awards are valued based on the closing trading value of the Company&#8217;s common stock on the date of grant and then amortized on a straight-line basis over the requisite service period of the award.  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1834171b31bd46bfb7a63d851abfe326" continuedAt="ibe6c0616cea645039f10578c4214fe12">During the six months ended November&#160;30, 2022 and 2021, the Company granted performance share units under the 2020 Plan to certain employees.  The awards may be earned by achieving performance levels over the requisite service period.  The performance criteria are based on achieving certain performance targets and the total shareholder return (&#8220;TSR&#8221;) of the Company&#8217;s common stock relative to the TSR of the common stock of a pre-defined industry peer-group.  The fair value of these awards is based on a Monte Carlo simulation model.  </ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibe6c0616cea645039f10578c4214fe12">As of November&#160;30, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjMwMg_e3dc5ac7-7f7a-4cdb-a492-59e33c74d0d5">24.4</ix:nonFraction> million of unrecognized compensation expense related to share-based payment arrangements.  These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjQ3OA_7258dea1-d34c-4181-b9f2-5722001c9eba">two years</ix:nonNumeric>.  The Company has sufficient shares to satisfy expected share-based payment arrangements.</ix:continuation>  </span></div><div id="i897c24ef20684c93801e686a95e6abcc_61"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RleHRyZWdpb246ZDBjMmYxMTU1NGQ4NGNjZDllZDIxZDZmNTg1MDFiNWNfNjY2_5e0af118-28a7-4c89-8d7f-2005095724d2" continuedAt="i99ee093c737c4131ae5292ded3ec4d80" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i99ee093c737c4131ae5292ded3ec4d80"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is based on the weighted average number of common shares outstanding without consideration of potential common stock. Diluted earnings per share includes the dilutive effect of potential common stock consisting of stock options, restricted stock units and performance stock units, provided that the inclusion of such securities is not anti-dilutive. In periods with a net loss, stock options and restricted stock units are not included in the computation of diluted loss per share as the impact would be anti-dilutive.</span></div><div style="text-indent:22.5pt"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RleHRyZWdpb246ZDBjMmYxMTU1NGQ4NGNjZDllZDIxZDZmNTg1MDFiNWNfNjcw_3fc2584a-e515-496c-b4a4-f0c95e65197b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles basic to diluted weighted-average shares outstanding: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.513%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three&#160;Months&#160;Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi0xLTEtMS01MzkwNg_f615353c-1191-4da3-887c-4e98c29a95ea">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi0zLTEtMS01MzkwNg_47c07c99-8c43-4006-bf16-7ddc2111cc1b">39,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi01LTEtMS01MzkwNg_9dd29ac2-6eec-4683-a6bb-9cf6f29902d3">39,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi03LTEtMS01MzkwNg_8789302c-af5a-4d05-9e4b-bb64c550a8d4">38,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy0xLTEtMS01MzkwNg_ee554fe5-6907-4320-91a0-8a7a0107d6c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy0zLTEtMS01MzkwNg_0b2b81ae-ed2f-4732-8d53-23fc5fd1a2b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy01LTEtMS01MzkwNg_495264f5-9dc0-4e67-8d45-4198ba82cb3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy03LTEtMS01MzkwNg_2434913b-770f-4580-862f-8b855bc926a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC0xLTEtMS01MzkwNg_e9526fa6-2079-4a70-ba6f-746a432d86f7">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC0zLTEtMS01MzkwNg_8ce5950c-b156-4a1f-9385-141012ccd453">39,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC01LTEtMS01MzkwNg_4b1c84ee-9372-45b2-975f-790a3c3cb56f">39,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC03LTEtMS01MzkwNg_080fdce4-a27c-4681-a497-7ddc3f0a15c6">38,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities excluded as their inclusion would be anti-dilutive</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi0xLTEtMS01MzkwNg_9f020193-cf5f-4e4b-bba6-8fce9c254498">3,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi0zLTEtMS01MzkwNg_e0f55cff-8621-4a02-8e2f-214b0a6f204c">3,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi01LTEtMS01MzkwNg_243fd853-0b0c-48e9-9750-0ce8e68c5259">3,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi03LTEtMS01MzkwNg_ffe9852f-f28a-4a41-ab05-39104841b5e4">3,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjQyMw_7a01208a-b995-4db6-b471-bacd37e5ab14" continuedAt="i396fc85316634419a726a33a1f98caad" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i396fc85316634419a726a33a1f98caad" continuedAt="id7008ebf44334da2acedef54d555467f"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment information</span></div><div style="margin-bottom:9pt;text-indent:21.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews its segments and the approach used by the chief operating decision maker, the President and Chief Executive Officer ("CEO"), and management to evaluate performance and allocate resources.  Prior to the first quarter of fiscal year 2023, the Company considered the business to be a single operating segment engaged in the development, manufacture and sale of medical devices for vascular access, peripheral vascular disease and oncology on a global basis.  Commencing with the first quarter of fiscal year 2023, the Company began to manage its operations through <ix:nonFraction unitRef="segment" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfNjA1_db02c173-ff67-4450-92c8-6ce358c07543">two</ix:nonFraction> segments, Med Tech and Med Device to align with the transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company.  The Company's chief operating decision maker evaluates these <ix:nonFraction unitRef="segment" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfOTA4_db02c173-ff67-4450-92c8-6ce358c07543">two</ix:nonFraction> segments based on net sales and gross margin to, among other items, allocate resources and assess performance.  Executives reporting to the CEO include those responsible for commercial operations, manufacturing operations, regulatory and quality and certain corporate functions.  The CEO evaluates all other elements of profitability, investment and cash flow metrics on a consolidated global basis due to shared infrastructure and resources. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company manages its assets on a total company basis, not by operating segment; therefore, the CEO does not review any asset information by operating segment and, accordingly, asset information is not reported or evaluated by operating segment.  Total assets were $<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMTA5OTUxMTYzMDU2NA_a4a725c5-0124-4a7e-b4d9-134d75f97b8d">558.2</ix:nonFraction> million as of November&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="ango:ScheduleOfNetRevenueByProductGroupTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjQzMg_07c8334e-074f-44cb-b756-abd3d2a2e761" continuedAt="i617671a12c814f7c93ee6fecab365815" escape="true">The table below summarizes net sales and gross margin by Med Tech and Med Device including prior periods during which the Company considered the business to be a single operating segment, in order to conform to the current period presentation:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="id7008ebf44334da2acedef54d555467f" continuedAt="ib8b8ce10293a4caeb0b1e0389b185a1d"><div style="margin-bottom:9pt"><ix:continuation id="i617671a12c814f7c93ee6fecab365815"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy0xLTEtMS01MzkwNg_d9a8703e-453f-4da9-8a06-7ed2ef7ab704">24,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy0zLTEtMS01MzkwNg_77852287-4531-41c6-9c56-3eed676e9f45">18,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy01LTEtMS01MzkwNg_3fa52ca4-e4df-4247-9a59-4837d0f4a3e2">47,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy03LTEtMS01MzkwNg_ff72aad4-bc50-4183-b6b7-6dd25669d3ba">36,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC0xLTEtMS01MzkwNg_4472d82a-c9d0-4b29-9e42-68f728424aa3">15,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC0zLTEtMS01MzkwNg_09a8dd1e-4d72-492d-923a-6b6181e7aa80">12,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC01LTEtMS01Nzg0Mw_9519998a-f3b8-4309-b3db-f11ebb4d05d9">30,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC03LTEtMS01Nzg1Mg_831f6697-2c85-4cc5-8e2c-bebdd293e8e0">24,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS0xLTEtMS01MzkwNg_3a89d169-7fec-43a4-ae1e-7ab4662c8d96">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS0zLTEtMS01MzkwNg_c9de2a44-850f-4511-bee3-611cf87b78b7">66.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS01LTEtMS01ODkyNA_b5c8d42d-1609-4b64-a31c-fe7aa087ad47">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS03LTEtMS01ODkyNA_8259a8a7-3d38-44da-b61b-afd8021f28fb">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy0xLTEtMS01MzkwNg_7f45a9e8-b306-48d2-bed1-1352156e6e54">60,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy0zLTEtMS01MzkwNg_47ad14d6-8f4a-46ce-bc7b-c3445d6b6c01">59,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy01LTEtMS01MzkwNg_2fd19173-6fef-4a90-9222-4b313d49b26a">119,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy03LTEtMS01MzkwNg_8c9b0aad-5ce8-41aa-9e53-9118f334a89d">118,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC0xLTEtMS01MzkwNg_879c1573-156d-4451-b41d-b1b1684dc01d">29,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC0zLTEtMS01MzkwNg_66f0b9da-c007-44a4-b245-e19f721b66fa">27,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC01LTEtMS01Nzg2MQ_5ebb625d-11ae-480b-9b37-8d3d97bef438">57,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC03LTEtMS01Nzg3MQ_09726aa9-808b-4560-bd98-44311ccc31e2">56,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS0xLTEtMS01MzkwNg_09c62cbe-2d02-4198-92bc-c7b3fab59bf0">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS0zLTEtMS01MzkwNg_67759b88-01b6-4f1a-bbc9-0dd566c29d9d">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS01LTEtMS01ODk0OA_36061b02-1061-4cb0-9f0c-86f0519ef910">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS03LTEtMS01ODk0OA_64e41b8a-a0a8-43fe-ad21-29d81a11f018">47.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtMS0xLTEtNTM5MDY_7c52205f-fc99-4e2a-82d4-e7704fc86d7b">85,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtMy0xLTEtNTM5MDY_46f110a4-5beb-4705-87df-b9da8e7dc5ef">78,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtNS0xLTEtNTM5MDY_af9164c3-0c8a-408c-b6fd-6506febff56e">166,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtNy0xLTEtNTM5MDY_ff02c581-8415-4db4-8f0a-1b213acd82b5">155,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItMS0xLTEtNTM5MDY_914daaef-a00a-4508-bb9a-a258124df269">45,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItMy0xLTEtNTM5MDY_58da206b-4a06-4174-8247-3947721f9a82">40,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItNS0xLTEtNTk1MzE_6cbe8d10-4d00-4115-acad-9f9f18c8de58">87,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItNy0xLTEtNTk1MzE_83f51b05-c9c1-4026-9827-651450496a69">80,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtMS0xLTEtNTM5MDY_e53f5b6e-47a1-4389-9092-a90ec2b2c0fd">52.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtMy0xLTEtNTM5MDY_fd52b4e2-1f20-40f1-9ab9-c66a7aaa042d">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtNS0xLTEtNTg0NDc_4abb22d2-4726-4fea-94f3-30183582d22c">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="3" name="ango:GrossMarginPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtNy0xLTEtNTg0NTM_45506ef5-0157-4696-a53e-70e9e43ac5ea">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic information</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjQyOA_198dc25e-377c-46d6-b519-fa36323b61dc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes net sales by geographic area based on external customer location:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c2fd9d28c04a93ae03769f99f5b982_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy0xLTEtMS01MzkwNg_f074a8cd-2832-48b4-8b49-1d6f7c115b3d">71,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69be4f7a7d4e429f9786923e58bb233a_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy0zLTEtMS01MzkwNg_7d7a3981-f992-4a7e-9cfb-2743507f9c8b">65,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1532603b5d5344d2b521ebca95510e2d_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy01LTEtMS01MzkwNg_db2b3ea3-efd3-42d2-be49-9150e9119493">140,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fa11be4a974f91a8f83c64c4b79d43_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy03LTEtMS01MzkwNg_1f6d24d1-d77f-4f19-a59b-a502d6cdf56a">129,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84b2cc1c77648d59e643ea5bca9cd40_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC0xLTEtMS01MzkwNg_1d5732a3-c1bd-4f83-b57c-08f8f3812519">13,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5207d4b6e44c3bb870e98f47ae464f_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC0zLTEtMS01MzkwNg_8966f00a-2f99-4f65-a96d-ead0a8fc8b20">12,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102e00650df64160ab95f91283be5671_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC01LTEtMS01MzkwNg_371d4b92-b8e6-456d-8102-9b3f915c3d00">26,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbd65f28780439d8d4b3739c60451f2_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC03LTEtMS01MzkwNg_5d382f78-3607-4c19-958b-b694ee51f93b">25,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi0xLTEtMS01MzkwNg_83e67bc4-6ae5-4d3e-a12b-55b94f5aa8d3">85,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi0zLTEtMS01MzkwNg_89963319-09c3-4503-b342-0101faf11fc9">78,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi01LTEtMS01MzkwNg_336655da-e0f3-4309-94c6-50c0dacf1243">166,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi03LTEtMS01MzkwNg_9a3dbde0-44b0-4949-bab2-a8626d85cd5d">155,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="ib8b8ce10293a4caeb0b1e0389b185a1d">For the three months ended November&#160;30, 2022 and 2021, international sales as a percentage of total net sales were <ix:nonFraction unitRef="number" contextRef="id088a0af0c2d43b9ad0bda298d1ff754_D20220901-20221130" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjA3Ng_cdba627e-1b74-4136-be13-5b658ae5e915">16.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ibc69fb0bea484528bc57184c81e8345b_D20210901-20211130" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjA4Mw_5dc947b8-b83c-4b3b-9e48-1a1e28ab4329">16.5</ix:nonFraction>%, respectively.  For the six months ended November&#160;30, 2022 and 2021, international sales as a percentage of total net sales were <ix:nonFraction unitRef="number" contextRef="i731c9ba446ab4192a1491d1c6f27c373_D20220601-20221130" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMTA5OTUxMTYzMDI3MA_39245c7b-e248-41f9-8225-8ca2ddfebe91">15.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i636ddb4bd5b74d3f8a431176bd1d93e5_D20210601-20211130" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMTA5OTUxMTYzMDI3Mw_11a3b41d-5602-4c78-9a31-690569536208">16.4</ix:nonFraction>%, respectively.  Sales to any one country outside the U.S., as determined by shipment destination, did not comprise a material portion of net sales in any of the last three fiscal years. In addition, no one customer represents more than 10% of consolidated net sales and <ix:nonFraction unitRef="number" contextRef="ibbe2c52f725c437ab009d57429836a32_D20220601-20221130" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjM1Ng_103e71cd-354c-42b9-9963-23e50000799b">96</ix:nonFraction>% of long-lived assets are located within the United States.</ix:continuation>  </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_67"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI2Ng_9f49d865-0cc9-4bbc-b9e1-6a3c432df5fe" continuedAt="i7f2bb1767e93434a9d2bdec633ffe45a" escape="true">FAIR VALUE</ix:nonNumeric></span></div><ix:continuation id="i7f2bb1767e93434a9d2bdec633ffe45a" continuedAt="if89c16491dda4df998a001e7ed5bc6a6"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company measures certain financial assets and financial liabilities at fair value based upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, the Company applies valuation techniques to estimate fair value. FASB ASC Topic 820,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of financial assets and financial liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.  The three levels of the hierarchy are defined as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Inputs to the valuation methodology are significant unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial instruments include cash and cash equivalents, accounts receivable, accounts payable and contingent consideration. The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities.  The recurring fair value measurements using significant unobservable inputs (Level 3) relate to contingent consideration liabilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="if89c16491dda4df998a001e7ed5bc6a6" continuedAt="i6c4c92b0fb764889af0afdceb4002b75"><div style="margin-bottom:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI4Mw_7cbbae31-d962-48db-96b9-ed4db0f7a7a8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value Measurements using inputs considered as:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value at Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration for acquisition earn outs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a313731ab245768b6c5d3dfb85c22a_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItMS0xLTEtNTM5MDY_b9378f24-03e1-4826-a88c-a9a28653cbab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ad2ccb7c6b41e89084e3b945f40e64_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItMy0xLTEtNTM5MDY_c7379fb5-750a-4e5b-9b86-ef99ea61f3c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia25b0cac0e4a4dac8864feacd65915ec_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItNS0xLTEtNTM5MDY_decc177b-8dcb-4d99-afd1-1d9e74fd7fce">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1288467e0d4c2b98b2092131400cc2_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItNy0xLTEtNTM5MDY_03390c5b-1efc-4a16-9bf9-847f5a2b431c">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Financial Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a313731ab245768b6c5d3dfb85c22a_I20221130" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtMS0xLTEtNTM5MDY_a38d22cc-837e-44fe-b191-ddd15d1b94d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ad2ccb7c6b41e89084e3b945f40e64_I20221130" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtMy0xLTEtNTM5MDY_e18fa073-8df0-40e9-ada0-4c76bb857cbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia25b0cac0e4a4dac8864feacd65915ec_I20221130" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtNS0xLTEtNTM5MDY_0d8b7a22-c58a-42fb-87c5-44fe131e3f58">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1288467e0d4c2b98b2092131400cc2_I20221130" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtNy0xLTEtNTM5MDY_7b58bc9b-e690-4dd3-837c-43a485ed40cf">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value Measurements using inputs considered as:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value at May&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration for acquisition earn outs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eebdc1dda64c488bf0ee527902d32d_I20220531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtMS0xLTEtNTM5MDY_9d716292-f2d0-4e71-b91c-f952161ad64e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bf28259a0f48979d1480adb13bf9ec_I20220531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtMy0xLTEtNTM5MDY_c3f74931-bf92-48e6-84e4-2e340a9ef5c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e7d990beb04157bf2af35e180e5437_I20220531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtNS0xLTEtNTM5MDY_0bd3d69e-6481-4046-bfae-3fcf62019a36">16,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50932b29e3234e39be7fd89538f9ae51_I20220531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtNy0xLTEtNTM5MDY_ecd88f5a-e315-4616-bf84-ea119394b658">16,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Financial Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eebdc1dda64c488bf0ee527902d32d_I20220531" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtMS0xLTEtNTM5MDY_e1120ef0-3c60-4255-b39d-406436735842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bf28259a0f48979d1480adb13bf9ec_I20220531" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtMy0xLTEtNTM5MDY_e26e7508-e93b-48cd-8568-0a3a3d21a2a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e7d990beb04157bf2af35e180e5437_I20220531" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtNS0xLTEtNTM5MDY_f1e29948-ebe5-421e-9738-4aaffa3be1e0">16,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50932b29e3234e39be7fd89538f9ae51_I20220531" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtNy0xLTEtNTM5MDY_3986d5b6-58e8-4b6a-97ad-74074236385d">16,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level 1, 2 and 3 for the three and six months ended November&#160;30, 2022 and 2021.</span></div><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI3OA_5bc9350b-24f3-404a-b8de-dbf7ac6d62b9" continuedAt="icb11d500e8ba48119bd0b68d02185e1d" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in fair value components of Level 3 instruments:     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, August 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605f35cad602428b8143074fa8c31ba8_I20220831" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfMi0xLTEtMS01MzkwNg_bc72942d-bd30-4827-bde1-18228f8d895d">17,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in present value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfNC0xLTEtMS01MzkwNg_7f656501-471b-4384-9b3f-1511a9f61728">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency gain from remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="ango:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfNS0xLTEtMS01MzkwNg_fe275d81-80ea-46ba-88e3-2f7138d4c9c1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfNi0xLTEtMS01MzkwNg_54c46098-e0c7-43a4-8cb1-6b3c395f3dba">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, May 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfMi0xLTEtMS01OTUzMw_578df072-83b4-437a-96c4-b1cb1c9f833d">16,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in present value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:ChangeInFairValueOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfNC0xLTEtMS01OTUzMw_0645bec6-395e-4498-adac-300bc751d684">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency gain from remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfNS0xLTEtMS01OTUzMw_fac96de5-75f8-470c-8e61-9ad704f53416">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfNi0xLTEtMS01OTUzMw_1dadfff9-f020-42f2-be16-2364de922c9a">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="icb11d500e8ba48119bd0b68d02185e1d">(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Liability for Acquisition Earn Outs</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's business combinations involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones or various other performance conditions. Payment of the additional consideration is generally contingent on the acquired company reaching certain performance milestones, including attaining specified revenue levels or product development targets. Contingent consideration is recorded at the estimated fair value of the contingent payments on the acquisition date. The fair value of the contingent consideration is remeasured at the estimated fair value at each reporting period with the change in fair value recognized as income or expense within change in fair value of contingent consideration in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the initial liability and remeasures the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements, which is determined using a discounted cash flow model applied to projected net sales, using probabilities of achieving projected net sales and projected payment dates. Projected net </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="i6c4c92b0fb764889af0afdceb4002b75" continuedAt="i0eb4a786f7194ad6bddbb8813c738d46"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales are based on internal projections and extensive analysis of the target market and the sales potential. Increases or decreases in any valuation inputs in isolation may result in a significantly lower or higher fair value measurement in the future. </span></div><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI4MQ_d3bd66e1-030b-491b-809d-bc3c9a338924" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of November&#160;30, 2022:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:25.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue based payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd9433e4df6a4d73bdb71c139f61a75a_I20221130" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMS0xLTEtMS01MzkwNg_15cb867f-97da-48af-b3e0-6c1db608d7d6">18,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i360405dac2ac408196db947950f5fcdd_I20221130" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMS03LTEtMS01MzkwNg_87c71ead-038b-48fe-ab17-14a346e8e10f">5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d7862e7cad34bfd8d2c83decfca3201_I20221130" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMi03LTEtMS01MzkwNi90ZXh0cmVnaW9uOmFmMjIzOWU0ZThiZDRjYjc4NmIyOTMxNjQ2MGEwZDJjXzQ_fb80494f-a656-4838-8b4e-249774f750cd">90</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i86ec9e06fac9486392729b869d82f434_I20221130" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMi03LTEtMS01MzkwNi90ZXh0cmVnaW9uOmFmMjIzOWU0ZThiZDRjYjc4NmIyOTMxNjQ2MGEwZDJjXzk_8c44aff4-49c5-4e4e-8fde-e02f477b44fd">100</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2025</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0eb4a786f7194ad6bddbb8813c738d46">At November&#160;30, 2022, the amount of undiscounted future contingent consideration that the Company expects to pay as a result of all completed acquisitions is approximately $<ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-5" name="ango:UndiscountedContingentConsiderationDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDAxNg_0d4b6271-343f-4d10-b1f5-a91e5bf8ee7f">20.0</ix:nonFraction>&#160;million.  The milestones, including revenue projections and technical milestones associated with the contingent consideration, must be reached in future periods ranging from fiscal years 2023 to 2029 in order for the associated consideration to be paid.</ix:continuation> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_70"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc1Nw_4a99ba60-3d71-4c58-b7fb-5083752257a6" continuedAt="i917ea3c961a54e79ac53cb37c9625967" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i917ea3c961a54e79ac53cb37c9625967" continuedAt="ie2f32521ad434feb8b99064ecfed1062"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception of the contract.  The Company has operating leases for buildings, primarily for office space, R&amp;D, manufacturing and warehousing.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date.  Many of the lease agreements contain renewal or termination clauses that are factored into the determination of the lease term if it is reasonably certain that these options would be exercised.  The Company recognizes lease expense for these leases on a straight-line basis over the lease term.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="ango:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc2Mg_36aaf87b-0397-4b45-8aea-8f021985c524" continuedAt="ic4cbe1608b9946f9917f39e9981079f9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0zLTEtMS01MzkwNg_a2a64b55-11c5-4fc7-b948-c7cd37fa6645">5,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi01LTEtMS01MzkwNg_ce44080e-5ecd-4a00-b43a-2a1cdfe672f5">6,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0zLTEtMS01MzkwNg_b4a93ba2-6920-4f3f-966b-c9923a8a473d">2,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC01LTEtMS01MzkwNg_ac1f3d95-8180-4854-afa6-d89f25ee0f5b">2,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0zLTEtMS01MzkwNg_00efdbfc-3316-47cd-aa51-72764316bace">3,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS01LTEtMS01MzkwNg_0e5c0b0a-fc76-4c86-bd68-4e82956058b8">4,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNi0zLTEtMS01MzkwNg_1df79834-dd53-4da5-971a-358a8bcea398">5,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNi01LTEtMS01MzkwNg_3954571b-09a2-43d2-811a-572e23594ed7">7,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate implicit in lease agreements is typically not readily determinable, and as such the Company used the incremental borrowing rate based on the information available at commencement date in determining the present value of future payments.  The incremental borrowing rate is defined as the interest the Company would pay to borrow on a collateralized basis, considering factors such as length of lease term.  <ix:continuation id="ic4cbe1608b9946f9917f39e9981079f9" continuedAt="ib2f66b2facd648ccac858e173643e1fe">The following table presents the weighted average remaining lease term and discount rate:</ix:continuation></span><ix:continuation id="ib2f66b2facd648ccac858e173643e1fe"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjA5ZjdjMTdjYWRlMTQwYjhiM2IyNGE3MjRjZTBmMDAyL3RhYmxlcmFuZ2U6MDlmN2MxN2NhZGUxNDBiOGIzYjI0YTcyNGNlMGYwMDJfMS0xLTEtMS01MzkwNg_b0ff33da-9561-40fd-8e54-65cfb65921bd">2.88</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjA5ZjdjMTdjYWRlMTQwYjhiM2IyNGE3MjRjZTBmMDAyL3RhYmxlcmFuZ2U6MDlmN2MxN2NhZGUxNDBiOGIzYjI0YTcyNGNlMGYwMDJfMi0xLTEtMS01MzkwNg_f8b57457-ff21-451e-811d-249dbf3d1499">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="ie2f32521ad434feb8b99064ecfed1062"><div style="margin-bottom:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc2MA_52721dc0-feeb-4ccc-9e1a-f59339955a4a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturities of the lease liabilities for each of the following fiscal years is:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMS0xLTEtMS01MzkwNg_70aaf878-205e-42bf-a656-66cd21aca37a">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMi0xLTEtMS01MzkwNg_994be80c-51aa-4b37-bcd5-07f51c3ffab9">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMy0xLTEtMS01MzkwNg_5678f50a-983d-4f8a-b058-cd647773fe5f">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfNC0xLTEtMS01MzkwNg_fc15dc67-b03b-43c9-9ed5-9f265f9292ef">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="ango:LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfNS0xLTEtMS01MzkwNg_38b6eab6-afec-4961-99cd-be63ae069942">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfNy0xLTEtMS01MzkwNg_1f6a3420-5861-4a6a-8b07-90a0a7f83cbb">6,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfOC0xLTEtMS01MzkwNg_16c24534-b627-4b63-9ed4-e63a3a0fe3ba">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfOS0xLTEtMS01MzkwNg_1df79834-dd53-4da5-971a-358a8bcea398">5,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMTAtMS0xLTEtNTM5MDY_b4a93ba2-6920-4f3f-966b-c9923a8a473d">2,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMTEtMS0xLTEtNTM5MDY_2a958529-db65-4132-8bb3-08b066bd359f">3,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended November&#160;30, 2022 and 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTQ1NQ_87384461-b096-4271-85bd-4e779af0dc58">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTQ2Mg_223da7c5-f841-438b-9906-5f48346a79de">0.7</ix:nonFraction> million of operating lease expense, respectively, which includes immaterial short-term leases.  During the six months ended November 20, 2022 and 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTA5OTUxMTYyOTc3NQ_d94f4ee1-a253-4f3b-b03c-08fa91a96fbd">1.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTA5OTUxMTYyOTc3Mw_27b8e45a-a41c-4a00-9008-9f1bf29e6f9e">1.4</ix:nonFraction>&#160;million of operating leases expense, respectively, which includes immaterial short-term leases.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc2Mw_f2ee50e1-2f37-4248-aee5-1df9b1d3fd32" continuedAt="i766a6e90bd2f42c9a60ad6f8a495e3a3" escape="true">The expenses on the Consolidated Statement of Operations were classified as follows:</ix:nonNumeric></span><ix:continuation id="i766a6e90bd2f42c9a60ad6f8a495e3a3" continuedAt="ida932f7151ce42f5a81fbd780b4c7ea6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254de9e531fb4e0c9d03f1d1943e752e_D20220901-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi0xLTEtMS01MzkwNg_28a3203b-5c53-4c60-9804-9f89c0debfa6">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544584d510904231bd6fd4ad6edaceed_D20210901-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi0zLTEtMS01MzkwNg_9ac55a68-b97c-41e2-992a-6d41db30a66c">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d99785b1194e778010f6582bcc0573_D20220601-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi01LTEtMS01MzkwNg_7178464f-1134-44cf-be8e-b174f40e61a7">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412326f7f86f49389bc84bbcd7b983b4_D20210601-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi03LTEtMS01MzkwNg_05c561b0-f7ec-4025-9101-ac380d99955a">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58f23a0eada416e97df8f458b27fbb9_D20220901-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy0xLTEtMS01MzkwNg_eea6990b-98b3-435c-a389-106bb3f63142">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7c661bc93a4242beb5a3453d1917a2_D20210901-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy0zLTEtMS01MzkwNg_f0c1ac21-75c0-4f00-a9a7-858d7a07b0ef">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i404cfafae04d4964a4bf5b13fba7cb2a_D20220601-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy01LTEtMS01MzkwNg_39c09e59-1c95-42c7-a307-b01a8e982d4b">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c51f234e672471b8e71d406f6c8a7e7_D20210601-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy03LTEtMS01MzkwNg_3b21bb5e-ac77-464f-b78b-4b5419c593b8">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27add22ce5d243fab019d5956cd78ed3_D20220901-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC0xLTEtMS01MzkwNg_8084dceb-99b6-4131-9923-4f2d534bb014">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa1f09bc0264f0faa5e3f247394dddd_D20210901-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC0zLTEtMS01MzkwNg_945087de-bb20-4c12-a3d4-505bf7f6f4fe">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie222d4925bad48388ddbb56ee9bec5a3_D20220601-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC01LTEtMS01MzkwNg_f7a347d5-0b7c-4727-a189-6426c8b24d9d">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9f367db484179bc46e4196b143896_D20210601-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC03LTEtMS01MzkwNg_1c3a8198-cba6-47e8-a310-24c3c2aaee8a">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a056055ed471eb130b5c3aa8d0761_D20220901-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS0xLTEtMS01MzkwNg_a62ee5b4-afdf-43e2-aad1-1d19bcc0e1eb">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea95b9fd5b84377910bba4663837245_D20210901-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS0zLTEtMS01MzkwNg_2e78c726-156d-4df8-b679-c3b92292e0ad">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4307997465a748938dd80b54c9b60cf4_D20220601-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS01LTEtMS01MzkwNg_e2ef7e14-8619-46ae-ba53-59756b9a6505">725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6fe7fe11684c62858764a7d401b9f1_D20210601-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS03LTEtMS01MzkwNg_f4699843-d696-443d-b7bf-6de4f35d474e">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi0xLTEtMS01MzkwNg_a60d506c-2b04-4896-bd14-8188e9733783">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi0zLTEtMS01MzkwNg_2e8acef0-46fc-44f7-803f-be0d30f51aae">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi01LTEtMS01MzkwNg_f561e847-ce7a-4954-9756-9f63e579ee62">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi03LTEtMS01MzkwNg_5c7c62ed-a405-4641-b969-455bbed0128d">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><ix:continuation id="ida932f7151ce42f5a81fbd780b4c7ea6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow and other information related to leases for the six months ended:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfMi0xLTEtMS01MzkwNg_270068f1-1f09-4a41-a7c6-121f23b71fa5">1,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfMi0zLTEtMS01MzkwNg_572a902c-92ee-498a-ad10-7b573543fb0a">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfNC0xLTEtMS01MzkwNg_3d69da25-a39a-4c85-907e-224a78d3e9b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfNC0zLTEtMS01MzkwNg_4757c4e6-7e39-4349-8314-bc00110b6906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_73"></div><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfNjg2NA_b7203ec3-75df-47af-b00a-5be876a59abc" continuedAt="i8cf81a2e6f0b4a3b93b765cf2e8c3bab" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="margin-bottom:0.9pt"><span><br/></span></div><ix:continuation id="i8cf81a2e6f0b4a3b93b765cf2e8c3bab" continuedAt="i1d31134c7513456cb0c7166adab6c20c"><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various legal proceedings, including commercial, intellectual property, product liability, and regulatory matters of a nature considered normal for its business.  The Company accrues for amounts related to these matters if it is probable that a liability has been incurred, and an amount can be reasonably estimated.  The Company discloses such matters when there is at least a reasonable possibility that a material loss may have been incurred.  However, the Company cannot predict the outcome of any litigation or the potential for future litigation.</span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.R. Bard, Inc. v. AngioDynamics, Inc.</span></div><div style="margin-bottom:0.9pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 11, 2012, C.R. Bard, Inc. (&#8220;Bard&#8221;) filed a suit in the United States District Court of Utah claiming certain of the Company's implantable port products infringe on <ix:nonFraction unitRef="patent" contextRef="i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111" decimals="INF" name="ango:NumberOfPatentsAssertedForReexamination" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfODM1_b37ac397-ce21-47f8-b2c6-538163e3da29">three</ix:nonFraction> U.S. patents held by Bard (US Patent Nos. 7,785,302 ("302"), 7,959,615 (&#8220;615&#8221;) and 7,947,022 ("022")).  The case was stayed pending reexamination in the US Patent and Trademark Office ("USPTO").  Following the reexamination proceedings, and the parties&#8217; related appeals to the Federal Circuit which resulted in further proceedings at the USPTO, certain claims of the 615 patent were held invalid, while the remaining claims of the 615 patent and the other <ix:nonFraction unitRef="patent" contextRef="i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111" decimals="INF" name="ango:NumberOfPatentsUpheldOverPriorArtReferences" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfMTI5NA_fc26534b-1c09-46c4-8573-8d14d7e5f071">two</ix:nonFraction> patents were upheld over the prior art references considered in the reexamination proceedings.  Thereafter, the case was transferred from the District of Utah to the United States District Court for the District of Delaware (&#8220;District of Delaware&#8221;).  A scheduling order was entered on March 23, 2021.  On July 22, 2021, in another case against a different defendant, the District of Utah invalidated multiple claims of the &#8216;302, &#8216;022, and &#8216;615 Patents under 35 USC &#167;101, including claims asserted against the Company.  Following the Utah court&#8217;s decision, the Company filed a Motion for Judgment on the Pleadings based on collateral estoppel on August 9, 2021. Bard filed its opposition brief on September 2, 2021 and the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="i1d31134c7513456cb0c7166adab6c20c"><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company filed a reply on September 9, 2021. Following a hearing on the Motion for Judgment on the Pleadings on December 21, 2021, the District of Delaware stayed the case pending the Federal Circuit's resolution of Bard's appeal from the Utah Decision. Previously, the Company had filed a Motion for Leave to Amend its Answer and Counterclaims on April 14, 2021. This motion sought to add counterclaims for infringement of U.S. Patent Nos. 9,168,365; 9,895,523; and 10,632,295, as well as a counterclaim of inequitable conduct. On November 5, 2021, the Company notified the District of Delaware that the Utah decision was certified for appeal to the Court of Appeals for the Federal Circuit. Contemporaneously, the Company withdrew its Motion for Leave to Amend its Answer and Counterclaims without prejudice to refile. Oral argument has been scheduled for February 10, 2023, and the appeal remains pending. The Company believes these claims are without merit and intends to defend them vigorously. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.  </span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2015, Bard and Bard Peripheral Vascular filed suit in the District of Delaware claiming certain of the Company's implantable port products infringe on <ix:nonFraction unitRef="patent" contextRef="i274e4b0db3ab4da292cee7a42340b2fd_D20150310-20150310" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfMzQxMA_465d1611-bf69-4dc0-b3b2-ba862ee81e52">three</ix:nonFraction> U.S. patents held by Bard (US Patent Nos. 8,475,417, 8,545,460, 8,805,478).  The case proceeded through trial which began on March 4, 2019.  At the close of Bard&#8217;s case, the Court granted the Company's oral motion for judgment as a matter of law as well as its motions for summary judgment on the grounds that the asserted patents are invalid, ineligible, not infringed and not willfully infringed. On May 10, 2019, the Company filed a motion for attorney fees and non-taxable expenses under 35 USC Sec. 285. Bard appealed the judgment to the Federal Circuit and on November 10, 2020, the Federal Circuit reversed the judgment in part with respect to Section 101 (subject matter eligibility), and vacated and remanded the trial court&#8217;s invalidity and non-infringement judgments.  Following remand from the Federal Circuit, a jury trial commenced in the District of Delaware beginning November 14, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 22, 2022, a jury entered a verdict finding that certain of the Company&#8217;s implantable port products infringe certain claims of U.S. patents held by Bard. The issue of damages was bifurcated by the Court during trial, was not determined by the jury and will be subject to a separate proceeding. The Company strongly disagrees with the claims and the verdict. The issues presented to the jury do not comprise all of the issues to be determined in the case. Equitable issues and patent eligibility issues remain to be decided by the judge, and damages remain to be decided by a jury. The Company believes it has meritorious defenses and positions with respect to the matters remaining to be decided and the jury decision, and intends to vigorously pursue all available remedies and defenses, including post-trial motions and appeals. The parties proposed a post-trial briefing schedule with opening briefs to be filed January 20, 2023. The Company maintains its belief that Bard&#8217;s claims are without merit. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2021, Bard filed suit in the District of Delaware asserting certain of the Company&#8217;s port products (including certain related infusion sets) infringe U.S. Patent Nos. 8,025,639, 9,603,992 (&#8220;992&#8221;) and 9,603,993 (&#8220;993&#8221;).  On May 20, 2021, the Company filed a Motion to Dismiss Bard&#8217;s claims with respect to the &#8217;992 and &#8217;993 patents. On July 22, 2021, the Company submitted the Utah court&#8217;s decision invalidating claims of the related &#8216;302, &#8216;022, and &#8216;615 Patents as supplemental authority in support of its Motion to Dismiss. The parties agreed to submit supplemental briefing to address the Utah court&#8217;s decision. Bard submitted its brief on August 12, 2021, and the Company submitted its reply on September 2, 2021. On December 21, 2021, the District of Delaware stayed the case pending the Federal Circuit's resolution of Bard's appeal of the Utah decision invalidating multiple claims of the &#8216;302, &#8216;022, and &#8216;615 patents under 35 USC &#167;101. The Company maintains its belief that Bard's claims are without merit. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. v. C.R. Bard, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:0.9pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2017, the Company commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&#8220;Bard&#8221;).  In this action, the Company alleged that Bard had illegally tied the sales of its tip location systems to the sales of its PICCs in violation of federal antitrust laws and this practice had an anti-competitive effect in the US market for PICCs.  The Company sought both monetary damages and injunctive relief.  On October 6, 2022, a jury verdict was rendered finding Bard did not restrain competition in violation of federal antitrust laws.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_76"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RleHRyZWdpb246NTdlNzg3NGI2Y2QwNGMwOWIxMDU0ZTdiNmQ4MTRmYTRfNjM3_c15bd6a7-df51-4921-94fe-edcb31cce488" continuedAt="ic6122d53dfd3454eaa978db01c6358f9" escape="true">ACQUISITION, RESTRUCTURING, AND OTHER ITEMS, NET</ix:nonNumeric></span></div><ix:continuation id="ic6122d53dfd3454eaa978db01c6358f9" continuedAt="i598e6b0db4aa47c4bda4588ac73c7506"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition, Restructuring and Other Items</span></div><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RleHRyZWdpb246NTdlNzg3NGI2Y2QwNGMwOWIxMDU0ZTdiNmQ4MTRmYTRfNjM4_c1877d7d-c6a7-4f46-8107-9d9086f6b727" continuedAt="i26dc794fe06641c28947378efcba1523" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition, restructuring and other items, net, consisted of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd57db09d954401a970450cb332edc2_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi0xLTEtMS01MzkwNg_7b2b790f-9093-4e99-82bf-5ab37b8646d1">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3cc03838394279b14c503789157f07_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi0zLTEtMS01MzkwNg_1180f4ab-de14-442c-a30a-57ade3dac7db">2,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bbc169a6da4a36952422f9fd58300c_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi01LTEtMS01MzkwNg_1afd0129-6b22-427f-98ca-1566c26483d4">4,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31c5d45239404a43ada7157497ae9c3e_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi03LTEtMS01MzkwNg_c5cb418b-2901-4fcf-a431-007102b79c60">4,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mergers and acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1113d3caab5d408faab5a5f245311b15_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy0xLTEtMS01MzkwNg_5263c34d-8d87-40db-9f66-c7f22e9fc826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee2fde770274d08a3b8af0bb66c465b_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy0zLTEtMS01MzkwNg_8d090fa2-d838-423d-bcbf-a49f6fdac028">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f83e0c893cb4e7fb69e22ed93dc6a55_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy01LTEtMS01MzkwNg_28214fc5-fd57-4329-b50f-f94f9b535728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bc7936712144249aa26ca9905b3c8e_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy03LTEtMS01MzkwNg_3ff9d80d-2ca3-4d4f-965b-4d9e542cd18a">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing relocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ef1be6232914c8490f870666a771ffa_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi0xLTEtMS01MzkwNg_3a2107cb-c4bf-473f-95ac-616e0e1706d6">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab1f2674fe04183b7df7f14ea9f167c_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi0zLTEtMS01MzkwNg_dbaf7edf-8133-4497-8125-7e15a2efed7a">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1aa84fb02d4395a39a7bf23b044eab_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi01LTEtMS01MzkwNg_0c6fb6a8-c020-4eff-8d21-c047c3a64364">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06523c7cb754445ab38517c2cb05ce7d_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi03LTEtMS01MzkwNg_2d9900dc-8ec6-42e9-894a-cb058d9236d2">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli Innovation Authority prepayment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cec44cbde2244a9a355ca544f33885f_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC0xLTEtMS01MzkwNg_51bbab92-b91c-4e78-a83e-c2fd45d9c63d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7706a0f7dae740418007c9381795d2bd_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC0zLTEtMS01MzkwNg_2dd86cdb-03a5-4aed-85ec-708131a04d99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4dd796fd591465c8eb9c1eb60615285_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC01LTEtMS01NjM4Nw_32f9b55b-c75f-4691-99ee-bd6a61d318a9">3,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47789d4315de4707952ba298e204a6ed_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC03LTEtMS01NjQxOQ_603acd35-5d42-4bfe-b112-4276267a224b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044eeedb625141a788d4e6c857cff53e_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS0xLTEtMS01MzkwNg_d3604b76-6f3c-4ed2-a3c7-66fdef36bedd">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bdb9b48a8f461b95594363296e37f6_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS0zLTEtMS01MzkwNg_eb3c67ab-7907-4b9a-a0fa-66ab660173ec">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9266e9d5e54f4e03aa9bff8df03159b5_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS01LTEtMS01MzkwNg_e1c506ee-bc62-49bf-835e-058b6dcfb6d1">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f28e909af74b0abe3ae31344d25373_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS03LTEtMS01MzkwNg_cca0ad6b-3dda-494a-83fb-0023a83b8682">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtMS0xLTEtNTM5MDY_5028f118-c848-4d6a-a044-46dfac1b65d2">3,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtMy0xLTEtNTM5MDY_1b70997f-f932-4517-a8c4-dbe75eb18899">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtNS0xLTEtNTM5MDY_bdb9a7c0-b025-4bff-8fdf-65720537e327">8,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130" decimals="-3" name="ango:AcquisitionRestructuringAndOtherItemsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtNy0xLTEtNTM5MDY_7a077e7c-9284-4739-8c47-e8363999e639">4,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Legal expenses related to litigation that is outside the normal course of business. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Legal and due diligence expenses related to mergers and acquisitions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Expenses to relocate certain manufacturing lines from Queensbury, NY to Costa Rica.  </span></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i598e6b0db4aa47c4bda4588ac73c7506" continuedAt="i0389035a54b14e1ea6dfda24f223fff6"><ix:continuation id="i26dc794fe06641c28947378efcba1523" continuedAt="id62e90ba9f2548afad531f6da0cc1331">(4) I</ix:continuation></ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i0389035a54b14e1ea6dfda24f223fff6"><ix:continuation id="id62e90ba9f2548afad531f6da0cc1331">n the first quarter of fiscal year 2023, a $<ix:nonFraction unitRef="usd" contextRef="i96f682ba85b44a3598400d9868b15c05_D20220601-20220831" decimals="-5" name="us-gaap:PaymentsForPreviousAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RleHRyZWdpb246NTdlNzg3NGI2Y2QwNGMwOWIxMDU0ZTdiNmQ4MTRmYTRfMzkz_c50a00ad-f0bb-4379-a884-26a3b2cd20d7">3.5</ix:nonFraction>&#160;million payment was made to the Israeli Innovation Authority to fully satisfy the obligation related to grant funds that were provided to Eximo for development of the Auryon laser prior to the acquisition in the second quarter of fiscal year 2020.</ix:continuation></ix:continuation>  </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_79"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RleHRyZWdpb246MjhiOWM3ODhhMzI1NDE1NGE3ZmMzNGMxZDgyYTZmY2FfMTQ4_7f6fdd77-ace3-44ce-8fb1-c3e8138e0f09" continuedAt="idbda6ca4a0834cd1bd98bd3b06fc99c4" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="idbda6ca4a0834cd1bd98bd3b06fc99c4"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RleHRyZWdpb246MjhiOWM3ODhhMzI1NDE1NGE3ZmMzNGMxZDgyYTZmY2FfMTUw_bceba231-6638-4a40-8879-778a864e8b15" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in each component of accumulated other comprehensive income, net of tax, are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at August 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fe5b4172864faa8f8941f2d91a82a5_I20220831" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfMi0xLTEtMS01MzkwNg_0547be53-4f1a-4fa8-b227-ac7df004e958">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8e6825fbb074aa89f3481933a0524ff_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfMy0xLTEtMS01MzkwNg_a3b96977-7f29-4e41-bd15-5ab2b5cc04dd">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8e6825fbb074aa89f3481933a0524ff_D20220901-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfNS0xLTEtMS01MzkwNg_fca7a4d9-c23e-4602-b90a-18fc611b740f">1,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc3c6dba44947808123f698ace071df_I20221130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfNi0xLTEtMS01MzkwNg_63ecc589-8f8c-4ab5-90da-859ca3f90719">288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at May 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd649e5bedd943d9a3a7267d44a89998_I20220531" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfMi0xLTEtMS01OTU0MQ_face1f4d-8e41-452e-8a3d-a9238cc03a22">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec41db309d8b4a96899fae9d890284b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfMy0xLTEtMS01NzYxNQ_f3a4119d-0904-458f-bc28-c7fed3792542">1,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec41db309d8b4a96899fae9d890284b7_D20220601-20221130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfNS0xLTEtMS01OTU0MQ_2203dc9c-06a3-4ede-a95a-a27786104a16">1,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc3c6dba44947808123f698ace071df_I20221130" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfNi0xLTEtMS01OTU0MQ_2997060f-6b0d-417f-b95d-498f8ce7d580">288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.  <ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY184Mi9mcmFnOjI3YWQzNTk4YjQ1MzQyZjBhYWQ5MjhhN2M0M2I3OTgwL3RleHRyZWdpb246MjdhZDM1OThiNDUzNDJmMGFhZDkyOGE3YzQzYjc5ODBfNTg_5e64c8e2-d31b-4565-9847-6d2a4ea037b8" continuedAt="i4f51764b203a48e5a8debb3777d3e3e3" escape="true"><ix:nonNumeric contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY184Mi9mcmFnOjI3YWQzNTk4YjQ1MzQyZjBhYWQ5MjhhN2M0M2I3OTgwL3RleHRyZWdpb246MjdhZDM1OThiNDUzNDJmMGFhZDkyOGE3YzQzYjc5ODBfNjg_952431a6-d6e9-4089-b811-2b9ad516b1d3" continuedAt="i653b7f0fc6f747cc9c3f9d13d1b7981b" escape="true">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="i4f51764b203a48e5a8debb3777d3e3e3" continuedAt="i85e8445eace644e78f6ef8e076e9d30a"><ix:continuation id="i653b7f0fc6f747cc9c3f9d13d1b7981b" continuedAt="i034be9d0d80d48b792aad3d5f788d639"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recently Issued Accounting Pronouncements - Adopted</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><ix:continuation id="i85e8445eace644e78f6ef8e076e9d30a"><ix:continuation id="i034be9d0d80d48b792aad3d5f788d639"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:20.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">ASU 2021-10,&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This ASU increases the transparency of government assistance to include the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company adopted the new standard in the first quarter of fiscal year 2023 and it did not have an impact on the Company's consolidated financial statements. </span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:20.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2021-08,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This ASU</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company plans to adopt the new standard in the first quarter of fiscal year 2024 and does not expect there to be a material impact to the consolidated financial statements.</span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information should be read together with the consolidated financial statements and the notes thereto and other information included elsewhere in this quarterly report on Form 10-Q.  The following discussion should be read in conjunction with the Company's 2022 Annual Report on Form 10-K, and the consolidated financial statements and notes thereto included elsewhere in the Form 10-Q.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Regarding Forward-Looking Statements</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q, including the sections entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements regarding AngioDynamics' expected future financial position, results of operations, cash flows, business strategy, budgets, projected costs, capital expenditures, products, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include the words such as "expects," "reaffirms," "intends," "anticipates," "plans," "believes," "seeks," "estimates," "projects," "optimistic," or variations of such words and similar expressions, are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Investors are cautioned that actual events or results may differ materially from AngioDynamics' expectations, expressed or implied. Factors that may affect the actual results achieved by AngioDynamics include, without limitation, the scale and scope of the COVID-19 global pandemic, the ability of AngioDynamics to develop its existing and new products, technological advances and patents attained by competitors, infringement of AngioDynamics' technology or assertions that AngioDynamics' technology infringes the technology of third parties, the ability of AngioDynamics to effectively compete against competitors that have substantially greater resources, future actions by the FDA or other regulatory agencies, domestic and foreign health care reforms and government regulations, results of pending or future clinical trials, overall economic conditions (including inflation, labor shortages and supply chain challenges including the cost and availability of raw materials), the results of on-going litigation, challenges with respect to third-party distributors or joint venture partners or collaborators, the results of sales efforts, the effects of product recalls and product liability claims, changes in key personnel, the ability of AngioDynamics to execute on strategic initiatives, the effects of economic, credit and capital market conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from group purchasing organizations and competition, the ability of AngioDynamics to obtain regulatory clearances or approval of its products, or to integrate acquired businesses. Other risks and uncertainties include, but are not limited to, the factors described from time to time in our reports filed with the Securities and Exchange Commission (the "SEC").</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this quarterly report on Form 10-Q will prove to be accurate.  In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. Any forward-looking statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and, as such, investors are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date stated, or if no date is stated, as of the date of this report. AngioDynamics disclaims any obligation to update the forward-looking statements.&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Regarding Trademarks</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes trademarks, tradenames and service marks that are our property or the property of other third parties. Solely for convenience, such trademarks and tradenames sometimes appear without any &#8220;&#8482;&#8221; or &#8220;&#174;&#8221; symbol. However, failure to include such symbols is not intended to suggest, in any way, that we will not assert our rights or the rights of any applicable licensor, to these trademarks and tradenames.  For a complete listing of all our trademarks, tradenames and service marks please visit www.angiodynamics.com/IP.  Information on our website or connected to our website is not incorporated by reference into this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Overview</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients.  We design, manufacture and sell a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Our devices are generally used in minimally invasive, image-guided procedures. Many of our products are intended to be used once and then discarded, or they may be temporarily implanted for short- or long-term use. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations cross a variety of markets. Our financial performance is impacted by changing market dynamics, which have included an emergence of value-based purchasing by healthcare providers, consolidation of healthcare providers, the increased role of the consumer in health care decision-making and an aging population, among others. In addition, our growth is impacted by changes within our sector, such as the merging of competitors to gain scale and influence; changes in the regulatory environment for medical devices; and fluctuations in the global economy. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and profitability growth also depends, in part, on the introduction of new and innovative products, together with ongoing enhancements to our existing products. Expansions of our product offerings are created through internal and external product development, technology licensing and strategic alliances. We recognize the importance of, and intend to continue to make investments in research and development activities and selective business development opportunities to provide growth opportunities. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products in the United States primarily through a direct sales force, and outside the U.S. through a combination of direct sales and distributor relationships. Our end users include interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists and critical care nurses.  We expect our businesses to grow in both sales and profitability by expanding geographically, penetrating new markets, introducing new products and increasing our presence internationally.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 global pandemic has impacted our business and may continue to pose future risks with the emergence of new variants.  Even with the public health actions that have been taken to reduce the spread of the virus, the market continues to experience disruptions with respect to consumer demand, hospital operating procedures and workflow, trends that may continue.  The Company's ability to manufacture products, the reliability of our supply chain, labor shortages, backlog and inflation (including the cost and availability of raw materials, direct labor and shipping) have impacted our business, trends that may continue.  Accordingly, management continues to evaluate the Company&#8217;s liquidity position, communicate with and monitor the actions of our customers and suppliers, and review our near-term financial performance. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2022, the Company repaid all amounts outstanding under its then existing credit agreement and entered into a new Credit Agreement.  The new Credit Agreement provides for a $75.0&#160;million Revolving Facility and a $30.0&#160;million Delayed Draw Term Loan as of November&#160;30, 2022, $25.0 million was drawn on the Revolving Facility and $25.0 million was drawn on the Delayed Draw Term Loan.  See Note 7 "Long-Term Debt" set forth in the Notes to the consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-indent:21.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the first quarter of fiscal year 2023, the Company began to manage its operations through two segments, Med Tech and Med Device to align with the transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating the operating performance of our business, management focuses on company-wide and segment revenue and gross margin and company-wide operating income, earnings per share and cash flow from operations. A summary of these key financial metrics for the three and six months ended November&#160;30, 2022 compared to the three and six months ended November&#160;30, 2021 are as follows: </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended November&#160;30, 2022:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Revenue increased by 9.1% to $85.4 million.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Med Tech growth of 29.7% and Med Device growth of 2.6%.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit increased 100 bps to 52.8%.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Med Tech gross profit decreased 290 bps to 63.7% and Med Device gross profit increased 130 bps to 48.4%.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss increased by $0.1 million to $8.5 million.  </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss per share was consistent at a loss of $0.21.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six months ended November&#160;30, 2022:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Revenue increased by 7.5% to $167.0 million.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Med Tech growth of 29.7% and Med Device growth of 0.7%.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit increased 30 bps to 52.3%.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Med Tech gross profit decreased 250 bps to 63.5% and Med Device gross profit increased 20 bps to 47.9%.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss increased by $6.2 million to $21.5 million.  </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss per share increased by $0.16 to a loss of $0.55.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Med Tech revenue, comprised of Auryon, the thrombus management platform and NanoKnife, grew 29.7% in the second quarter of fiscal year 2023.  The growth in Auryon and NanoKnife capital and disposables was partially offset by decreased thrombus management platform sales.  Our Med Device revenue grew 2.6% in the second quarter of fiscal year 2023 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">driven by growth in Core, Dialysis, Ports and Microwave products, partially offset by the backlog in Vascular Access products and continued pressures from reductions in Oncology procedure volumes due to challenges resulting from the COVID-19 pandemic, a trend that may continue.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended November&#160;30, 2022, the Company reported a net loss of $8.5 million, or a loss of $0.21 per diluted share, on net sales of $85.4 million, compared with a net loss of $8.4 million, or a loss of $0.21 per diluted share, on net sales of $78.3 million during the same quarter of the prior year.  For the six months ended November&#160;30, 2022, the Company reported a net loss of $21.5 million, or a loss of $0.55 per diluted share, on net sales of $167.0 million, compared with a net loss of $15.3 million, or a loss of $0.39 per diluted share, on net sales of $155.3 million during the same quarter of the prior year.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Sales</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -  Net sales are derived from the sale of products and related freight charges, less discounts, rebates and returns. </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales by Geography</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended November&#160;30, 2022, net sales increased $7.1 million to $85.4 million compared to the same period in the prior year.  For the six months ended November&#160;30, 2022, net sales increased $11.7 million to $167.0 million compared to the same period in the prior year.  At November&#160;30, 2022, the Company had a backlog of $5.0 million, a decrease of $2.1 million from August 31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Med Tec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h segment net sales increased $5.6 million and $10.8 million fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r the three and six months ended November&#160;30, 2022 compared to the same periods in the prior year, respectively.  The change in sales for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased Auryon sales of $3.8 million and $6.7 million compared to the same periods in the prior year, respectively;  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Growth in the thrombus management platform of $2.4 million for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended November&#160;30, 2022 compared to the same period in the prior year, while the thrombus management platform was flat for the three months ended November&#160;30, 2022 compared to the same period in the prior year.  Increased sales in the mechanical thrombectomy platform of $2.2 million f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended November&#160;30, 2022 compared to the same period in the prior year, was driven by the AlphaVac product; and  </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased NanoKnife sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.8 million and $1.7 million compared to the same periods in the prior year, respectively</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was primarily driven by increased probe sales domestically and internationally.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Me</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d Device segment net sales increased $1.5 million and $0.9 million for</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the three and six months ended November&#160;30, 2022 compared to the same periods in the prior year, respectively.  The change in sales for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The backlog of $5.0 million at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;30, 2022, which</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily impacted sales of Core and Vascular Access products; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core, Dialysis and Ports, despite the impact of the backlog, along with increased Microwave sales for the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;30, 2022 compared to the same period in the prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $1.9 million, $1.6 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, $0.6 million and $0.3 million, respectively.  These increases were partially offset by decreased </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Venous, PICCs and other Oncology sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;30, 2022 compared to the same period in the prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $1.2 million, $0.8 million and $0.7 million, respectively; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core and Dialysis, despite the impact of the backlog, along with increased Microwave sales for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;30, 2022 compared to the same period in the prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $2.8 million, $2.8 million and $0.6 million, respectively.  These increases were partially offset by decreased </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Venous, PICCs, Midlines and other Oncology and Vascular Access sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;30, 2022 compared to the same period in the prior year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $1.7 million, $1.4 million, $0.4 million and $1.5 million, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Gross Profit </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six  Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit % of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit % of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit % of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - Gross profit consists of net sales less the cost of goods sold, which includes the costs of materials, products purchased from third parties and sold by us, manufacturing personnel, royalties, freight, business insurance, depreciation of property and equipment and other manufacturing overhead, exclusive of intangible amortization.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Company gross profit increased by $4.5 million and $6.7 million for the three months and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended November&#160;30, 2022 compared to the same periods in the prior year.  The change for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales volume, which positively impacted gross profit by $4.2 million and $6.9 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Production volume, mix and other incentives which positively impacted gross profit by $2.8 million and $5.5 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pricing, which negatively impacted gross profit by $1.9 million and $3.3 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Inflationary costs on raw materials, labor shortages and freight costs, which negatively impacted gross profit by $1.1 million for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> months ended November&#160;30, 2022; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Depreciation on placement units of $0.5 million and $1.2 million, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Med Tech segment gross profit increased by $3.0 million and $5.9 million for the three and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended November&#160;30, 2022 compared to the same periods in the prior year.  The change for both periods was primarily driven by:&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales volume, which positively impacted gross profit by $4.6 million and $8.6 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Production volume, overhead, manufacturing and other incentives which positively impacted gross profit by $1.1 million and $1.9 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pricing pressures and mix, which negatively impacted gross profit by $2.4 million and $3.8 million, respectively; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Depreciation on placement units of $0.3 million and $0.7 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Med Device segment gross profit increased by $1.5 million and $0.7 million for the three and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> months ended November&#160;30, 2022 compared to the same periods in the prior year.  The change for both periods was primarily driven by:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales volume, which positively impacted gross profit by $0.5 million and $0.1 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Production volume, manufacturing and other incentives which positively impacted gross profit by $2.5 million and $3.7 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pricing pressures and mix, which negatively impacted gross profit by $0.5 million and $0.8 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Inflationary costs on raw materials, labor shortages and freight costs, which negatively impacted gross profit by $1.0 and $2.1 million, respectively; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Depreciation on placement units of $0.1 million and $0.2 million, respectively.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Operating Expenses, and Other Income (expense)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.367%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Research and development expense</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> - Research and development (&#8220;R&amp;D&#8221;) expense includes internal and external costs to develop new products, enhance existing products, validate new and enhanced products, and manage clinical, regulatory and medical affairs.  </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D expense decreased $1.4 million and $0.4 million for t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he three and six months ended November&#160;30, 2022 compared to the same periods in the prior year, respectively.  The change for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing of certain projects and clinical spend associated with the ongoing clinical trials, which decreased R&amp;D expense by $1.4 million and $0.5 million, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sales and marketing expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Sales and marketing (&#8220;S&amp;M&#8221;) expense consists primarily of salaries, commissions, travel and related business expenses, attendance at medical society meetings, product promotions and marketing activities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S&amp;M expense increased $2.4 million and $4.5 million for t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he three and six months ended November&#160;30, 2022 compared to the same periods in the prior year, respectively.  The change for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional headcount from the build-out of the Auryon and mechanical thrombectomy sales and marketing teams, which increased compensation and benefits expense by $1.2 million and $2.5 million, respectively; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Travel, meeting and tradeshow expenses, which increased $1.3 million and $2.7 million, respectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and was partially offset by decreased facilities, depreciation and other expenses of $0.3 million and $0.6 million, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - General and administrative (&#8220;G&amp;A&#8221;) expense includes executive management, finance, information technology, human resources, business development, legal, and the administrative and professional costs associated with those activities.  </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">xpense increased $1.2 million and $2.3 million for th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e three and six months ended November&#160;30, 2022 compared to the same periods in the prior year, respectively.  The change for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compensation and benefits and travel expenses, which increased $0.6 million for the six months ended November&#160;30, 2022 and decreased $0.2 million for the three months ended November&#160;30, 2022; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other outside consultant spend for legal and IT which increased $1.2 million and $1.6 million, respectively.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, restructuring and other items, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,492)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amortization of intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents the amount of amortization expense that was taken on intangibles assets held by the Company.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amortization expense remained consistent with </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the prior year.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in fair value of contingent consideration</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents changes in contingent consideration driven by changes to estimated future payments on earn-out liabilities created through acquisitions and amortization of present value discounts on long-term contingent consideration. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The change in the fair value for the three and six months ended November&#160;30, 2022 is related to the Eximo contingent consideration and the increased probability of achieving the revenue milestones.  </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition, restructuring and other items, net</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents costs associated with mergers and acquisitions, restructuring expenses, legal costs that are related to litigation that is not in the ordinary course of business, legal settlements and other one-time items.</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition, restructuring and other item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, net, increased by $0.8 million and $3.9 million for</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the three and six months ended November&#160;30, 2022, compared to the same periods in the prior year, respectively.  The change for both periods was primarily driven by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manufacturing relocation expense related to the move of certain manufacturing lines to Costa Rica, which increased $0.5 million and $0.7 million, respectively;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legal expense, re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lated to litigation that is outside of the normal course of business, which increased $0.4 million and $0.1 million, respectively; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other expenses (mainly severance associated with organizational changes), which decreased $0.3 million for the six months ended November&#160;30, 2022; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The payment to the Israeli Innovation Authority of $3.5 million related to grant funds that were provided to Eximo to develop the Auryon laser prior to the acquisition in the second quarter of fiscal year 2020.  These grant funds were fully repaid in the first quarter of fiscal year 2023 to satisfy the obligation which was otherwise being paid as a royalty based on a percentage of sales.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other expense, net</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Other expenses include interest expense, foreign currency impacts, bank fees, and amortization of deferred financing costs.  </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The change in other expe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nse of $0.8 million for </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">both the three and six months ended November&#160;30, 2022 compared to the same periods in the prior year, is primarily due to increased interest expense of $0.5 million and $0.7 million, respectively and unrealized foreign currency fluctuations of $0.3 million and $0.1 million, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate including discrete items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate including discrete items for the three months ended November&#160;30, 2022 and 2021 was 6.2% and 5.8%, respectively.  Our effective tax rate including discrete items for the six months ended November&#160;30, 2022 and 2021 was 6.2% and 12.3%, respectively.  In fiscal year 2023, the Company&#8217;s effective tax rate differs from the U.S. statutory rate primarily due to the impact of the valuation allowance, foreign taxes, and other non-deductible permanent items (such as non-deductible meals and entertainment, Section 162(m) excess compensation and non-deductible share-based compensation). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review our liquidity and anticipated capital requirements in light of the significant uncertainty created by the COVID-19 global pandemic. We believe that our current cash on hand and availability under our Credit Agreement provides sufficient liquidity to meet our anticipated needs for capital for at least the next 12 months. We are closely monitoring receivables and payables.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents totaled $29.9 million as of November&#160;30, 2022, compared with $28.8 million as of May&#160;31, 2022.  As of November&#160;30, 2022 and May&#160;31, 2022, total debt outstanding related to the Credit Agreement was $50.0 million ($25.0 million on the Revolving Facility and $25.0 million on the Delayed Draw Term Loan) and $25.0 million, respectively.  The fair value of contingent consideration liability as of November&#160;30, 2022 and May&#160;31, 2022, was $18.8 million and $16.9 million, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,870)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarters ended November&#160;30, 2022 and 2021, cash flows consisted of the following:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash used in operating activities</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six months ended November&#160;30, 2022 and 2021:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss of $21.5 million and $15.3 million, respectively, plus the non-cash items, primarily driven by depreciation and amortization and stock based compensation, along with the changes in working capital below, contributed to cash used in operations of $17.2 million and $7.0 million, respectively, for these periods. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For the period ended November&#160;30, 2022, working capital was unfavorably impacted by decreased accounts payable, accrued liabilities and other liabilities of $2.8 million, along with increased accounts rec</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eivable, inventory and prepaid expenses of $1.0 million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $11.8 million and $3.9 million, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively.  </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For the period ended November&#160;30, 2021, working capital was unfavorably impacted by decreased accounts payable, accrued liabilities and other liabilities of $4.5 million, along with increased receivables of $2.9 million. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash used in investing activities</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six months ended November&#160;30, 2022 and 2021:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$2.1 million and $2.2 million, respectively, of cash was used for fixed asset additions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$3.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $7.2 million, respectively, of cash was used for Auryon placement and evaluation unit additions; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.5 million of cash was used for the acquisition of an exclusive license in the first quarter of fiscal year 2023; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$3.6 million of cash was used for the QX Medical asset acquisition in the first quarter of fiscal year 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash provided by financing activities</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six months ended November&#160;30, 2022 and 2021:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$70.0 million in proceeds on long-term debt less the repayment of $45.0 million associated with the new Credit Agreement in the first quarter of fiscal year 2023.  The $25.0 million draw on the Delayed Draw Term Loan associated with the new Credit Agreement is to fund the historical and planned fiscal year 2023 purchases of Auryon placement and evaluation units.  See Note 7 "Long-Term Debt" set forth in the Notes to the consolidated financial statements; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.8 million of deferred financing costs associated with the new Credit Agreement; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$5.0 million draw on the Revolving Facility in the first quarter of fiscal year 2022 for the QX Medical asset acquisition; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.2 million and $1.4 million, respectively, of proceeds from stock option and ESPP activity.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On August 30, 2022, the Company repaid all amounts outstanding under its then existing credit agreement and entered into a new Credit Agreement.  The new Credit Agreement provides for a $75.0&#160;million Revolving Facility and a $30.0&#160;million Delayed Draw Term Loan, and also includes an uncommitted expansion feature that allows the Company to increase the total revolving commitments and/or add new tranches of term loans in an aggregate amount not to exceed $75.0 million.&#160; The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, two financial covenants. One financial covenant requires us to maintain a fixed charge coverage ratio of not less than 1.25 to 1.00. The other financial covenant requires us to maintain a total leverage ratio of not greater than 3.00 to 1.00.  The total leverage ratio is based upon our trailing twelve months total adjusted EBITDA (as defined in the Credit Agreement).  The amount that we can borrow under our Credit Agreement is directly based on our leverage ratio.  The interest rate at November&#160;30, 2022 applicable to each was 5.59%.  The Company was in compliance with the Credit Agreement covenants as of November&#160;30, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023 and in connection with the new Credit Agreement, the Company drew $25.0 million on the Revolving Facility.  The Company also drew $25.0 million on the Delayed Draw Term Loan to fund the historical and planned fiscal year 2023 purchases of Auryon placement and evaluation units for total long-term debt outstanding of $50.0 million.  In the first quarter of fiscal year 2022, the Company made a $5.0 million draw on the Revolving Facility in conjunction with the QX Medical asset acquisition.  We believe that our current cash balance, together with cash generated from operations and access to our Revolving Facility, will provide sufficient liquidity to meet our anticipated needs for capital for at least the next 12 months. If we seek to make acquisitions of other businesses or technologies in the future for cash, we may require external financing.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements is included in Note 17 to our consolidated financial statements in this Quarterly Report on Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk from changes in currency exchange rates, as well as interest rate fluctuations on our Credit Agreement and investments that could impact our results of operations and financial position.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transact sales in currencies other than the U.S. Dollar, particularly the Euro, British Pound and Canadian Dollar. For the six months ended November&#160;30, 2022, approximately 5% of our sales were denominated in foreign currencies. We do not have expenses denominated in foreign currencies at the level of our sales and as a result, our profitability is exposed to currency fluctuations.  When the U.S. Dollar strengthens, our sales and gross profit will be negatively impacted.  In addition, we have assets and liabilities denominated in non-functional currencies which are remeasured at each reporting period, with the offset to changes presented as a component of Other (Expenses) Income.  Significant non-functional balances include accounts receivable due from a sub-section of our international customers.   </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement provides for a $75.0&#160;million Revolving Facility and a $30.0&#160;million Delayed Draw Term Loan.  Interest on the Revolving Facility and Delayed Draw Term Loan will be based, at the Company's option, on a rate equal to (i) the SOFR plus 0.10% (subject to a floor of 0%), or (ii) if the Company elects to treat a borrowing as an ABR Borrowing, an alternate base rate based on SOFR, plus, in each case an applicable margin of 1.25%, 1.50% or 1.75%, depending on the leverage ratio.  If any amount is not paid when due, the interest rate may be increased by 2.0%.  As of November&#160;30, 2022, there was $25.0&#160;million outstanding on the Delayed Draw Term Loan and $25.0&#160;million outstanding on the Revolving Facility and the interest rate at November&#160;30, 2022 was 5.59%.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, our Credit Facility and trade accounts receivable.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents at various institutions and performs periodic evaluations of the relative credit standings of these financial institutions to ensure their credit worthiness.  In addition, the Credit Agreement is structured across three above investment grade banks.  The Company has the ability to draw amongst the three banks which limits the concentration of credit risk of one institution.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of credit risk with respect to trade accounts receivable is limited due to the large number of customers that purchase products from the Company.  No single customer represents more than 10% of total sales.  The Company monitors the creditworthiness of its customers.  As the Company&#8217;s standard payment terms are 30 to 90 days from invoicing, the Company does not provide any significant financing to its customers.  Although the Company does not currently foresee a significant credit risk associated with the outstanding accounts receivable, repayment is dependent upon the financial stability of our customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this report, our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective to provide reasonable assurance that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting for the fiscal quarter ended November&#160;30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-top:12pt;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. and Subsidiaries</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II: OTHER INFORMATION</span></div><div id="i897c24ef20684c93801e686a95e6abcc_97"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:21.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 14 "Commitments and Contingencies" set forth in the notes to our consolidated financial statements included in Part I, Item I of this Quarterly Report on Form 10-Q.</span></div><div id="i897c24ef20684c93801e686a95e6abcc_100"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to information set forth in this report, you should carefully consider the factors discussed in &#8220;Part I, Item&#160;1A. Risk Factors&#8221; of our annual report on Form 10-K for our fiscal year ended May&#160;31, 2022 which set forth information relating to important risks and uncertainties that could materially adversely affect our business, financial condition or operating results. You should review and consider such Risk Factors in making any investment decision with respect to our securities. An investment in our securities continues to involve a high degree of risk.  There have been no material changes to the risk factors previously disclosed in our annual report on Form 10-K.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span><br/></span></div><div id="i897c24ef20684c93801e686a95e6abcc_103"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information with respect to the shares of the Company&#8217;s common stock repurchased during the three months ended November&#160;30, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuer Purchases of Equity Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Number&#160;of<br/>Shares<br/>Purchased (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average<br/>Price&#160;Paid<br/>per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Number of<br/>Shares<br/>Purchased<br/>as Part of<br/>Publicly<br/>Announced<br/>Programs (2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maximum<br/>Approximate<br/>Dollar Value<br/>of Shares<br/>that May Yet<br/>Be<br/>Purchased<br/>Under Plans<br/>or Programs (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2022 - September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022 - October 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022 - November 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These shares were purchased from employees to satisfy tax withholding requirements on the vesting of restricted shares/units from equity-based awards.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts are not applicable as the Company currently does not have a share repurchase program in effect.</span></div><div id="i897c24ef20684c93801e686a95e6abcc_106"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults on Senior Securities.</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i897c24ef20684c93801e686a95e6abcc_109"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i897c24ef20684c93801e686a95e6abcc_112"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT INDEX</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filing Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11302022-exx311.htm">Certification pursuant to Rule 13a-14(a) or 15d-14 under the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11302022-exx312.htm">Certification pursuant to Rule 13a-14(a) or 15d-14 under the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11302022-exx321.htm">Certification of Chief Executive Officer pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11302022-exx322.htm">Certification of Chief Financial Officer pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Calculation Linkbase Documents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Labels Linkbase Documents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Presentation Linkbase Documents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i897c24ef20684c93801e686a95e6abcc_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i897c24ef20684c93801e686a95e6abcc_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:4.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANGIODYNAMICS, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 6, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ S /&#160;&#160;&#160;&#160;JAMES C. CLEMMER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">James C. Clemmer, President,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 6, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ S /&#160;&#160;&#160;&#160;STEPHEN A. TROWBRIDGE&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen A. Trowbridge, Executive Vice President,<br/>Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a11302022-exx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i925d4dabc3f443d18b1096083d0e80e0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James C. Clemmer, certify that&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this quarterly report on Form 10-Q of AngioDynamics, Inc.&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  January&#160;6, 2023 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47; S &#47; JAMES C. CLEMMER                                                                                                                   </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James C. Clemmer, President,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a11302022-exx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3cfef964d21543988ddd7586b7099660_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen A. Trowbridge, certify that&#58;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this quarterly report on Form 10-Q of AngioDynamics, Inc.&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; January&#160;6, 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47; S &#47; STEPHEN A. TROWBRIDGE                                                                                                              </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen A. Trowbridge, Executive Vice President,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a11302022-exx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i00f43a82ce1c432485cded4b9d19b01a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO TITLE 18,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James C. Clemmer, President, Chief Executive Officer and Director of ANGIODYNAMICS, Inc. (the &#34;Company&#34;), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge&#58;</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the quarterly report on Form 10-Q of the Company for the fiscal quarter ended November&#160;30, 2022 (the &#34;Report&#34;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; January&#160;6, 2023 </font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; S &#47; JAMES C. CLEMMER</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James C. Clemmer, President,<br>Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>a11302022-exx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id7aa8bfac15046fd91a88fd2a6b917d3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen A. Trowbridge, Executive Vice President and Chief Financial Officer of ANGIODYNAMICS, Inc. (the &#34;Company&#34;), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge&#58;</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the quarterly report on Form 10-Q of the Company for the fiscal quarter ended November&#160;30, 2022 (the &#34;Report&#34;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; January&#160;6, 2023 </font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; S &#47; STEPHEN A. TROWBRIDGE</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen A. Trowbridge, Executive Vice President,<br>Chief Financial Officer </font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ango-20221130.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:57ef1ee5-794e-4e06-bd71-294e22fc989b,g:b5d7794f-41e8-47c1-b455-924b13840c85-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ango="http://www.angiodynamics.com/20221130" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.angiodynamics.com/20221130">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20221130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20221130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20221130_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20221130_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.angiodynamics.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000002 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedFinancialStatements" roleURI="http://www.angiodynamics.com/role/ConsolidatedFinancialStatements">
        <link:definition>0000008 - Disclosure - Consolidated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.angiodynamics.com/role/Acquisitions">
        <link:definition>0000009 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomers" roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomers">
        <link:definition>0000010 - Disclosure - Revenue from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.angiodynamics.com/role/Inventories">
        <link:definition>0000011 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssets">
        <link:definition>0000012 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://www.angiodynamics.com/role/AccruedLiabilities">
        <link:definition>0000013 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.angiodynamics.com/role/LongTermDebt">
        <link:definition>0000014 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.angiodynamics.com/role/IncomeTaxes">
        <link:definition>0000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.angiodynamics.com/role/ShareBasedCompensation">
        <link:definition>0000016 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.angiodynamics.com/role/EarningsPerShare">
        <link:definition>0000017 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformation">
        <link:definition>0000018 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.angiodynamics.com/role/FairValue">
        <link:definition>0000019 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.angiodynamics.com/role/Leases">
        <link:definition>0000020 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.angiodynamics.com/role/CommitmentsandContingencies">
        <link:definition>0000021 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringandOtherItemsNet" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet">
        <link:definition>0000022 - Disclosure - Acquisition, Restructuring and Other Items, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>0000023 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentlyIssuedAccountingPronouncements" roleURI="http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements">
        <link:definition>0000024 - Disclosure - Recently Issued Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentlyIssuedAccountingPronouncementsPolicies" roleURI="http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies">
        <link:definition>0000025 - Disclosure - Recently Issued Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersTables" roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables">
        <link:definition>0000026 - Disclosure - Revenue from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.angiodynamics.com/role/InventoriesTables">
        <link:definition>0000027 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000028 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesTables">
        <link:definition>0000029 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.angiodynamics.com/role/LongTermDebtTables">
        <link:definition>0000030 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.angiodynamics.com/role/EarningsPerShareTables">
        <link:definition>0000031 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationTables" roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationTables">
        <link:definition>0000032 - Disclosure - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.angiodynamics.com/role/FairValueTables">
        <link:definition>0000033 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.angiodynamics.com/role/LeasesTables">
        <link:definition>0000034 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringandOtherItemsNetTables" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables">
        <link:definition>0000035 - Disclosure - Acquisition, Restructuring and Other Items, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>0000036 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDetails" roleURI="http://www.angiodynamics.com/role/AcquisitionsDetails">
        <link:definition>0000037 - Disclosure - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersDisaggregationofRevenueDetails" roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails">
        <link:definition>0000038 - Disclosure - Revenue from Contracts with Customers - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersNarrativeDetails" roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails">
        <link:definition>0000039 - Disclosure - Revenue from Contracts with Customers - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersContractBalanceswithCustomersDetails" roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails">
        <link:definition>0000040 - Disclosure - Revenue from Contracts with Customers - Contract Balances with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesScheduleofInventoriesDetails" roleURI="http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails">
        <link:definition>0000041 - Disclosure - Inventories - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNarrativeDetails" roleURI="http://www.angiodynamics.com/role/InventoriesNarrativeDetails">
        <link:definition>0000042 - Disclosure - Inventories - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>0000043 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsChangeinGoodwillDetails" roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails">
        <link:definition>0000044 - Disclosure - Goodwill and Intangible Assets - Change in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsDetails" roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails">
        <link:definition>0000045 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails" roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails">
        <link:definition>0000046 - Disclosure - Goodwill and Intangible Assets - Expected Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails">
        <link:definition>0000047 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails">
        <link:definition>0000048 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofDebtDetails" roleURI="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails">
        <link:definition>0000049 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails">
        <link:definition>0000050 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationDetails" roleURI="http://www.angiodynamics.com/role/ShareBasedCompensationDetails">
        <link:definition>0000051 - Disclosure - Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails">
        <link:definition>0000052 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationNarrativeDetails" roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails">
        <link:definition>0000053 - Disclosure - Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails" roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails">
        <link:definition>0000054 - Disclosure - Segment and Geographic Information - Summary of Net Sales by Product Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails" roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails">
        <link:definition>0000055 - Disclosure - Segment and Geographic Information - Summary of Net Sales by Geographic Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>0000056 - Disclosure - Fair Value - Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails" roleURI="http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails">
        <link:definition>0000057 - Disclosure - Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails" roleURI="http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails">
        <link:definition>0000058 - Disclosure - Fair Value - Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueAdditionalInformationDetails" roleURI="http://www.angiodynamics.com/role/FairValueAdditionalInformationDetails">
        <link:definition>0000059 - Disclosure - Fair Value - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>0000060 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLiabilityMaturityScheduleDetails" roleURI="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails">
        <link:definition>0000061 - Disclosure - Leases - Liability Maturity Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLiabilityMaturityScheduleDetails_1" roleURI="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1">
        <link:definition>0000061 - Disclosure - Leases - Liability Maturity Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalStatementofOperationsInformationDetails" roleURI="http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails">
        <link:definition>0000062 - Disclosure - Leases - Supplemental Statement of Operations Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>0000063 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000064 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringandOtherItemsNetDetails" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails">
        <link:definition>0000065 - Disclosure - Acquisition, Restructuring and Other Items, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000066 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ango_ContractWithCustomerRightOfReturnRestockingCharge" abstract="false" name="ContractWithCustomerRightOfReturnRestockingCharge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ango_DebtInstrumentFloorInterestRate" abstract="false" name="DebtInstrumentFloorInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ango_AssetAcquisitionInventoryAndFixedAssets" abstract="false" name="AssetAcquisitionInventoryAndFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" abstract="false" name="ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" abstract="false" name="CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_NumberOfPatentsUpheldOverPriorArtReferences" abstract="false" name="NumberOfPatentsUpheldOverPriorArtReferences" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" abstract="false" name="DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" abstract="false" name="DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" abstract="true" name="WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ango_MergersandAcquisitionsMember" abstract="true" name="MergersandAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_MedTechMember" abstract="true" name="MedTechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" abstract="true" name="QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_CrBardIncMember" abstract="true" name="CrBardIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_DebtInstrumentDebtDefaultInterestRateIncrease" abstract="false" name="DebtInstrumentDebtDefaultInterestRateIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ango_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ango_AcquisitionRestructuringAndOtherItemsNet" abstract="false" name="AcquisitionRestructuringAndOtherItemsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_GrossMarginPercentage" abstract="false" name="GrossMarginPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ango_PreferredStockPurchaseRightsMember" abstract="true" name="PreferredStockPurchaseRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_RevenueBasedPaymentMember" abstract="true" name="RevenueBasedPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_LegalCostsMember" abstract="true" name="LegalCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_MeasurementInputProbabilityofPaymentMember" abstract="true" name="MeasurementInputProbabilityofPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_TheDelawareActionMember" abstract="true" name="TheDelawareActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_ScheduleOfIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" abstract="false" name="ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_IsraeliInnovationAuthorityPrepaymentMember" abstract="true" name="IsraeliInnovationAuthorityPrepaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_ChangeInFairValueOfContingentConsideration" abstract="false" name="ChangeInFairValueOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" abstract="false" name="DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ango_A2020StockAndIncentiveAwardPlanMember" abstract="true" name="A2020StockAndIncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_ChangeInFairValueOfContingentConsiderationOne" abstract="false" name="ChangeInFairValueOfContingentConsiderationOne" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" abstract="false" name="ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_ManufacturingRelocationMember" abstract="true" name="ManufacturingRelocationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_ProductTechnologiesMember" abstract="true" name="ProductTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_UndiscountedContingentConsiderationDisclosure" abstract="false" name="UndiscountedContingentConsiderationDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_NonCashLeaseExpense" abstract="false" name="NonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" abstract="false" name="ScheduleOfNetRevenueByProductGroupTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ango_MedDeviceMember" abstract="true" name="MedDeviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ango_LineOfCreditFacilityNumberOfCovenants" abstract="false" name="LineOfCreditFacilityNumberOfCovenants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ango_NumberOfPatentsAssertedForReexamination" abstract="false" name="NumberOfPatentsAssertedForReexamination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ango_RevenuePerformanceObligationPaymentTerm" abstract="false" name="RevenuePerformanceObligationPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>ango-20221130_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:57ef1ee5-794e-4e06-bd71-294e22fc989b,g:b5d7794f-41e8-47c1-b455-924b13840c85-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93016375-4f5f-42ae-9f70-70a6a13d5c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0c6b5157-8c69-4148-9ed7-371303168df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93016375-4f5f-42ae-9f70-70a6a13d5c2c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0c6b5157-8c69-4148-9ed7-371303168df3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b81e58a5-4ee8-4dc8-b931-e207e1ab751d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93016375-4f5f-42ae-9f70-70a6a13d5c2c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b81e58a5-4ee8-4dc8-b931-e207e1ab751d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c999ec4f-cecb-4181-8352-510dae01db56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c707f83e-5b61-4980-8375-bddd5cff82da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c999ec4f-cecb-4181-8352-510dae01db56" xlink:to="loc_us-gaap_GrossProfit_c707f83e-5b61-4980-8375-bddd5cff82da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_bf0b28d2-832b-4647-bbee-cc6c87e8e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c999ec4f-cecb-4181-8352-510dae01db56" xlink:to="loc_us-gaap_OperatingExpenses_bf0b28d2-832b-4647-bbee-cc6c87e8e7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fceca6c6-2f37-4e77-8553-4371b120eed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fceca6c6-2f37-4e77-8553-4371b120eed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_15a5182a-e7d9-4093-9a3d-8f4aa4712f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_15a5182a-e7d9-4093-9a3d-8f4aa4712f65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1f1c5aeb-fc40-4b17-a0de-bb3f489ed3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1f1c5aeb-fc40-4b17-a0de-bb3f489ed3ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_40faafc3-2100-45cb-a740-77379b534683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_40faafc3-2100-45cb-a740-77379b534683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsiderationOne_16553746-c3d9-4989-8487-f8be2d242ac4" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsiderationOne"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:to="loc_ango_ChangeInFairValueOfContingentConsiderationOne_16553746-c3d9-4989-8487-f8be2d242ac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_e273e2cc-f3e4-40ae-ab5f-0d89cfd0d1e1" xlink:href="ango-20221130.xsd#ango_AcquisitionRestructuringAndOtherItemsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_15ed12cc-35d0-448d-a68c-0bfa7577b38c" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_e273e2cc-f3e4-40ae-ab5f-0d89cfd0d1e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_880ac693-a70a-425e-9066-90bbbce1930e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3146b150-f992-4b7e-8fcb-ad2a7999f743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_880ac693-a70a-425e-9066-90bbbce1930e" xlink:to="loc_us-gaap_InterestExpense_3146b150-f992-4b7e-8fcb-ad2a7999f743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d530a834-5341-438f-a4a0-d142cd9d50f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_880ac693-a70a-425e-9066-90bbbce1930e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d530a834-5341-438f-a4a0-d142cd9d50f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ebe04a40-99b8-4f37-857a-2f9069494fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a09f8c26-af7d-41f0-bb84-96a1b9532133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ebe04a40-99b8-4f37-857a-2f9069494fe0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a09f8c26-af7d-41f0-bb84-96a1b9532133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6a536a-c83f-4bfa-8842-5a2f8cd62862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ebe04a40-99b8-4f37-857a-2f9069494fe0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6a536a-c83f-4bfa-8842-5a2f8cd62862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_132e2eca-b598-4951-a04d-17d916985cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_69c2aea4-f845-4466-9ea7-549b40ab2667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_132e2eca-b598-4951-a04d-17d916985cdb" xlink:to="loc_us-gaap_OperatingIncomeLoss_69c2aea4-f845-4466-9ea7-549b40ab2667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_53fee7f4-1b67-4208-bc4c-fa2d84a5d727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_132e2eca-b598-4951-a04d-17d916985cdb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_53fee7f4-1b67-4208-bc4c-fa2d84a5d727" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e70b4ea6-656f-4f08-a6a3-a3fdf087e168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_c040e432-3ad2-4064-a083-205fea5c2d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e70b4ea6-656f-4f08-a6a3-a3fdf087e168" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_c040e432-3ad2-4064-a083-205fea5c2d9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_00a53bea-2429-4781-a5c5-c43acfff7db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e70b4ea6-656f-4f08-a6a3-a3fdf087e168" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_00a53bea-2429-4781-a5c5-c43acfff7db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4d83745d-87fb-44ad-a5e0-290c92bc4507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_32bde44c-7dfe-4f62-909d-7b1aabd54f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4d83745d-87fb-44ad-a5e0-290c92bc4507" xlink:to="loc_us-gaap_NetIncomeLoss_32bde44c-7dfe-4f62-909d-7b1aabd54f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bf42afa1-6d43-4940-a94c-013759f57bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4d83745d-87fb-44ad-a5e0-290c92bc4507" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bf42afa1-6d43-4940-a94c-013759f57bdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_894be0e1-b97e-481e-ab6f-d3081ff37a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2ffb3cfb-9b6d-441c-a4a3-d295dfaf4831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_894be0e1-b97e-481e-ab6f-d3081ff37a73" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2ffb3cfb-9b6d-441c-a4a3-d295dfaf4831" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_531d5811-ac2c-46ce-b7ac-2b7eadb9bf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a07d34f-7446-4b5b-85fc-25aaa3970d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_531d5811-ac2c-46ce-b7ac-2b7eadb9bf2a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a07d34f-7446-4b5b-85fc-25aaa3970d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0b7fb9ce-0fc5-480e-9e04-f636241918aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_531d5811-ac2c-46ce-b7ac-2b7eadb9bf2a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0b7fb9ce-0fc5-480e-9e04-f636241918aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0f12f332-f6a2-4980-a5e5-5b0de34713c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_531d5811-ac2c-46ce-b7ac-2b7eadb9bf2a" xlink:to="loc_us-gaap_InventoryNet_0f12f332-f6a2-4980-a5e5-5b0de34713c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f0105325-07b1-44b9-ba2d-247ae57a980b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_531d5811-ac2c-46ce-b7ac-2b7eadb9bf2a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f0105325-07b1-44b9-ba2d-247ae57a980b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_63c3f283-fba2-4619-ba79-42877f7644fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_db755dc9-c42f-4ac0-b0e4-8cea147cb089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63c3f283-fba2-4619-ba79-42877f7644fd" xlink:to="loc_us-gaap_AccountsPayableCurrent_db755dc9-c42f-4ac0-b0e4-8cea147cb089" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b56e6fcb-829d-42d1-9ed2-59f7d0e3ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63c3f283-fba2-4619-ba79-42877f7644fd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b56e6fcb-829d-42d1-9ed2-59f7d0e3ddc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_57989d1f-322e-4ce0-9817-b0a79da82302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63c3f283-fba2-4619-ba79-42877f7644fd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_57989d1f-322e-4ce0-9817-b0a79da82302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8b1fb875-3706-40d6-9d52-1c01ef32c212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63c3f283-fba2-4619-ba79-42877f7644fd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8b1fb875-3706-40d6-9d52-1c01ef32c212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dbac8651-e003-47fe-876b-4a53c094147d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f1d790ae-bba8-416d-a6a5-395962729aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbac8651-e003-47fe-876b-4a53c094147d" xlink:to="loc_us-gaap_LiabilitiesCurrent_f1d790ae-bba8-416d-a6a5-395962729aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_0b78f102-0476-4822-9c69-b4c8f7ab9719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbac8651-e003-47fe-876b-4a53c094147d" xlink:to="loc_us-gaap_LongTermLoansPayable_0b78f102-0476-4822-9c69-b4c8f7ab9719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_50731ee2-3db5-48ea-ac3e-82932297bf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbac8651-e003-47fe-876b-4a53c094147d" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_50731ee2-3db5-48ea-ac3e-82932297bf8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_59555a26-9d76-4555-9e13-447d08e445d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbac8651-e003-47fe-876b-4a53c094147d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_59555a26-9d76-4555-9e13-447d08e445d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c276c3c2-1008-4ded-bc04-c7d0290e35e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbac8651-e003-47fe-876b-4a53c094147d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c276c3c2-1008-4ded-bc04-c7d0290e35e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8a0328b9-6a2d-4943-a3f3-9d59a45ee043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_966934c2-07fc-4d19-97f3-499492006f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a0328b9-6a2d-4943-a3f3-9d59a45ee043" xlink:to="loc_us-gaap_AssetsCurrent_966934c2-07fc-4d19-97f3-499492006f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_efda4265-f494-4d28-97ab-35ce2cae968f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a0328b9-6a2d-4943-a3f3-9d59a45ee043" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_efda4265-f494-4d28-97ab-35ce2cae968f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f82b8585-9808-4b17-b68e-675c040b5c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a0328b9-6a2d-4943-a3f3-9d59a45ee043" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f82b8585-9808-4b17-b68e-675c040b5c0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_72eca44f-7c00-4128-9a90-4844ea6ee7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a0328b9-6a2d-4943-a3f3-9d59a45ee043" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_72eca44f-7c00-4128-9a90-4844ea6ee7e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc583322-331a-4a9a-801f-78da31acb355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a0328b9-6a2d-4943-a3f3-9d59a45ee043" xlink:to="loc_us-gaap_Goodwill_cc583322-331a-4a9a-801f-78da31acb355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a58981b3-d2ae-4c6a-89ba-bc2e09d46aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_05a16060-7c79-4850-8788-edfd770ea8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a58981b3-d2ae-4c6a-89ba-bc2e09d46aea" xlink:to="loc_us-gaap_Liabilities_05a16060-7c79-4850-8788-edfd770ea8f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_dc134709-e82e-4453-bd5c-f71455e0f79a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a58981b3-d2ae-4c6a-89ba-bc2e09d46aea" xlink:to="loc_us-gaap_CommitmentsAndContingencies_dc134709-e82e-4453-bd5c-f71455e0f79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f8396166-d6b4-4d01-93ff-a848304d38fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a58981b3-d2ae-4c6a-89ba-bc2e09d46aea" xlink:to="loc_us-gaap_StockholdersEquity_f8396166-d6b4-4d01-93ff-a848304d38fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_873b6ad2-e374-48ab-af79-0c952597f79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:to="loc_us-gaap_PreferredStockValue_873b6ad2-e374-48ab-af79-0c952597f79c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_39497d36-4e68-4b08-9116-98cb1ceb4e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:to="loc_us-gaap_CommonStockValue_39497d36-4e68-4b08-9116-98cb1ceb4e74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_638ab374-83aa-4e41-82a2-a88fce730ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_638ab374-83aa-4e41-82a2-a88fce730ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f764756-9b6e-4072-9688-d1bf3e46084d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f764756-9b6e-4072-9688-d1bf3e46084d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_14091e56-78d9-4dff-a3ff-e6ccfb78e04a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:to="loc_us-gaap_TreasuryStockValue_14091e56-78d9-4dff-a3ff-e6ccfb78e04a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e0ee156-d7a0-4a1b-a0d3-15c1e01f675d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_99c24cac-948c-4a75-b2cb-9151baad388e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e0ee156-d7a0-4a1b-a0d3-15c1e01f675d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b23265de-4742-45c1-ae16-1d564219d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f3aa84e1-51ed-4f54-a47e-b9c9da19d53d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b23265de-4742-45c1-ae16-1d564219d33a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f3aa84e1-51ed-4f54-a47e-b9c9da19d53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_945b9029-c48c-4f80-8600-ea921d9e7b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b23265de-4742-45c1-ae16-1d564219d33a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_945b9029-c48c-4f80-8600-ea921d9e7b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_fd1e676a-a70c-440d-b63f-0bcecbc40d8f" xlink:href="ango-20221130.xsd#ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b23265de-4742-45c1-ae16-1d564219d33a" xlink:to="loc_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_fd1e676a-a70c-440d-b63f-0bcecbc40d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3849209f-119e-4e6f-a896-27a65a9f78e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b23265de-4742-45c1-ae16-1d564219d33a" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3849209f-119e-4e6f-a896-27a65a9f78e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4af89666-d1cf-48c3-8995-311fa60f2bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_32ca2283-b9ca-40c9-a197-2356e784d190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4af89666-d1cf-48c3-8995-311fa60f2bd5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_32ca2283-b9ca-40c9-a197-2356e784d190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7083e75-c1cc-4f86-a9e6-bd558d7ef0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4af89666-d1cf-48c3-8995-311fa60f2bd5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7083e75-c1cc-4f86-a9e6-bd558d7ef0fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d65d82a-fb30-44b9-afeb-77245983955d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4af89666-d1cf-48c3-8995-311fa60f2bd5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d65d82a-fb30-44b9-afeb-77245983955d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9c5723e7-8cb8-4a96-a4ea-e4f9db7d8713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4af89666-d1cf-48c3-8995-311fa60f2bd5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9c5723e7-8cb8-4a96-a4ea-e4f9db7d8713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bcd5259a-193c-4655-aab1-82285b183e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6e779519-d1e6-4d81-8661-fe547bc628a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bcd5259a-193c-4655-aab1-82285b183e7f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6e779519-d1e6-4d81-8661-fe547bc628a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquipmentOnLease_b357f612-7b1a-4c6b-a675-8a1e19119f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquipmentOnLease"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bcd5259a-193c-4655-aab1-82285b183e7f" xlink:to="loc_us-gaap_PaymentsToAcquireEquipmentOnLease_b357f612-7b1a-4c6b-a675-8a1e19119f70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b29f806e-1ecb-46f8-a24f-4aa9365b70a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bcd5259a-193c-4655-aab1-82285b183e7f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b29f806e-1ecb-46f8-a24f-4aa9365b70a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d73b8280-9cd7-47b8-b835-58d18f44805c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_NetIncomeLoss_d73b8280-9cd7-47b8-b835-58d18f44805c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c562f014-8ffc-42da-8282-a8f680874384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_DepreciationAndAmortization_c562f014-8ffc-42da-8282-a8f680874384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NonCashLeaseExpense_501ff955-c6bc-4f32-9bde-8e6e45ef1bc1" xlink:href="ango-20221130.xsd#ango_NonCashLeaseExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_ango_NonCashLeaseExpense_501ff955-c6bc-4f32-9bde-8e6e45ef1bc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b7b1ce92-e391-43ce-8988-a964073ae78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_ShareBasedCompensation_b7b1ce92-e391-43ce-8988-a964073ae78c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsiderationOne_3e069e6e-59db-4dde-965b-010630da13cd" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsiderationOne"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_ango_ChangeInFairValueOfContingentConsiderationOne_3e069e6e-59db-4dde-965b-010630da13cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d6a14f22-0e2c-4ff3-bc74-f2e805516d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d6a14f22-0e2c-4ff3-bc74-f2e805516d60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_44be3ded-1ba3-49e1-8811-9bb27d0216a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_44be3ded-1ba3-49e1-8811-9bb27d0216a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_195e8e81-f687-44ff-84da-a7ad3f5515c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_195e8e81-f687-44ff-84da-a7ad3f5515c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_81a1cde2-061b-449c-911a-521e1d315b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_81a1cde2-061b-449c-911a-521e1d315b6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b3478d4f-3a3e-4103-ba62-f3cc3d54193f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b3478d4f-3a3e-4103-ba62-f3cc3d54193f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4367bf50-c404-401b-a076-151655b24045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4367bf50-c404-401b-a076-151655b24045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_59caa208-fd58-4c0f-9e05-6aa1270cc809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_59caa208-fd58-4c0f-9e05-6aa1270cc809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_b59672f4-7456-4d85-8ae6-154024da100e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ebac45-79ad-4096-93ef-ab4e1c5ee5ae" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_b59672f4-7456-4d85-8ae6-154024da100e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#InventoriesScheduleofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_987e6f3c-d6a6-4ee3-a538-d9ab10de0eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_5826f032-ad70-4aec-b211-362586718286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_987e6f3c-d6a6-4ee3-a538-d9ab10de0eb3" xlink:to="loc_us-gaap_InventoryRawMaterials_5826f032-ad70-4aec-b211-362586718286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_e8ebfdb6-7b0f-404a-b3f8-1969724a4c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_987e6f3c-d6a6-4ee3-a538-d9ab10de0eb3" xlink:to="loc_us-gaap_InventoryWorkInProcess_e8ebfdb6-7b0f-404a-b3f8-1969724a4c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_e2e83982-c88a-46d4-a703-38d2c5f9cdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_987e6f3c-d6a6-4ee3-a538-d9ab10de0eb3" xlink:to="loc_us-gaap_InventoryFinishedGoods_e2e83982-c88a-46d4-a703-38d2c5f9cdfb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ff7fd73f-7862-4592-80e4-3dfd2b284f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64d35111-d578-4277-880c-b80c979102e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ff7fd73f-7862-4592-80e4-3dfd2b284f39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64d35111-d578-4277-880c-b80c979102e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c051ef92-bc2f-4865-8384-e319ad0178b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ff7fd73f-7862-4592-80e4-3dfd2b284f39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c051ef92-bc2f-4865-8384-e319ad0178b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6a92b35-3e59-43f2-8b6b-5823d22ae270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6a92b35-3e59-43f2-8b6b-5823d22ae270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6b3bab40-44d4-42d3-8048-cb7df15c7e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6b3bab40-44d4-42d3-8048-cb7df15c7e11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c0028397-2111-4a45-a7f8-d6933799f2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c0028397-2111-4a45-a7f8-d6933799f2f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7de01666-2b3a-4580-9db0-6447db063ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7de01666-2b3a-4580-9db0-6447db063ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7b864fbc-83ac-4eca-8f14-597e55c1fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7b864fbc-83ac-4eca-8f14-597e55c1fedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_fb65a82a-f170-4a77-a5e4-31325b362be1" xlink:href="ango-20221130.xsd#ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c421f12-b2df-49c8-ac11-87c78ccf5fab" xlink:to="loc_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_fb65a82a-f170-4a77-a5e4-31325b362be1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5267a5a7-29a3-497c-bb98-5e75513fc5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5267a5a7-29a3-497c-bb98-5e75513fc5f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_f9366382-09f1-4e8d-878e-46a4b3b72ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_f9366382-09f1-4e8d-878e-46a4b3b72ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_a103d9b0-895a-4775-acfd-31f48decbffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_a103d9b0-895a-4775-acfd-31f48decbffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8e526d76-02a5-4b6c-9e3c-1fbe7fa643b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8e526d76-02a5-4b6c-9e3c-1fbe7fa643b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AccruedResearchAndDevelopmentCurrent_2232faef-27b6-408d-8137-8791fcb5e3c2" xlink:href="ango-20221130.xsd#ango_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_ango_AccruedResearchAndDevelopmentCurrent_2232faef-27b6-408d-8137-8791fcb5e3c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_c498b75e-6849-4c79-a019-ed6817c2432c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_c498b75e-6849-4c79-a019-ed6817c2432c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_dbb63bdc-d6c7-47d3-8611-973f4cbc7219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0690b40f-e0e5-4c94-9efa-502cbb7a26ad" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_dbb63bdc-d6c7-47d3-8611-973f4cbc7219" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6ee15239-57b7-48da-9400-a635f72cce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_530e9cc1-7662-4ad7-aee0-c25a6a940ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6ee15239-57b7-48da-9400-a635f72cce5b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_530e9cc1-7662-4ad7-aee0-c25a6a940ba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_55d6ffd4-c246-494d-a5cf-62911cea41ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6ee15239-57b7-48da-9400-a635f72cce5b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_55d6ffd4-c246-494d-a5cf-62911cea41ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b2e0161-b690-48bd-8e11-34c6a1f51418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_382ac45d-b599-45a5-8d88-08b62563e887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b2e0161-b690-48bd-8e11-34c6a1f51418" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_382ac45d-b599-45a5-8d88-08b62563e887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4993b8e6-87c6-408c-b9c7-f22c7d5c67bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b2e0161-b690-48bd-8e11-34c6a1f51418" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4993b8e6-87c6-408c-b9c7-f22c7d5c67bb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_97e54cdd-92a2-46c3-8763-2d9eec6e7c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4e1506df-1aba-4000-b7a6-2d5800427ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_97e54cdd-92a2-46c3-8763-2d9eec6e7c69" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4e1506df-1aba-4000-b7a6-2d5800427ade" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b02ff510-53eb-47bc-bdba-c3995d347449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b9b8c08-28fd-4325-af1d-e752aa46f607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_b02ff510-53eb-47bc-bdba-c3995d347449" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b9b8c08-28fd-4325-af1d-e752aa46f607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f346d357-b8c3-4512-b42e-871ba30aa566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_b02ff510-53eb-47bc-bdba-c3995d347449" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f346d357-b8c3-4512-b42e-871ba30aa566" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesLiabilityMaturityScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a5a8423-d654-4155-9a52-692c32ed8654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_90ca9c84-839c-4d93-94d1-86b55e9a5531" xlink:href="ango-20221130.xsd#ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a5a8423-d654-4155-9a52-692c32ed8654" xlink:to="loc_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_90ca9c84-839c-4d93-94d1-86b55e9a5531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_142b948a-78ba-4042-bde7-d70d635cb8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a5a8423-d654-4155-9a52-692c32ed8654" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_142b948a-78ba-4042-bde7-d70d635cb8ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_551afc19-8337-4222-9fb5-049e2b148f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a5a8423-d654-4155-9a52-692c32ed8654" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_551afc19-8337-4222-9fb5-049e2b148f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c935c2c4-c7d4-45d3-874d-a6266b5151fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a5a8423-d654-4155-9a52-692c32ed8654" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c935c2c4-c7d4-45d3-874d-a6266b5151fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3bb262c8-9016-4e72-bae4-b34a04c7821a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a5a8423-d654-4155-9a52-692c32ed8654" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3bb262c8-9016-4e72-bae4-b34a04c7821a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesLiabilityMaturityScheduleDetails_1"/>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36418365-30c2-4b1b-83b0-dc775850b7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7bcfd50f-3166-40e0-b533-6060fdc9e8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36418365-30c2-4b1b-83b0-dc775850b7d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7bcfd50f-3166-40e0-b533-6060fdc9e8de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_19907618-01e3-4084-b110-a79cd59de1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36418365-30c2-4b1b-83b0-dc775850b7d7" xlink:to="loc_us-gaap_OperatingLeaseLiability_19907618-01e3-4084-b110-a79cd59de1a2" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>ango-20221130_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:57ef1ee5-794e-4e06-bd71-294e22fc989b,g:b5d7794f-41e8-47c1-b455-924b13840c85-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CoverPage" xlink:type="simple" xlink:href="ango-20221130.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CoverPage" xlink:type="extended" id="ie75259bf865e4e879bfef5b38f2c6f32_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9800e742-41b2-4dba-a9cb-9a47db4991b7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_AmendmentFlag_9800e742-41b2-4dba-a9cb-9a47db4991b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_8a17084f-e338-4e09-8880-67aecef7ffe2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentFiscalYearFocus_8a17084f-e338-4e09-8880-67aecef7ffe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4d850d7c-0c1c-490f-9337-26e2527ec8e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4d850d7c-0c1c-490f-9337-26e2527ec8e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bbd9caa3-71e6-454b-9a3b-c8ee79481507" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityCentralIndexKey_bbd9caa3-71e6-454b-9a3b-c8ee79481507" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6f64d2dd-1f56-47c3-afc1-e15fdf5c5aa3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_CurrentFiscalYearEndDate_6f64d2dd-1f56-47c3-afc1-e15fdf5c5aa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_afb01340-5869-466d-8058-66ac6d58f185" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_NoTradingSymbolFlag_afb01340-5869-466d-8058-66ac6d58f185" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bff92c55-c85b-419d-b38e-817a0aedbb14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentType_bff92c55-c85b-419d-b38e-817a0aedbb14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1b14e4f5-e0b4-4463-b296-cbf96124ae35" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentQuarterlyReport_1b14e4f5-e0b4-4463-b296-cbf96124ae35" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1aa41339-637d-4014-961b-fa6b8948efb3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentPeriodEndDate_1aa41339-637d-4014-961b-fa6b8948efb3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b084b32e-81fa-44e2-a318-5b9fc8535900" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentTransitionReport_b084b32e-81fa-44e2-a318-5b9fc8535900" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8c61f2c3-b010-4f75-a430-546eaac75645" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityFileNumber_8c61f2c3-b010-4f75-a430-546eaac75645" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_deaf3eaa-f94f-493c-967f-8bc867147f2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityRegistrantName_deaf3eaa-f94f-493c-967f-8bc867147f2d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_55e94a5e-0967-43ed-9eb2-3145e3af574d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityIncorporationStateCountryCode_55e94a5e-0967-43ed-9eb2-3145e3af574d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fd1f8e9c-994f-43c3-a000-5adfcb9fdbd9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityTaxIdentificationNumber_fd1f8e9c-994f-43c3-a000-5adfcb9fdbd9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_57cec231-41a9-4fd9-bf6c-2fe096a96b88" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressAddressLine1_57cec231-41a9-4fd9-bf6c-2fe096a96b88" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_02981e3e-7400-4b07-9b17-1c06cb5d6328" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressCityOrTown_02981e3e-7400-4b07-9b17-1c06cb5d6328" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ed658eeb-c414-469e-b4c0-7beddde2bc0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressStateOrProvince_ed658eeb-c414-469e-b4c0-7beddde2bc0f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6c7bebd8-8a2a-4da4-aa62-814b5a97e8b6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressPostalZipCode_6c7bebd8-8a2a-4da4-aa62-814b5a97e8b6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0e8cd635-6ba4-42dd-ac82-d65a644b9baf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_CityAreaCode_0e8cd635-6ba4-42dd-ac82-d65a644b9baf" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_868e37c3-7c13-4bf3-8834-ca952cd65c1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_LocalPhoneNumber_868e37c3-7c13-4bf3-8834-ca952cd65c1c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a59c9d75-03d3-493c-83c0-33086592823e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_Security12bTitle_a59c9d75-03d3-493c-83c0-33086592823e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_09270b16-d6a9-417a-8247-7620c927d78f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_TradingSymbol_09270b16-d6a9-417a-8247-7620c927d78f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_42ccca23-640b-4f96-8248-04b66f3f64ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_SecurityExchangeName_42ccca23-640b-4f96-8248-04b66f3f64ac" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e9c63926-3c95-4ff1-9ea1-e681bbf6b14b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityCurrentReportingStatus_e9c63926-3c95-4ff1-9ea1-e681bbf6b14b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c24ac339-68da-41f3-bdc6-2f5fc31deb5d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityInteractiveDataCurrent_c24ac339-68da-41f3-bdc6-2f5fc31deb5d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_260c07cc-e420-48f6-94e5-158dad1b5f1b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntitySmallBusiness_260c07cc-e420-48f6-94e5-158dad1b5f1b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_02d8754a-a3f2-41cf-b86d-aae26b878f3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityEmergingGrowthCompany_02d8754a-a3f2-41cf-b86d-aae26b878f3a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_01905111-f2ea-4704-99ab-d78dd0c11850" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityShellCompany_01905111-f2ea-4704-99ab-d78dd0c11850" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_de39ec20-b741-44b2-b21a-018d9db15a75" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_de39ec20-b741-44b2-b21a-018d9db15a75" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6af8a3e2-0dae-4d93-b221-3bcda3e5c231" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityFilerCategory_6af8a3e2-0dae-4d93-b221-3bcda3e5c231" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_595cd991-22d5-4a95-bc64-5755ef5cabfd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:to="loc_us-gaap_ClassOfStockDomain_595cd991-22d5-4a95-bc64-5755ef5cabfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:to="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b561635f-4ca3-40bf-97f0-98c28b475793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:to="loc_us-gaap_CommonStockMember_b561635f-4ca3-40bf-97f0-98c28b475793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_PreferredStockPurchaseRightsMember_1f8eb3e7-366a-49f1-bff8-8fe75ba89b07" xlink:href="ango-20221130.xsd#ango_PreferredStockPurchaseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:to="loc_ango_PreferredStockPurchaseRightsMember_1f8eb3e7-366a-49f1-bff8-8fe75ba89b07" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i8665c6fe99414f6f966eb61e16640031_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2beaa683-3784-4a45-8d3d-70f0b2c777e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2beaa683-3784-4a45-8d3d-70f0b2c777e9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f98d01f5-0cbe-462f-bd24-f7f3ba694a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f98d01f5-0cbe-462f-bd24-f7f3ba694a6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cc2ca5de-f59c-4e2f-979b-cbd9f41dec83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockholdersEquity_cc2ca5de-f59c-4e2f-979b-cbd9f41dec83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_18d864a2-2c1c-4f0c-86da-ae00289e13ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_18d864a2-2c1c-4f0c-86da-ae00289e13ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a7709c83-b719-47cc-a157-7db864443048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_NetIncomeLoss_a7709c83-b719-47cc-a157-7db864443048" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674c31f1-1e30-460c-93b5-a64f2565e276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674c31f1-1e30-460c-93b5-a64f2565e276" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba11b4d7-3cb1-48dc-ac64-0a73d9c4d724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba11b4d7-3cb1-48dc-ac64-0a73d9c4d724" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_153ddb67-9304-49f4-bfa2-8b1b231aa453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_153ddb67-9304-49f4-bfa2-8b1b231aa453" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_75045e7f-24ed-4a14-9050-adfeea7d6f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_75045e7f-24ed-4a14-9050-adfeea7d6f95" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_740ad7f6-b6c2-406f-a7d6-43937e65c507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_740ad7f6-b6c2-406f-a7d6-43937e65c507" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_21fed771-6b26-4358-aada-3fdb7948901e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_21fed771-6b26-4358-aada-3fdb7948901e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b74583fb-b629-4eb9-8c16-38df7558247f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b74583fb-b629-4eb9-8c16-38df7558247f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05ed5dd5-2e97-4010-bbc0-13d6d51077e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05ed5dd5-2e97-4010-bbc0-13d6d51077e5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_64e2ca1c-7df4-4b1a-9604-cc98446aa01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19366bf0-1fb5-4f42-9794-07f558c682ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e4ddaddf-01d8-4066-adb8-250edef4437a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2beaa683-3784-4a45-8d3d-70f0b2c777e9" xlink:to="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b17ea14f-84f8-402c-86f3-d7c9a5f696b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:to="loc_us-gaap_EquityComponentDomain_b17ea14f-84f8-402c-86f3-d7c9a5f696b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:to="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_240aeaa4-acfe-411c-9ca3-d363d44049e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_CommonStockMember_240aeaa4-acfe-411c-9ca3-d363d44049e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8245878d-13a8-4cfb-a7e2-bdd15340d318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8245878d-13a8-4cfb-a7e2-bdd15340d318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9e71c49f-e8ab-4fb2-94f1-028c56431e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_RetainedEarningsMember_9e71c49f-e8ab-4fb2-94f1-028c56431e48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a4f1e55-a703-45ae-a5ad-d68d413ddd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a4f1e55-a703-45ae-a5ad-d68d413ddd89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_90f3211c-74a4-440e-96b9-39128e735431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_TreasuryStockCommonMember_90f3211c-74a4-440e-96b9-39128e735431" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:to="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95cd0a7d-228e-426b-b9b8-3797c61bbd9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95cd0a7d-228e-426b-b9b8-3797c61bbd9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a9207584-00f6-4f4f-8983-7fc431ccf670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a9207584-00f6-4f4f-8983-7fc431ccf670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5e001974-8838-417a-afdd-3a5ac0cf66ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:to="loc_us-gaap_PerformanceSharesMember_5e001974-8838-417a-afdd-3a5ac0cf66ee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionsDetails" xlink:type="extended" id="ia08cbf4a7e5f494f84595adc7036af44_AcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_031ad05e-d337-4aeb-a92b-652ff7d06e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_031ad05e-d337-4aeb-a92b-652ff7d06e9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c255ea9e-f7e8-4d6f-b9d2-8db19af97d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c255ea9e-f7e8-4d6f-b9d2-8db19af97d1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8d3d04af-0314-45e5-b0e3-f2d5504d5710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8d3d04af-0314-45e5-b0e3-f2d5504d5710" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_bf90b492-a7c3-4608-98b8-a7640738a15f" xlink:href="ango-20221130.xsd#ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_bf90b492-a7c3-4608-98b8-a7640738a15f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AssetAcquisitionInventoryAndFixedAssets_1a5f8973-6dd4-44e4-a12c-1a6ea7256fb7" xlink:href="ango-20221130.xsd#ango_AssetAcquisitionInventoryAndFixedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_ango_AssetAcquisitionInventoryAndFixedAssets_1a5f8973-6dd4-44e4-a12c-1a6ea7256fb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_10c3500f-dedd-4ee3-b49a-eecd2e54b813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_10c3500f-dedd-4ee3-b49a-eecd2e54b813" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_95e3df3f-3032-4c90-8205-55befff00ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_95e3df3f-3032-4c90-8205-55befff00ea2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_704d5a2b-7c5e-41de-bda0-c632421d024d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_704d5a2b-7c5e-41de-bda0-c632421d024d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15cf2447-c458-454d-89cf-af1773372e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15cf2447-c458-454d-89cf-af1773372e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6a0f599c-3491-41b6-9efa-b4f4af14a0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15cf2447-c458-454d-89cf-af1773372e9e" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6a0f599c-3491-41b6-9efa-b4f4af14a0e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:to="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_eb65138a-a1be-4d48-a391-0ecec9dc79db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:to="loc_us-gaap_AssetAcquisitionDomain_eb65138a-a1be-4d48-a391-0ecec9dc79db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_7285fc31-48ff-44b6-a7ba-566a5fb538a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:to="loc_us-gaap_AssetAcquisitionDomain_7285fc31-48ff-44b6-a7ba-566a5fb538a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_8adbb03e-7ea4-40e0-b86b-b925343f631e" xlink:href="ango-20221130.xsd#ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_7285fc31-48ff-44b6-a7ba-566a5fb538a9" xlink:to="loc_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_8adbb03e-7ea4-40e0-b86b-b925343f631e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomersDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails" xlink:type="extended" id="i6f3ed8d9fb97492190357b0daecb71d0_RevenuefromContractswithCustomersDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e05362e8-c57a-48c2-a3b7-fd29cd34a089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dca7bf8f-35a0-45b5-b008-7edf259d7f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e05362e8-c57a-48c2-a3b7-fd29cd34a089" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dca7bf8f-35a0-45b5-b008-7edf259d7f11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e05362e8-c57a-48c2-a3b7-fd29cd34a089" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:to="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_150d9d37-fabe-40ab-8a67-a024012c7e3e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:to="loc_srt_ProductsAndServicesDomain_150d9d37-fabe-40ab-8a67-a024012c7e3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:to="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember_eda2ecbd-8ade-44d3-be0d-6e3647d6c7a4" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:to="loc_ango_MedTechMember_eda2ecbd-8ade-44d3-be0d-6e3647d6c7a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember_b8f18dd0-b3c3-4878-905d-9c4f7231c0dc" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:to="loc_ango_MedDeviceMember_b8f18dd0-b3c3-4878-905d-9c4f7231c0dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:to="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fc6c31b5-9812-4c5d-9381-d987f14a0636_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:to="loc_srt_SegmentGeographicalDomain_fc6c31b5-9812-4c5d-9381-d987f14a0636_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:to="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2a86e868-f8ac-498f-a718-88d3eea3ae1b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:to="loc_country_US_2a86e868-f8ac-498f-a718-88d3eea3ae1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4ef20913-f977-4e41-b6d8-bc37fbfcbb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:to="loc_us-gaap_NonUsMember_4ef20913-f977-4e41-b6d8-bc37fbfcbb43" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="extended" id="ia369bc6bed524eef93184e958ff64cd5_RevenuefromContractswithCustomersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenuePerformanceObligationPaymentTerm_97d0fc22-8651-46ea-bb2c-172ffd9df78a" xlink:href="ango-20221130.xsd#ango_RevenuePerformanceObligationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_RevenuePerformanceObligationPaymentTerm_97d0fc22-8651-46ea-bb2c-172ffd9df78a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_57d6105e-5b5b-47b0-ab7d-753eccb32432" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_57d6105e-5b5b-47b0-ab7d-753eccb32432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnRestockingCharge_3283b36c-4e16-4fde-bef1-85617f86452e" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnRestockingCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_ContractWithCustomerRightOfReturnRestockingCharge_3283b36c-4e16-4fde-bef1-85617f86452e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_a34f3d15-e407-4a7b-9bfa-fb34d38588f8" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_a34f3d15-e407-4a7b-9bfa-fb34d38588f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_095aa60e-7fbe-4865-85ed-14098c094afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_095aa60e-7fbe-4865-85ed-14098c094afb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_0f7a2df6-c30a-4448-97c5-c57458313491" xlink:href="ango-20221130.xsd#ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_0f7a2df6-c30a-4448-97c5-c57458313491" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:to="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_07e026ed-98dc-42e6-be98-7dd402ef665e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:to="loc_srt_RangeMember_07e026ed-98dc-42e6-be98-7dd402ef665e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:to="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e26d9a9b-1a2f-4a21-91c6-c1c1df36d74c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:to="loc_srt_MinimumMember_e26d9a9b-1a2f-4a21-91c6-c1c1df36d74c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c139be3-d9b7-4ce1-9841-bd429543405d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:to="loc_srt_MaximumMember_5c139be3-d9b7-4ce1-9841-bd429543405d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="ia16613b41b4e4b709f0a51468fac324e_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_39fdbca8-4a18-484f-861a-321c06ee8244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_NumberOfReportingUnits_39fdbca8-4a18-484f-861a-321c06ee8244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8479ff8c-6465-4f8f-91e9-769ffeaabb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8479ff8c-6465-4f8f-91e9-769ffeaabb4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e36ea617-1dbc-405f-881e-ee8a060b1277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e36ea617-1dbc-405f-881e-ee8a060b1277" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fc62e498-e8dd-4b87-99b7-ede24611f320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fc62e498-e8dd-4b87-99b7-ede24611f320" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_72f93ec3-6263-4bf6-a783-0901e19204d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_72f93ec3-6263-4bf6-a783-0901e19204d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:to="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b36fa65-d348-4f25-b74e-371b0ba7e62a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:to="loc_srt_RangeMember_6b36fa65-d348-4f25-b74e-371b0ba7e62a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:to="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fa10d5a-c1ba-455e-9a7a-4ae5ff41b0cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:to="loc_srt_MinimumMember_0fa10d5a-c1ba-455e-9a7a-4ae5ff41b0cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_abcd8986-a6a3-4fb9-848f-d2a9173d0e0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:to="loc_srt_MaximumMember_abcd8986-a6a3-4fb9-848f-d2a9173d0e0c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsChangeinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails" xlink:type="extended" id="i63cd7b5039644508917b0a4df3a8de6c_GoodwillandIntangibleAssetsChangeinGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_140cf825-3870-4708-b6a6-43c1c27f7853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_140cf825-3870-4708-b6a6-43c1c27f7853" xlink:to="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe8aa06b-6c32-43c8-945c-965be2fcdbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:to="loc_us-gaap_Goodwill_fe8aa06b-6c32-43c8-945c-965be2fcdbfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a182f711-dff8-4680-965b-ee9ea8dd63ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a182f711-dff8-4680-965b-ee9ea8dd63ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff3d84a1-f5c2-47dc-984e-b461bf3406b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_140cf825-3870-4708-b6a6-43c1c27f7853" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:to="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_ed611871-8c86-441d-be3b-2379b9f4a327_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:to="loc_us-gaap_ReportingUnitDomain_ed611871-8c86-441d-be3b-2379b9f4a327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:to="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember_54b052da-12fb-4526-abe1-7ff5cff64d59" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:to="loc_ango_MedTechMember_54b052da-12fb-4526-abe1-7ff5cff64d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember_5f4e0342-ac2e-4499-9c4a-b498a4fecf76" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:to="loc_ango_MedDeviceMember_5f4e0342-ac2e-4499-9c4a-b498a4fecf76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended" id="i57dd75e38c834ae99da19272634c0355_GoodwillandIntangibleAssetsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e75e10f6-de53-4142-a93b-f6f5d02e6cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e75e10f6-de53-4142-a93b-f6f5d02e6cef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce051e8d-de36-48bb-ad75-ffb03def4d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce051e8d-de36-48bb-ad75-ffb03def4d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914cb24c-7ede-4929-8423-04b0a328c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914cb24c-7ede-4929-8423-04b0a328c5c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ProductTechnologiesMember_7df17ae2-1ed8-4354-9ba3-2c6c46d04255" xlink:href="ango-20221130.xsd#ango_ProductTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_ango_ProductTechnologiesMember_7df17ae2-1ed8-4354-9ba3-2c6c46d04255" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1ac4b933-6bcb-4c9e-9a5f-447c0314c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1ac4b933-6bcb-4c9e-9a5f-447c0314c8e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4406fc3c-78ae-4715-add2-626acaa560ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_us-gaap_TrademarksMember_4406fc3c-78ae-4715-add2-626acaa560ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_deceead2-ec33-4063-8cf2-7189f32c45e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_deceead2-ec33-4063-8cf2-7189f32c45e6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="ie1259fe4ad534050a5af0adc55c0eff2_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b2769e7f-e3de-47ae-bf18-2086fddafef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b2769e7f-e3de-47ae-bf18-2086fddafef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_035cd22a-2613-4afe-9a25-7968204df609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_035cd22a-2613-4afe-9a25-7968204df609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0b6906a8-7f6a-49b9-920c-b116c6da883f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0b6906a8-7f6a-49b9-920c-b116c6da883f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_64d8f7fc-1386-4303-b6a9-9f3a64307b1d" xlink:href="ango-20221130.xsd#ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_64d8f7fc-1386-4303-b6a9-9f3a64307b1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_35d08eb8-8f84-4f31-94fa-a0148759b074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentTerm_35d08eb8-8f84-4f31-94fa-a0148759b074" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b6403066-4797-403d-8895-5dfcf93f0b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b6403066-4797-403d-8895-5dfcf93f0b0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentFloorInterestRate_11aea82b-c48a-4e0a-bbaa-555dddb995a2" xlink:href="ango-20221130.xsd#ango_DebtInstrumentFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentFloorInterestRate_11aea82b-c48a-4e0a-bbaa-555dddb995a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentDebtDefaultInterestRateIncrease_7e66750e-0efa-45bf-a9f0-0f82ee4efc55" xlink:href="ango-20221130.xsd#ango_DebtInstrumentDebtDefaultInterestRateIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentDebtDefaultInterestRateIncrease_7e66750e-0efa-45bf-a9f0-0f82ee4efc55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_aa89bfd2-1cea-4a32-a93f-e18360bbf920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_aa89bfd2-1cea-4a32-a93f-e18360bbf920" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LineOfCreditFacilityNumberOfCovenants_3b0b5f17-840d-49cb-820d-cfc7bd9c3ddb" xlink:href="ango-20221130.xsd#ango_LineOfCreditFacilityNumberOfCovenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_LineOfCreditFacilityNumberOfCovenants_3b0b5f17-840d-49cb-820d-cfc7bd9c3ddb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_d183fbc3-7ee1-470a-a4fe-c75a7c985226" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_d183fbc3-7ee1-470a-a4fe-c75a7c985226" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_e96d51b4-792d-448b-8f0b-30060c0fac7a" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_e96d51b4-792d-448b-8f0b-30060c0fac7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_91337617-92e8-40ef-bf5d-d37fbcbe714f" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_91337617-92e8-40ef-bf5d-d37fbcbe714f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_44e517f4-089e-4ae9-8d3c-2b74e45cb792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCredit_44e517f4-089e-4ae9-8d3c-2b74e45cb792" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b216fbf4-bdbd-468a-a947-2e5d5995e50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LongTermDebt_b216fbf4-bdbd-468a-a947-2e5d5995e50c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_70f0f482-d49c-42e1-b2b2-def41f7aee65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_70f0f482-d49c-42e1-b2b2-def41f7aee65" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_8b7a7103-0838-4252-9e00-cde1b9de6f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_8b7a7103-0838-4252-9e00-cde1b9de6f06" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_77ed8684-1490-448b-8118-00fef68e5a20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_77ed8684-1490-448b-8118-00fef68e5a20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a8b962d-3e3b-40db-bedc-f9c4ba81109e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a8b962d-3e3b-40db-bedc-f9c4ba81109e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_99f32952-9faf-4b52-81b6-e8151e0446f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a8b962d-3e3b-40db-bedc-f9c4ba81109e" xlink:to="loc_us-gaap_LineOfCreditMember_99f32952-9faf-4b52-81b6-e8151e0446f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c2e066ea-eb20-4c14-a48f-eab446bec036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:to="loc_us-gaap_CreditFacilityDomain_c2e066ea-eb20-4c14-a48f-eab446bec036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:to="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fe18c283-5f5c-4cf8-a6ad-d9e2afd2770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fe18c283-5f5c-4cf8-a6ad-d9e2afd2770c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_74e816e4-d9ca-4fbe-af5f-7796138f1b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:to="loc_us-gaap_SecuredDebtMember_74e816e4-d9ca-4fbe-af5f-7796138f1b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_02c424d8-9657-4a40-82f1-183fda9a1e4d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:to="loc_srt_RangeMember_02c424d8-9657-4a40-82f1-183fda9a1e4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:to="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1226179f-a82a-4ae1-9190-f8d58ef469af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:to="loc_srt_MinimumMember_1226179f-a82a-4ae1-9190-f8d58ef469af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1af66f0-4583-4ef4-a37c-f7bf34ee5dd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:to="loc_srt_MaximumMember_c1af66f0-4583-4ef4-a37c-f7bf34ee5dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_977565f5-885f-4778-9131-4c9daeefb70a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:to="loc_us-gaap_VariableRateDomain_977565f5-885f-4778-9131-4c9daeefb70a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:to="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f2c710a2-28ec-47ab-8a74-efa4885a27c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f2c710a2-28ec-47ab-8a74-efa4885a27c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e1680769-5681-4c8b-bb0b-2279739972e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:to="loc_us-gaap_BaseRateMember_e1680769-5681-4c8b-bb0b-2279739972e4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended" id="i6d27b80d74554eeb9e7c669046aa58f6_LongTermDebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_199a4a67-2e2e-4af7-a153-7eb478262bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_199a4a67-2e2e-4af7-a153-7eb478262bb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7cec83c4-eb32-4a4f-9793-879d53d3ac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7cec83c4-eb32-4a4f-9793-879d53d3ac3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d376aa19-e23a-4625-af2b-141c42ad22d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_LongTermDebt_d376aa19-e23a-4625-af2b-141c42ad22d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f9675526-385f-4e8b-9bdb-43c7668a9fcc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f9675526-385f-4e8b-9bdb-43c7668a9fcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a0eadab-3f28-43a6-8049-3e54a1ae14a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a0eadab-3f28-43a6-8049-3e54a1ae14a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_a9792828-18a4-4b54-8ff3-a3fc1a18a02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3a0eadab-3f28-43a6-8049-3e54a1ae14a6" xlink:to="loc_us-gaap_LineOfCreditMember_a9792828-18a4-4b54-8ff3-a3fc1a18a02b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:to="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_19373974-4021-4e09-b39f-64cb69f56870_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:to="loc_us-gaap_CreditFacilityDomain_19373974-4021-4e09-b39f-64cb69f56870_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:to="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b2976f0f-f1dd-4f91-b63c-050791192ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b2976f0f-f1dd-4f91-b63c-050791192ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_35fd9509-44af-42bc-809c-e983c396935b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:to="loc_us-gaap_SecuredDebtMember_35fd9509-44af-42bc-809c-e983c396935b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#ShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ShareBasedCompensationDetails" xlink:type="extended" id="i1100678e909a41a49211416a82be968f_ShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_916eab50-7fd8-4a15-90e8-7230f69c54eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_916eab50-7fd8-4a15-90e8-7230f69c54eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aab6b6b4-064c-4a47-a37f-9fd8fef73ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aab6b6b4-064c-4a47-a37f-9fd8fef73ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ad338446-8bdc-4d34-8343-14eb8e39d722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ad338446-8bdc-4d34-8343-14eb8e39d722" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4d0f8c0b-978b-45f2-80b3-81bcd2683e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4d0f8c0b-978b-45f2-80b3-81bcd2683e8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_27ad0b39-8b87-4d7a-9114-d2969034af52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_27ad0b39-8b87-4d7a-9114-d2969034af52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:to="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_13389a84-d353-4d9c-bcc0-678780e2ec69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:to="loc_us-gaap_PlanNameDomain_13389a84-d353-4d9c-bcc0-678780e2ec69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:to="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_A2020StockAndIncentiveAwardPlanMember_77d219b4-37e5-4fe5-8233-704909adbd3a" xlink:href="ango-20221130.xsd#ango_A2020StockAndIncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:to="loc_ango_A2020StockAndIncentiveAwardPlanMember_77d219b4-37e5-4fe5-8233-704909adbd3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_EmployeeStockPurchasePlanMember_85e9b6dd-dfe2-4925-82cf-34e1bd38a2a3" xlink:href="ango-20221130.xsd#ango_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:to="loc_ango_EmployeeStockPurchasePlanMember_85e9b6dd-dfe2-4925-82cf-34e1bd38a2a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails" xlink:type="extended" id="i7c7ce7316cb94fc4965294ea145564d9_SegmentandGeographicInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ec7e3477-26cf-4e76-8db5-e306672d7591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ec7e3477-26cf-4e76-8db5-e306672d7591" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c21160a9-91fa-42bf-b8a8-2f76a357092e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_Assets_c21160a9-91fa-42bf-b8a8-2f76a357092e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cda68eef-8d02-47cd-9eaf-e365f50774af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cda68eef-8d02-47cd-9eaf-e365f50774af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_74c5b287-b254-4cef-ba14-c19ecea17300_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:to="loc_srt_SegmentGeographicalDomain_74c5b287-b254-4cef-ba14-c19ecea17300_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:to="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_874aa53c-f1ff-43cf-a19e-dfd0a65d0c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:to="loc_us-gaap_NonUsMember_874aa53c-f1ff-43cf-a19e-dfd0a65d0c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b8db9d13-7e87-4fd6-909d-5286e954592e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:to="loc_country_US_b8db9d13-7e87-4fd6-909d-5286e954592e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a4c17cbc-648a-41ac-aa69-da53fc85e57d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a4c17cbc-648a-41ac-aa69-da53fc85e57d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_fad60181-fa8f-498d-9c58-bf4c05199544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_fad60181-fa8f-498d-9c58-bf4c05199544" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetsGeographicAreaMember_b06ae160-29fe-4b1c-aae7-ee70075de521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetAssetsGeographicAreaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:to="loc_us-gaap_NetAssetsGeographicAreaMember_b06ae160-29fe-4b1c-aae7-ee70075de521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d282fe38-a94c-476d-87ee-607fcbd81e28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d282fe38-a94c-476d-87ee-607fcbd81e28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_61d95cf1-88be-4f09-b6b6-2dce11b1cb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_61d95cf1-88be-4f09-b6b6-2dce11b1cb08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_70d0be5e-4528-4eab-96c6-49ca90bc3e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_61d95cf1-88be-4f09-b6b6-2dce11b1cb08" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_70d0be5e-4528-4eab-96c6-49ca90bc3e58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails" xlink:type="extended" id="i57d15662c8044e67821661f11ff93fcb_SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffeb3277-eca4-4298-80d3-3ea975c2a214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffeb3277-eca4-4298-80d3-3ea975c2a214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cd01e46b-013a-4f9c-874e-1d7ba8690a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_us-gaap_GrossProfit_cd01e46b-013a-4f9c-874e-1d7ba8690a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_GrossMarginPercentage_c1398abc-a00d-4d95-8f3d-666cb0977cf7" xlink:href="ango-20221130.xsd#ango_GrossMarginPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_ango_GrossMarginPercentage_c1398abc-a00d-4d95-8f3d-666cb0977cf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:to="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c4ab610-3a7f-47a1-8f8c-044420cf6602_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:to="loc_srt_ProductsAndServicesDomain_2c4ab610-3a7f-47a1-8f8c-044420cf6602_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:to="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember_8c7512ba-82ad-421f-a36d-ccfc7371a6cd" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:to="loc_ango_MedTechMember_8c7512ba-82ad-421f-a36d-ccfc7371a6cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember_8e0c308a-744f-4f82-b7a4-0e3eaacb4941" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:to="loc_ango_MedDeviceMember_8e0c308a-744f-4f82-b7a4-0e3eaacb4941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:to="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_951632ac-43f1-432b-9e33-3199da62a152_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:to="loc_srt_SegmentGeographicalDomain_951632ac-43f1-432b-9e33-3199da62a152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_98cf5dd0-f137-4a45-b110-8c1566b82d92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:to="loc_srt_SegmentGeographicalDomain_98cf5dd0-f137-4a45-b110-8c1566b82d92" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails" xlink:type="extended" id="id3d77efb26db46b1a79bf8e4e8fe29f4_SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ed2060dc-415c-4e94-a41c-1ec0d9ba63a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf33a3db-03ca-4ea4-8276-693510d9a68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ed2060dc-415c-4e94-a41c-1ec0d9ba63a1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf33a3db-03ca-4ea4-8276-693510d9a68e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ed2060dc-415c-4e94-a41c-1ec0d9ba63a1" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:to="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ef32223-76fb-46be-80f3-408ab687e021_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:to="loc_srt_SegmentGeographicalDomain_3ef32223-76fb-46be-80f3-408ab687e021_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:to="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a0712684-3497-4d1e-aa38-4bbb470b7977" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:to="loc_country_US_a0712684-3497-4d1e-aa38-4bbb470b7977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_67c6ee5a-046e-4862-9c33-14eaab4befa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:to="loc_us-gaap_NonUsMember_67c6ee5a-046e-4862-9c33-14eaab4befa6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="i907a1799885040d294ee838eef98bcd1_FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78f80d68-c718-493e-b7b7-bc3ca0153802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78f80d68-c718-493e-b7b7-bc3ca0153802" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aa74462e-0e66-48f2-95f6-a31e6cdc33dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aa74462e-0e66-48f2-95f6-a31e6cdc33dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_db41406b-423c-4af6-9cb4-421b88def6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_db41406b-423c-4af6-9cb4-421b88def6f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78f80d68-c718-493e-b7b7-bc3ca0153802" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_833966e7-749e-44d0-bfb4-c741a29b1d08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_833966e7-749e-44d0-bfb4-c741a29b1d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_11310d86-3115-4e0c-a93f-fb22bff5a7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_11310d86-3115-4e0c-a93f-fb22bff5a7ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_87198aa9-405f-44a1-89a7-2e3a5a0ae8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_87198aa9-405f-44a1-89a7-2e3a5a0ae8d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b65315bd-8068-4cc4-89c3-3ecd18c47af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b65315bd-8068-4cc4-89c3-3ecd18c47af5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_310a909c-f880-4459-b264-f00a9cd263db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_310a909c-f880-4459-b264-f00a9cd263db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_91002de1-28ca-41c6-830d-0e269d086b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_91002de1-28ca-41c6-830d-0e269d086b55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_df379c01-7063-4992-bf1f-b57855026c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_91002de1-28ca-41c6-830d-0e269d086b55" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_df379c01-7063-4992-bf1f-b57855026c9e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails" xlink:type="extended" id="i242de6895724441e99ce61cd94cecf2b_FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6b146e1-9799-4c23-8982-31cd6f942fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6b146e1-9799-4c23-8982-31cd6f942fbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4c46d087-09f7-4d29-92ce-0eed2aa2ba43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4c46d087-09f7-4d29-92ce-0eed2aa2ba43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_031d22dd-8374-47c3-a25f-d692d33a2203_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_031d22dd-8374-47c3-a25f-d692d33a2203_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_9ccd02f6-74aa-49d8-9a69-1f2d4d22e4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_9ccd02f6-74aa-49d8-9a69-1f2d4d22e4c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MeasurementInputProbabilityofPaymentMember_6406ebcd-64e5-4d9b-a23c-ccfb82a77c71" xlink:href="ango-20221130.xsd#ango_MeasurementInputProbabilityofPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:to="loc_ango_MeasurementInputProbabilityofPaymentMember_6406ebcd-64e5-4d9b-a23c-ccfb82a77c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d0c86d11-83d3-453a-9c83-3610c6b8f47e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d0c86d11-83d3-453a-9c83-3610c6b8f47e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_63a8b648-fd09-486f-b408-54da6f407d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_63a8b648-fd09-486f-b408-54da6f407d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenueBasedPaymentMember_db84959e-d280-4f45-9698-8e29896a80a0" xlink:href="ango-20221130.xsd#ango_RevenueBasedPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_63a8b648-fd09-486f-b408-54da6f407d0d" xlink:to="loc_ango_RevenueBasedPaymentMember_db84959e-d280-4f45-9698-8e29896a80a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dcda66da-d5f1-46d8-8ad8-cc4412c37d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dcda66da-d5f1-46d8-8ad8-cc4412c37d22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a83b40e2-7f05-450e-ab12-2022773d0571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dcda66da-d5f1-46d8-8ad8-cc4412c37d22" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a83b40e2-7f05-450e-ab12-2022773d0571" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_470c62c7-4ad8-492a-a5a2-6618ef7414cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_470c62c7-4ad8-492a-a5a2-6618ef7414cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ec06fd0-3fe7-4ce2-95c7-fe06365245e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ec06fd0-3fe7-4ce2-95c7-fe06365245e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_238ac920-3bef-4f18-9b9b-519fc46b9baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ec06fd0-3fe7-4ce2-95c7-fe06365245e8" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_238ac920-3bef-4f18-9b9b-519fc46b9baa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_459675fe-7818-404e-aeec-6b03cc0e6e45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:to="loc_us-gaap_ValuationTechniqueDomain_459675fe-7818-404e-aeec-6b03cc0e6e45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_972431a8-2dcd-46f1-b3a4-f236b0d80dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:to="loc_us-gaap_ValuationTechniqueDomain_972431a8-2dcd-46f1-b3a4-f236b0d80dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_04104259-d017-453a-94f8-337e65287467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_972431a8-2dcd-46f1-b3a4-f236b0d80dc4" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_04104259-d017-453a-94f8-337e65287467" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29812bac-2d34-47ad-878e-52c82afc7f3a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:to="loc_srt_RangeMember_29812bac-2d34-47ad-878e-52c82afc7f3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:to="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dc3eb893-b44c-4c02-8b28-66de45c19f61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:to="loc_srt_MinimumMember_dc3eb893-b44c-4c02-8b28-66de45c19f61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9ee8fad8-defc-4298-9052-fc7c5ff33452" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:to="loc_srt_MaximumMember_9ee8fad8-defc-4298-9052-fc7c5ff33452" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesSupplementalStatementofOperationsInformationDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails" xlink:type="extended" id="i7365d91270db4177abc5ee0fcd6a9de1_LeasesSupplementalStatementofOperationsInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_10f72e9a-7dd1-49ba-9680-e2ace14e9d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_686e6f90-67ff-4bd3-8b6d-633300b02ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_10f72e9a-7dd1-49ba-9680-e2ace14e9d7a" xlink:to="loc_us-gaap_OperatingLeaseExpense_686e6f90-67ff-4bd3-8b6d-633300b02ef3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_10f72e9a-7dd1-49ba-9680-e2ace14e9d7a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9d3f6201-5f04-4f5b-a3c0-b4da35c11958_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9d3f6201-5f04-4f5b-a3c0-b4da35c11958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_191b470c-6669-4464-b2ad-1c55eef8492a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_CostOfSalesMember_191b470c-6669-4464-b2ad-1c55eef8492a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_02b06c26-7072-40da-af90-ce0e504579dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_02b06c26-7072-40da-af90-ce0e504579dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_00dc1c8f-9c01-4fc7-8829-f2150669d114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_00dc1c8f-9c01-4fc7-8829-f2150669d114" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cb9f58d7-bc7a-4212-a8a3-3bfc18644ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cb9f58d7-bc7a-4212-a8a3-3bfc18644ab9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i746154e6bcad43608e87a08ddcc88646_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NumberOfPatentsAssertedForReexamination_d66c2193-5abe-4e84-b8b1-836ab89c0a14" xlink:href="ango-20221130.xsd#ango_NumberOfPatentsAssertedForReexamination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_ango_NumberOfPatentsAssertedForReexamination_d66c2193-5abe-4e84-b8b1-836ab89c0a14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NumberOfPatentsUpheldOverPriorArtReferences_f922ef50-f30c-4034-b600-3a4495505ffe" xlink:href="ango-20221130.xsd#ango_NumberOfPatentsUpheldOverPriorArtReferences"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_ango_NumberOfPatentsUpheldOverPriorArtReferences_f922ef50-f30c-4034-b600-3a4495505ffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c587ee93-f964-4db4-9c6e-e5de1c8be7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c587ee93-f964-4db4-9c6e-e5de1c8be7ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:to="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_03630142-94cf-4c76-a95f-665d63c6829f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:to="loc_srt_LitigationCaseTypeDomain_03630142-94cf-4c76-a95f-665d63c6829f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:to="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_CrBardIncMember_dcdf8986-934c-4b49-ab45-2d912dfac10c" xlink:href="ango-20221130.xsd#ango_CrBardIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:to="loc_ango_CrBardIncMember_dcdf8986-934c-4b49-ab45-2d912dfac10c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_TheDelawareActionMember_3a898b85-ffe8-46aa-8176-8e74115c6031" xlink:href="ango-20221130.xsd#ango_TheDelawareActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:to="loc_ango_TheDelawareActionMember_3a898b85-ffe8-46aa-8176-8e74115c6031" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AcquisitionRestructuringandOtherItemsNetDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails" xlink:type="extended" id="i2c34d09aba21418787b9d4c499cb0461_AcquisitionRestructuringandOtherItemsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_54e49ee0-80de-4c7a-baee-e148dfc4c7d3" xlink:href="ango-20221130.xsd#ango_AcquisitionRestructuringAndOtherItemsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_54e49ee0-80de-4c7a-baee-e148dfc4c7d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_3fa580d1-8d9c-4936-9be9-3ca1faabfbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_3fa580d1-8d9c-4936-9be9-3ca1faabfbf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LegalCostsMember_c4691c59-5e40-4afa-9129-a3415540093e" xlink:href="ango-20221130.xsd#ango_LegalCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_LegalCostsMember_c4691c59-5e40-4afa-9129-a3415540093e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MergersandAcquisitionsMember_b5a981ae-ed92-4658-bed1-e1ada57371a5" xlink:href="ango-20221130.xsd#ango_MergersandAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_MergersandAcquisitionsMember_b5a981ae-ed92-4658-bed1-e1ada57371a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ManufacturingRelocationMember_13f97aa4-3633-43c5-8c0e-0c00e81f5173" xlink:href="ango-20221130.xsd#ango_ManufacturingRelocationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_ManufacturingRelocationMember_13f97aa4-3633-43c5-8c0e-0c00e81f5173" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_IsraeliInnovationAuthorityPrepaymentMember_27182176-2e52-459b-9953-a944901ee7da" xlink:href="ango-20221130.xsd#ango_IsraeliInnovationAuthorityPrepaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_IsraeliInnovationAuthorityPrepaymentMember_27182176-2e52-459b-9953-a944901ee7da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_ef871f4a-6106-4fa1-a185-0e7c93b88c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_us-gaap_OtherExpenseMember_ef871f4a-6106-4fa1-a185-0e7c93b88c93" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ie34045fa688a4b3dbf3874c578f7706a_AccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3078824-e562-4a3c-938f-0aa8734e0b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3078824-e562-4a3c-938f-0aa8734e0b2a" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7ca0b964-2d9d-48a7-8c2d-571989f1f42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_StockholdersEquity_7ca0b964-2d9d-48a7-8c2d-571989f1f42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_42d351bf-7241-4540-9dc8-9e1befc76d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_42d351bf-7241-4540-9dc8-9e1befc76d88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bae6d9fc-b921-4ef6-99ef-4f0a1c10962e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bae6d9fc-b921-4ef6-99ef-4f0a1c10962e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1aea1414-c0bc-48ff-aba3-acf5aae3ca11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3078824-e562-4a3c-938f-0aa8734e0b2a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2642c4cc-049c-444f-a550-feb4ff44917c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:to="loc_us-gaap_EquityComponentDomain_2642c4cc-049c-444f-a550-feb4ff44917c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2e8130db-7a41-4ffd-8077-84a5bcbc0489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:to="loc_us-gaap_EquityComponentDomain_2e8130db-7a41-4ffd-8077-84a5bcbc0489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7b569a91-8bc6-4772-987e-24fbf3d6c506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2e8130db-7a41-4ffd-8077-84a5bcbc0489" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7b569a91-8bc6-4772-987e-24fbf3d6c506" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ango-20221130_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:57ef1ee5-794e-4e06-bd71-294e22fc989b,g:b5d7794f-41e8-47c1-b455-924b13840c85-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_7ef60be5-b327-4304-93db-619bd0271a61_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_a17a578a-fcff-45da-b3df-3b345d7d56b6_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_714c2032-7612-4c86-b750-6a411ebe2b64_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5116749e-954b-464c-977a-12259f92de9a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_28949125-f094-42de-b50e-e5eb339d8ea3_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9e8e9a86-618f-4ac1-99c3-8860c78f9379_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3f45b946-2478-437b-b83f-b77a251477a5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_21c54c83-40e1-4611-8b28-e3db45a96289_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease ROU asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_93a104d7-1911-4842-9b8c-4bf3ac9ff6ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7916657f-ab49-4b25-88c3-53f81c96348d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_6e8d5283-d95f-48bf-860a-af232ef22018_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_99270c69-9c5b-4921-a393-e0741ee74378_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_bee883f5-31a8-45e6-8bde-b0cb43c90bca_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_MergersandAcquisitionsMember_da029fb0-7715-4b31-a6c8-e4756a993259_terseLabel_en-US" xlink:label="lab_ango_MergersandAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers and acquisitions</link:label>
    <link:label id="lab_ango_MergersandAcquisitionsMember_label_en-US" xlink:label="lab_ango_MergersandAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers and Acquisitions [Member]</link:label>
    <link:label id="lab_ango_MergersandAcquisitionsMember_documentation_en-US" xlink:label="lab_ango_MergersandAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers and Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MergersandAcquisitionsMember" xlink:href="ango-20221130.xsd#ango_MergersandAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_MergersandAcquisitionsMember" xlink:to="lab_ango_MergersandAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_a479dd4a-5d34-4cb5-874e-8b060613bc23_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and franchise taxes</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_72f9408e-65a8-44e3-bde3-aedefc478197_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a27098bd-897b-45bc-9041-e244227d0e5e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_CrBardIncMember_251cd2ec-c44b-418d-bc7e-821d0b8a76f2_terseLabel_en-US" xlink:label="lab_ango_CrBardIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.R. Bard, Inc.</link:label>
    <link:label id="lab_ango_CrBardIncMember_label_en-US" xlink:label="lab_ango_CrBardIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cr Bard Inc [Member]</link:label>
    <link:label id="lab_ango_CrBardIncMember_documentation_en-US" xlink:label="lab_ango_CrBardIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.R. Bard, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_CrBardIncMember" xlink:href="ango-20221130.xsd#ango_CrBardIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_CrBardIncMember" xlink:to="lab_ango_CrBardIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_56f3ffe8-83c9-4de5-85a9-741a2effe7b2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3c1e2732-e682-4d4c-9a16-ca632861b186_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances with Customers</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_6f7dc030-c5da-408f-95b9-b0b46b01de10_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_acb93a05-3866-4881-b49d-08479714c6cb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ManufacturingRelocationMember_e45877c8-2d8f-47a4-9bf9-1007ab655a6f_terseLabel_en-US" xlink:label="lab_ango_ManufacturingRelocationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing relocation</link:label>
    <link:label id="lab_ango_ManufacturingRelocationMember_label_en-US" xlink:label="lab_ango_ManufacturingRelocationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Relocation [Member]</link:label>
    <link:label id="lab_ango_ManufacturingRelocationMember_documentation_en-US" xlink:label="lab_ango_ManufacturingRelocationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Relocation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ManufacturingRelocationMember" xlink:href="ango-20221130.xsd#ango_ManufacturingRelocationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ManufacturingRelocationMember" xlink:to="lab_ango_ManufacturingRelocationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_e4e1c70d-9dad-45ca-90c9-b6c02456b8df_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed upon</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ca2703b3-c911-4463-acf1-2bb1a6beebab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_f865273d-0fc0-4ef7-a31a-a1d5c84f9a81_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b35e61f6-dc9d-47d3-9972-bfa010c2a656_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_69ab0717-c62e-4750-9634-8d47bdce58fa_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e318ef40-cfa1-4542-933e-1d09b60d03f1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_02d0a307-01fe-43e2-9deb-4986ed2f5df2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payment percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_fa93d076-c69d-49cb-8b3d-b97d13ad4b99_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60e44b3d-9ec0-47bd-b42d-6221bd34353f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7367f5c3-f8c6-4a64-90dd-0cfd0a79b71a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_DebtInstrumentFloorInterestRate_4f428993-4f64-4383-ad75-e6d3b3c317b3_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floor interest rate</link:label>
    <link:label id="lab_ango_DebtInstrumentFloorInterestRate_label_en-US" xlink:label="lab_ango_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:label id="lab_ango_DebtInstrumentFloorInterestRate_documentation_en-US" xlink:label="lab_ango_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentFloorInterestRate" xlink:href="ango-20221130.xsd#ango_DebtInstrumentFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentFloorInterestRate" xlink:to="lab_ango_DebtInstrumentFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f30bfd4e-9fb0-4a15-9f6e-7139630a7378_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_d14ff4fc-2847-4408-80dd-0d3f0967339a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for capital expenditures incurred during the period</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_9abc2c25-71a9-4e89-a37b-4bbbcfb0caa9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_AccruedResearchAndDevelopmentCurrent_e596d4e6-18a8-4cf2-ae8c-9c2681ce201a_terseLabel_en-US" xlink:label="lab_ango_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ango_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_ango_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:label id="lab_ango_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_ango_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AccruedResearchAndDevelopmentCurrent" xlink:href="ango-20221130.xsd#ango_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_ango_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_d024a23a-581c-4ed8-bfea-9e4fc90a406a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed and intangible asset impairments and disposals</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_23947b32-8ac7-4396-a500-14b9749c052c_terseLabel_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, restructuring and other items, net</link:label>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_label_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Restructuring and Other Items Net</link:label>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_documentation_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Restructuring And Other Items Net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet" xlink:href="ango-20221130.xsd#ango_AcquisitionRestructuringAndOtherItemsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AcquisitionRestructuringAndOtherItemsNet" xlink:to="lab_ango_AcquisitionRestructuringAndOtherItemsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_59bd72f8-b68d-426e-82a9-8c1e8493dbf7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_14da469e-21d3-458f-8a4f-1f0c1a24724b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities excluded as their inclusion would be anti-dilutive (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6c444f22-e145-458e-9bb7-9bf079ab654b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_d47e6641-18a8-414a-8a84-73cd5b42869b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_PreferredStockPurchaseRightsMember_9be2c2cf-49e0-4995-b059-cc10999f5359_terseLabel_en-US" xlink:label="lab_ango_PreferredStockPurchaseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Purchase Rights</link:label>
    <link:label id="lab_ango_PreferredStockPurchaseRightsMember_label_en-US" xlink:label="lab_ango_PreferredStockPurchaseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Purchase Rights [Member]</link:label>
    <link:label id="lab_ango_PreferredStockPurchaseRightsMember_documentation_en-US" xlink:label="lab_ango_PreferredStockPurchaseRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Purchase Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_PreferredStockPurchaseRightsMember" xlink:href="ango-20221130.xsd#ango_PreferredStockPurchaseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PreferredStockPurchaseRightsMember" xlink:to="lab_ango_PreferredStockPurchaseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_be74d47d-bf0a-4a53-85cd-2a2e7e6e9848_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee (percentage)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_7a88959d-96dc-47ed-95c1-8c4556de0580_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_2c92c386-e5b7-4bca-acf5-bcfbc6f0b8b9_terseLabel_en-US" xlink:label="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_label_en-US" xlink:label="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds (Outlays), Issuance Of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:label id="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_documentation_en-US" xlink:label="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds (Outlays), Issuance Of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" xlink:href="ango-20221130.xsd#ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" xlink:to="lab_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_72895038-0b79-43bd-abde-d8ad7abe0464_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93a2b679-6095-47e5-9345-49daf435cc35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_684c23d6-3951-4da3-807a-039859696956_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a093a65d-1949-42ad-a0c7-27d71bb10b80_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_68c5d415-29ab-4b61-b9f3-983142c859d2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_83dada6c-b75e-41ca-86b8-99986b6bcfde_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_29b700d8-db28-432f-8f33-d42ea398387f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_525cb1be-49ab-48d6-9b66-b7d76d73210c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_516d9ee4-5373-406a-9d40-25411d90a36d_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f4b3030d-0f72-4527-b99b-e239db7d39cc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6d8fe90c-e316-4cd2-8717-c0e562045d92_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_ee24e2fd-42f1-4e26-92a9-641d0156b9d8_terseLabel_en-US" xlink:label="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_label_en-US" xlink:label="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Outstanding, Basic And Diluted [Abstract]</link:label>
    <link:label id="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Outstanding, Basic And Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" xlink:href="ango-20221130.xsd#ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" xlink:to="lab_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForPreviousAcquisition_02978f28-7ff8-4d80-b4ac-07d635f35550_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPreviousAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsForPreviousAcquisition_label_en-US" xlink:label="lab_us-gaap_PaymentsForPreviousAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Previous Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPreviousAcquisition" xlink:to="lab_us-gaap_PaymentsForPreviousAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_a409ed63-de45-4f11-a4a4-7ad6baeeab43_terseLabel_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in present value of contingent consideration</link:label>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_label_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Fair Value of Contingent Consideration</link:label>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_documentation_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The expense charged against earnings in the period resulting from remeasurement to fair value of contingent earn out liabilities related to acquisitions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ChangeInFairValueOfContingentConsideration" xlink:to="lab_ango_ChangeInFairValueOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ca1adb63-1f6a-4a3b-bf8e-d63f807c0a80_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_GrossMarginPercentage_cb9f6ac1-72bc-4531-82ba-81b103bef141_terseLabel_en-US" xlink:label="lab_ango_GrossMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_ango_GrossMarginPercentage_label_en-US" xlink:label="lab_ango_GrossMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Margin, Percentage</link:label>
    <link:label id="lab_ango_GrossMarginPercentage_documentation_en-US" xlink:label="lab_ango_GrossMarginPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Margin, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_GrossMarginPercentage" xlink:href="ango-20221130.xsd#ango_GrossMarginPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_GrossMarginPercentage" xlink:to="lab_ango_GrossMarginPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_b729b374-4775-44c1-b19a-21fe3dde0c30_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a1a6b02a-0fab-494c-8d05-2eab02bdec0b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a34095f5-f2b2-4be3-8f25-edd80089c80e_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ac568fab-87ab-4730-85d9-bacf8e1d7d5e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8dd01a4-8c38-48f3-9499-bce0231be17a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_682327f1-b773-4c8e-b46d-f34e68a5f6f2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_53e476f8-999c-439e-9d26-e5220c433de6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ac24b681-e57e-4f0b-985e-d979c6a81332_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_ba230d78-168a-4201-ba4b-4f6803d97b40_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_NonCashLeaseExpense_fffdda83-7dc6-4e9d-b333-6eb3cfd42e4a_terseLabel_en-US" xlink:label="lab_ango_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_ango_NonCashLeaseExpense_label_en-US" xlink:label="lab_ango_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Lease Expense</link:label>
    <link:label id="lab_ango_NonCashLeaseExpense_documentation_en-US" xlink:label="lab_ango_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NonCashLeaseExpense" xlink:href="ango-20221130.xsd#ango_NonCashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NonCashLeaseExpense" xlink:to="lab_ango_NonCashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_38272f33-60a2-4e9e-86e3-2821b1c559c1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8a09adc7-2324-4863-a975-49b55c205695_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_6ee68c50-94bc-4045-8061-458b8a0cf67e_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_505867a1-2c1c-4740-a787-022396e15901_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_RevenueBasedPaymentMember_3c1eacc4-b6ea-4ed0-80fe-dec1f5c65328_terseLabel_en-US" xlink:label="lab_ango_RevenueBasedPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue based payments</link:label>
    <link:label id="lab_ango_RevenueBasedPaymentMember_label_en-US" xlink:label="lab_ango_RevenueBasedPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payment [Member]</link:label>
    <link:label id="lab_ango_RevenueBasedPaymentMember_documentation_en-US" xlink:label="lab_ango_RevenueBasedPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenueBasedPaymentMember" xlink:href="ango-20221130.xsd#ango_RevenueBasedPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RevenueBasedPaymentMember" xlink:to="lab_ango_RevenueBasedPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d1a2cd78-f39d-42d7-a6c2-2386d3096379_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities, beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_52c5f598-c235-4090-9b76-51f6aefa8afc_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities, ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_7b833620-1862-484e-bfa4-1311b87bc197_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_ec7b219b-8ea1-4a3c-9e79-d425d2fdae4d_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_dcd04851-a53a-484e-8514-f76df3afe1d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_da4c8507-123d-4ac1-971d-fbdcc6a90912_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d0d5f66d-fe77-4ee9-8251-7795e141b98d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1b868f54-6493-4158-ac92-d066078cc60d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of shares issuable through two stock-based compensation plans (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_fd85bdc5-d2ee-4aec-9ba8-afc05ab54745_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_7189b1c1-c53b-4630-b145-a89981bfa697_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accounts receivable allowances</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_a4acac77-316a-4b74-8af9-2e386bcf619f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Sales by Geographic Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_d1689c32-5a07-4db1-8f66-0d0f2efc8d6d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_056ff797-b32d-4672-bb52-a0b18a4617e1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_5d7017d1-9cf2-44e3-a91c-bae85ffbd25b_terseLabel_en-US" xlink:label="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Sales by Product Category</link:label>
    <link:label id="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_label_en-US" xlink:label="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Revenue by Product Group [Table Text Block]</link:label>
    <link:label id="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_documentation_en-US" xlink:label="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net revenue by product group.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:href="ango-20221130.xsd#ango_ScheduleOfNetRevenueByProductGroupTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:to="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_0e20f323-6821-44c7-9dc3-4586f3ad7265_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_49e3ce71-8867-4a63-b2b9-7b691f42f71f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7de5f493-d573-477a-8491-86a66e832b42_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding draw term loan</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_2c493b53-d40f-42e8-b4af-8fd0f0aa727c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c08dd353-64b5-4e42-9137-c67a39ba95bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0b9a51b0-2482-44f4-81d1-11e5579fcaea_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_ed3fa11d-5cc7-4b1b-beb9-3947037c4ace_terseLabel_en-US" xlink:label="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_label_en-US" xlink:label="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Three</link:label>
    <link:label id="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_documentation_en-US" xlink:label="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:href="ango-20221130.xsd#ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:to="lab_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_591e0b3c-0901-4692-8a53-7a3f3980c235_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_155fe939-eab7-4c99-8b9e-e805199bd7dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3225c6fa-0464-4d18-b011-15309cf4b4ac_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_NumberOfPatentsAssertedForReexamination_d8e0b411-5cfd-423a-b793-9283a879f3f0_terseLabel_en-US" xlink:label="lab_ango_NumberOfPatentsAssertedForReexamination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of petitions filed for reexamination of patents</link:label>
    <link:label id="lab_ango_NumberOfPatentsAssertedForReexamination_label_en-US" xlink:label="lab_ango_NumberOfPatentsAssertedForReexamination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patents Asserted For Reexamination</link:label>
    <link:label id="lab_ango_NumberOfPatentsAssertedForReexamination_documentation_en-US" xlink:label="lab_ango_NumberOfPatentsAssertedForReexamination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents asserted for reexamination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NumberOfPatentsAssertedForReexamination" xlink:href="ango-20221130.xsd#ango_NumberOfPatentsAssertedForReexamination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NumberOfPatentsAssertedForReexamination" xlink:to="lab_ango_NumberOfPatentsAssertedForReexamination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_660fc217-d2a7-40bb-8a2c-3f9bb019f75c_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_06cffe54-04a3-43f2-81f9-05eb0b1f0d7a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_93b8c88f-ecd2-49b3-9c62-242d0f118f37_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_1e359337-8949-4528-97f7-e4d3a76c088f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_27b9860a-eabe-45a4-bf5b-1209e59c333c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price holdbacks</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ca5d3339-c9fb-4704-a1a6-59881540f2da_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_143299b6-3919-4fef-8203-bc89125bccb0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_379c8fa5-0cad-41ca-98d8-b7da93e2b01f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_2df98416-9172-4060-89f6-bcdf3cd7238a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6d19b3f2-33ab-41dc-9e5f-2fc1b0559a21_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_907633f6-e195-4f67-94a2-415f96ac65d4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_a6497b2e-0940-408e-bf8d-a45ab2fd1069_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_69dccc58-0b8c-40a2-88aa-04c4bcf1f055_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_22889919-8059-4de5-9ce4-ebcfbca79b06_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_37e375b0-fcbc-44ce-8905-16b98196d1b8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Financial Statements</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_ae20c814-aa63-42db-ba19-d825e758a7a5_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_e5efaf36-077b-4f3f-9ad5-ad953d03b16f_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6b0384dd-d325-464d-84e1-7d4b3036bd94_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_dd763dcb-c71e-4844-921b-ed8e6c7bfa1c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_986dc08e-1747-4895-96eb-9e53aa455e7d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement_816b6495-7543-4ad7-8bbb-fed7abb5031f_terseLabel_en-US" xlink:label="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency gain from remeasurement</link:label>
    <link:label id="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement_label_en-US" xlink:label="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Gain (Loss) From Remeasurement</link:label>
    <link:label id="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement_documentation_en-US" xlink:label="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Gain (Loss) From Remeasurement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" xlink:href="ango-20221130.xsd#ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" xlink:to="lab_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_be9ce720-714d-42cd-95d6-f2dac94fdf34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_e9e8a257-e51b-4d51-9db1-6d0d8e7afee6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_2d34341a-8ece-46a8-8daf-20dbae397f7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c6886fd5-19b0-48b5-9af2-cd7f308c6a2d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_MeasurementInputProbabilityofPaymentMember_47df6e5d-071c-4c9d-bc3b-61839e8500f1_terseLabel_en-US" xlink:label="lab_ango_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment</link:label>
    <link:label id="lab_ango_MeasurementInputProbabilityofPaymentMember_label_en-US" xlink:label="lab_ango_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Payment [Member]</link:label>
    <link:label id="lab_ango_MeasurementInputProbabilityofPaymentMember_documentation_en-US" xlink:label="lab_ango_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MeasurementInputProbabilityofPaymentMember" xlink:href="ango-20221130.xsd#ango_MeasurementInputProbabilityofPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_MeasurementInputProbabilityofPaymentMember" xlink:to="lab_ango_MeasurementInputProbabilityofPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7d6b453c-5945-4a94-8a30-4c0a52693f73_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_42225cb3-d41d-47e2-b9a0-76bb1f4e805e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9d972b45-33eb-494d-9e3b-38e0e19e1fa7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_03afb85f-13be-4dcb-9506-d6431abce2d5_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f38318c9-7eab-4f6c-9c6e-e0baead90a50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_4961c2c2-807d-4e60-94bb-a0651832162c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation income</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_4157a3a0-9211-41e7-ab63-544356545d23_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4167b39a-ee16-40f6-803b-c794d4c778d7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d1569793-f28b-41c0-9dbf-ddca711d208d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences_ab227195-bae8-461e-a6c8-cc50fe235cc5_terseLabel_en-US" xlink:label="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents upheld over prior art references</link:label>
    <link:label id="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences_label_en-US" xlink:label="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patents Upheld Over Prior Art References</link:label>
    <link:label id="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences_documentation_en-US" xlink:label="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patents Upheld Over Prior Art References</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NumberOfPatentsUpheldOverPriorArtReferences" xlink:href="ango-20221130.xsd#ango_NumberOfPatentsUpheldOverPriorArtReferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NumberOfPatentsUpheldOverPriorArtReferences" xlink:to="lab_ango_NumberOfPatentsUpheldOverPriorArtReferences" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_c85e4cda-9b43-45d7-8457-afc61af7cf6b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3a8ec80e-0c33-43b3-be70-5d2a3bd4b212_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_e6e8bea7-0152-4e97-85c9-42bd053dc667_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_04489052-4bb9-4625-9d31-5db75d15f7fd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0c672692-0419-41ab-bf37-fa8392861a1e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f15be6c3-6262-4d96-b2b3-6b8936bf1b37_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share, 75,000,000 shares authorized; 39,874,144 and 39,541,173 shares issued and 39,504,144 and 39,171,173 shares outstanding at November&#160;30, 2022 and May 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_f6ec2209-3c6b-4abd-a5ba-dd2df749c748_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_3f5ada18-cd76-420c-b5e3-c25455606437_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bd985d58-593c-4ff6-a1c0-fffea7972d0a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_20a9a31e-c430-4a46-a726-5d8f50f6ae60_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_6984802b-aad3-4de0-9b27-ba0ed2d8e351_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_84e9030e-1326-4926-a216-5ca9b194c698_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_230f604f-c3ab-4ea3-ba3d-4c7f42587b98_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e8530376-9208-4972-9418-44f9a7be5094_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_48107b4d-e2b3-4cf3-b0b1-62b827cc5b68_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_44ca51cc-99f1-47e9-a603-a5dc21fde6d6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_06772d5a-6546-4f75-be3d-7d32a33620a8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1c0ae56e-747c-408e-9d73-1235a008f748_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_ebe4b77c-bd76-4369-a660-b138284ddaed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs on long-term debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_EmployeeStockPurchasePlanMember_30414abd-a652-4ea0-9b31-7c3557f5807e_terseLabel_en-US" xlink:label="lab_ango_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_ango_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_ango_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_ango_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_ango_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_EmployeeStockPurchasePlanMember" xlink:href="ango-20221130.xsd#ango_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_EmployeeStockPurchasePlanMember" xlink:to="lab_ango_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_LegalCostsMember_75167878-4aae-42ae-8a36-d52d86bff97c_terseLabel_en-US" xlink:label="lab_ango_LegalCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal</link:label>
    <link:label id="lab_ango_LegalCostsMember_label_en-US" xlink:label="lab_ango_LegalCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs [Member]</link:label>
    <link:label id="lab_ango_LegalCostsMember_documentation_en-US" xlink:label="lab_ango_LegalCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LegalCostsMember" xlink:href="ango-20221130.xsd#ango_LegalCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LegalCostsMember" xlink:to="lab_ango_LegalCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_aaf3c1d0-c79e-4826-8935-af55111b6d96_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum total leverage ratio</link:label>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_label_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio</link:label>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_documentation_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" xlink:to="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_83da7ef9-eb6e-447f-98a4-7e63dc218dd3_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_44ef9d53-aec8-43d9-99b0-459afbb87271_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_5e40bf76-5ffa-46a7-93c2-239dd1440159_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_acf01d2c-12f3-4e93-88c4-8ccb1f2fd203_terseLabel_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Days after purchase after which pre-approval is required for product return</link:label>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_label_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Right Of Return, Product Return Period After Purchase Date Requiring Pre-Approval</link:label>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_documentation_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Right Of Return, Product Return Period After Purchase Date Requiring Pre-Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" xlink:to="lab_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_2d1c892a-66a8-48df-81a7-f762880013e5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_77c1151d-0139-4bae-b831-d59863c224b1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f418bd0b-76a2-45ca-a408-593b95e67918_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_UndiscountedContingentConsiderationDisclosure_43d8bdde-8864-4018-890c-839f717ed5e1_terseLabel_en-US" xlink:label="lab_ango_UndiscountedContingentConsiderationDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential amount of undiscounted future contingent consideration</link:label>
    <link:label id="lab_ango_UndiscountedContingentConsiderationDisclosure_label_en-US" xlink:label="lab_ango_UndiscountedContingentConsiderationDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted Contingent Consideration Disclosure</link:label>
    <link:label id="lab_ango_UndiscountedContingentConsiderationDisclosure_documentation_en-US" xlink:label="lab_ango_UndiscountedContingentConsiderationDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted Contingent Consideration Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_UndiscountedContingentConsiderationDisclosure" xlink:href="ango-20221130.xsd#ango_UndiscountedContingentConsiderationDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_UndiscountedContingentConsiderationDisclosure" xlink:to="lab_ango_UndiscountedContingentConsiderationDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e00435f-0113-493d-92d5-f60066eec46a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c0674773-7ee7-4428-9200-37c151453b55_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_893c2d0f-9144-44f2-b3d3-a37092f53003_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8c92054a-1282-44f8-887b-56db40188fcd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_448c7b2a-6e06-48c2-b288-0fe81cb97bbb_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ad5fbb0-7a58-4876-849e-935a8bf38f76_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_95210e2b-0aa7-427b-a3f8-b9cbae800693_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_4f1fe9d7-f785-403e-b535-d64769ba715c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_cffd50e5-723c-4c77-9e50-6ef4bca79932_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_03321fd1-c58e-46aa-8b9d-4e66fec02c09_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_5fe5b16e-50db-46c1-9b5c-4885abca5aa5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_82e162ab-bdee-4be2-98ef-27dca59c28c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense:</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_2f22d4bc-3fb7-424e-8f93-94da9fe3d49d_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_8b831407-06ee-40b2-a28a-9c10c091a98a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2d435d2f-3019-4712-a3da-db505e1fe5c2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6d1b6506-9f4e-43e2-a76b-c9dc524a4cbb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_824ea0ad-c148-4e03-9843-6cfbfd30080d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_abb509a2-ff5c-4550-80e7-35bae96ac37f_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_e9c38b65-29d7-494e-8a81-e2e7eb5bafce_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efdafdd1-bdfc-4b6d-95ea-b7446ca060f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4b922bfd-547a-4ee8-b369-492c0a80711f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_78e937e0-1146-45c4-a999-6095c693d2b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_27cd5267-bcd7-46fd-aabc-e2b8c61fe63d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_eb6e5666-657a-4c1a-b778-9da6f8c44e39_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Restructuring and Other Items, Net</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_faad7644-998d-4ac7-9c88-23b218b48623_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_cb9a80e1-3cec-47eb-83b6-e783c0af6cc1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b8dedc31-dfbb-4f0d-8b8a-d3a7ff4dd8c9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_b5354fca-d7c6-4ed0-8d05-f82c3aaba701_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_d294c510-d95b-4e28-85ef-f1c2db8e3841_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense related to items of other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f9ddcfea-0a4c-4320-af92-cb0bf46a549d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_1b3bede6-af10-47a1-9286-d0c058a57bbc_terseLabel_en-US" xlink:label="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">QX Medical, LLC Camaro Support Catheter Asset Acquisition</link:label>
    <link:label id="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_label_en-US" xlink:label="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">QX Medical, LLC Camaro Support Catheter Asset Acquisition [Member]</link:label>
    <link:label id="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_documentation_en-US" xlink:label="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">QX Medical, LLC Camaro Support Catheter Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" xlink:href="ango-20221130.xsd#ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" xlink:to="lab_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1b2347ff-67cd-4652-9cd8-e9041cfc6c74_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability, current, statement of financial position, extensible list</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ProductTechnologiesMember_4607aea4-246e-4f23-8894-162073e6dec7_terseLabel_en-US" xlink:label="lab_ango_ProductTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product technologies</link:label>
    <link:label id="lab_ango_ProductTechnologiesMember_label_en-US" xlink:label="lab_ango_ProductTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Technologies [Member]</link:label>
    <link:label id="lab_ango_ProductTechnologiesMember_documentation_en-US" xlink:label="lab_ango_ProductTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product technologies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ProductTechnologiesMember" xlink:href="ango-20221130.xsd#ango_ProductTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ProductTechnologiesMember" xlink:to="lab_ango_ProductTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_333843bd-6f82-48f5-a91c-f480dc85cf9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bf5c20d7-1958-48a3-9bd3-e2064b057110_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_d0af253b-e950-4ffb-931a-dd767b682c75_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_ad06bd58-658e-417e-baa2-a75ef845917f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_34c3a521-4a7a-4419-81e6-000e7c6a913d_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_c26f690c-1b8d-4b72-ab3d-b062f33e9c75_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at period end (percentage)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_060e706c-8c51-459e-9735-5cf1ebf94463_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c076618f-00c8-43b1-aafb-e77b7f23bf04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f140b4f-afdc-4161-bd30-977524d996db_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6064a49b-3c22-489d-9d46-0dfcbd6c79a6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fb6f50b0-283e-44ff-b071-09a808422672_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_367875df-b1be-44eb-9c63-4acfaf81828f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3c524f02-2b15-417d-ba15-b482a14eb081_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6ff8c375-12a3-4993-b570-6a280bddd42c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8fd99a52-4c5d-4baf-9cc3-e4ad5a097529_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability Schedule</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_8f8fb224-906c-4127-bac1-3129f2077c81_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fc1c45d3-bdf0-4573-b15f-9cb5c484b16b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b7c886fc-ba80-4c36-a1aa-d87da278e5b8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5b5d1363-d13b-4dc5-8963-86c0405896db_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7bcbb323-5f1b-4ade-9e2d-b247813e3b60_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_380e1c77-573e-4275-bd1a-58ceea8e4003_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved increase of common stock reserve (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_af95eebf-f2ba-4e46-8a18-f90e84f7501f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1d88b7f1-31a7-4e45-86a1-648d70cc0a59_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_262c8d2b-93c4-4931-bd85-18b7ccf0c8ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock_c7d31b90-b505-4d15-b9be-011ce70193b9_terseLabel_en-US" xlink:label="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="ango-20221130.xsd#ango_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_ango_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_87539998-b283-4b1d-a707-c37b63edd5d7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5cd6cb81-beb1-4715-a9ae-b8a7cc84917a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_RevenuePerformanceObligationPaymentTerm_5ec735a1-9dd5-45d8-8f43-b2891d408aa2_terseLabel_en-US" xlink:label="lab_ango_RevenuePerformanceObligationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment term</link:label>
    <link:label id="lab_ango_RevenuePerformanceObligationPaymentTerm_label_en-US" xlink:label="lab_ango_RevenuePerformanceObligationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Term</link:label>
    <link:label id="lab_ango_RevenuePerformanceObligationPaymentTerm_documentation_en-US" xlink:label="lab_ango_RevenuePerformanceObligationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenuePerformanceObligationPaymentTerm" xlink:href="ango-20221130.xsd#ango_RevenuePerformanceObligationPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RevenuePerformanceObligationPaymentTerm" xlink:to="lab_ango_RevenuePerformanceObligationPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_5c005de8-66e9-45f2-84c9-699f158695a6_terseLabel_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum remaining period prior to product expiration</link:label>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_label_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Right Of Return, Minimum Remaining Product Life Prior To Return</link:label>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_documentation_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Right Of Return, Minimum Remaining Product Life Prior To Return</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" xlink:to="lab_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a2d5c2e2-62cd-4997-b8e8-b84c7b4bb331_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6b0ec1e5-5f6b-427c-978a-d0cd7215a62b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_A2020StockAndIncentiveAwardPlanMember_1c3fc694-10fa-456e-bb4a-efa550c72a92_terseLabel_en-US" xlink:label="lab_ango_A2020StockAndIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock And Incentive Award Plan</link:label>
    <link:label id="lab_ango_A2020StockAndIncentiveAwardPlanMember_label_en-US" xlink:label="lab_ango_A2020StockAndIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock And Incentive Award Plan [Member]</link:label>
    <link:label id="lab_ango_A2020StockAndIncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_ango_A2020StockAndIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock And Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_A2020StockAndIncentiveAwardPlanMember" xlink:href="ango-20221130.xsd#ango_A2020StockAndIncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_A2020StockAndIncentiveAwardPlanMember" xlink:to="lab_ango_A2020StockAndIncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6d139060-c443-4b30-a436-9c15e38fb9e8_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f7092777-35a3-4153-8be5-253621c79b2b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_0746d094-1675-408a-b55c-9d124efc4d0e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_efa0eab3-96cf-46a2-98e3-2b0d47f46260_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_e4f47379-eb0c-4c42-aa28-f81dae32d1f8_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bdf7d51a-c3f4-4a8b-9f4c-291905313d46_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_e458ce60-d5e3-4d75-b9bd-2648ae9eef1c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_580d17d3-fd94-405a-ace4-15c906be3022_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3ea27127-8283-425e-b4c5-a4d6c3d320bd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_52f247b7-b074-4307-9aa9-1d89a84cd067_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock under ESPP, Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_93a0e6d4-1e75-42f6-96b9-8c7c446d60b2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_57503534-e6d2-4c36-a411-6000f62fc452_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetAssetsGeographicAreaMember_0bf87b20-8303-4f2e-8869-69853f5e72d2_terseLabel_en-US" xlink:label="lab_us-gaap_NetAssetsGeographicAreaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets, Geographic Area</link:label>
    <link:label id="lab_us-gaap_NetAssetsGeographicAreaMember_label_en-US" xlink:label="lab_us-gaap_NetAssetsGeographicAreaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets, Geographic Area [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetsGeographicAreaMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetAssetsGeographicAreaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetAssetsGeographicAreaMember" xlink:to="lab_us-gaap_NetAssetsGeographicAreaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_962b4454-55cd-4399-803d-ab051edbe83f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted cash flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cf8ab482-6800-4756-b063-9d97881b4b7d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ea506892-2c40-4d61-9fdc-edd8040c9b35_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_59dc282e-5a06-4c94-8154-06de32018658_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6c072abc-3e1a-482f-87a0-a9ee6a27c0fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Using Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c91cc129-bff8-4a1e-a541-98e28fcff580_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0bf211f-c9b5-4a3e-9177-0584347f6e37_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7d819322-f9a8-43b8-a163-bcac221064be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_915a773a-e392-49b6-8420-09767f0fff1f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $2,110 and $1,939 respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a2674868-dfa7-4b99-b085-f2d901fcfb29_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_dc9b0dd4-4883-47c3-b099-010fa68f76eb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5a278f5b-d996-4ba6-a44e-6c107b67824c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings on long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c1b7924a-6e9a-4ed7-917c-18227a930d80_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56327fb2-0405-499f-aab3-3fd78a1321a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9fd3ca34-3b36-4cc6-8440-a79e3aa4fd14_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_7025f888-8138-43bd-8712-3828d75a3501_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_102fcfcd-40e9-4961-8d86-d72df3d93fae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6923ff56-0dcb-4bc7-82de-e19e70b41dfe_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_08bde70a-d797-415c-9f01-a89442767afc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_09b63316-b278-409c-8aa4-12ffe6a05efd_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7231a981-8747-43d0-a6aa-05d58eb12fb2_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_4e7d1577-42d5-42cb-a5be-0e21af2da7bd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_416b69b7-6319-4b80-b51e-38c14c341400_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_157ecebb-2aee-4cb0-a77b-534299fae8e5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_ac5608af-7403-48db-a869-96e3328d0e5f_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_65bcf571-0506-41c3-bdd5-edcee1ffba55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_633c503b-bc77-4076-89ed-847c86d53170_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a3b7e981-d71b-4ef4-b282-76df93be9834_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, net of current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_5f7cc43d-8777-440e-ae2d-617340b0e3c2_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_b5ceb5da-8544-45c8-be12-ff87041c7d25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic to Diluted Weighted-Average Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_364ab8d0-c03a-4a81-8566-f5c64e73c552_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_016e214b-df38-4348-b0ba-6fd80f58386b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_895d7313-f9e4-4101-a4a6-5b2c6c6d5764_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance/Cancellation of performance share units and restricted stock units, net, Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_087cfa30-2629-4ca9-8020-93b655cd8a1f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8b705db0-b661-4566-9294-f738637be185_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_84be7804-6b5f-4c4e-8977-2f830b8522a6_terseLabel_en-US" xlink:label="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:href="ango-20221130.xsd#ango_ScheduleOfIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:to="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_4b5ea2f9-4777-416a-93e6-5af38744cfb0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_cf075cbe-701f-4bac-96e9-54623e73ef27_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8f56fed9-4637-4641-80e4-70b628fb03c8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance/Cancellation of performance share units and restricted stock units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_78886ad3-d728-438c-bde3-b55dd419bdca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7a857e8c-20b4-4200-a9f6-7f0ba8e0c425_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ede3ad7c-caa4-4420-bdb4-25b8c0347d86_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_LineOfCreditFacilityNumberOfCovenants_59f18185-97e6-45b6-afc4-999cafe94200_terseLabel_en-US" xlink:label="lab_ango_LineOfCreditFacilityNumberOfCovenants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of covenants</link:label>
    <link:label id="lab_ango_LineOfCreditFacilityNumberOfCovenants_label_en-US" xlink:label="lab_ango_LineOfCreditFacilityNumberOfCovenants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Covenants</link:label>
    <link:label id="lab_ango_LineOfCreditFacilityNumberOfCovenants_documentation_en-US" xlink:label="lab_ango_LineOfCreditFacilityNumberOfCovenants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Covenants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LineOfCreditFacilityNumberOfCovenants" xlink:href="ango-20221130.xsd#ango_LineOfCreditFacilityNumberOfCovenants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LineOfCreditFacilityNumberOfCovenants" xlink:to="lab_ango_LineOfCreditFacilityNumberOfCovenants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_84c59a2d-3512-46d5-b641-02d93d48ed7c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9a9598ef-c63a-42c9-901e-f0c938379e45_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life of intangible assets other than goodwill</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_b2a6bbf3-5a93-4c0b-b757-8729a82bc111_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLoansPayable_191b4ec0-c9d5-468c-9ee6-ae5b08f82a96_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermLoansPayable_label_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="lab_us-gaap_LongTermLoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_222f2014-4394-4eed-8848-5f6a457b22a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_dcdd95ad-2ad6-47fa-b9eb-1ebb25e21dbf_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum total leverage ratio subsequent to material acquisitions</link:label>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_label_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio, Subsequent To Material Acquisitions</link:label>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_documentation_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio, Subsequent To Material Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" xlink:to="lab_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbeb8a46-82a3-4d4d-8804-e3c7b1fb10d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e7c7d3dc-824a-4498-a1f4-5b5d1e595bac_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_MedDeviceMember_7a0bb054-cd0e-46dd-8725-e38b2809f408_terseLabel_en-US" xlink:label="lab_ango_MedDeviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Med Device</link:label>
    <link:label id="lab_ango_MedDeviceMember_label_en-US" xlink:label="lab_ango_MedDeviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Med Device [Member]</link:label>
    <link:label id="lab_ango_MedDeviceMember_documentation_en-US" xlink:label="lab_ango_MedDeviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Med Device</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_MedDeviceMember" xlink:to="lab_ango_MedDeviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_fd072dc9-0120-473a-be44-e6b2a29e03bd_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9b035280-3c53-4b80-99a7-96308250af9d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_926aa8f3-2e2e-43ea-8f6b-a3a1dc0fba6e_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_25ead9da-9785-44c5-b9ea-e0df95d5d275_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9bbfd4d3-156a-452f-bf67-71591d338a7e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_322155af-a927-410c-ab92-ef333c2a9bac_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_be42e93a-659c-485a-b388-c2734beee78a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b16e5756-69fa-41c3-9331-d033724c75b7_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_ac80315b-35e7-4dc4-9456-e767132b6f91_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_7b055717-3d9d-4866-9ea4-433b6e641538_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_65157897-001f-4926-986b-214e7e14f531_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration for acquisition earn outs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_526c02f4-72bc-42c9-90e2-74b5d1be68c4_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30dedde-eed2-4959-b7fe-d5a5a4da8ad7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_205d44ab-e30e-42ae-b66b-784f1017bd4a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_db51707e-6c68-40f3-970d-50584b01f670_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_388ce308-b77f-4193-b918-520c0f5ad556_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_79a93d35-4e97-42e3-8754-98fa09518465_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2eefc526-a6b3-473c-a026-f350d095d230_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_0ba3e6b5-de9c-456d-84d3-87d52684f2ad_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_b5f24739-5898-40f0-807c-c7827afa6087_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_67fe108b-3bef-464d-84b4-9e993de1da84_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_194b8735-0309-4be6-b88c-0a8ed92b0030_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_384c3c26-1fb4-402e-b2bf-287d09b9aaca_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_15872c9a-a8a8-4904-b2ff-e58877ad1be1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3823b071-3996-4756-974a-0accc4161a4e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_3530a740-7bbc-4379-b15a-e1ec7ef224a1_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_b0bb62ba-3c69-4336-86fb-b0b03962cd5e_terseLabel_en-US" xlink:label="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="ango-20221130.xsd#ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_20777deb-d262-4702-99fd-e9611ca267b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f58253a2-7158-4f35-9fd2-39cec5720251_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8e9b17c5-d1e1-42f2-84cd-1408d76ad212_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_3b6c3950-8604-446f-b90c-3ded89f15186_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6dda8a39-8851-4d98-b238-86221d99f924_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_118f591c-ecbb-4590-9fad-ca07408f16e1_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, 370,000 shares at November&#160;30, 2022 and May 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_AssetAcquisitionInventoryAndFixedAssets_0a6e1a42-1112-471b-9f44-a89782093d1e_terseLabel_en-US" xlink:label="lab_ango_AssetAcquisitionInventoryAndFixedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory and fixed assets</link:label>
    <link:label id="lab_ango_AssetAcquisitionInventoryAndFixedAssets_label_en-US" xlink:label="lab_ango_AssetAcquisitionInventoryAndFixedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Inventory And Fixed Assets</link:label>
    <link:label id="lab_ango_AssetAcquisitionInventoryAndFixedAssets_documentation_en-US" xlink:label="lab_ango_AssetAcquisitionInventoryAndFixedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Inventory And Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AssetAcquisitionInventoryAndFixedAssets" xlink:href="ango-20221130.xsd#ango_AssetAcquisitionInventoryAndFixedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AssetAcquisitionInventoryAndFixedAssets" xlink:to="lab_ango_AssetAcquisitionInventoryAndFixedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_f2eab8e6-5060-4f6c-a67a-4c15f8adf960_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9e90646e-dbd5-4956-8381-ea817226dfa1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_43122edb-063b-43e7-aa95-3dd415e946a6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c9bad91e-83f3-4f8a-86b3-efec27b597bc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8745b4b4-dc5c-4eb4-b62b-0ead4a80e213_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets and Liabilities Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_506e1e2d-a2cc-4af6-a6ce-75b225f86358_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7aab8563-89af-4c3e-9003-16eee631f573_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_eb71abae-919d-4a04-a0d1-5530fc7b371f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_d528d7c0-da28-4c37-af73-e18679e3793f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_eb0fd3e2-c005-4ad8-a59d-9d2fdf420062_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_eabfec1a-77a8-47d2-81d6-c9cf994d8ee0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c4411546-8b65-4b92-b602-743d3b2d3485_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f1f8f05a-f3a3-4690-891e-af219dbb4b79_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a2d80afc-9331-41c0-a2b7-b87bed6a2b88_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9eeb1aac-1f9f-4639-8967-86567901158f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales (exclusive of intangible amortization)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_36d60ea5-c2c2-49eb-aa30-24cf4b931747_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b5ae1e30-4b38-4813-a8c3-3d14f119781e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_74bbff09-30d6-4c75-9f48-17be4f08b0e4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4413c268-6bc5-46d9-90aa-0658b57a01e3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_20d21980-3db1-415d-93f8-ff3d40fecff1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_eb11ac89-a07e-4565-af41-18710560d522_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_7bf5dee1-72e8-4ee3-92f6-d6aa0bc2c8f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term (years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_88623070-fed3-43e2-8b3b-74d73c7db4d4_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7fbcb6a3-ceb3-4b49-b91f-e98652df21b5_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_47e29ed1-bb85-47b2-ad36-0698f4de05c8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_a74f8935-a3a0-4b06-b732-594abe94d910_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1d11b7ad-f2f5-4942-873f-8161a728f471_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_62afc929-6106-4727-ada1-f3867dbda8fe_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_b18b85b0-e2e4-4433-8bf3-5bbd40c7465b_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum fixed charge coverage ratio</link:label>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_label_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Minimum Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_documentation_en-US" xlink:label="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Minimum Fixed Charge Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" xlink:to="lab_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_60ddb05d-9b25-4b6f-95b4-e3b02ce268bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2ca720fa-cb0b-49a6-8824-ef790ae7e9e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d98930db-efdc-4748-a35f-aaf660af7e84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2eda01e7-3f16-4e85-9355-c7eaad0f2722_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_cc1f8805-9f89-4374-9ee0-c966df855788_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_05e62bfa-4462-492e-9195-92e3ff34f2dc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_e6eef481-0437-4c4d-993b-c6746b51bfe8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_cb79028a-c459-4217-b087-d4bdaebddf60_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_e16d8fac-8b3d-4ea7-9a53-f6bc055bb38a_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_9f8b61c0-dc11-4e7f-afee-d9dd5c434a0d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_ce3388f6-682d-44e3-984e-32b9c7750e31_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_279a943d-aa35-423c-84dd-6faabd428947_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability, noncurrent, statement of financial position, extensible list</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquipmentOnLease_1ef9b142-16e9-48c2-9bed-d5438761022e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to placement and evaluation units</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquipmentOnLease_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equipment on Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquipmentOnLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:to="lab_us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_e6c2aa93-0df0-4db0-9819-87d13dd5f61a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_bd95b565-54b7-4aa2-acc4-e7e28d405877_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_beb781c8-d3ff-4839-90e3-6736f30524c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_bc4a2dcc-b750-40bf-af3f-cf7f6af4adb0_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges against income for share-based payment arrangements</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_09487446-4930-482a-b3ae-27d7411d6e62_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_9cce0dfb-7cb1-4056-928a-0648c6cdcbec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_f1a5cde4-a42e-41fa-91b3-0eac713550f0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_a649b0f3-ab34-4103-9e64-12ebc070a685_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a7085a3-664c-414c-b76f-8f80188bbfba_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e813b3fb-5626-41a9-91b4-4dac40231e42_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b7b5fb38-789a-4c67-bbb5-db9887c29152_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_725055dc-4f09-4452-8f78-9bd1917c7e45_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_514f218b-2c66-442b-9487-d6d138f960a2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_164a09f2-9cd9-4afc-9e26-322fdffc3bd8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b943d3c2-fa89-4193-a348-1391cdde8123_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_8edab7a8-37c3-49f9-add5-e8187db02770_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying value, finite intangible items</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_c08c66e2-a8c0-47f1-908d-5fb07c0111db_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_ec703235-50a8-4ac0-b1f0-b51df9976473_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_85f9432d-7772-4968-97db-020cb3411660_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease_582ee37a-5ca0-48f7-9c64-26304fb22f85_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt default interest rate increase (percentage)</link:label>
    <link:label id="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease_label_en-US" xlink:label="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Debt Default, Interest Rate Increase</link:label>
    <link:label id="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease_documentation_en-US" xlink:label="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Debt Default, Interest Rate Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentDebtDefaultInterestRateIncrease" xlink:href="ango-20221130.xsd#ango_DebtInstrumentDebtDefaultInterestRateIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentDebtDefaultInterestRateIncrease" xlink:to="lab_ango_DebtInstrumentDebtDefaultInterestRateIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d4349b50-9b28-4389-a762-8ea2a7036544_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_b30383c4-3723-4b78-be03-5899555ec4fe_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates</link:label>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4d61c448-9120-4281-9a18-e57c50548ec7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9853cdfc-19e8-4381-8cfb-3440b0c9707b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96503975-c16c-4130-b344-ff6acc32b7de_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1b34b6f-87d6-4adb-93cd-23a76e1f5041_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15655c9f-ab9c-4827-baf6-79286ce62ff1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_a3310aec-02fc-42fa-aa10-d571ea1e71ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_MedTechMember_3c0c17f9-1ded-4b45-8612-9c7859d917d2_terseLabel_en-US" xlink:label="lab_ango_MedTechMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Med Tech</link:label>
    <link:label id="lab_ango_MedTechMember_label_en-US" xlink:label="lab_ango_MedTechMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Med Tech [Member]</link:label>
    <link:label id="lab_ango_MedTechMember_documentation_en-US" xlink:label="lab_ango_MedTechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Med Tech</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_MedTechMember" xlink:to="lab_ango_MedTechMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d2c175b1-61e1-4d06-b6e6-4723e39dc356_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_6b2c09bd-e9c9-4f48-8bc9-1c42a7b80ad3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_117aa566-9da7-4298-b416-40dda9a3cd46_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (percentage)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseAgreementTermsMember_947486ab-946b-4698-966e-1f5ac0a09d25_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicenseAgreementTermsMember_label_en-US" xlink:label="lab_us-gaap_LicenseAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement Terms [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAgreementTermsMember" xlink:to="lab_us-gaap_LicenseAgreementTermsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c27815e7-090d-44fc-97b7-b4e68c0221ef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_30883c9e-89c5-46af-ae10-492eda9047fe_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_99a8433e-b02f-4c65-ada5-30269b96c59f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_74f56b96-f562-4b4e-a196-df72bfbea45c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_dbfbe883-874b-4883-8c33-b956d9007ddf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_87631e66-f16e-4ea3-9080-c7c40d6fa09e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b244a4c2-8c12-4ce4-9fd9-a93946356b37_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of common stock under ESPP</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bd85ff32-cc1d-410b-b396-72a797c60f5a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_c9b22c01-9aa3-4a41-886a-ce4c5c4b6733_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_4f236ffa-48f3-4c7a-ad5d-3385bff7221c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0d4b0127-e905-4984-8612-4dccac90e793_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8ecdb09d-2e56-4e72-abfd-a145274e383b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_IsraeliInnovationAuthorityPrepaymentMember_dc3c1154-592c-4c94-a4ed-5bc7b4832969_terseLabel_en-US" xlink:label="lab_ango_IsraeliInnovationAuthorityPrepaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Innovation Authority Prepayment</link:label>
    <link:label id="lab_ango_IsraeliInnovationAuthorityPrepaymentMember_label_en-US" xlink:label="lab_ango_IsraeliInnovationAuthorityPrepaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Innovation Authority Prepayment [Member]</link:label>
    <link:label id="lab_ango_IsraeliInnovationAuthorityPrepaymentMember_documentation_en-US" xlink:label="lab_ango_IsraeliInnovationAuthorityPrepaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Innovation Authority Prepayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_IsraeliInnovationAuthorityPrepaymentMember" xlink:href="ango-20221130.xsd#ango_IsraeliInnovationAuthorityPrepaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IsraeliInnovationAuthorityPrepaymentMember" xlink:to="lab_ango_IsraeliInnovationAuthorityPrepaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ed10f7cc-42ca-41bd-b792-332e393d0615_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_ad6e3a67-d064-4b5c-ab1e-9c76ea04aa2d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge_d21cd572-fb75-40c9-9dc6-8d25664bb3be_terseLabel_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restocking charge (as percent)</link:label>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge_label_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Right Of Return, Restocking Charge</link:label>
    <link:label id="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge_documentation_en-US" xlink:label="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Right Of Return, Restocking Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnRestockingCharge" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnRestockingCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ContractWithCustomerRightOfReturnRestockingCharge" xlink:to="lab_ango_ContractWithCustomerRightOfReturnRestockingCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_ccdd56ad-baf8-46f3-a3e6-44ab2ee7a2d7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_bdc66c75-2be6-47b2-a991-6d7fc41b0a9a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_62bf904e-81d0-45e8-baf2-4cade185bdcb_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_1dc26b1c-f985-4c77-960c-cbfc69ffb2cf_terseLabel_en-US" xlink:label="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit accordion feature</link:label>
    <link:label id="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_label_en-US" xlink:label="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Accordion Feature</link:label>
    <link:label id="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_documentation_en-US" xlink:label="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Accordion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" xlink:href="ango-20221130.xsd#ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" xlink:to="lab_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent_9e5114bd-48a7-4025-88ae-f1dfe4408989_terseLabel_en-US" xlink:label="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated federal statutory income tax rate</link:label>
    <link:label id="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent_label_en-US" xlink:label="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Before Discreet Items, Percent</link:label>
    <link:label id="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent_documentation_en-US" xlink:label="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Before Discreet Items, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" xlink:href="ango-20221130.xsd#ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" xlink:to="lab_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dc9d6489-edbd-426d-bd81-4fc80d595ae8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_757a0865-665a-4994-a60a-41cbd106bce3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_5baba11f-52cd-49a9-8faf-df41f6d39791_terseLabel_en-US" xlink:label="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_label_en-US" xlink:label="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer With Customer, Liability, Revenue Recognized, Including Current Period</link:label>
    <link:label id="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_documentation_en-US" xlink:label="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer With Customer, Liability, Revenue Recognized, Including Current Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" xlink:href="ango-20221130.xsd#ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" xlink:to="lab_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_35ffd7a8-62a1-45cd-aa7d-0295502366ba_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expenses related to share-based payment arrangements</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_72bae691-4f9c-4bb0-b4d0-0cd2f7851143_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ef6b007d-e58a-433c-86df-fa4801273176_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying value, finite intangible items</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_823434ce-8963-4897-a55a-9563b94bdc92_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d2ef35dc-1f31-4102-b5f8-6599d0fc830d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_dd9b030a-db90-4420-aa20-593e88dcb718_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_b9b4f65a-1eac-401e-9153-5e37f237cab5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset, statement of financial position, extensible list</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_f683e30f-d5ee-477b-a8b7-4f4884fa08eb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_ef9b684a-762e-4fb0-afd1-75233a013f1e_terseLabel_en-US" xlink:label="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential future contingent consideration</link:label>
    <link:label id="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="ango-20221130.xsd#ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsiderationOne_9628079d-5f89-4a25-a9a7-463281e4e427_terseLabel_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsiderationOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsiderationOne_label_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsiderationOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value Of Contingent Consideration One</link:label>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsiderationOne_documentation_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsiderationOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value Of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsiderationOne" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsiderationOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ChangeInFairValueOfContingentConsiderationOne" xlink:to="lab_ango_ChangeInFairValueOfContingentConsiderationOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_54562493-580c-45ce-af6f-bccd5dcf20ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill for Each Reporting Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_29b0d254-9b35-4151-ac8f-c86396e0b779_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_540676c0-6f7b-47a3-a41b-f7de406c812a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b4cf2eeb-3ed8-47ab-8b61-1268f73e52b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ango_TheDelawareActionMember_13ef318d-43cc-4073-ae17-bbf4c1475aa9_terseLabel_en-US" xlink:label="lab_ango_TheDelawareActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Delaware Action</link:label>
    <link:label id="lab_ango_TheDelawareActionMember_label_en-US" xlink:label="lab_ango_TheDelawareActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Delaware Action [Member]</link:label>
    <link:label id="lab_ango_TheDelawareActionMember_documentation_en-US" xlink:label="lab_ango_TheDelawareActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Delaware Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ango_TheDelawareActionMember" xlink:href="ango-20221130.xsd#ango_TheDelawareActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TheDelawareActionMember" xlink:to="lab_ango_TheDelawareActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_861de799-76ee-46e9-b50e-7dd3fe5812b9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_e398452d-91cf-409b-bcab-12f58a4a0485_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0cdf195c-a18b-4876-a0ea-c7f39c998d6f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contingent consideration for IPR&amp;D Write-off</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ango-20221130_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:57ef1ee5-794e-4e06-bd71-294e22fc989b,g:b5d7794f-41e8-47c1-b455-924b13840c85-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CoverPage" xlink:type="simple" xlink:href="ango-20221130.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_32f99c43-a63b-474b-b6b8-fa4e80daa40c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32f99c43-a63b-474b-b6b8-fa4e80daa40c" xlink:to="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_595cd991-22d5-4a95-bc64-5755ef5cabfd" xlink:to="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b561635f-4ca3-40bf-97f0-98c28b475793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:to="loc_us-gaap_CommonStockMember_b561635f-4ca3-40bf-97f0-98c28b475793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_PreferredStockPurchaseRightsMember_1f8eb3e7-366a-49f1-bff8-8fe75ba89b07" xlink:href="ango-20221130.xsd#ango_PreferredStockPurchaseRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fc72e747-d7cf-4ba8-80e0-66bd38718cc9" xlink:to="loc_ango_PreferredStockPurchaseRightsMember_1f8eb3e7-366a-49f1-bff8-8fe75ba89b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_abfb6ef4-74c0-400b-b2ec-b9dae80b3a1c" xlink:to="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9800e742-41b2-4dba-a9cb-9a47db4991b7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_AmendmentFlag_9800e742-41b2-4dba-a9cb-9a47db4991b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_8a17084f-e338-4e09-8880-67aecef7ffe2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentFiscalYearFocus_8a17084f-e338-4e09-8880-67aecef7ffe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4d850d7c-0c1c-490f-9337-26e2527ec8e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4d850d7c-0c1c-490f-9337-26e2527ec8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bbd9caa3-71e6-454b-9a3b-c8ee79481507" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityCentralIndexKey_bbd9caa3-71e6-454b-9a3b-c8ee79481507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6f64d2dd-1f56-47c3-afc1-e15fdf5c5aa3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_CurrentFiscalYearEndDate_6f64d2dd-1f56-47c3-afc1-e15fdf5c5aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_afb01340-5869-466d-8058-66ac6d58f185" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_NoTradingSymbolFlag_afb01340-5869-466d-8058-66ac6d58f185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bff92c55-c85b-419d-b38e-817a0aedbb14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentType_bff92c55-c85b-419d-b38e-817a0aedbb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1b14e4f5-e0b4-4463-b296-cbf96124ae35" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentQuarterlyReport_1b14e4f5-e0b4-4463-b296-cbf96124ae35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1aa41339-637d-4014-961b-fa6b8948efb3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentPeriodEndDate_1aa41339-637d-4014-961b-fa6b8948efb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b084b32e-81fa-44e2-a318-5b9fc8535900" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_DocumentTransitionReport_b084b32e-81fa-44e2-a318-5b9fc8535900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8c61f2c3-b010-4f75-a430-546eaac75645" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityFileNumber_8c61f2c3-b010-4f75-a430-546eaac75645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_deaf3eaa-f94f-493c-967f-8bc867147f2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityRegistrantName_deaf3eaa-f94f-493c-967f-8bc867147f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_55e94a5e-0967-43ed-9eb2-3145e3af574d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityIncorporationStateCountryCode_55e94a5e-0967-43ed-9eb2-3145e3af574d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fd1f8e9c-994f-43c3-a000-5adfcb9fdbd9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityTaxIdentificationNumber_fd1f8e9c-994f-43c3-a000-5adfcb9fdbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_57cec231-41a9-4fd9-bf6c-2fe096a96b88" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressAddressLine1_57cec231-41a9-4fd9-bf6c-2fe096a96b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_02981e3e-7400-4b07-9b17-1c06cb5d6328" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressCityOrTown_02981e3e-7400-4b07-9b17-1c06cb5d6328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ed658eeb-c414-469e-b4c0-7beddde2bc0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressStateOrProvince_ed658eeb-c414-469e-b4c0-7beddde2bc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6c7bebd8-8a2a-4da4-aa62-814b5a97e8b6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityAddressPostalZipCode_6c7bebd8-8a2a-4da4-aa62-814b5a97e8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0e8cd635-6ba4-42dd-ac82-d65a644b9baf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_CityAreaCode_0e8cd635-6ba4-42dd-ac82-d65a644b9baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_868e37c3-7c13-4bf3-8834-ca952cd65c1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_LocalPhoneNumber_868e37c3-7c13-4bf3-8834-ca952cd65c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a59c9d75-03d3-493c-83c0-33086592823e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_Security12bTitle_a59c9d75-03d3-493c-83c0-33086592823e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_09270b16-d6a9-417a-8247-7620c927d78f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_TradingSymbol_09270b16-d6a9-417a-8247-7620c927d78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_42ccca23-640b-4f96-8248-04b66f3f64ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_SecurityExchangeName_42ccca23-640b-4f96-8248-04b66f3f64ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e9c63926-3c95-4ff1-9ea1-e681bbf6b14b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityCurrentReportingStatus_e9c63926-3c95-4ff1-9ea1-e681bbf6b14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c24ac339-68da-41f3-bdc6-2f5fc31deb5d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityInteractiveDataCurrent_c24ac339-68da-41f3-bdc6-2f5fc31deb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_260c07cc-e420-48f6-94e5-158dad1b5f1b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntitySmallBusiness_260c07cc-e420-48f6-94e5-158dad1b5f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_02d8754a-a3f2-41cf-b86d-aae26b878f3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityEmergingGrowthCompany_02d8754a-a3f2-41cf-b86d-aae26b878f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_01905111-f2ea-4704-99ab-d78dd0c11850" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityShellCompany_01905111-f2ea-4704-99ab-d78dd0c11850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_de39ec20-b741-44b2-b21a-018d9db15a75" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_de39ec20-b741-44b2-b21a-018d9db15a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6af8a3e2-0dae-4d93-b221-3bcda3e5c231" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_67a85008-89d4-49d9-9c1e-d5c69e738508" xlink:to="loc_dei_EntityFilerCategory_6af8a3e2-0dae-4d93-b221-3bcda3e5c231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_067d1438-8b1e-4620-825f-2175ed1bf092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_067d1438-8b1e-4620-825f-2175ed1bf092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ebd222b8-d3a5-4760-880d-8daddc4311ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ebd222b8-d3a5-4760-880d-8daddc4311ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_45c50a8e-db24-4191-8c4d-e618ed7966d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_GrossProfit_45c50a8e-db24-4191-8c4d-e618ed7966d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ff002deb-3c2e-44ee-abe0-ad42f9314f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ff002deb-3c2e-44ee-abe0-ad42f9314f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_3095e805-b722-4f46-a6de-da138b466f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_us-gaap_SellingAndMarketingExpense_3095e805-b722-4f46-a6de-da138b466f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cc49498a-55e7-4c59-9d56-cf315e0a7824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cc49498a-55e7-4c59-9d56-cf315e0a7824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e7bd958c-ad41-43ed-b345-214652d22a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e7bd958c-ad41-43ed-b345-214652d22a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsiderationOne_67c3720a-7b48-4a49-9511-daae09ac45ca" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsiderationOne"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_ango_ChangeInFairValueOfContingentConsiderationOne_67c3720a-7b48-4a49-9511-daae09ac45ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_86e63662-e401-4df8-ab38-1c8c61a676f3" xlink:href="ango-20221130.xsd#ango_AcquisitionRestructuringAndOtherItemsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_86e63662-e401-4df8-ab38-1c8c61a676f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_37fdef39-eb6c-4861-8ee4-efa0f5cfef17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba2fcc44-2a8c-4208-9564-0af1ae0429ff" xlink:to="loc_us-gaap_OperatingExpenses_37fdef39-eb6c-4861-8ee4-efa0f5cfef17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a23e4863-877e-418a-90b4-d8558a7c50be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_OperatingIncomeLoss_a23e4863-877e-418a-90b4-d8558a7c50be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_86c60869-20c5-4131-a066-14330d01cc17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_86c60869-20c5-4131-a066-14330d01cc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_66720d2f-f38e-4621-8c3a-7fe16460c092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_86c60869-20c5-4131-a066-14330d01cc17" xlink:to="loc_us-gaap_InterestExpense_66720d2f-f38e-4621-8c3a-7fe16460c092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0fcabd5b-a044-4b46-9e7f-380626950a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_86c60869-20c5-4131-a066-14330d01cc17" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0fcabd5b-a044-4b46-9e7f-380626950a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5caaac72-d3c7-480d-a0c1-95d26a22eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_86c60869-20c5-4131-a066-14330d01cc17" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5caaac72-d3c7-480d-a0c1-95d26a22eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_552e1301-3ef2-4ebe-b0ea-19b4ac0236ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_552e1301-3ef2-4ebe-b0ea-19b4ac0236ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_800e1b1b-b755-472c-8800-9d4a2dd1a0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_800e1b1b-b755-472c-8800-9d4a2dd1a0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_64f73e56-0b6f-4c8b-a2dc-095fc33120ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_NetIncomeLoss_64f73e56-0b6f-4c8b-a2dc-095fc33120ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_3d344add-f7a6-474f-bdae-dfded897684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_3d344add-f7a6-474f-bdae-dfded897684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1e7180ef-dd93-4fd0-a750-d0be928d046a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3d344add-f7a6-474f-bdae-dfded897684f" xlink:to="loc_us-gaap_EarningsPerShareBasic_1e7180ef-dd93-4fd0-a750-d0be928d046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4e113912-dfd5-47a1-b9ef-ba2d9c526adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3d344add-f7a6-474f-bdae-dfded897684f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4e113912-dfd5-47a1-b9ef-ba2d9c526adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_5cd71d4d-e5d9-409e-8fb9-3db49f70a7c2" xlink:href="ango-20221130.xsd#ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6061edbb-6847-4813-91c0-6bb81d516b13" xlink:to="loc_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_5cd71d4d-e5d9-409e-8fb9-3db49f70a7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_100be3c5-8934-4351-bdc1-374e058536e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_5cd71d4d-e5d9-409e-8fb9-3db49f70a7c2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_100be3c5-8934-4351-bdc1-374e058536e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_33445b92-f3b8-4564-a19d-5961d53eb5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract_5cd71d4d-e5d9-409e-8fb9-3db49f70a7c2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_33445b92-f3b8-4564-a19d-5961d53eb5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_37e047c3-b1cb-4a16-80a2-da60ec8cdd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92e79d26-c891-45a4-8f1f-6ef53c4d22ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_37e047c3-b1cb-4a16-80a2-da60ec8cdd80" xlink:to="loc_us-gaap_NetIncomeLoss_92e79d26-c891-45a4-8f1f-6ef53c4d22ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_b95d057a-8e2e-48c5-b29a-dee46a5d9e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_37e047c3-b1cb-4a16-80a2-da60ec8cdd80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_b95d057a-8e2e-48c5-b29a-dee46a5d9e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_a76390a2-9964-4117-b489-b9ce8e9ca4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_b95d057a-8e2e-48c5-b29a-dee46a5d9e7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_a76390a2-9964-4117-b489-b9ce8e9ca4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_7948d5a4-c728-458e-9dd8-495dfec6f7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_b95d057a-8e2e-48c5-b29a-dee46a5d9e7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_7948d5a4-c728-458e-9dd8-495dfec6f7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_79a984bd-7e21-4baf-811c-2d8b4d75bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_b95d057a-8e2e-48c5-b29a-dee46a5d9e7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_79a984bd-7e21-4baf-811c-2d8b4d75bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_adb5c90e-205c-4f9b-bf0f-102a8a8461e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_b95d057a-8e2e-48c5-b29a-dee46a5d9e7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_adb5c90e-205c-4f9b-bf0f-102a8a8461e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b8a3cb14-2428-4a3c-911e-62e55523c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_37e047c3-b1cb-4a16-80a2-da60ec8cdd80" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b8a3cb14-2428-4a3c-911e-62e55523c7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fe0278d7-6c8a-43ca-93e0-dc32052ce71f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe0278d7-6c8a-43ca-93e0-dc32052ce71f" xlink:to="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_58253127-b340-4ce9-afe0-4f4abe9b7fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_58253127-b340-4ce9-afe0-4f4abe9b7fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4531cbe4-4326-4a12-b295-6e815ed9ddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4531cbe4-4326-4a12-b295-6e815ed9ddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b54ee52c-e4e9-4946-ac73-d4050b079617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:to="loc_us-gaap_InventoryNet_b54ee52c-e4e9-4946-ac73-d4050b079617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34f08784-f0ba-42ab-877f-3427b748ad11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34f08784-f0ba-42ab-877f-3427b748ad11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f1a4c57f-6411-4002-8457-0fbb7766ecc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d69067a4-9af1-4c9c-9e17-9932c702191c" xlink:to="loc_us-gaap_AssetsCurrent_f1a4c57f-6411-4002-8457-0fbb7766ecc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1f722e85-63f8-42d6-942e-b6c482e5b57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1f722e85-63f8-42d6-942e-b6c482e5b57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_71bc0661-59e0-43eb-9638-26f4f9d9b488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_71bc0661-59e0-43eb-9638-26f4f9d9b488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_551038c1-8db5-4778-9b58-b14edf36ac8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:to="loc_us-gaap_Goodwill_551038c1-8db5-4778-9b58-b14edf36ac8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_77de7702-7aaa-458c-ad7c-9a5b0bedd0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_77de7702-7aaa-458c-ad7c-9a5b0bedd0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_48d3c89b-9475-4688-a403-47ff62f1ea59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94aab33c-13d0-4f0f-b234-f96c72dddf56" xlink:to="loc_us-gaap_Assets_48d3c89b-9475-4688-a403-47ff62f1ea59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe0278d7-6c8a-43ca-93e0-dc32052ce71f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0e24ba39-59a4-4989-94a7-10a54e7988bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:to="loc_us-gaap_AccountsPayableCurrent_0e24ba39-59a4-4989-94a7-10a54e7988bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_60e217fa-6eb6-425e-8e7c-4b9c586d14bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_60e217fa-6eb6-425e-8e7c-4b9c586d14bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e5da760b-b19b-4abf-b935-7f11f2f26b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e5da760b-b19b-4abf-b935-7f11f2f26b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1aad6da5-4a42-4b14-9d77-abf93fb0ba80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1aad6da5-4a42-4b14-9d77-abf93fb0ba80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_870682af-0b8e-40af-ad7f-d3a43f3c7122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0b55e43-4cfd-4de6-ab95-7d9e639ded3a" xlink:to="loc_us-gaap_LiabilitiesCurrent_870682af-0b8e-40af-ad7f-d3a43f3c7122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_d93997a4-338f-4f77-ae06-215941a26421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_LongTermLoansPayable_d93997a4-338f-4f77-ae06-215941a26421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_6f53287d-4a17-41cb-b602-8ec59541b830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_6f53287d-4a17-41cb-b602-8ec59541b830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a5783db0-062f-4cdb-9d20-71b5c55dd52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a5783db0-062f-4cdb-9d20-71b5c55dd52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7b35f689-1711-45ad-952c-6a894e4932d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7b35f689-1711-45ad-952c-6a894e4932d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1645b7c1-0557-4150-9d47-e2882f2dd6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_Liabilities_1645b7c1-0557-4150-9d47-e2882f2dd6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_05c99db6-986a-4159-bbd6-1bc423379450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_CommitmentsAndContingencies_05c99db6-986a-4159-bbd6-1bc423379450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_76791b6e-4676-4a47-bba7-79c949f763e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_PreferredStockValue_76791b6e-4676-4a47-bba7-79c949f763e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_79429f49-cb5d-49f6-8522-fcaa3242371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_CommonStockValue_79429f49-cb5d-49f6-8522-fcaa3242371a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ff82f36c-621c-4aae-919e-e38d795f2cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ff82f36c-621c-4aae-919e-e38d795f2cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d75911be-a6b9-459f-a720-1c20d8239779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d75911be-a6b9-459f-a720-1c20d8239779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3eb259cf-4c57-4fea-831c-22f12753e533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_TreasuryStockValue_3eb259cf-4c57-4fea-831c-22f12753e533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8c4cb3c7-233e-42d9-9764-61f2db49ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8c4cb3c7-233e-42d9-9764-61f2db49ab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f00bdae-e977-4ce8-a956-f4096205500e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_60988c1c-68c1-4364-87e0-78ee51a92f5d" xlink:to="loc_us-gaap_StockholdersEquity_7f00bdae-e977-4ce8-a956-f4096205500e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9725469-a524-4b73-80bc-7c6c5cc1b5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddec081-a1f5-4aef-b977-90ca9f3a7f45" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9725469-a524-4b73-80bc-7c6c5cc1b5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_729f3c2c-db99-4445-a30f-05367dca7545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_729f3c2c-db99-4445-a30f-05367dca7545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2dbf4f2c-2b84-4e4d-8315-b90bdfb770c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2dbf4f2c-2b84-4e4d-8315-b90bdfb770c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7c24096a-6aad-4104-9068-8e2545f4863f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7c24096a-6aad-4104-9068-8e2545f4863f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_90ce6cc1-3340-4037-9dd4-fe1db7b24ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_90ce6cc1-3340-4037-9dd4-fe1db7b24ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c2b5ca93-be62-4531-a80c-5d772aa44faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c2b5ca93-be62-4531-a80c-5d772aa44faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a786c6c7-d8ef-457c-9322-28d6c3f9801f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a786c6c7-d8ef-457c-9322-28d6c3f9801f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cd02b958-2f40-4fb7-93ce-e493916bf851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cd02b958-2f40-4fb7-93ce-e493916bf851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b85cf8e8-75b9-4550-b000-e907ba8a272b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_CommonStockSharesIssued_b85cf8e8-75b9-4550-b000-e907ba8a272b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_09f4b264-9281-4143-b7a5-6d87d4900559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_09f4b264-9281-4143-b7a5-6d87d4900559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_cf452e37-9a6e-4b02-aa1b-df044a7c7a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c05011c-5461-4416-8f6c-23683f03f79a" xlink:to="loc_us-gaap_TreasuryStockShares_cf452e37-9a6e-4b02-aa1b-df044a7c7a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad8831a3-3f38-4c1a-b10a-bad9c24ead34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad8831a3-3f38-4c1a-b10a-bad9c24ead34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8b3ab7e-067f-468f-be26-0d504ea7f294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad8831a3-3f38-4c1a-b10a-bad9c24ead34" xlink:to="loc_us-gaap_NetIncomeLoss_a8b3ab7e-067f-468f-be26-0d504ea7f294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad8831a3-3f38-4c1a-b10a-bad9c24ead34" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e6ee237d-8b19-41df-8ebb-1808820103bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_DepreciationAndAmortization_e6ee237d-8b19-41df-8ebb-1808820103bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NonCashLeaseExpense_8ea4e52c-1f50-40a3-8e43-5e5a3991de3a" xlink:href="ango-20221130.xsd#ango_NonCashLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_ango_NonCashLeaseExpense_8ea4e52c-1f50-40a3-8e43-5e5a3991de3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ddbf25c5-2abd-44cb-b805-097169b03dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_ShareBasedCompensation_ddbf25c5-2abd-44cb-b805-097169b03dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsiderationOne_9dcb5e87-e912-4796-a092-69e3155795f3" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsiderationOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_ango_ChangeInFairValueOfContingentConsiderationOne_9dcb5e87-e912-4796-a092-69e3155795f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e3daca67-3667-44a1-90a3-2e6da6a3d452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e3daca67-3667-44a1-90a3-2e6da6a3d452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1811124d-e225-47ed-9faf-65094b4e6248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1811124d-e225-47ed-9faf-65094b4e6248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_60ed2d32-ea3d-4f3b-8a25-aa25f125f3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_60ed2d32-ea3d-4f3b-8a25-aa25f125f3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_31e55d0f-e6ef-4ee3-94cf-853e39fdcf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_31e55d0f-e6ef-4ee3-94cf-853e39fdcf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49d06471-b968-471f-b7f7-f33f3f2a609a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49d06471-b968-471f-b7f7-f33f3f2a609a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ce68c152-5fee-4796-8eac-b917d333e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49d06471-b968-471f-b7f7-f33f3f2a609a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ce68c152-5fee-4796-8eac-b917d333e02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f0953a0b-e0b6-4ef7-b79f-3648399e0ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49d06471-b968-471f-b7f7-f33f3f2a609a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f0953a0b-e0b6-4ef7-b79f-3648399e0ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca661fc3-cc51-4721-86fa-001d717803e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49d06471-b968-471f-b7f7-f33f3f2a609a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca661fc3-cc51-4721-86fa-001d717803e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4375a778-a221-41c1-a85a-b8f9a3942a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_49d06471-b968-471f-b7f7-f33f3f2a609a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4375a778-a221-41c1-a85a-b8f9a3942a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_772d1b75-d224-46fb-a174-da3a31ae09a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_153e5e9c-cc85-48e2-a28c-6a9c745b5b2a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_772d1b75-d224-46fb-a174-da3a31ae09a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd850251-df39-43ce-9333-8d95990bf374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd850251-df39-43ce-9333-8d95990bf374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_384b8f14-4a96-4b44-95f9-249819c7bcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd850251-df39-43ce-9333-8d95990bf374" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_384b8f14-4a96-4b44-95f9-249819c7bcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquipmentOnLease_17b6b5e0-d736-4c8a-84b4-3b645926b2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquipmentOnLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd850251-df39-43ce-9333-8d95990bf374" xlink:to="loc_us-gaap_PaymentsToAcquireEquipmentOnLease_17b6b5e0-d736-4c8a-84b4-3b645926b2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c0749de8-4885-4a62-8f92-882e7ac698e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd850251-df39-43ce-9333-8d95990bf374" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c0749de8-4885-4a62-8f92-882e7ac698e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4320a649-6927-48e4-8f37-5e835cd1d4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd850251-df39-43ce-9333-8d95990bf374" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4320a649-6927-48e4-8f37-5e835cd1d4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_73ab69dd-149d-42f1-b61c-16083108b41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_73ab69dd-149d-42f1-b61c-16083108b41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f93977e6-e0d3-4952-a43b-bedf79885c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f93977e6-e0d3-4952-a43b-bedf79885c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_37ccd0e4-24f4-4e08-8867-342d4eddbbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_37ccd0e4-24f4-4e08-8867-342d4eddbbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_82fd4415-da60-463c-86bd-2ef7652a3ba3" xlink:href="ango-20221130.xsd#ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:to="loc_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised_82fd4415-da60-463c-86bd-2ef7652a3ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_53b55851-db88-48df-bfe2-016d88f778ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7bffdebe-7fb1-49f5-94e8-8424c1bcbef2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_53b55851-db88-48df-bfe2-016d88f778ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e268a71-f3aa-4973-93d8-a35a25c8815d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e268a71-f3aa-4973-93d8-a35a25c8815d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4ff08150-bc46-4fb4-9ed5-8603faa8fb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4ff08150-bc46-4fb4-9ed5-8603faa8fb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05c84366-01b9-45a7-a4c2-8bcc1c7ba3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05c84366-01b9-45a7-a4c2-8bcc1c7ba3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de39c2dd-c6b8-4ffa-b1e2-cf1673b6e442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de39c2dd-c6b8-4ffa-b1e2-cf1673b6e442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_73092ec9-3689-4ae4-94bd-44deaad41f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_118ae823-5611-4eeb-a73a-4e6e21b187d1" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_73092ec9-3689-4ae4-94bd-44deaad41f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_e24edb42-f426-4e24-977f-ea5e1c133342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_73092ec9-3689-4ae4-94bd-44deaad41f14" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_e24edb42-f426-4e24-977f-ea5e1c133342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b38ee5e5-eab8-4836-8dbb-468fbce61448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b38ee5e5-eab8-4836-8dbb-468fbce61448" xlink:to="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b17ea14f-84f8-402c-86f3-d7c9a5f696b1" xlink:to="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_240aeaa4-acfe-411c-9ca3-d363d44049e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_CommonStockMember_240aeaa4-acfe-411c-9ca3-d363d44049e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8245878d-13a8-4cfb-a7e2-bdd15340d318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8245878d-13a8-4cfb-a7e2-bdd15340d318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9e71c49f-e8ab-4fb2-94f1-028c56431e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_RetainedEarningsMember_9e71c49f-e8ab-4fb2-94f1-028c56431e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a4f1e55-a703-45ae-a5ad-d68d413ddd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a4f1e55-a703-45ae-a5ad-d68d413ddd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_90f3211c-74a4-440e-96b9-39128e735431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69f1be4d-e630-440d-9d93-bb1b0fb1b650" xlink:to="loc_us-gaap_TreasuryStockCommonMember_90f3211c-74a4-440e-96b9-39128e735431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:to="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_95cd0a7d-228e-426b-b9b8-3797c61bbd9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a9207584-00f6-4f4f-8983-7fc431ccf670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a9207584-00f6-4f4f-8983-7fc431ccf670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5e001974-8838-417a-afdd-3a5ac0cf66ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d37cdca-13be-4dbd-9778-ffc994917c40" xlink:to="loc_us-gaap_PerformanceSharesMember_5e001974-8838-417a-afdd-3a5ac0cf66ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2beaa683-3784-4a45-8d3d-70f0b2c777e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c3dc93c7-9c19-4c52-8ca4-abda503963f0" xlink:to="loc_us-gaap_StatementLineItems_2beaa683-3784-4a45-8d3d-70f0b2c777e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2beaa683-3784-4a45-8d3d-70f0b2c777e9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f98d01f5-0cbe-462f-bd24-f7f3ba694a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f98d01f5-0cbe-462f-bd24-f7f3ba694a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cc2ca5de-f59c-4e2f-979b-cbd9f41dec83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockholdersEquity_cc2ca5de-f59c-4e2f-979b-cbd9f41dec83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_18d864a2-2c1c-4f0c-86da-ae00289e13ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_18d864a2-2c1c-4f0c-86da-ae00289e13ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a7709c83-b719-47cc-a157-7db864443048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_NetIncomeLoss_a7709c83-b719-47cc-a157-7db864443048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674c31f1-1e30-460c-93b5-a64f2565e276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674c31f1-1e30-460c-93b5-a64f2565e276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba11b4d7-3cb1-48dc-ac64-0a73d9c4d724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba11b4d7-3cb1-48dc-ac64-0a73d9c4d724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_153ddb67-9304-49f4-bfa2-8b1b231aa453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_153ddb67-9304-49f4-bfa2-8b1b231aa453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_75045e7f-24ed-4a14-9050-adfeea7d6f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_75045e7f-24ed-4a14-9050-adfeea7d6f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_740ad7f6-b6c2-406f-a7d6-43937e65c507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_740ad7f6-b6c2-406f-a7d6-43937e65c507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_21fed771-6b26-4358-aada-3fdb7948901e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_21fed771-6b26-4358-aada-3fdb7948901e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b74583fb-b629-4eb9-8c16-38df7558247f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b74583fb-b629-4eb9-8c16-38df7558247f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05ed5dd5-2e97-4010-bbc0-13d6d51077e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05ed5dd5-2e97-4010-bbc0-13d6d51077e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_64e2ca1c-7df4-4b1a-9604-cc98446aa01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_64e2ca1c-7df4-4b1a-9604-cc98446aa01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19366bf0-1fb5-4f42-9794-07f558c682ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_StockholdersEquity_19366bf0-1fb5-4f42-9794-07f558c682ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e4ddaddf-01d8-4066-adb8-250edef4437a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2357e90c-9472-4d4d-b164-d39d24c7f0eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_e4ddaddf-01d8-4066-adb8-250edef4437a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedFinancialStatements" xlink:type="simple" xlink:href="ango-20221130.xsd#ConsolidatedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedFinancialStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_665393a6-68e9-4883-9c04-c4e02b0ff7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1a2e91bd-835d-4b2e-9284-2893ea47053c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_665393a6-68e9-4883-9c04-c4e02b0ff7a2" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1a2e91bd-835d-4b2e-9284-2893ea47053c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/Acquisitions" xlink:type="simple" xlink:href="ango-20221130.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5cb0380f-7962-47ec-9641-c0e35c9e97c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_f8680fd4-77ad-4225-be0d-17ef0fcf9f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5cb0380f-7962-47ec-9641-c0e35c9e97c1" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_f8680fd4-77ad-4225-be0d-17ef0fcf9f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomers" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7aa96960-ef8f-4671-8cb6-1f0058c6423c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a3c1e115-cd89-4f5a-829e-a8c3626352c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7aa96960-ef8f-4671-8cb6-1f0058c6423c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a3c1e115-cd89-4f5a-829e-a8c3626352c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/Inventories" xlink:type="simple" xlink:href="ango-20221130.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_9eb3a5e5-5872-43df-9898-21161991ceb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_38f2e566-ee3b-43bd-88bf-5d831511352c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_9eb3a5e5-5872-43df-9898-21161991ceb0" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_38f2e566-ee3b-43bd-88bf-5d831511352c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3aff6709-d076-4212-9803-b829102363f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b5b843b2-456b-40d8-98de-3ef2e938c753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3aff6709-d076-4212-9803-b829102363f8" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b5b843b2-456b-40d8-98de-3ef2e938c753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="ango-20221130.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ddc0c570-efd6-4a76-abb3-d653e5460cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_bfdf8b03-db0d-4beb-95ff-cc8ccaba47b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ddc0c570-efd6-4a76-abb3-d653e5460cc9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_bfdf8b03-db0d-4beb-95ff-cc8ccaba47b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebt" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_77219b53-ef62-45c5-ad90-9d6675d3700d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_c59df214-3e6a-43bb-a57d-3961e8f3179d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77219b53-ef62-45c5-ad90-9d6675d3700d" xlink:to="loc_us-gaap_LongTermDebtTextBlock_c59df214-3e6a-43bb-a57d-3961e8f3179d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ango-20221130.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e4a9bb82-6986-4a0f-8d24-fee71466b850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c646774e-8c06-4704-b19c-5f2040b9d930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e4a9bb82-6986-4a0f-8d24-fee71466b850" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c646774e-8c06-4704-b19c-5f2040b9d930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="ango-20221130.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fabe1e31-5bd5-4368-ad35-6c81d7aedf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f53e0476-67fd-4303-9383-955309471313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fabe1e31-5bd5-4368-ad35-6c81d7aedf2a" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f53e0476-67fd-4303-9383-955309471313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShare" xlink:type="simple" xlink:href="ango-20221130.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_816671df-03ce-4a82-bea6-a64349affb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2fa28203-db0e-4c33-89dd-ddd1e85a36db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_816671df-03ce-4a82-bea6-a64349affb6b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2fa28203-db0e-4c33-89dd-ddd1e85a36db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b02b000e-a694-4851-a1b0-64b57f42c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_a7944d6c-7c18-41f4-a591-2928e5b85abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b02b000e-a694-4851-a1b0-64b57f42c65e" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_a7944d6c-7c18-41f4-a591-2928e5b85abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValue" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0faa43ae-bb1b-4942-810d-ddb4cd526aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c80aefe9-3456-442c-81b1-9363c1872974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0faa43ae-bb1b-4942-810d-ddb4cd526aa6" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c80aefe9-3456-442c-81b1-9363c1872974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/Leases" xlink:type="simple" xlink:href="ango-20221130.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9b362d4b-2d78-42e2-845e-5a71f5b554e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_e7fa9be0-5196-451f-a174-4c4038562e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9b362d4b-2d78-42e2-845e-5a71f5b554e6" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_e7fa9be0-5196-451f-a174-4c4038562e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ango-20221130.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6665bfe8-20f6-4b50-b4c8-9d8ad3871581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_dae9823c-0045-4666-b1f4-9bf9467bba11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6665bfe8-20f6-4b50-b4c8-9d8ad3871581" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_dae9823c-0045-4666-b1f4-9bf9467bba11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet" xlink:type="simple" xlink:href="ango-20221130.xsd#AcquisitionRestructuringandOtherItemsNet"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_64f53087-f775-4e10-ba4b-bdca9090e802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6a61f6b9-3b62-4caa-a606-c0ffbd4e218f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_64f53087-f775-4e10-ba4b-bdca9090e802" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6a61f6b9-3b62-4caa-a606-c0ffbd4e218f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="ango-20221130.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ea36b952-179d-46cd-8a02-2c3432bc53df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_34834c37-cd89-4d14-a946-44e87e412d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ea36b952-179d-46cd-8a02-2c3432bc53df" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_34834c37-cd89-4d14-a946-44e87e412d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements" xlink:type="simple" xlink:href="ango-20221130.xsd#RecentlyIssuedAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_f5c44b2c-7d63-4f98-8506-79e40a345e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_0ab39b6b-d38c-433f-b0ba-ce5124462626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_f5c44b2c-7d63-4f98-8506-79e40a345e3c" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_0ab39b6b-d38c-433f-b0ba-ce5124462626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="ango-20221130.xsd#RecentlyIssuedAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0dec21cc-b705-48d2-b4f0-1b556f3a82ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_59169f6a-e481-47ec-a102-d5637ec1627f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0dec21cc-b705-48d2-b4f0-1b556f3a82ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_59169f6a-e481-47ec-a102-d5637ec1627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_aa48c8e1-9095-4c24-85e4-726778933be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0dec21cc-b705-48d2-b4f0-1b556f3a82ed" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_aa48c8e1-9095-4c24-85e4-726778933be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomersTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cc1e2375-2575-4f6f-8c8a-5b2189730971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7059e731-b875-4bd5-a3ce-24a4435c1d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cc1e2375-2575-4f6f-8c8a-5b2189730971" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7059e731-b875-4bd5-a3ce-24a4435c1d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4e52d206-ec78-4743-93cd-a45668c6c2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cc1e2375-2575-4f6f-8c8a-5b2189730971" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4e52d206-ec78-4743-93cd-a45668c6c2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesTables" xlink:type="simple" xlink:href="ango-20221130.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0f3fefad-2476-4745-b505-8145d6fe866c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fdbd0544-6e18-4758-bc8e-ed4a2f52daf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0f3fefad-2476-4745-b505-8145d6fe866c" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fdbd0544-6e18-4758-bc8e-ed4a2f52daf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9608e9a-76fc-4ba9-a4d1-07c56d90e838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock_dcf27a82-d02b-43e8-80e8-eb0d26b5582d" xlink:href="ango-20221130.xsd#ango_ScheduleOfIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9608e9a-76fc-4ba9-a4d1-07c56d90e838" xlink:to="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock_dcf27a82-d02b-43e8-80e8-eb0d26b5582d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_83a901bc-677b-4d52-a269-10d76ab07886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9608e9a-76fc-4ba9-a4d1-07c56d90e838" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_83a901bc-677b-4d52-a269-10d76ab07886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6b251f44-2e56-4cb9-8bb9-850e2267a59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9608e9a-76fc-4ba9-a4d1-07c56d90e838" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6b251f44-2e56-4cb9-8bb9-850e2267a59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="ango-20221130.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_50fa6171-bc35-4428-8540-e7879388bf85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c87d81ba-8f9a-49eb-8d62-106298d5c47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_50fa6171-bc35-4428-8540-e7879388bf85" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c87d81ba-8f9a-49eb-8d62-106298d5c47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d114a9a8-3092-49b9-9ca0-322350740b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_69455370-d783-4552-af50-b4fb76e39892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d114a9a8-3092-49b9-9ca0-322350740b75" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_69455370-d783-4552-af50-b4fb76e39892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="ango-20221130.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2fa0189c-8857-4fc9-86cc-40b9c87877e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_bd7166d3-e4a3-4923-9c7e-33344d007993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2fa0189c-8857-4fc9-86cc-40b9c87877e9" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_bd7166d3-e4a3-4923-9c7e-33344d007993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d84045fb-b836-485d-a9e8-ef3cdc98452b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_384bdcd7-3ed0-446c-85b2-25acaf36f024" xlink:href="ango-20221130.xsd#ango_ScheduleOfNetRevenueByProductGroupTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d84045fb-b836-485d-a9e8-ef3cdc98452b" xlink:to="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_384bdcd7-3ed0-446c-85b2-25acaf36f024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ff910274-85f6-46ef-8929-93d66f4bc433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d84045fb-b836-485d-a9e8-ef3cdc98452b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ff910274-85f6-46ef-8929-93d66f4bc433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueTables" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b9b8712f-58c8-4be7-8854-8ac4b9f82019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2f77ced9-940a-4916-9e8d-8675099b5985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9b8712f-58c8-4be7-8854-8ac4b9f82019" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2f77ced9-940a-4916-9e8d-8675099b5985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_32c520e3-3ee4-4f5c-a857-49b47ea4ea04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9b8712f-58c8-4be7-8854-8ac4b9f82019" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_32c520e3-3ee4-4f5c-a857-49b47ea4ea04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_a57c6e70-c454-44d0-bb8c-1e2ce64bc7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9b8712f-58c8-4be7-8854-8ac4b9f82019" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_a57c6e70-c454-44d0-bb8c-1e2ce64bc7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesTables" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e5e1208e-5a11-4a8e-b698-7cd53ad81686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AssetsAndLiabilitiesLesseeTableTextBlock_b3d923cd-33cc-4d76-9a45-1abc216fb8be" xlink:href="ango-20221130.xsd#ango_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e5e1208e-5a11-4a8e-b698-7cd53ad81686" xlink:to="loc_ango_AssetsAndLiabilitiesLesseeTableTextBlock_b3d923cd-33cc-4d76-9a45-1abc216fb8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a9b67c81-acc8-4874-be22-8eb64f14ee90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e5e1208e-5a11-4a8e-b698-7cd53ad81686" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a9b67c81-acc8-4874-be22-8eb64f14ee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_20c51b76-84f4-42cd-b4ee-53aa7752d911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e5e1208e-5a11-4a8e-b698-7cd53ad81686" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_20c51b76-84f4-42cd-b4ee-53aa7752d911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables" xlink:type="simple" xlink:href="ango-20221130.xsd#AcquisitionRestructuringandOtherItemsNetTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3da4eaf5-1277-48c5-ac47-d616ecfcbbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61506de4-1de5-4d9d-ac02-0a54f4a3d6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3da4eaf5-1277-48c5-ac47-d616ecfcbbc7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61506de4-1de5-4d9d-ac02-0a54f4a3d6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="ango-20221130.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5648de74-ecac-4be0-9743-6fd9933228f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_95084dd4-37e1-4c18-9486-e90ec7bf9e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5648de74-ecac-4be0-9743-6fd9933228f4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_95084dd4-37e1-4c18-9486-e90ec7bf9e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d9cfe7e0-4fa5-4bd4-8d58-ced96f3e0076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d9cfe7e0-4fa5-4bd4-8d58-ced96f3e0076" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15cf2447-c458-454d-89cf-af1773372e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_704d5a2b-7c5e-41de-bda0-c632421d024d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15cf2447-c458-454d-89cf-af1773372e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6a0f599c-3491-41b6-9efa-b4f4af14a0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15cf2447-c458-454d-89cf-af1773372e9e" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6a0f599c-3491-41b6-9efa-b4f4af14a0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:to="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_7285fc31-48ff-44b6-a7ba-566a5fb538a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_eb65138a-a1be-4d48-a391-0ecec9dc79db" xlink:to="loc_us-gaap_AssetAcquisitionDomain_7285fc31-48ff-44b6-a7ba-566a5fb538a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_8adbb03e-7ea4-40e0-b86b-b925343f631e" xlink:href="ango-20221130.xsd#ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_7285fc31-48ff-44b6-a7ba-566a5fb538a9" xlink:to="loc_ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember_8adbb03e-7ea4-40e0-b86b-b925343f631e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a87bd64f-f7ae-45e7-8c5f-c94232425bd2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_031ad05e-d337-4aeb-a92b-652ff7d06e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_031ad05e-d337-4aeb-a92b-652ff7d06e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c255ea9e-f7e8-4d6f-b9d2-8db19af97d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c255ea9e-f7e8-4d6f-b9d2-8db19af97d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8d3d04af-0314-45e5-b0e3-f2d5504d5710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8d3d04af-0314-45e5-b0e3-f2d5504d5710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_bf90b492-a7c3-4608-98b8-a7640738a15f" xlink:href="ango-20221130.xsd#ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount_bf90b492-a7c3-4608-98b8-a7640738a15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AssetAcquisitionInventoryAndFixedAssets_1a5f8973-6dd4-44e4-a12c-1a6ea7256fb7" xlink:href="ango-20221130.xsd#ango_AssetAcquisitionInventoryAndFixedAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_ango_AssetAcquisitionInventoryAndFixedAssets_1a5f8973-6dd4-44e4-a12c-1a6ea7256fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_10c3500f-dedd-4ee3-b49a-eecd2e54b813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_10c3500f-dedd-4ee3-b49a-eecd2e54b813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_95e3df3f-3032-4c90-8205-55befff00ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0f493795-6728-4ef7-bbdd-b9fce5600f2c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_95e3df3f-3032-4c90-8205-55befff00ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomersDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_50281ae5-79c5-4d7c-8585-4a9fdf07d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_50281ae5-79c5-4d7c-8585-4a9fdf07d67b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:to="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_150d9d37-fabe-40ab-8a67-a024012c7e3e" xlink:to="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember_eda2ecbd-8ade-44d3-be0d-6e3647d6c7a4" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:to="loc_ango_MedTechMember_eda2ecbd-8ade-44d3-be0d-6e3647d6c7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember_b8f18dd0-b3c3-4878-905d-9c4f7231c0dc" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_24609069-efda-471a-9986-ea23ca7e99bf" xlink:to="loc_ango_MedDeviceMember_b8f18dd0-b3c3-4878-905d-9c4f7231c0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:to="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fc6c31b5-9812-4c5d-9381-d987f14a0636" xlink:to="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2a86e868-f8ac-498f-a718-88d3eea3ae1b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:to="loc_country_US_2a86e868-f8ac-498f-a718-88d3eea3ae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4ef20913-f977-4e41-b6d8-bc37fbfcbb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b20a4c51-24d1-4124-8cac-17894ed19e85" xlink:to="loc_us-gaap_NonUsMember_4ef20913-f977-4e41-b6d8-bc37fbfcbb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e05362e8-c57a-48c2-a3b7-fd29cd34a089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c3728a2e-241e-4b2f-a898-dce7eaefab01" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e05362e8-c57a-48c2-a3b7-fd29cd34a089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dca7bf8f-35a0-45b5-b008-7edf259d7f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e05362e8-c57a-48c2-a3b7-fd29cd34a089" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dca7bf8f-35a0-45b5-b008-7edf259d7f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c0def8b7-4f36-491e-859b-428647802e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c0def8b7-4f36-491e-859b-428647802e5e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:to="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_07e026ed-98dc-42e6-be98-7dd402ef665e" xlink:to="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e26d9a9b-1a2f-4a21-91c6-c1c1df36d74c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:to="loc_srt_MinimumMember_e26d9a9b-1a2f-4a21-91c6-c1c1df36d74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c139be3-d9b7-4ce1-9841-bd429543405d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec937193-a195-4768-a7a0-984e68363b8f" xlink:to="loc_srt_MaximumMember_5c139be3-d9b7-4ce1-9841-bd429543405d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_14d203d2-0ed6-44ff-999b-a8584f304baf" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenuePerformanceObligationPaymentTerm_97d0fc22-8651-46ea-bb2c-172ffd9df78a" xlink:href="ango-20221130.xsd#ango_RevenuePerformanceObligationPaymentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_RevenuePerformanceObligationPaymentTerm_97d0fc22-8651-46ea-bb2c-172ffd9df78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_57d6105e-5b5b-47b0-ab7d-753eccb32432" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval_57d6105e-5b5b-47b0-ab7d-753eccb32432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnRestockingCharge_3283b36c-4e16-4fde-bef1-85617f86452e" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnRestockingCharge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_ContractWithCustomerRightOfReturnRestockingCharge_3283b36c-4e16-4fde-bef1-85617f86452e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_a34f3d15-e407-4a7b-9bfa-fb34d38588f8" xlink:href="ango-20221130.xsd#ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn_a34f3d15-e407-4a7b-9bfa-fb34d38588f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_095aa60e-7fbe-4865-85ed-14098c094afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_095aa60e-7fbe-4865-85ed-14098c094afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_0f7a2df6-c30a-4448-97c5-c57458313491" xlink:href="ango-20221130.xsd#ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_66af750f-7ccd-4a9f-856d-ea0b7909e49c" xlink:to="loc_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod_0f7a2df6-c30a-4448-97c5-c57458313491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#RevenuefromContractswithCustomersContractBalanceswithCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6c9b5188-b264-43f3-a5b0-9e001f84d7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_199d5898-988f-4dd4-83d5-77c1c72d4604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6c9b5188-b264-43f3-a5b0-9e001f84d7eb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_199d5898-988f-4dd4-83d5-77c1c72d4604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_1718919b-7afc-46ff-aee6-453f3f3b4233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6c9b5188-b264-43f3-a5b0-9e001f84d7eb" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_1718919b-7afc-46ff-aee6-453f3f3b4233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e0d55656-2db2-42e3-bf2c-bb6f49e80183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6c9b5188-b264-43f3-a5b0-9e001f84d7eb" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e0d55656-2db2-42e3-bf2c-bb6f49e80183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#InventoriesScheduleofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a5ee5593-7274-4d11-913f-abd908fba92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_105eb069-834a-496b-9d1d-aa60d4a7c8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a5ee5593-7274-4d11-913f-abd908fba92c" xlink:to="loc_us-gaap_InventoryRawMaterials_105eb069-834a-496b-9d1d-aa60d4a7c8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_c29406ef-9f67-45a5-b1b0-8805e0ee154b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a5ee5593-7274-4d11-913f-abd908fba92c" xlink:to="loc_us-gaap_InventoryWorkInProcess_c29406ef-9f67-45a5-b1b0-8805e0ee154b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_4f3a9ffa-b041-438f-8e44-1b56a43ed433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a5ee5593-7274-4d11-913f-abd908fba92c" xlink:to="loc_us-gaap_InventoryFinishedGoods_4f3a9ffa-b041-438f-8e44-1b56a43ed433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_97e79840-6909-4328-aaf8-4608fc3b80ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a5ee5593-7274-4d11-913f-abd908fba92c" xlink:to="loc_us-gaap_InventoryNet_97e79840-6909-4328-aaf8-4608fc3b80ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#InventoriesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/InventoriesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_841cdd94-4ac0-49ae-9daf-e1e1aa21e71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_f10e053a-96d7-4b7c-b36b-30f6e2f4b1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_841cdd94-4ac0-49ae-9daf-e1e1aa21e71d" xlink:to="loc_us-gaap_InventoryValuationReserves_f10e053a-96d7-4b7c-b36b-30f6e2f4b1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_37cf7724-1088-4a5b-bd72-574229dfcd16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_37cf7724-1088-4a5b-bd72-574229dfcd16" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:to="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6b36fa65-d348-4f25-b74e-371b0ba7e62a" xlink:to="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fa10d5a-c1ba-455e-9a7a-4ae5ff41b0cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:to="loc_srt_MinimumMember_0fa10d5a-c1ba-455e-9a7a-4ae5ff41b0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_abcd8986-a6a3-4fb9-848f-d2a9173d0e0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b7d6fd58-442d-4d83-9f9c-ae34457db072" xlink:to="loc_srt_MaximumMember_abcd8986-a6a3-4fb9-848f-d2a9173d0e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8438ae7e-f65f-4356-8a0f-9672aa472ef2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_39fdbca8-4a18-484f-861a-321c06ee8244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_NumberOfReportingUnits_39fdbca8-4a18-484f-861a-321c06ee8244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8479ff8c-6465-4f8f-91e9-769ffeaabb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8479ff8c-6465-4f8f-91e9-769ffeaabb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e36ea617-1dbc-405f-881e-ee8a060b1277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e36ea617-1dbc-405f-881e-ee8a060b1277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fc62e498-e8dd-4b87-99b7-ede24611f320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fc62e498-e8dd-4b87-99b7-ede24611f320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_72f93ec3-6263-4bf6-a783-0901e19204d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6e833fb5-63ce-4b75-81f1-a721e91e85bd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_72f93ec3-6263-4bf6-a783-0901e19204d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsChangeinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ee480b9b-7f6d-43da-af22-c9a7a708b78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ee480b9b-7f6d-43da-af22-c9a7a708b78b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:to="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_ed611871-8c86-441d-be3b-2379b9f4a327" xlink:to="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember_54b052da-12fb-4526-abe1-7ff5cff64d59" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:to="loc_ango_MedTechMember_54b052da-12fb-4526-abe1-7ff5cff64d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember_5f4e0342-ac2e-4499-9c4a-b498a4fecf76" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_fec8270f-25a6-40f4-a6fc-601dc08501d5" xlink:to="loc_ango_MedDeviceMember_5f4e0342-ac2e-4499-9c4a-b498a4fecf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_140cf825-3870-4708-b6a6-43c1c27f7853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_306dee46-bb7b-4a26-a516-5a3310cc864d" xlink:to="loc_us-gaap_GoodwillLineItems_140cf825-3870-4708-b6a6-43c1c27f7853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_140cf825-3870-4708-b6a6-43c1c27f7853" xlink:to="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe8aa06b-6c32-43c8-945c-965be2fcdbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:to="loc_us-gaap_Goodwill_fe8aa06b-6c32-43c8-945c-965be2fcdbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a182f711-dff8-4680-965b-ee9ea8dd63ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a182f711-dff8-4680-965b-ee9ea8dd63ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff3d84a1-f5c2-47dc-984e-b461bf3406b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_316231a5-dda0-4f74-986d-4cc5d7b38b27" xlink:to="loc_us-gaap_Goodwill_ff3d84a1-f5c2-47dc-984e-b461bf3406b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe378008-e24c-4927-84e5-f1c7b74a9c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe378008-e24c-4927-84e5-f1c7b74a9c43" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_199ed0d7-3c5a-4e43-8860-d44b9bb2dd05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ProductTechnologiesMember_7df17ae2-1ed8-4354-9ba3-2c6c46d04255" xlink:href="ango-20221130.xsd#ango_ProductTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_ango_ProductTechnologiesMember_7df17ae2-1ed8-4354-9ba3-2c6c46d04255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1ac4b933-6bcb-4c9e-9a5f-447c0314c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1ac4b933-6bcb-4c9e-9a5f-447c0314c8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4406fc3c-78ae-4715-add2-626acaa560ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_us-gaap_TrademarksMember_4406fc3c-78ae-4715-add2-626acaa560ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_deceead2-ec33-4063-8cf2-7189f32c45e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73860ded-5d33-43cb-bd6a-21a6bc41a291" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_deceead2-ec33-4063-8cf2-7189f32c45e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bd1966b9-2306-468c-ad56-ec93c863f093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e75e10f6-de53-4142-a93b-f6f5d02e6cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e75e10f6-de53-4142-a93b-f6f5d02e6cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce051e8d-de36-48bb-ad75-ffb03def4d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce051e8d-de36-48bb-ad75-ffb03def4d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914cb24c-7ede-4929-8423-04b0a328c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5885bf3-f0d2-4829-aff8-f2dfa816addb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914cb24c-7ede-4929-8423-04b0a328c5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9b8159e5-b021-4077-adb2-69c94cde6c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9b8159e5-b021-4077-adb2-69c94cde6c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c908301b-e434-4f72-9414-7318cc8a0479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c908301b-e434-4f72-9414-7318cc8a0479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f0af6440-df73-4616-b02d-1589af6c4fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f0af6440-df73-4616-b02d-1589af6c4fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9a5fa608-1b7a-4e8d-9eb4-6b6a00d7bc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9a5fa608-1b7a-4e8d-9eb4-6b6a00d7bc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2c227460-6c4c-4d97-85f2-9a99090b18ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2c227460-6c4c-4d97-85f2-9a99090b18ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_0b5c4e14-f257-4a56-92e7-45765a0ab8ac" xlink:href="ango-20221130.xsd#ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_0b5c4e14-f257-4a56-92e7-45765a0ab8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d450cc12-7025-4d13-9556-ed8ae3b453b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_52626cd4-87d6-4b28-9257-f1e4eff69dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d450cc12-7025-4d13-9556-ed8ae3b453b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_51dfec7f-2337-4ca4-96a0-179c98b1a0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_51dfec7f-2337-4ca4-96a0-179c98b1a0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_c04111fd-052d-473a-b1f6-5769d8073a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_c04111fd-052d-473a-b1f6-5769d8073a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_56ad00a0-1968-47f2-95fd-c5c667f7dcec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_56ad00a0-1968-47f2-95fd-c5c667f7dcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AccruedResearchAndDevelopmentCurrent_53c7a7d3-e846-47cf-9897-31f664ac0fb1" xlink:href="ango-20221130.xsd#ango_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_ango_AccruedResearchAndDevelopmentCurrent_53c7a7d3-e846-47cf-9897-31f664ac0fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_47ac5ef2-7e13-4cae-9c28-102233fcf2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_47ac5ef2-7e13-4cae-9c28-102233fcf2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_af70e98d-e333-48af-beea-d7a37fbea9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_af70e98d-e333-48af-beea-d7a37fbea9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_0d644543-5df1-4d39-8463-4f7741e5e334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_0d644543-5df1-4d39-8463-4f7741e5e334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2cfd24a1-34a6-464d-b796-fb907923c811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b704c5fa-ca07-43f8-9319-10275d40894c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2cfd24a1-34a6-464d-b796-fb907923c811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0a6a07e1-6eaf-4c97-abd2-52853a956898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0a6a07e1-6eaf-4c97-abd2-52853a956898" xlink:to="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a8b962d-3e3b-40db-bedc-f9c4ba81109e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_77ed8684-1490-448b-8118-00fef68e5a20" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a8b962d-3e3b-40db-bedc-f9c4ba81109e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_99f32952-9faf-4b52-81b6-e8151e0446f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a8b962d-3e3b-40db-bedc-f9c4ba81109e" xlink:to="loc_us-gaap_LineOfCreditMember_99f32952-9faf-4b52-81b6-e8151e0446f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c2e066ea-eb20-4c14-a48f-eab446bec036" xlink:to="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fe18c283-5f5c-4cf8-a6ad-d9e2afd2770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fe18c283-5f5c-4cf8-a6ad-d9e2afd2770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_74e816e4-d9ca-4fbe-af5f-7796138f1b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff0d55c-83e3-4728-8853-d98ee892c5e9" xlink:to="loc_us-gaap_SecuredDebtMember_74e816e4-d9ca-4fbe-af5f-7796138f1b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_02c424d8-9657-4a40-82f1-183fda9a1e4d" xlink:to="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1226179f-a82a-4ae1-9190-f8d58ef469af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:to="loc_srt_MinimumMember_1226179f-a82a-4ae1-9190-f8d58ef469af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1af66f0-4583-4ef4-a37c-f7bf34ee5dd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_54594103-8445-43b6-83d5-4b4ee2eba369" xlink:to="loc_srt_MaximumMember_c1af66f0-4583-4ef4-a37c-f7bf34ee5dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_977565f5-885f-4778-9131-4c9daeefb70a" xlink:to="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f2c710a2-28ec-47ab-8a74-efa4885a27c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f2c710a2-28ec-47ab-8a74-efa4885a27c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e1680769-5681-4c8b-bb0b-2279739972e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1e556682-3db7-4691-bcb8-e92054ed965a" xlink:to="loc_us-gaap_BaseRateMember_e1680769-5681-4c8b-bb0b-2279739972e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11145b6e-a4d7-491b-8066-fd7f40871678" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b2769e7f-e3de-47ae-bf18-2086fddafef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b2769e7f-e3de-47ae-bf18-2086fddafef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_035cd22a-2613-4afe-9a25-7968204df609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_035cd22a-2613-4afe-9a25-7968204df609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0b6906a8-7f6a-49b9-920c-b116c6da883f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0b6906a8-7f6a-49b9-920c-b116c6da883f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_64d8f7fc-1386-4303-b6a9-9f3a64307b1d" xlink:href="ango-20221130.xsd#ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature_64d8f7fc-1386-4303-b6a9-9f3a64307b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_35d08eb8-8f84-4f31-94fa-a0148759b074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentTerm_35d08eb8-8f84-4f31-94fa-a0148759b074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b6403066-4797-403d-8895-5dfcf93f0b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b6403066-4797-403d-8895-5dfcf93f0b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentFloorInterestRate_11aea82b-c48a-4e0a-bbaa-555dddb995a2" xlink:href="ango-20221130.xsd#ango_DebtInstrumentFloorInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentFloorInterestRate_11aea82b-c48a-4e0a-bbaa-555dddb995a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentDebtDefaultInterestRateIncrease_7e66750e-0efa-45bf-a9f0-0f82ee4efc55" xlink:href="ango-20221130.xsd#ango_DebtInstrumentDebtDefaultInterestRateIncrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentDebtDefaultInterestRateIncrease_7e66750e-0efa-45bf-a9f0-0f82ee4efc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_aa89bfd2-1cea-4a32-a93f-e18360bbf920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_aa89bfd2-1cea-4a32-a93f-e18360bbf920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LineOfCreditFacilityNumberOfCovenants_3b0b5f17-840d-49cb-820d-cfc7bd9c3ddb" xlink:href="ango-20221130.xsd#ango_LineOfCreditFacilityNumberOfCovenants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_LineOfCreditFacilityNumberOfCovenants_3b0b5f17-840d-49cb-820d-cfc7bd9c3ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_d183fbc3-7ee1-470a-a4fe-c75a7c985226" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio_d183fbc3-7ee1-470a-a4fe-c75a7c985226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_e96d51b4-792d-448b-8f0b-30060c0fac7a" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions_e96d51b4-792d-448b-8f0b-30060c0fac7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_91337617-92e8-40ef-bf5d-d37fbcbe714f" xlink:href="ango-20221130.xsd#ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio_91337617-92e8-40ef-bf5d-d37fbcbe714f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_44e517f4-089e-4ae9-8d3c-2b74e45cb792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCredit_44e517f4-089e-4ae9-8d3c-2b74e45cb792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b216fbf4-bdbd-468a-a947-2e5d5995e50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LongTermDebt_b216fbf4-bdbd-468a-a947-2e5d5995e50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_70f0f482-d49c-42e1-b2b2-def41f7aee65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_70f0f482-d49c-42e1-b2b2-def41f7aee65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_8b7a7103-0838-4252-9e00-cde1b9de6f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c0c57af-3862-4531-a803-14cce01c6e91" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_8b7a7103-0838-4252-9e00-cde1b9de6f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ed0da913-c7af-40c1-a639-d1427f524ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ed0da913-c7af-40c1-a639-d1427f524ad4" xlink:to="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a0eadab-3f28-43a6-8049-3e54a1ae14a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9675526-385f-4e8b-9bdb-43c7668a9fcc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a0eadab-3f28-43a6-8049-3e54a1ae14a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_a9792828-18a4-4b54-8ff3-a3fc1a18a02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3a0eadab-3f28-43a6-8049-3e54a1ae14a6" xlink:to="loc_us-gaap_LineOfCreditMember_a9792828-18a4-4b54-8ff3-a3fc1a18a02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:to="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_19373974-4021-4e09-b39f-64cb69f56870" xlink:to="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b2976f0f-f1dd-4f91-b63c-050791192ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b2976f0f-f1dd-4f91-b63c-050791192ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_35fd9509-44af-42bc-809c-e983c396935b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_efbd4e9a-295b-4265-a511-2440d8f13849" xlink:to="loc_us-gaap_SecuredDebtMember_35fd9509-44af-42bc-809c-e983c396935b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_adbb1ba1-7efe-447e-b999-4ba901f57be6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_199a4a67-2e2e-4af7-a153-7eb478262bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_199a4a67-2e2e-4af7-a153-7eb478262bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7cec83c4-eb32-4a4f-9793-879d53d3ac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7cec83c4-eb32-4a4f-9793-879d53d3ac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d376aa19-e23a-4625-af2b-141c42ad22d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fe93609-cdec-4365-bea2-78448e341d3c" xlink:to="loc_us-gaap_LongTermDebt_d376aa19-e23a-4625-af2b-141c42ad22d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_554c6637-d1f1-4098-8d4f-3900de8ebe93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent_42a15036-887b-405f-b148-dba95b142241" xlink:href="ango-20221130.xsd#ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_554c6637-d1f1-4098-8d4f-3900de8ebe93" xlink:to="loc_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent_42a15036-887b-405f-b148-dba95b142241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#ShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75b15cbd-2531-41e6-b0b1-3a8578668ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75b15cbd-2531-41e6-b0b1-3a8578668ac1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:to="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_13389a84-d353-4d9c-bcc0-678780e2ec69" xlink:to="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_A2020StockAndIncentiveAwardPlanMember_77d219b4-37e5-4fe5-8233-704909adbd3a" xlink:href="ango-20221130.xsd#ango_A2020StockAndIncentiveAwardPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:to="loc_ango_A2020StockAndIncentiveAwardPlanMember_77d219b4-37e5-4fe5-8233-704909adbd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_EmployeeStockPurchasePlanMember_85e9b6dd-dfe2-4925-82cf-34e1bd38a2a3" xlink:href="ango-20221130.xsd#ango_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dfe75972-6092-449f-bb95-f823e94e5411" xlink:to="loc_ango_EmployeeStockPurchasePlanMember_85e9b6dd-dfe2-4925-82cf-34e1bd38a2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d461d52c-8d0d-4dca-8c89-0d1fe9d272bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_916eab50-7fd8-4a15-90e8-7230f69c54eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_916eab50-7fd8-4a15-90e8-7230f69c54eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aab6b6b4-064c-4a47-a37f-9fd8fef73ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aab6b6b4-064c-4a47-a37f-9fd8fef73ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ad338446-8bdc-4d34-8343-14eb8e39d722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ad338446-8bdc-4d34-8343-14eb8e39d722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4d0f8c0b-978b-45f2-80b3-81bcd2683e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4d0f8c0b-978b-45f2-80b3-81bcd2683e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_27ad0b39-8b87-4d7a-9114-d2969034af52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bbbf1133-ac92-43ec-a3f1-a52ae5b3a591" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_27ad0b39-8b87-4d7a-9114-d2969034af52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7642f5cf-4f70-4f15-81f1-d822eba28c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_178cfaa2-43a5-4c20-ab7a-f74f6bf06e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7642f5cf-4f70-4f15-81f1-d822eba28c17" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_178cfaa2-43a5-4c20-ab7a-f74f6bf06e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b8910dde-c655-444a-a62e-851a67957569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7642f5cf-4f70-4f15-81f1-d822eba28c17" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b8910dde-c655-444a-a62e-851a67957569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f28b5ef9-507d-4a92-882f-d42d35420301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7642f5cf-4f70-4f15-81f1-d822eba28c17" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f28b5ef9-507d-4a92-882f-d42d35420301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b99e153-8f51-4878-9f5d-8840145b5f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7642f5cf-4f70-4f15-81f1-d822eba28c17" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b99e153-8f51-4878-9f5d-8840145b5f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a6cd9458-57ff-4cef-a7b4-e0883c61bfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a6cd9458-57ff-4cef-a7b4-e0883c61bfd4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_74c5b287-b254-4cef-ba14-c19ecea17300" xlink:to="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_874aa53c-f1ff-43cf-a19e-dfd0a65d0c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:to="loc_us-gaap_NonUsMember_874aa53c-f1ff-43cf-a19e-dfd0a65d0c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b8db9d13-7e87-4fd6-909d-5286e954592e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cd3fe3bb-9b80-4e48-9fa8-69a2b4d8d327" xlink:to="loc_country_US_b8db9d13-7e87-4fd6-909d-5286e954592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a4c17cbc-648a-41ac-aa69-da53fc85e57d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_fad60181-fa8f-498d-9c58-bf4c05199544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_fad60181-fa8f-498d-9c58-bf4c05199544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetsGeographicAreaMember_b06ae160-29fe-4b1c-aae7-ee70075de521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetAssetsGeographicAreaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_096317fa-43d8-4e63-ace5-ac98bb1a2e5e" xlink:to="loc_us-gaap_NetAssetsGeographicAreaMember_b06ae160-29fe-4b1c-aae7-ee70075de521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_61d95cf1-88be-4f09-b6b6-2dce11b1cb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d282fe38-a94c-476d-87ee-607fcbd81e28" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_61d95cf1-88be-4f09-b6b6-2dce11b1cb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_70d0be5e-4528-4eab-96c6-49ca90bc3e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_61d95cf1-88be-4f09-b6b6-2dce11b1cb08" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_70d0be5e-4528-4eab-96c6-49ca90bc3e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c06474-2009-4f3d-b56d-8b6eaee2da8d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ec7e3477-26cf-4e76-8db5-e306672d7591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ec7e3477-26cf-4e76-8db5-e306672d7591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c21160a9-91fa-42bf-b8a8-2f76a357092e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_Assets_c21160a9-91fa-42bf-b8a8-2f76a357092e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cda68eef-8d02-47cd-9eaf-e365f50774af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e038ec2-2f19-4e4e-8d10-7b5853fc0ccd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cda68eef-8d02-47cd-9eaf-e365f50774af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_aec7d4cf-8a3b-4ea9-a48a-47597d1b3c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_aec7d4cf-8a3b-4ea9-a48a-47597d1b3c4d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:to="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2c4ab610-3a7f-47a1-8f8c-044420cf6602" xlink:to="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedTechMember_8c7512ba-82ad-421f-a36d-ccfc7371a6cd" xlink:href="ango-20221130.xsd#ango_MedTechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:to="loc_ango_MedTechMember_8c7512ba-82ad-421f-a36d-ccfc7371a6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MedDeviceMember_8e0c308a-744f-4f82-b7a4-0e3eaacb4941" xlink:href="ango-20221130.xsd#ango_MedDeviceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2f3cef69-23a6-4061-844f-83132837f102" xlink:to="loc_ango_MedDeviceMember_8e0c308a-744f-4f82-b7a4-0e3eaacb4941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:to="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_98cf5dd0-f137-4a45-b110-8c1566b82d92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_951632ac-43f1-432b-9e33-3199da62a152" xlink:to="loc_srt_SegmentGeographicalDomain_98cf5dd0-f137-4a45-b110-8c1566b82d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fc88b151-590f-4307-95c8-07684f89ea9f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffeb3277-eca4-4298-80d3-3ea975c2a214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffeb3277-eca4-4298-80d3-3ea975c2a214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cd01e46b-013a-4f9c-874e-1d7ba8690a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_us-gaap_GrossProfit_cd01e46b-013a-4f9c-874e-1d7ba8690a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_GrossMarginPercentage_c1398abc-a00d-4d95-8f3d-666cb0977cf7" xlink:href="ango-20221130.xsd#ango_GrossMarginPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a82cb022-21a3-4914-be69-f3edf5236582" xlink:to="loc_ango_GrossMarginPercentage_c1398abc-a00d-4d95-8f3d-666cb0977cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e388b62c-6394-4b59-b86f-0e6c48158fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e388b62c-6394-4b59-b86f-0e6c48158fab" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:to="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3ef32223-76fb-46be-80f3-408ab687e021" xlink:to="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a0712684-3497-4d1e-aa38-4bbb470b7977" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:to="loc_country_US_a0712684-3497-4d1e-aa38-4bbb470b7977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_67c6ee5a-046e-4862-9c33-14eaab4befa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fdee991c-0c21-488e-ae53-d8a649303a0b" xlink:to="loc_us-gaap_NonUsMember_67c6ee5a-046e-4862-9c33-14eaab4befa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ed2060dc-415c-4e94-a41c-1ec0d9ba63a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_65c1d25e-8b7b-44c9-b14b-e31855a77e6f" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ed2060dc-415c-4e94-a41c-1ec0d9ba63a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf33a3db-03ca-4ea4-8276-693510d9a68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ed2060dc-415c-4e94-a41c-1ec0d9ba63a1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf33a3db-03ca-4ea4-8276-693510d9a68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_52dc8a1e-03df-4705-bbd2-25f95019ee03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_52dc8a1e-03df-4705-bbd2-25f95019ee03" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_833966e7-749e-44d0-bfb4-c741a29b1d08" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_11310d86-3115-4e0c-a93f-fb22bff5a7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_11310d86-3115-4e0c-a93f-fb22bff5a7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_87198aa9-405f-44a1-89a7-2e3a5a0ae8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_87198aa9-405f-44a1-89a7-2e3a5a0ae8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b65315bd-8068-4cc4-89c3-3ecd18c47af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4652fcce-0e2d-4790-8e31-783727873ba0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b65315bd-8068-4cc4-89c3-3ecd18c47af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_91002de1-28ca-41c6-830d-0e269d086b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_310a909c-f880-4459-b264-f00a9cd263db" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_91002de1-28ca-41c6-830d-0e269d086b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_df379c01-7063-4992-bf1f-b57855026c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_91002de1-28ca-41c6-830d-0e269d086b55" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_df379c01-7063-4992-bf1f-b57855026c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78f80d68-c718-493e-b7b7-bc3ca0153802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_04d33154-f998-431c-8f6d-5f1842d29b8e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78f80d68-c718-493e-b7b7-bc3ca0153802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78f80d68-c718-493e-b7b7-bc3ca0153802" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aa74462e-0e66-48f2-95f6-a31e6cdc33dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aa74462e-0e66-48f2-95f6-a31e6cdc33dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_db41406b-423c-4af6-9cb4-421b88def6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ef11c595-b87c-4f04-be14-1371e617c77b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_db41406b-423c-4af6-9cb4-421b88def6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_92b9e272-3a4f-4aee-8426-e52a686b1797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_29ca35df-dab1-4e6b-a010-0e1f33a7a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_92b9e272-3a4f-4aee-8426-e52a686b1797" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_29ca35df-dab1-4e6b-a010-0e1f33a7a80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_203c616d-84e7-4eaf-b8fc-0d92100eba15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_29ca35df-dab1-4e6b-a010-0e1f33a7a80a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_203c616d-84e7-4eaf-b8fc-0d92100eba15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_01895308-396e-4c84-ae95-b4161622633a" xlink:href="ango-20221130.xsd#ango_ChangeInFairValueOfContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_29ca35df-dab1-4e6b-a010-0e1f33a7a80a" xlink:to="loc_ango_ChangeInFairValueOfContingentConsideration_01895308-396e-4c84-ae95-b4161622633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement_28662c8c-8aa1-43e1-a76b-a3ef570909b2" xlink:href="ango-20221130.xsd#ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_29ca35df-dab1-4e6b-a010-0e1f33a7a80a" xlink:to="loc_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement_28662c8c-8aa1-43e1-a76b-a3ef570909b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6c973bf9-2646-4218-bc16-2345b63192aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_29ca35df-dab1-4e6b-a010-0e1f33a7a80a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6c973bf9-2646-4218-bc16-2345b63192aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4a170537-fb34-4d89-9b24-88ed35b3672a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4a170537-fb34-4d89-9b24-88ed35b3672a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_031d22dd-8374-47c3-a25f-d692d33a2203" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_9ccd02f6-74aa-49d8-9a69-1f2d4d22e4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_9ccd02f6-74aa-49d8-9a69-1f2d4d22e4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MeasurementInputProbabilityofPaymentMember_6406ebcd-64e5-4d9b-a23c-ccfb82a77c71" xlink:href="ango-20221130.xsd#ango_MeasurementInputProbabilityofPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_013158ef-84f5-49c7-b37b-bb99c85e1153" xlink:to="loc_ango_MeasurementInputProbabilityofPaymentMember_6406ebcd-64e5-4d9b-a23c-ccfb82a77c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_63a8b648-fd09-486f-b408-54da6f407d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d0c86d11-83d3-453a-9c83-3610c6b8f47e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_63a8b648-fd09-486f-b408-54da6f407d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_RevenueBasedPaymentMember_db84959e-d280-4f45-9698-8e29896a80a0" xlink:href="ango-20221130.xsd#ango_RevenueBasedPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_63a8b648-fd09-486f-b408-54da6f407d0d" xlink:to="loc_ango_RevenueBasedPaymentMember_db84959e-d280-4f45-9698-8e29896a80a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dcda66da-d5f1-46d8-8ad8-cc4412c37d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef87bdc7-5002-458f-86eb-cf7a9dcc9b71" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dcda66da-d5f1-46d8-8ad8-cc4412c37d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a83b40e2-7f05-450e-ab12-2022773d0571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dcda66da-d5f1-46d8-8ad8-cc4412c37d22" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a83b40e2-7f05-450e-ab12-2022773d0571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ec06fd0-3fe7-4ce2-95c7-fe06365245e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_470c62c7-4ad8-492a-a5a2-6618ef7414cf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ec06fd0-3fe7-4ce2-95c7-fe06365245e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_238ac920-3bef-4f18-9b9b-519fc46b9baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ec06fd0-3fe7-4ce2-95c7-fe06365245e8" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_238ac920-3bef-4f18-9b9b-519fc46b9baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_972431a8-2dcd-46f1-b3a4-f236b0d80dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_459675fe-7818-404e-aeec-6b03cc0e6e45" xlink:to="loc_us-gaap_ValuationTechniqueDomain_972431a8-2dcd-46f1-b3a4-f236b0d80dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_04104259-d017-453a-94f8-337e65287467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_972431a8-2dcd-46f1-b3a4-f236b0d80dc4" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_04104259-d017-453a-94f8-337e65287467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_29812bac-2d34-47ad-878e-52c82afc7f3a" xlink:to="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dc3eb893-b44c-4c02-8b28-66de45c19f61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:to="loc_srt_MinimumMember_dc3eb893-b44c-4c02-8b28-66de45c19f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9ee8fad8-defc-4298-9052-fc7c5ff33452" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_165d711c-c923-4dd2-a80d-09d8abe652f0" xlink:to="loc_srt_MaximumMember_9ee8fad8-defc-4298-9052-fc7c5ff33452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abe42203-b21c-47f7-9072-35797f884b06" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6b146e1-9799-4c23-8982-31cd6f942fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6b146e1-9799-4c23-8982-31cd6f942fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4c46d087-09f7-4d29-92ce-0eed2aa2ba43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_044861f3-b682-4261-82db-067ae7903574" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4c46d087-09f7-4d29-92ce-0eed2aa2ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueAdditionalInformationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#FairValueAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e6dcbc8e-8597-42ea-825d-f328448f1d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_UndiscountedContingentConsiderationDisclosure_785151e3-dbfd-4b08-98c0-3d5b61c37ddc" xlink:href="ango-20221130.xsd#ango_UndiscountedContingentConsiderationDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e6dcbc8e-8597-42ea-825d-f328448f1d1a" xlink:to="loc_ango_UndiscountedContingentConsiderationDisclosure_785151e3-dbfd-4b08-98c0-3d5b61c37ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_02a94a8a-6e46-45c2-89f6-810d1d9db15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_02a94a8a-6e46-45c2-89f6-810d1d9db15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9b5ffd6f-db92-4a24-8774-7a2b3007f453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9b5ffd6f-db92-4a24-8774-7a2b3007f453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0fa2d1b4-2210-40f2-8fb1-2152b2db3108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0fa2d1b4-2210-40f2-8fb1-2152b2db3108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f22f6e7f-4a27-4d1a-a4b1-aa23a94a487d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseLiability_f22f6e7f-4a27-4d1a-a4b1-aa23a94a487d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_91e4cd6b-f82c-4c73-a712-93dda7f6a53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_91e4cd6b-f82c-4c73-a712-93dda7f6a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ea0ffd43-7867-44fd-b490-b1b7c9d87011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ea0ffd43-7867-44fd-b490-b1b7c9d87011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_0a0028e9-70bf-4185-898f-ff271e10788e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_0a0028e9-70bf-4185-898f-ff271e10788e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ea6bb552-5e54-4090-aeed-1f8c9d912503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ea6bb552-5e54-4090-aeed-1f8c9d912503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_704a2d74-33a1-43b5-97bf-4d453dc80a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_148b2c19-8845-4759-8c72-a5ce631c6e09" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_704a2d74-33a1-43b5-97bf-4d453dc80a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesLiabilityMaturityScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_163fad6a-6822-4378-a5c5-6cdd2a56c837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_163fad6a-6822-4378-a5c5-6cdd2a56c837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_87139a05-a8d2-4aa1-937d-9029206b3465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_87139a05-a8d2-4aa1-937d-9029206b3465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7ce663c2-6ac3-4100-a51e-d92973341402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7ce663c2-6ac3-4100-a51e-d92973341402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54c1c3f7-34e6-4f32-ae66-2a44331d85e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54c1c3f7-34e6-4f32-ae66-2a44331d85e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_bb219537-bc2d-4282-a259-73c178183a67" xlink:href="ango-20221130.xsd#ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_bb219537-bc2d-4282-a259-73c178183a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c52b3b5-b87f-4381-b858-ed91e30cf0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c52b3b5-b87f-4381-b858-ed91e30cf0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a37538f1-442f-45fa-9917-7249beb3f516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a37538f1-442f-45fa-9917-7249beb3f516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b84e2033-b42e-418f-a1ad-2ca54deb051e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_OperatingLeaseLiability_b84e2033-b42e-418f-a1ad-2ca54deb051e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_863f24ce-a731-4eb6-8330-195c50a08f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_863f24ce-a731-4eb6-8330-195c50a08f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79e3894d-4434-4e3d-8e0b-4bdee3d8fc09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41d81485-5e4c-4b38-83c8-9ee62cb58d42" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79e3894d-4434-4e3d-8e0b-4bdee3d8fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesLiabilityMaturityScheduleDetails_1"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesSupplementalStatementofOperationsInformationDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aa7a45fb-8e03-4028-b628-3a3fbc2dd4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aa7a45fb-8e03-4028-b628-3a3fbc2dd4d0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9d3f6201-5f04-4f5b-a3c0-b4da35c11958" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_191b470c-6669-4464-b2ad-1c55eef8492a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_CostOfSalesMember_191b470c-6669-4464-b2ad-1c55eef8492a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_02b06c26-7072-40da-af90-ce0e504579dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_02b06c26-7072-40da-af90-ce0e504579dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_00dc1c8f-9c01-4fc7-8829-f2150669d114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_00dc1c8f-9c01-4fc7-8829-f2150669d114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cb9f58d7-bc7a-4212-a8a3-3bfc18644ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_50ea8f66-29cf-4cf2-a31f-68b47d23145c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cb9f58d7-bc7a-4212-a8a3-3bfc18644ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_10f72e9a-7dd1-49ba-9680-e2ace14e9d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_488dbff6-ea30-4980-8eba-27583317d397" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_10f72e9a-7dd1-49ba-9680-e2ace14e9d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_686e6f90-67ff-4bd3-8b6d-633300b02ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_10f72e9a-7dd1-49ba-9680-e2ace14e9d7a" xlink:to="loc_us-gaap_OperatingLeaseExpense_686e6f90-67ff-4bd3-8b6d-633300b02ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e1d8ec2d-0fa7-4b9a-81c6-7620873829b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_1ebc6f54-14c4-4944-bbc6-d333fccc8ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e1d8ec2d-0fa7-4b9a-81c6-7620873829b8" xlink:to="loc_us-gaap_OperatingLeasePayments_1ebc6f54-14c4-4944-bbc6-d333fccc8ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_501867df-7031-4188-8aea-5b71ef3e6740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e1d8ec2d-0fa7-4b9a-81c6-7620873829b8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_501867df-7031-4188-8aea-5b71ef3e6740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e731651-eca6-4477-b25b-04aae72a7d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e731651-eca6-4477-b25b-04aae72a7d45" xlink:to="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:to="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_03630142-94cf-4c76-a95f-665d63c6829f" xlink:to="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_CrBardIncMember_dcdf8986-934c-4b49-ab45-2d912dfac10c" xlink:href="ango-20221130.xsd#ango_CrBardIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:to="loc_ango_CrBardIncMember_dcdf8986-934c-4b49-ab45-2d912dfac10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_TheDelawareActionMember_3a898b85-ffe8-46aa-8176-8e74115c6031" xlink:href="ango-20221130.xsd#ango_TheDelawareActionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7e8964a9-6d68-4fc9-8a48-c7031d720aab" xlink:to="loc_ango_TheDelawareActionMember_3a898b85-ffe8-46aa-8176-8e74115c6031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f7ba8d14-832d-4b8b-a334-9e3d1401b128" xlink:to="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NumberOfPatentsAssertedForReexamination_d66c2193-5abe-4e84-b8b1-836ab89c0a14" xlink:href="ango-20221130.xsd#ango_NumberOfPatentsAssertedForReexamination"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_ango_NumberOfPatentsAssertedForReexamination_d66c2193-5abe-4e84-b8b1-836ab89c0a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_NumberOfPatentsUpheldOverPriorArtReferences_f922ef50-f30c-4034-b600-3a4495505ffe" xlink:href="ango-20221130.xsd#ango_NumberOfPatentsUpheldOverPriorArtReferences"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_ango_NumberOfPatentsUpheldOverPriorArtReferences_f922ef50-f30c-4034-b600-3a4495505ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c587ee93-f964-4db4-9c6e-e5de1c8be7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_380a1082-147b-4709-924b-d9160a12bba0" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c587ee93-f964-4db4-9c6e-e5de1c8be7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AcquisitionRestructuringandOtherItemsNetDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7b10d33e-d423-48d4-b6e9-063e338ee66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7b10d33e-d423-48d4-b6e9-063e338ee66d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cfcf0217-9e23-47a9-aad9-b4dc3b3cda97" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_LegalCostsMember_c4691c59-5e40-4afa-9129-a3415540093e" xlink:href="ango-20221130.xsd#ango_LegalCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_LegalCostsMember_c4691c59-5e40-4afa-9129-a3415540093e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_MergersandAcquisitionsMember_b5a981ae-ed92-4658-bed1-e1ada57371a5" xlink:href="ango-20221130.xsd#ango_MergersandAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_MergersandAcquisitionsMember_b5a981ae-ed92-4658-bed1-e1ada57371a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_ManufacturingRelocationMember_13f97aa4-3633-43c5-8c0e-0c00e81f5173" xlink:href="ango-20221130.xsd#ango_ManufacturingRelocationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_ManufacturingRelocationMember_13f97aa4-3633-43c5-8c0e-0c00e81f5173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_IsraeliInnovationAuthorityPrepaymentMember_27182176-2e52-459b-9953-a944901ee7da" xlink:href="ango-20221130.xsd#ango_IsraeliInnovationAuthorityPrepaymentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_ango_IsraeliInnovationAuthorityPrepaymentMember_27182176-2e52-459b-9953-a944901ee7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_ef871f4a-6106-4fa1-a185-0e7c93b88c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3621a0bd-a513-4d49-b626-78bd0db5147a" xlink:to="loc_us-gaap_OtherExpenseMember_ef871f4a-6106-4fa1-a185-0e7c93b88c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9abda90d-b22e-4a2f-ac0d-2aad85a77a5a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_54e49ee0-80de-4c7a-baee-e148dfc4c7d3" xlink:href="ango-20221130.xsd#ango_AcquisitionRestructuringAndOtherItemsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_54e49ee0-80de-4c7a-baee-e148dfc4c7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_3fa580d1-8d9c-4936-9be9-3ca1faabfbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67659252-66ed-4133-932c-a748a6c0473a" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_3fa580d1-8d9c-4936-9be9-3ca1faabfbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ango-20221130.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_45dc716d-c05a-485e-b537-de841110ff32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_45dc716d-c05a-485e-b537-de841110ff32" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2e8130db-7a41-4ffd-8077-84a5bcbc0489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2642c4cc-049c-444f-a550-feb4ff44917c" xlink:to="loc_us-gaap_EquityComponentDomain_2e8130db-7a41-4ffd-8077-84a5bcbc0489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7b569a91-8bc6-4772-987e-24fbf3d6c506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2e8130db-7a41-4ffd-8077-84a5bcbc0489" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7b569a91-8bc6-4772-987e-24fbf3d6c506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3078824-e562-4a3c-938f-0aa8734e0b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31c3d678-1fef-4a59-9e17-0b3806ef5129" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3078824-e562-4a3c-938f-0aa8734e0b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b3078824-e562-4a3c-938f-0aa8734e0b2a" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7ca0b964-2d9d-48a7-8c2d-571989f1f42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_StockholdersEquity_7ca0b964-2d9d-48a7-8c2d-571989f1f42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_42d351bf-7241-4540-9dc8-9e1befc76d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_42d351bf-7241-4540-9dc8-9e1befc76d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bae6d9fc-b921-4ef6-99ef-4f0a1c10962e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bae6d9fc-b921-4ef6-99ef-4f0a1c10962e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1aea1414-c0bc-48ff-aba3-acf5aae3ca11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f9cc5bcb-d4f0-4462-91fa-4ac96cfd4ba7" xlink:to="loc_us-gaap_StockholdersEquity_1aea1414-c0bc-48ff-aba3-acf5aae3ca11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ango-20221130_g1.gif
<TEXT>
begin 644 ango-20221130_g1.gif
M1TE&.#EA(@2A /<   TB/S E/P\E1 \G2!8K1Q$J31LO2ATD01TR3Q,M4QXU
M5RH]5B4\7"$W53DH1!TY8AL[:Q<^>1D]=B4^8T,H1%(L1UHS3V<W4W(]<'H\
M;AA ?B9 :RQ#9SI+8C5*:R-"<2E)>RI(=S!/?S-0?#5&7TE9;E=">4=2:FU!
M=EAF>GA!5:4>-JH>.+(>/+@>/J0G/84[598[5:HK0KXF1K4I1+ Y3J(^6JLT
M4(DZ:*D_9^D83LHI3L0H2M,L4]HL5MXM6<@U5]4P6-LT7= X6\\O6N4E5ND@
M5.HF6.,J6>$G6.$R7LHY8M<Z9.,U8>PT9.(O8)U#7K9'6[A%6J5!6HY&;;M6
M:*U+<<I 7M1+;^U";^Y1>NE9?>I'<<%D=,AM?=-@>AA"A!=&CQ],D"E/C"A+
MBRQ1BC)4B2!-D251EBU4D#19D3-<G51$@U5PF&=TAV1SB69XDD)HI%!TJU]_
MLK!SCL=R@=QKA?!@A?%ND/-]F^!TC7:"DVV+N7"(JWR7P(:0GY6>JZ2LMYBD
MN,R C=*.FM><I]R4H_2+IO6:L>.;JMVAK=VJL_>HO/"CMHNBQYFNSI.GQK.Z
MPZBYU:ZWQ..XP.^QP_BWQ[;%W,+(S]'5V^C'S?G%T^[5V?O4WNW)T<71X]/<
MZM7:X>'CY_3CYOSBZ>+H\?#Q\_SQ\_#S^
M
M
M
M
M
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M^DJH<JNO.RS)9QW"5[J21+(I)8DH#"" "$!&GAFQQ-[.LP(34$2C5A(%A?+
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MD;P;M>EC2OOZ1\7@42@J#50PT2%9@QH%/21$IPZ%"#<]T>?0N@5ITGHROX5
MA>D#P<604V3LCU+P0M"Q4SWD"-ITBC=MD25E#.TY4XA(0&+,"5Y,T9UZP9Q(
M0"&MESY='5#L#5&MBCTE"7/DPCE<Q[UQ@15(C%/@NY"S*#"I S#=%4FHT!>3
MU(A A8*3 W034X)H4?Y(S)Y9U'3;57VSC6N,G]0@T_C@'1T=B%CSFE:#S#5X
MA$N"U.W9U(P85D*C$.W4'%+=BH);@V]5B&D%3#_0.ZYP-W0CS8:0SBMCMC5
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M6\)/:%O$]1%0$)@Y>+7+/5D-!#N-/"/*95S,Q=P33%F<<<#^E;U<8&%  DO
M@1A$R8T/4%A<@KG<QXU<U[7=X*A<T'7<!4Q8HE#<!]1=M&7"VLV*#MC;(3G0
MMPF"%Y#0DM!2+BTN,)$!2KC=ZK5>@''6Z]7>^-C#T=W>[P7?\#4Y5<4+OL4.
MMSG%PX4(4K X!_4!",T/XQ3?^:7? L+1^L7?B\ RCH#1_/7?_P7@"-K"XP60
M)9@>):@!DMB$]G5?+VW> (;@Z\W>",9?8QP(I*7@#-;@#2:)E,0+!<,..CBA
M'9#8B&"$P87>M;C8%>B"!^;@%][)"8;A[7W(&9WA&\;A%QY0O"  "8","+
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4$1 /#@T,"PH)" <&!00# @$  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048565168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Jan. 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001275187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--05-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-50761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AngioDynamics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3146460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">14 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Latham<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">795-1400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,134,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANGO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ango_PreferredStockPurchaseRightsMember', window );">Preferred Stock Purchase Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock Purchase Rights<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ango_PreferredStockPurchaseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ango_PreferredStockPurchaseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048757328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 85,429<span></span>
</td>
<td class="nump">$ 78,280<span></span>
</td>
<td class="nump">$ 166,966<span></span>
</td>
<td class="nump">$ 155,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales (exclusive of intangible amortization)</a></td>
<td class="nump">40,351<span></span>
</td>
<td class="nump">37,725<span></span>
</td>
<td class="nump">79,583<span></span>
</td>
<td class="nump">74,557<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">45,078<span></span>
</td>
<td class="nump">40,555<span></span>
</td>
<td class="nump">87,383<span></span>
</td>
<td class="nump">80,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">6,838<span></span>
</td>
<td class="nump">8,199<span></span>
</td>
<td class="nump">15,171<span></span>
</td>
<td class="nump">15,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">26,007<span></span>
</td>
<td class="nump">23,606<span></span>
</td>
<td class="nump">52,550<span></span>
</td>
<td class="nump">48,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,835<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
<td class="nump">20,936<span></span>
</td>
<td class="nump">18,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">4,808<span></span>
</td>
<td class="nump">4,889<span></span>
</td>
<td class="nump">9,645<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ChangeInFairValueOfContingentConsiderationOne', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">609<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">3,059<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">8,640<span></span>
</td>
<td class="nump">4,693<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">53,193<span></span>
</td>
<td class="nump">49,234<span></span>
</td>
<td class="nump">108,799<span></span>
</td>
<td class="nump">97,473<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(8,115)<span></span>
</td>
<td class="num">(8,679)<span></span>
</td>
<td class="num">(21,416)<span></span>
</td>
<td class="num">(16,779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(684)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
<td class="num">(1,065)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(252)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(427)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(936)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(1,492)<span></span>
</td>
<td class="num">(692)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax benefit</a></td>
<td class="num">(9,051)<span></span>
</td>
<td class="num">(8,863)<span></span>
</td>
<td class="num">(22,908)<span></span>
</td>
<td class="num">(17,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(565)<span></span>
</td>
<td class="num">(512)<span></span>
</td>
<td class="num">(1,418)<span></span>
</td>
<td class="num">(2,148)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (8,486)<span></span>
</td>
<td class="num">$ (8,351)<span></span>
</td>
<td class="num">$ (21,490)<span></span>
</td>
<td class="num">$ (15,323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share, basic (USD per share)</a></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share, diluted (USD per share)</a></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">39,490<span></span>
</td>
<td class="nump">39,053<span></span>
</td>
<td class="nump">39,394<span></span>
</td>
<td class="nump">38,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">39,490<span></span>
</td>
<td class="nump">39,053<span></span>
</td>
<td class="nump">39,394<span></span>
</td>
<td class="nump">38,893<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AcquisitionRestructuringAndOtherItemsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Restructuring And Other Items Net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AcquisitionRestructuringAndOtherItemsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ChangeInFairValueOfContingentConsiderationOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value Of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ChangeInFairValueOfContingentConsiderationOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Number Of Shares Outstanding, Basic And Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048473456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (8,486)<span></span>
</td>
<td class="num">$ (8,351)<span></span>
</td>
<td class="num">$ (21,490)<span></span>
</td>
<td class="num">$ (15,323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Other comprehensive income (loss), before tax</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax expense related to items of other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss, net of tax</a></td>
<td class="num">$ (9,581)<span></span>
</td>
<td class="num">$ (7,532)<span></span>
</td>
<td class="num">$ (23,135)<span></span>
</td>
<td class="num">$ (13,914)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048707552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 29,857<span></span>
</td>
<td class="nump">$ 28,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $2,110 and $1,939 respectively</a></td>
<td class="nump">52,852<span></span>
</td>
<td class="nump">52,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">63,177<span></span>
</td>
<td class="nump">51,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">12,944<span></span>
</td>
<td class="nump">10,824<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">158,830<span></span>
</td>
<td class="nump">143,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">45,957<span></span>
</td>
<td class="nump">45,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">141,943<span></span>
</td>
<td class="nump">152,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">200,755<span></span>
</td>
<td class="nump">201,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">10,722<span></span>
</td>
<td class="nump">10,963<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">558,207<span></span>
</td>
<td class="nump">552,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">34,688<span></span>
</td>
<td class="nump">28,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">26,533<span></span>
</td>
<td class="nump">34,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of contingent consideration</a></td>
<td class="nump">9,760<span></span>
</td>
<td class="nump">8,783<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">2,586<span></span>
</td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">73,567<span></span>
</td>
<td class="nump">74,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Long-term debt</a></td>
<td class="nump">49,796<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">14,290<span></span>
</td>
<td class="nump">16,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration, net of current portion</a></td>
<td class="nump">9,072<span></span>
</td>
<td class="nump">8,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">3,524<span></span>
</td>
<td class="nump">4,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">150,249<span></span>
</td>
<td class="nump">128,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share, 75,000,000 shares authorized; 39,874,144 and 39,541,173 shares issued and 39,504,144 and 39,171,173 shares outstanding at November&#160;30, 2022 and May 31, 2022, respectively</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">593,482<span></span>
</td>
<td class="nump">586,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(179,903)<span></span>
</td>
<td class="num">(158,413)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, 370,000 shares at November&#160;30, 2022 and May 31, 2022, respectively</a></td>
<td class="num">(5,714)<span></span>
</td>
<td class="num">(5,714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="num">(288)<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">407,958<span></span>
</td>
<td class="nump">424,489<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 558,207<span></span>
</td>
<td class="nump">$ 552,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048458112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowances</a></td>
<td class="nump">$ 2,110<span></span>
</td>
<td class="nump">$ 1,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">39,874,144<span></span>
</td>
<td class="nump">39,541,173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">39,504,144<span></span>
</td>
<td class="nump">39,171,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047868912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (21,490)<span></span>
</td>
<td class="num">$ (15,323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">15,478<span></span>
</td>
<td class="nump">14,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_NonCashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">6,374<span></span>
</td>
<td class="nump">5,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ChangeInFairValueOfContingentConsiderationOne', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Gain on contingent consideration for IPR&amp;D Write-off</a></td>
<td class="num">(1,525)<span></span>
</td>
<td class="num">(2,259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Change in accounts receivable allowances</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Fixed and intangible asset impairments and disposals</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="num">(2,922)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(11,831)<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="num">(3,931)<span></span>
</td>
<td class="num">(4,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued and other liabilities</a></td>
<td class="num">(2,843)<span></span>
</td>
<td class="num">(4,514)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(17,246)<span></span>
</td>
<td class="num">(6,963)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(2,090)<span></span>
</td>
<td class="num">(2,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquipmentOnLease', window );">Additions to placement and evaluation units</a></td>
<td class="num">(3,442)<span></span>
</td>
<td class="num">(7,189)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="num">(540)<span></span>
</td>
<td class="num">(3,600)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,072)<span></span>
</td>
<td class="num">(12,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from borrowings on long-term debt</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(45,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred financing costs on long-term debt</a></td>
<td class="num">(751)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised', window );">Proceeds from exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">24,479<span></span>
</td>
<td class="nump">6,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(354)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="num">(13,870)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">28,825<span></span>
</td>
<td class="nump">48,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">29,857<span></span>
</td>
<td class="nump">34,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Accrual for capital expenditures incurred during the period</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ChangeInFairValueOfContingentConsiderationOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value Of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ChangeInFairValueOfContingentConsiderationOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds (Outlays), Issuance Of Shares, Share-based Payment Arrangement, Including Option Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquipmentOnLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payments to acquire rented equipment which is recorded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquipmentOnLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042760912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Restricted stock units</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Restricted stock units</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Performance share units</div>
</th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th">
<div>Additional paid in capital </div>
<div>Restricted stock units</div>
</th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Accumulated other comprehensive income</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at May. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,920,951,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at May. 31, 2021</a></td>
<td class="nump">$ 439,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 573,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (131,866)<span></span>
</td>
<td class="nump">$ 3,153<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning Balance, Treasury Shares at May. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance/Cancellation of performance share units and restricted stock units, net, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279,495,000<span></span>
</td>
<td class="nump">59,371,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance/Cancellation of performance share units and restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under ESPP, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,789,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchases of common stock under ESPP</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Aug. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,390,241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Aug. 31, 2021</a></td>
<td class="nump">435,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(138,838)<span></span>
</td>
<td class="nump">3,743<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending Balance, Treasury Shares at Aug. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at May. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,920,951,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at May. 31, 2021</a></td>
<td class="nump">439,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">573,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(131,866)<span></span>
</td>
<td class="nump">3,153<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning Balance, Treasury Shares at May. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Nov. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,455,193,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Nov. 30, 2021</a></td>
<td class="nump">432,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,189)<span></span>
</td>
<td class="nump">4,562<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending Balance, Treasury Shares at Nov. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at Aug. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,390,241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Aug. 31, 2021</a></td>
<td class="nump">435,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(138,838)<span></span>
</td>
<td class="nump">3,743<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning Balance, Treasury Shares at Aug. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,064,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance/Cancellation of performance share units and restricted stock units, net, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,695,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance/Cancellation of performance share units and restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under ESPP, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchases of common stock under ESPP</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Nov. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,455,193,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Nov. 30, 2021</a></td>
<td class="nump">$ 432,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,189)<span></span>
</td>
<td class="nump">4,562<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending Balance, Treasury Shares at Nov. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at May. 31, 2022</a></td>
<td class="nump">39,171,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,541,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at May. 31, 2022</a></td>
<td class="nump">$ 424,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158,413)<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning Balance, Treasury Shares at May. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (21,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Nov. 30, 2022</a></td>
<td class="nump">39,504,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,874,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Nov. 30, 2022</a></td>
<td class="nump">$ 407,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,903)<span></span>
</td>
<td class="num">(288)<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending Balance, Treasury Shares at Nov. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at Aug. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,847,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Aug. 31, 2022</a></td>
<td class="nump">414,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(171,417)<span></span>
</td>
<td class="nump">807<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning Balance, Treasury Shares at Aug. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,486)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,486)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance/Cancellation of performance share units and restricted stock units, net, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance/Cancellation of performance share units and restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (1,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Nov. 30, 2022</a></td>
<td class="nump">39,504,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,874,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Nov. 30, 2022</a></td>
<td class="nump">$ 407,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 593,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (179,903)<span></span>
</td>
<td class="num">$ (288)<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending Balance, Treasury Shares at Nov. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047212880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Financial Statements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Consolidated Financial Statements</a></td>
<td class="text">CONSOLIDATED FINANCIAL STATEMENTS<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Loss for the three and six months ended November&#160;30, 2022 and 2021, the Consolidated Balance Sheet as of November&#160;30, 2022, the Consolidated Statements of Cash Flows for the six months ended November&#160;30, 2022 and 2021, and the Consolidated Statements of Stockholders&#8217; Equity for the six months ended November&#160;30, 2022 and 2021 have been prepared by the Company and are unaudited. The Consolidated Balance Sheet as of May&#160;31, 2022 was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to state fairly the financial position, changes in stockholders&#8217; equity and comprehensive income, results of operations and cash flows as of and for the period ended November&#160;30, 2022 (and for all periods presented) have been made.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim consolidated financial statements for the three and six months ended November&#160;30, 2022 and 2021 include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries (collectively, the "Company", "we", "our" or "us").  All intercompany balances and transactions have been eliminated.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136138022144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">ACQUISITIONSCamaro Support Catheter Asset AcquisitionOn July 27, 2021, the Company acquired the Camaro support catheter (rebranded as Syntrax) from QX Medical, LLC for an aggregate purchase price of $4.0&#160;million, which included an upfront payment of $3.6&#160;million and $0.4&#160;million in purchase price holdbacks, along with $1.0&#160;million of potential future contingent consideration related to revenue milestones. This acquisition supports the Auryon product family and the Company's strategic plan.  The Company accounted for this acquisition as an asset purchase.  The Company recorded the amount paid at closing as inventory and fixed assets of $0.1&#160;million and an intangible asset product technology of $3.9&#160;million.  The intangible asset will be amortized over 15 years.  The contingent consideration is comprised of revenue milestones and will be accounted for when the contingency is resolved or becomes probable and reasonably estimable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136137971200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contracts with Customers</a></td>
<td class="text">REVENUE FROM CONTRACTS WITH CUSTOMERS<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one primary revenue stream which is the sales of its products.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company has previously announced, the Company is focused on its ongoing transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company that delivers unique and innovative health care solutions. The Company believes that this transformation will enable the Company to shift the portfolio from the mature, lower-growth markets where we have competed in the past by investing in technology and products that provide access to larger and faster growing markets. As such, we believe the growth in the near to mid-term will be driven by our Med Tech segment.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net sales by Med Tech, Med Device and by geography:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended November 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended November 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended November 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended November 30, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,655&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,814&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Product Revenue</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products consist of a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's products are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be implanted for short or long term use. The Company sells its products to its distributors and to end users, such as interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists and critical care nurses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with its customers based on customer purchase orders, which in many cases are governed by master purchasing agreements. The Company&#8217;s contracts with customers are generally for product only, and do not include other performance obligations such as services or other material rights. As part of its assessment of each contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price and Allocation to Performance Obligations</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction prices of products are typically based on contracted rates. Product revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to a customer, net of any variable consideration as described below.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products underlying each performance obligation. The Company has standard pricing for its products and determines standalone selling prices based on the price at which the performance obligation is sold separately.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company&#8217;s performance obligation is satisfied), which occurs at a point in time, and may be upon shipment from the Company&#8217;s manufacturing site or delivery to the customer&#8217;s named location, based on the shipping terms of a contract.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether control has transferred, the Company considers if there is a present right to payment from the customer and when physical possession, legal title and risks and rewards of ownership have transferred to the customer.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically invoices customers upon satisfaction of identified performance obligations.  As the Company&#8217;s standard payment terms are 30 to 90 days from invoicing, the Company does not provide any significant financing to its customers.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into agreements to place placement and evaluation units (&#8220;units&#8221;) at customer sites, but the Company retains title to the units. For the duration of these agreements the customer has the right to use the unit at no upfront charge in connection with the customer&#8217;s ongoing purchase of disposables. These types of agreements include an embedded operating lease for the right to use the units. In these arrangements, revenue recognized for the sale of the disposables is not allocated </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between the disposal revenue and lease revenue due to the insignificant value of the units in relation to the total agreement value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves: Revenue from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established for discounts, returns, rebates and allowances that are offered within contracts between the Company and its customers.  These reserves are based on the amounts earned or to be claimed on the related sales and are classified as a contra asset.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rebates and Allowances: The Company provides certain customers with rebates and allowances that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. The Company establishes reserves for such amounts, which is included in accrued expenses in the accompanying Consolidated Balance Sheets. These rebates and allowances result from performance-based offers that are primarily based on attaining contractually specified sales volumes.  The Company is also required to pay administrative fees to group purchasing organizations.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product Returns: The Company generally offers customers a limited right of return.  Product returns after 30 days must be pre-approved by the Company and customers may be subject to a 20% restocking charge.  To be accepted, a returned product must be unadulterated, undamaged and have at least twelve months remaining prior to its expiration date.  The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized.  The Company currently estimates product return liabilities using its historical product return information and considers other factors that it believes could significantly impact its expected returns, including product recalls.  During the six months ended November&#160;30, 2022, such product returns were not material.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances with Customers</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is generally recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer and generally coincide with revenue recognition. Accordingly, the Company does not have any contract assets associated with the future right to invoice its customers. In some cases, if control of the product has not yet transferred to the customer or the timing of the payments made by the customer precedes the Company&#8217;s fulfillment of the performance obligation, the Company recognizes a contract liability that is included in deferred revenue in the accompanying Consolidated Balance Sheets.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the Company&#8217;s receivables, contract assets and contract liabilities with customers:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended November&#160;30, 2022, the Company had additions to contract liabilities of $0.5 million.  This was offset by $0.5 million in revenue that was recognized during the six months ended November&#160;30, 2022. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs to Obtain or Fulfill a Customer Contract </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, the Company may recognize an asset for incremental costs of obtaining a contract with a customer if it expects to recover those costs. The Company&#8217;s sales incentive compensation plans qualify for capitalization since these plans are directly related to sales achieved during a period of time. However, the Company has elected the practical expedient under ASC 340-40-25-4 to expense the costs as they are incurred within selling and marketing expenses since the amortization period is less than one year.</span></div>The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping and handling are recorded in net sales.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050450608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at lower of cost and net realizable value (using the first-in, first-out method).  Inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,392&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The Company periodically reviews inventory for both obsolescence and loss of value.  The Company makes assumptions about the future demand for and market value of the inventory.  Based on these assumptions, the Company estimates the amount of obsolete, expiring and slow-moving inventory.  The total inventory reserve at November&#160;30, 2022 and May&#160;31, 2022 was $3.9 million and $3.7 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136138036288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized, but rather, is tested for impairment annually or more frequently if impairment indicators arise. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in each business combination. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically performed its annual goodwill assessment during the third quarter of each fiscal year.  During the fourth quarter of fiscal year 2022, the Company changed its annual impairment assessment date from December 31 to April 30 to more closely align the impairment assessment date with the Company's long term planning and forecasting process.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's annual testing for impairment of goodwill was completed as of April 30, 2022.  Prior to the first quarter of fiscal year 2023, the Company managed its operations as one reporting unit.  At the beginning of the first quarter of fiscal year 2023, the Company began to manage its operations as two operating segments and two reporting units, namely Med Tech and Med Device (see Note 11 "Segment and Geographic Information" set forth in the Notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q).  As a result of this change, goodwill was required to be allocated to each reporting unit and an interim goodwill impairment assessment was performed at the Company and reporting unit levels.  To determine the fair value of the individual reporting units and the entire company as of June 1, 2022, the Company utilized the income approach.  The income approach is based on the projected cash flows discounted to their present value using discount rates, that in the Company's judgment, consider the timing and risk of the forecasted cash flows using internally developed forecasts and assumptions.  Under the income approach, the discount rate used is the average estimated value of a market participant&#8217;s cost of capital and debt, derived using customary market metrics.  Other significant assumptions include revenue growth rates, profitability projections, and terminal value growth rates.  The market approach was also considered; however, the income approach was chosen as the Company determined it is a better representation of both the Med Tech and Med Device reporting units' projected long-term performance. The fair value of each reporting unit and the Company as a whole was assessed to determine if there was any impairment.  The Company compared each reporting unit's fair value to the adjusted carrying value to conclude that there was no impairment for either reporting unit or the Company as a whole.  The adjusted carrying value of each reporting unit was used to calculate the Company's book value to compare to its market capitalization at the assessment date.  Based on the results of this evaluation, there were no adjustments to goodwill for either reporting unit or the Company as a whole as of August 31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adjustments to goodwill for the six months ended November&#160;30, 2022 other than foreign currency translation adjustments.   </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even though the Company determined that there was no goodwill impairment at November&#160;30, 2022, the future occurrence of a potential indicator of impairment, such as a significant adverse change in legal, regulatory, business or economic conditions or a more-likely-than-not expectation that one of the reporting units or a significant portion of either of the reporting units will be sold or disposed of, would require an interim assessment for the reporting units prior to the next required annual assessment as of April 30, 2023.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill for each reporting unit is allocated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Med Tech </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Med Device </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, August 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adjustments to goodwill for the six months ended November&#160;30, 2022 other than foreign currency translation adjustments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill are amortized over their estimated useful lives on a straight-line basis. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0Mg_fc669142-82c7-49b8-a7a9-e8917629543b">two</span> to eighteen years.  The Company periodically reviews, and adjusts, if necessary, the estimated useful lives of its intangible assets and reviews such assets or asset groups for impairment whenever events or changes in circumstances indicate that the carrying value of the assets or asset groups may not be recoverable. If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross carrying value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net&#160;carrying value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,301)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171,323)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross carrying value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net&#160;carrying value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,141)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,989)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three months ended November&#160;30, 2022 and 2021 was $4.8 million and $4.9 million, respectively.  Amortization expense for the six months ended November&#160;30, 2022 and 2021 was $9.6 million and $9.7 million, respectively.  </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization expense related to the intangible assets for each of the following fiscal years is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050476544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">ACCRUED LIABILITIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and franchise taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,533&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136138085904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">LONG-TERM DEBT<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2022, the Company repaid all amounts outstanding under its then existing credit agreement and entered into a new Credit Agreement (the "Credit Agreement") with its lenders, JPMorgan Chase Bank, N.A., as Administrative Agent, sole bookrunner, and sole lead arranger, and Bank of America, N.A. and KeyBank National Association, as Syndication Agents. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement provides for a $75.0&#160;million secured revolving credit facility (the "Revolving Facility") and a $30.0&#160;million delayed draw term loan (the "Delayed Draw Term Loan"), and also includes an uncommitted expansion feature that allows the Company to increase the total revolving commitments and/or add new tranches of term loans in an aggregate amount not to exceed $75.0 million.&#160; Each exercise of such expansion feature must be drawn in $5.0&#160;million increments.  The proceeds of the Revolving Facility may be used for general corporate purposes, including permitted acquisitions.  The proceeds of the Delayed Draw Term Loan may be used for general corporate purposes, including primarily to finance the manufacturing costs of the Auryon laser capital equipment.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement has a five-year maturity.  Interest on the Revolving Facility and  Delayed Draw Term Loan will be based, at the Company's option, on a rate equal to (i) the Secured Overnight Financing Rate ("SOFR") plus 0.10% (subject to a floor of 0%), or (ii) if the Company elects to treat a borrowing as an ABR Borrowing, an alternate base rate based on SOFR, plus, in each case, an applicable margin of 1.25%, 1.50% or 1.75%, depending on the leverage ratio.  If any amounts are not paid when due, such overdue amounts will bear interest at an amount generally equal to 2.0% plus the existing loan rate.  The Credit Agreement also carries a commitment fee in the case of the Revolving Facility, and a ticking fee, in the case of the Delayed Draw Term Loans of 0.20% to 0.25% per annum on the unused portion.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations under the Credit Agreement are unconditionally guaranteed, jointly and severally, by the Company's material direct and indirect domestic subsidiaries (the &#8220;Guarantors&#8221;). All obligations of the Company and the Guarantors under the Credit Agreement are secured by first priority security interests in substantially all of the assets of the Company and the Guarantors.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, two quarterly financial covenants as follows:&#160;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maximum leverage ratio of consolidated total indebtedness* to consolidated EBITDA* of not greater than 3.00 to 1.00 (during certain periods following material acquisitions the ratio shall be increased to 3.50 to 1.00). </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Fixed charge coverage ratio of consolidated EBITDA minus consolidated capital expenditures* to&#160;consolidated interest expense* paid or payable in cash plus scheduled principal payments in respect of indebtedness under the Credit Agreement of not less than 1.25 to 1.00. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* The definitions of consolidated total indebtedness, consolidated EBITDA, consolidated capital expenditures and consolidated interest expense are specifically defined in the Credit Agreement included as an exhibit to Form 8-K filed on August 31, 2022.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;30, 2022, there was $25.0&#160;million outstanding on the Revolving Facility and $25.0&#160;million outstanding on the Delayed Draw Term Loan and the interest rate at November&#160;30, 2022 applicable to each was 5.59%.  As of November&#160;30, 2022 and May&#160;31, 2022, the carrying value of long-term debt approximated its fair market value.  </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments of approximately 3.57% on the Delayed Draw Term Loan will amortize in equal quarterly installments over a five year period beginning on the earlier of a full draw or the expiry of the draw period (March 1, 2024).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136138093344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year adjusted for any discrete events, which are recorded in the period that they occur. &#160;The estimated annual effective tax rate prior to discrete items was 5.8% as of the second quarter of fiscal year 2023, as compared to 12.3% for the same period in fiscal year 2022.  In fiscal year 2023, the Company&#8217;s effective tax rate differs from the U.S. statutory rate primarily due to the impact of the valuation allowance, foreign taxes, and other non-deductible permanent items (such as non-deductible meals and entertainment, Section 162(m) excess compensation and non-deductible share-based compensation). </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence.  Therefore, the Company has provided a valuation allowance on its federal and state net operating loss carryforwards, federal and state R&amp;D credit carryforwards and other net deferred tax assets that have a limited life and are not supportable by the naked credit deferred tax liability sourced income as of November&#160;30, 2022.  The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&#8217;s results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136138085904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 13, 2020, the Company's shareholders approved the 2020 Stock and Incentive Award Plan (the &#8220;2020 Plan&#8221;).  The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance share units, performance shares and other incentive awards to the Company's employees, directors and other service providers.  On November 3, 2022 the Company's shareholders approved an amendment to the 2020 Plan to increase the reserve of shares of common stock available for future grants by 1,950,000 shares.  As of November&#160;30, 2022, there was a maximum of 2.8&#160;million shares of common stock available for future grant under the 2020 Plan.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of the 2020 Plan, equity awards were issued under the 2004 Stock and Incentive Award Plan (the &#8220;2004 Plan&#8221;).  The adoption of the 2020 Plan did not impact the administration of equity awards issued under the 2004 Plan but following the adoption of the 2020 Plan, equity award grants are no longer made under the 2004 Plan.  </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has an employee stock purchase plan.  On November 3, 2022 the Company's shareholders approved an amendment to the employee stock purchase plan to increase the reserve of shares of common stock available for future grants by 1,000,000 shares.  As of November&#160;30, 2022, there was a maximum of 3.3&#160;million shares of common stock available for future grant under the employee stock purchase plan.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended November&#160;30, 2022 and 2021, share-based compensation expense was $3.4 million and $3.0 million, respectively.  For the six months ended November&#160;30, 2022 and 2021, share-based compensation expense was $6.4&#160;million and $5.4&#160;million, respectively.    </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended November&#160;30, 2022 and 2021, the Company granted stock options and restricted stock units under the 2020 Plan to certain employees and members of the Board of Directors.  Stock option awards are valued using the Black-Scholes option-pricing model and then amortized on a straight-line basis over the requisite service period of the award.  Restricted stock unit awards are valued based on the closing trading value of the Company&#8217;s common stock on the date of grant and then amortized on a straight-line basis over the requisite service period of the award.  </span></div>During the six months ended November&#160;30, 2022 and 2021, the Company granted performance share units under the 2020 Plan to certain employees.  The awards may be earned by achieving performance levels over the requisite service period.  The performance criteria are based on achieving certain performance targets and the total shareholder return (&#8220;TSR&#8221;) of the Company&#8217;s common stock relative to the TSR of the common stock of a pre-defined industry peer-group.  The fair value of these awards is based on a Monte Carlo simulation model.  As of November&#160;30, 2022, there was $24.4 million of unrecognized compensation expense related to share-based payment arrangements.  These costs are expected to be recognized over a weighted-average period of approximately two years.  The Company has sufficient shares to satisfy expected share-based payment arrangements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052436544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is based on the weighted average number of common shares outstanding without consideration of potential common stock. Diluted earnings per share includes the dilutive effect of potential common stock consisting of stock options, restricted stock units and performance stock units, provided that the inclusion of such securities is not anti-dilutive. In periods with a net loss, stock options and restricted stock units are not included in the computation of diluted loss per share as the impact would be anti-dilutive.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles basic to diluted weighted-average shares outstanding: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three&#160;Months&#160;Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities excluded as their inclusion would be anti-dilutive</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050254576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment information</span></div><div style="margin-bottom:9pt;text-indent:21.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews its segments and the approach used by the chief operating decision maker, the President and Chief Executive Officer ("CEO"), and management to evaluate performance and allocate resources.  Prior to the first quarter of fiscal year 2023, the Company considered the business to be a single operating segment engaged in the development, manufacture and sale of medical devices for vascular access, peripheral vascular disease and oncology on a global basis.  Commencing with the first quarter of fiscal year 2023, the Company began to manage its operations through two segments, Med Tech and Med Device to align with the transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company.  The Company's chief operating decision maker evaluates these two segments based on net sales and gross margin to, among other items, allocate resources and assess performance.  Executives reporting to the CEO include those responsible for commercial operations, manufacturing operations, regulatory and quality and certain corporate functions.  The CEO evaluates all other elements of profitability, investment and cash flow metrics on a consolidated global basis due to shared infrastructure and resources. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company manages its assets on a total company basis, not by operating segment; therefore, the CEO does not review any asset information by operating segment and, accordingly, asset information is not reported or evaluated by operating segment.  Total assets were $558.2 million as of November&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes net sales and gross margin by Med Tech and Med Device including prior periods during which the Company considered the business to be a single operating segment, in order to conform to the current period presentation:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic information</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes net sales by geographic area based on external customer location:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>For the three months ended November&#160;30, 2022 and 2021, international sales as a percentage of total net sales were 16.2% and 16.5%, respectively.  For the six months ended November&#160;30, 2022 and 2021, international sales as a percentage of total net sales were 15.8% and 16.4%, respectively.  Sales to any one country outside the U.S., as determined by shipment destination, did not comprise a material portion of net sales in any of the last three fiscal years. In addition, no one customer represents more than 10% of consolidated net sales and 96% of long-lived assets are located within the United States.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052454096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">FAIR VALUE<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company measures certain financial assets and financial liabilities at fair value based upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, the Company applies valuation techniques to estimate fair value. FASB ASC Topic 820,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of financial assets and financial liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.  The three levels of the hierarchy are defined as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Inputs to the valuation methodology are significant unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial instruments include cash and cash equivalents, accounts receivable, accounts payable and contingent consideration. The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities.  The recurring fair value measurements using significant unobservable inputs (Level 3) relate to contingent consideration liabilities.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value Measurements using inputs considered as:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value at Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration for acquisition earn outs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Financial Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value Measurements using inputs considered as:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value at May&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration for acquisition earn outs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Financial Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level 1, 2 and 3 for the three and six months ended November&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in fair value components of Level 3 instruments:     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, August 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in present value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency gain from remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, May 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in present value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency gain from remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Liability for Acquisition Earn Outs</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's business combinations involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones or various other performance conditions. Payment of the additional consideration is generally contingent on the acquired company reaching certain performance milestones, including attaining specified revenue levels or product development targets. Contingent consideration is recorded at the estimated fair value of the contingent payments on the acquisition date. The fair value of the contingent consideration is remeasured at the estimated fair value at each reporting period with the change in fair value recognized as income or expense within change in fair value of contingent consideration in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the initial liability and remeasures the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements, which is determined using a discounted cash flow model applied to projected net sales, using probabilities of achieving projected net sales and projected payment dates. Projected net </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales are based on internal projections and extensive analysis of the target market and the sales potential. Increases or decreases in any valuation inputs in isolation may result in a significantly lower or higher fair value measurement in the future. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of November&#160;30, 2022:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.385%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue based payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90% - 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2025</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>At November&#160;30, 2022, the amount of undiscounted future contingent consideration that the Company expects to pay as a result of all completed acquisitions is approximately $20.0&#160;million.  The milestones, including revenue projections and technical milestones associated with the contingent consideration, must be reached in future periods ranging from fiscal years 2023 to 2029 in order for the associated consideration to be paid.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050314768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception of the contract.  The Company has operating leases for buildings, primarily for office space, R&amp;D, manufacturing and warehousing.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date.  Many of the lease agreements contain renewal or termination clauses that are factored into the determination of the lease term if it is reasonably certain that these options would be exercised.  The Company recognizes lease expense for these leases on a straight-line basis over the lease term.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,981&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate implicit in lease agreements is typically not readily determinable, and as such the Company used the incremental borrowing rate based on the information available at commencement date in determining the present value of future payments.  The incremental borrowing rate is defined as the interest the Company would pay to borrow on a collateralized basis, considering factors such as length of lease term.  The following table presents the weighted average remaining lease term and discount rate:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.88</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturities of the lease liabilities for each of the following fiscal years is:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended November&#160;30, 2022 and 2021, the Company recognized $0.7 million and $0.7 million of operating lease expense, respectively, which includes immaterial short-term leases.  During the six months ended November 20, 2022 and 2021, the Company recognized $1.4&#160;million and $1.4&#160;million of operating leases expense, respectively, which includes immaterial short-term leases.  The expenses on the Consolidated Statement of Operations were classified as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow and other information related to leases for the six months ended:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052261136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various legal proceedings, including commercial, intellectual property, product liability, and regulatory matters of a nature considered normal for its business.  The Company accrues for amounts related to these matters if it is probable that a liability has been incurred, and an amount can be reasonably estimated.  The Company discloses such matters when there is at least a reasonable possibility that a material loss may have been incurred.  However, the Company cannot predict the outcome of any litigation or the potential for future litigation.</span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.R. Bard, Inc. v. AngioDynamics, Inc.</span></div><div style="margin-bottom:0.9pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 11, 2012, C.R. Bard, Inc. (&#8220;Bard&#8221;) filed a suit in the United States District Court of Utah claiming certain of the Company's implantable port products infringe on three U.S. patents held by Bard (US Patent Nos. 7,785,302 ("302"), 7,959,615 (&#8220;615&#8221;) and 7,947,022 ("022")).  The case was stayed pending reexamination in the US Patent and Trademark Office ("USPTO").  Following the reexamination proceedings, and the parties&#8217; related appeals to the Federal Circuit which resulted in further proceedings at the USPTO, certain claims of the 615 patent were held invalid, while the remaining claims of the 615 patent and the other two patents were upheld over the prior art references considered in the reexamination proceedings.  Thereafter, the case was transferred from the District of Utah to the United States District Court for the District of Delaware (&#8220;District of Delaware&#8221;).  A scheduling order was entered on March 23, 2021.  On July 22, 2021, in another case against a different defendant, the District of Utah invalidated multiple claims of the &#8216;302, &#8216;022, and &#8216;615 Patents under 35 USC &#167;101, including claims asserted against the Company.  Following the Utah court&#8217;s decision, the Company filed a Motion for Judgment on the Pleadings based on collateral estoppel on August 9, 2021. Bard filed its opposition brief on September 2, 2021 and the </span></div><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company filed a reply on September 9, 2021. Following a hearing on the Motion for Judgment on the Pleadings on December 21, 2021, the District of Delaware stayed the case pending the Federal Circuit's resolution of Bard's appeal from the Utah Decision. Previously, the Company had filed a Motion for Leave to Amend its Answer and Counterclaims on April 14, 2021. This motion sought to add counterclaims for infringement of U.S. Patent Nos. 9,168,365; 9,895,523; and 10,632,295, as well as a counterclaim of inequitable conduct. On November 5, 2021, the Company notified the District of Delaware that the Utah decision was certified for appeal to the Court of Appeals for the Federal Circuit. Contemporaneously, the Company withdrew its Motion for Leave to Amend its Answer and Counterclaims without prejudice to refile. Oral argument has been scheduled for February 10, 2023, and the appeal remains pending. The Company believes these claims are without merit and intends to defend them vigorously. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.  </span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2015, Bard and Bard Peripheral Vascular filed suit in the District of Delaware claiming certain of the Company's implantable port products infringe on three U.S. patents held by Bard (US Patent Nos. 8,475,417, 8,545,460, 8,805,478).  The case proceeded through trial which began on March 4, 2019.  At the close of Bard&#8217;s case, the Court granted the Company's oral motion for judgment as a matter of law as well as its motions for summary judgment on the grounds that the asserted patents are invalid, ineligible, not infringed and not willfully infringed. On May 10, 2019, the Company filed a motion for attorney fees and non-taxable expenses under 35 USC Sec. 285. Bard appealed the judgment to the Federal Circuit and on November 10, 2020, the Federal Circuit reversed the judgment in part with respect to Section 101 (subject matter eligibility), and vacated and remanded the trial court&#8217;s invalidity and non-infringement judgments.  Following remand from the Federal Circuit, a jury trial commenced in the District of Delaware beginning November 14, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 22, 2022, a jury entered a verdict finding that certain of the Company&#8217;s implantable port products infringe certain claims of U.S. patents held by Bard. The issue of damages was bifurcated by the Court during trial, was not determined by the jury and will be subject to a separate proceeding. The Company strongly disagrees with the claims and the verdict. The issues presented to the jury do not comprise all of the issues to be determined in the case. Equitable issues and patent eligibility issues remain to be decided by the judge, and damages remain to be decided by a jury. The Company believes it has meritorious defenses and positions with respect to the matters remaining to be decided and the jury decision, and intends to vigorously pursue all available remedies and defenses, including post-trial motions and appeals. The parties proposed a post-trial briefing schedule with opening briefs to be filed January 20, 2023. The Company maintains its belief that Bard&#8217;s claims are without merit. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2021, Bard filed suit in the District of Delaware asserting certain of the Company&#8217;s port products (including certain related infusion sets) infringe U.S. Patent Nos. 8,025,639, 9,603,992 (&#8220;992&#8221;) and 9,603,993 (&#8220;993&#8221;).  On May 20, 2021, the Company filed a Motion to Dismiss Bard&#8217;s claims with respect to the &#8217;992 and &#8217;993 patents. On July 22, 2021, the Company submitted the Utah court&#8217;s decision invalidating claims of the related &#8216;302, &#8216;022, and &#8216;615 Patents as supplemental authority in support of its Motion to Dismiss. The parties agreed to submit supplemental briefing to address the Utah court&#8217;s decision. Bard submitted its brief on August 12, 2021, and the Company submitted its reply on September 2, 2021. On December 21, 2021, the District of Delaware stayed the case pending the Federal Circuit's resolution of Bard's appeal of the Utah decision invalidating multiple claims of the &#8216;302, &#8216;022, and &#8216;615 patents under 35 USC &#167;101. The Company maintains its belief that Bard's claims are without merit. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:0.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AngioDynamics, Inc. v. C.R. Bard, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:0.9pt"><span><br/></span></div><div style="margin-bottom:0.9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2017, the Company commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&#8220;Bard&#8221;).  In this action, the Company alleged that Bard had illegally tied the sales of its tip location systems to the sales of its PICCs in violation of federal antitrust laws and this practice had an anti-competitive effect in the US market for PICCs.  The Company sought both monetary damages and injunctive relief.  On October 6, 2022, a jury verdict was rendered finding Bard did not restrain competition in violation of federal antitrust laws.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050313536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, Net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Acquisition, Restructuring and Other Items, Net</a></td>
<td class="text">ACQUISITION, RESTRUCTURING, AND OTHER ITEMS, NET<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition, Restructuring and Other Items</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition, restructuring and other items, net, consisted of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mergers and acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing relocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli Innovation Authority prepayment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Legal expenses related to litigation that is outside the normal course of business. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Legal and due diligence expenses related to mergers and acquisitions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Expenses to relocate certain manufacturing lines from Queensbury, NY to Costa Rica.  </span></div>(4) In the first quarter of fiscal year 2023, a $3.5&#160;million payment was made to the Israeli Innovation Authority to fully satisfy the obligation related to grant funds that were provided to Eximo for development of the Auryon laser prior to the acquisition in the second quarter of fiscal year 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050314768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in each component of accumulated other comprehensive income, net of tax, are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at August 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at May 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050379040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recently Issued Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:20.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.137%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recently Issued Accounting Pronouncements - Adopted</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:20.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">ASU 2021-10,&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This ASU increases the transparency of government assistance to include the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company adopted the new standard in the first quarter of fiscal year 2023 and it did not have an impact on the Company's consolidated financial statements. </span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:20.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.431%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2021-08,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This ASU</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company plans to adopt the new standard in the first quarter of fiscal year 2024 and does not expect there to be a material impact to the consolidated financial statements.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048563536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recently Issued Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contracts with Customers</a></td>
<td class="text">Revenue Recognition<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span>, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company&#8217;s performance obligation is satisfied), which occurs at a point in time, and may be upon shipment from the Company&#8217;s manufacturing site or delivery to the customer&#8217;s named location, based on the shipping terms of a contract.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether control has transferred, the Company considers if there is a present right to payment from the customer and when physical possession, legal title and risks and rewards of ownership have transferred to the customer.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically invoices customers upon satisfaction of identified performance obligations.  As the Company&#8217;s standard payment terms are 30 to 90 days from invoicing, the Company does not provide any significant financing to its customers.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into agreements to place placement and evaluation units (&#8220;units&#8221;) at customer sites, but the Company retains title to the units. For the duration of these agreements the customer has the right to use the unit at no upfront charge in connection with the customer&#8217;s ongoing purchase of disposables. These types of agreements include an embedded operating lease for the right to use the units. In these arrangements, revenue recognized for the sale of the disposables is not allocated </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between the disposal revenue and lease revenue due to the insignificant value of the units in relation to the total agreement value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves: Revenue from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established for discounts, returns, rebates and allowances that are offered within contracts between the Company and its customers.  These reserves are based on the amounts earned or to be claimed on the related sales and are classified as a contra asset.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rebates and Allowances: The Company provides certain customers with rebates and allowances that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. The Company establishes reserves for such amounts, which is included in accrued expenses in the accompanying Consolidated Balance Sheets. These rebates and allowances result from performance-based offers that are primarily based on attaining contractually specified sales volumes.  The Company is also required to pay administrative fees to group purchasing organizations.</span></div>Product Returns: The Company generally offers customers a limited right of return.  Product returns after 30 days must be pre-approved by the Company and customers may be subject to a 20% restocking charge.  To be accepted, a returned product must be unadulterated, undamaged and have at least twelve months remaining prior to its expiration date.  The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized.  The Company currently estimates product return liabilities using its historical product return information and considers other factors that it believes could significantly impact its expected returns, including product recalls.  <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances with Customers</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is generally recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer and generally coincide with revenue recognition. Accordingly, the Company does not have any contract assets associated with the future right to invoice its customers. In some cases, if control of the product has not yet transferred to the customer or the timing of the payments made by the customer precedes the Company&#8217;s fulfillment of the performance obligation, the Company recognizes a contract liability that is included in deferred revenue in the accompanying Consolidated Balance Sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs to Obtain or Fulfill a Customer Contract </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, the Company may recognize an asset for incremental costs of obtaining a contract with a customer if it expects to recover those costs. The Company&#8217;s sales incentive compensation plans qualify for capitalization since these plans are directly related to sales achieved during a period of time. However, the Company has elected the practical expedient under ASC 340-40-25-4 to expense the costs as they are incurred within selling and marketing expenses since the amortization period is less than one year.</span></div>The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping and handling are recorded in net sales.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:20.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.137%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recently Issued Accounting Pronouncements - Adopted</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:20.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">ASU 2021-10,&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This ASU increases the transparency of government assistance to include the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company adopted the new standard in the first quarter of fiscal year 2023 and it did not have an impact on the Company's consolidated financial statements. </span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:20.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.431%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2021-08,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This ASU</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company plans to adopt the new standard in the first quarter of fiscal year 2024 and does not expect there to be a material impact to the consolidated financial statements.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052336112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following table summarizes net sales by Med Tech, Med Device and by geography:<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended November 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended November 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended November 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended November 30, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,655&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,814&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract Balances with Customers</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the Company&#8217;s receivables, contract assets and contract liabilities with customers:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050368448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at lower of cost and net realizable value (using the first-in, first-out method).  Inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,392&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052741536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ScheduleOfIntangibleAssetsTableTextBlock', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross carrying value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net&#160;carrying value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,301)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171,323)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross carrying value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net&#160;carrying value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,141)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,989)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization expense related to the intangible assets for each of the following fiscal years is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill for Each Reporting Unit</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill for each reporting unit is allocated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Med Tech </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Med Device </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, August 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ScheduleOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ScheduleOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050313536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and franchise taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,533&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050287904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Principal Obligations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136051286112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Basic to Diluted Weighted-Average Shares Outstanding</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles basic to diluted weighted-average shares outstanding: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three&#160;Months&#160;Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities excluded as their inclusion would be anti-dilutive</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048769152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock', window );">Summary of Net Sales by Product Category</a></td>
<td class="text">The table below summarizes net sales and gross margin by Med Tech and Med Device including prior periods during which the Company considered the business to be a single operating segment, in order to conform to the current period presentation:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Tech Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med Device Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Summary of Net Sales by Geographic Area</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes net sales by geographic area based on external customer location:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of net revenue by product group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ScheduleOfNetRevenueByProductGroupTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048562864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value of Assets and Liabilities Measured on a Recurring Basis</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value Measurements using inputs considered as:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value at Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration for acquisition earn outs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Financial Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value Measurements using inputs considered as:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value at May&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration for acquisition earn outs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Financial Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value Measurements Using Significant Unobservable Inputs</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in fair value components of Level 3 instruments:     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, August 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in present value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency gain from remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, May 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in present value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency gain from remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of November&#160;30, 2022:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.385%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue based payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90% - 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2025</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050424528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,981&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following table presents the weighted average remaining lease term and discount rate:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.88</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lease Liability Schedule</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturities of the lease liabilities for each of the following fiscal years is:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">The expenses on the Consolidated Statement of Operations were classified as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow and other information related to leases for the six months ended:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov&#160;30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050379040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition, restructuring and other items, net, consisted of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nov 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mergers and acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing relocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli Innovation Authority prepayment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Legal expenses related to litigation that is outside the normal course of business. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Legal and due diligence expenses related to mergers and acquisitions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Expenses to relocate certain manufacturing lines from Queensbury, NY to Costa Rica.  </span></div>(4) In the first quarter of fiscal year 2023, a $3.5&#160;million payment was made to the Israeli Innovation Authority to fully satisfy the obligation related to grant funds that were provided to Eximo for development of the Auryon laser prior to the acquisition in the second quarter of fiscal year 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052261136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Nov. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in each component of accumulated other comprehensive income, net of tax, are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at August 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six Months Ended Nov&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at May 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November&#160;30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047569296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 27, 2021</div></th>
<th class="th"><div>Dec. 17, 2019</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember', window );">QX Medical, LLC Camaro Support Catheter Asset Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Aggregate purchase price</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Purchase price holdbacks</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Potential future contingent consideration</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AssetAcquisitionInventoryAndFixedAssets', window );">Inventory and fixed assets</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible asset amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets | QX Medical, LLC Camaro Support Catheter Asset Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible asset acquired</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AssetAcquisitionInventoryAndFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Inventory And Fixed Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AssetAcquisitionInventoryAndFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042891200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 85,429<span></span>
</td>
<td class="nump">$ 78,280<span></span>
</td>
<td class="nump">$ 166,966<span></span>
</td>
<td class="nump">$ 155,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">71,631<span></span>
</td>
<td class="nump">65,350<span></span>
</td>
<td class="nump">140,655<span></span>
</td>
<td class="nump">129,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">13,798<span></span>
</td>
<td class="nump">12,930<span></span>
</td>
<td class="nump">26,311<span></span>
</td>
<td class="nump">25,437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedTechMember', window );">Med Tech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">24,502<span></span>
</td>
<td class="nump">18,886<span></span>
</td>
<td class="nump">47,318<span></span>
</td>
<td class="nump">36,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedTechMember', window );">Med Tech | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">20,550<span></span>
</td>
<td class="nump">16,243<span></span>
</td>
<td class="nump">40,991<span></span>
</td>
<td class="nump">31,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedTechMember', window );">Med Tech | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="nump">2,643<span></span>
</td>
<td class="nump">6,327<span></span>
</td>
<td class="nump">5,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedDeviceMember', window );">Med Device</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">60,927<span></span>
</td>
<td class="nump">59,394<span></span>
</td>
<td class="nump">119,648<span></span>
</td>
<td class="nump">118,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedDeviceMember', window );">Med Device | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">51,081<span></span>
</td>
<td class="nump">49,107<span></span>
</td>
<td class="nump">99,664<span></span>
</td>
<td class="nump">98,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedDeviceMember', window );">Med Device | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 9,846<span></span>
</td>
<td class="nump">$ 10,287<span></span>
</td>
<td class="nump">$ 19,984<span></span>
</td>
<td class="nump">$ 20,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_MedTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_MedTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_MedDeviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_MedDeviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048687248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval', window );">Days after purchase after which pre-approval is required for product return</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ContractWithCustomerRightOfReturnRestockingCharge', window );">Restocking charge (as percent)</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn', window );">Minimum remaining period prior to product expiration</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination', window );">Additions to contract liabilities</a></td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod', window );">Revenue recognized</a></td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_RevenuePerformanceObligationPaymentTerm', window );">Payment term</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_RevenuePerformanceObligationPaymentTerm', window );">Payment term</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Right Of Return, Minimum Remaining Product Life Prior To Return</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Right Of Return, Product Return Period After Purchase Date Requiring Pre-Approval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ContractWithCustomerRightOfReturnRestockingCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Right Of Return, Restocking Charge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ContractWithCustomerRightOfReturnRestockingCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer With Customer, Liability, Revenue Recognized, Including Current Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RevenuePerformanceObligationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RevenuePerformanceObligationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042659488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue from Contracts with Customers - Contract Balances with Customers (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 52,852<span></span>
</td>
<td class="nump">$ 52,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136051539040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Schedule of Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 33,732<span></span>
</td>
<td class="nump">$ 28,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">8,201<span></span>
</td>
<td class="nump">7,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">21,244<span></span>
</td>
<td class="nump">15,955<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 63,177<span></span>
</td>
<td class="nump">$ 51,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048764144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042832096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($) </div>
<div>unit </div>
<div>segment</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>unit</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,808,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,889,000<span></span>
</td>
<td class="nump">$ 9,645,000<span></span>
</td>
<td class="nump">$ 9,710,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047571376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Change in Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 201,038<span></span>
</td>
<td class="nump">$ 201,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(283)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">200,755<span></span>
</td>
<td class="nump">201,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=ango_MedTechMember', window );">Med Tech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">160,509<span></span>
</td>
<td class="nump">160,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(283)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">160,226<span></span>
</td>
<td class="nump">160,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=ango_MedDeviceMember', window );">Med Device</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">40,529<span></span>
</td>
<td class="nump">40,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 40,529<span></span>
</td>
<td class="nump">$ 40,529<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=ango_MedTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=ango_MedTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=ango_MedDeviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=ango_MedDeviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042844096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite intangible items</a></td>
<td class="nump">$ 313,266<span></span>
</td>
<td class="nump">$ 314,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(171,323)<span></span>
</td>
<td class="num">(161,989)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite intangible items</a></td>
<td class="nump">141,943<span></span>
</td>
<td class="nump">152,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_ProductTechnologiesMember', window );">Product technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite intangible items</a></td>
<td class="nump">237,863<span></span>
</td>
<td class="nump">239,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(119,301)<span></span>
</td>
<td class="num">(112,141)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite intangible items</a></td>
<td class="nump">118,562<span></span>
</td>
<td class="nump">127,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite intangible items</a></td>
<td class="nump">60,076<span></span>
</td>
<td class="nump">60,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(39,972)<span></span>
</td>
<td class="num">(38,003)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite intangible items</a></td>
<td class="nump">20,104<span></span>
</td>
<td class="nump">22,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite intangible items</a></td>
<td class="nump">9,950<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(7,326)<span></span>
</td>
<td class="num">(7,185)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite intangible items</a></td>
<td class="nump">2,624<span></span>
</td>
<td class="nump">2,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseAgreementTermsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite intangible items</a></td>
<td class="nump">5,377<span></span>
</td>
<td class="nump">4,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(4,724)<span></span>
</td>
<td class="num">(4,660)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite intangible items</a></td>
<td class="nump">$ 653<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_ProductTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_ProductTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048836960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Expected Future Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 9,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">16,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">16,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">16,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">16,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">66,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite intangible items</a></td>
<td class="nump">$ 141,943<span></span>
</td>
<td class="nump">$ 152,380<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048832480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">$ 10,185<span></span>
</td>
<td class="nump">$ 20,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">2,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Outside services</a></td>
<td class="nump">6,739<span></span>
</td>
<td class="nump">3,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AccruedResearchAndDevelopmentCurrent', window );">Research and development</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales and franchise taxes</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Rebates</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">5,322<span></span>
</td>
<td class="nump">5,353<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 26,533<span></span>
</td>
<td class="nump">$ 34,842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136043962928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 03, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($) </div>
<div>covenant</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from borrowings on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding draw term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from borrowings on long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_DebtInstrumentDebtDefaultInterestRateIncrease', window );">Debt default interest rate increase (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_LineOfCreditFacilityNumberOfCovenants', window );">Number of covenants | covenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio', window );">Maximum total leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions', window );">Maximum total leverage ratio subsequent to material acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio', window );">Minimum fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (percentage)</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_DebtInstrumentFloorInterestRate', window );">Floor interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature', window );">Line of credit accordion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at period end (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.59%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Term loan</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding draw term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Principal payment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Delayed Draw Term Loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Delayed Draw Term Loan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio, Subsequent To Material Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Terms, Minimum Fixed Charge Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentDebtDefaultInterestRateIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Debt Default, Interest Rate Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentDebtDefaultInterestRateIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Floor Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Accordion Feature</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_LineOfCreditFacilityNumberOfCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Number Of Covenants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_LineOfCreditFacilityNumberOfCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048838272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: unamortized debt issuance costs</a></td>
<td class="num">$ (204)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">49,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Credit Facility | Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050480112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent', window );">Estimated federal statutory income tax rate</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">12.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Before Discreet Items, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042767632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Charges against income for share-based payment arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expenses related to share-based payment arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ango_A2020StockAndIncentiveAwardPlanMember', window );">2020 Stock And Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Approved increase of common stock reserve (shares)</a></td>
<td class="nump">1,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Amount of shares issuable through two stock-based compensation plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ango_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Approved increase of common stock reserve (shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Amount of shares issuable through two stock-based compensation plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ango_A2020StockAndIncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ango_A2020StockAndIncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ango_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ango_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136048842976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">39,490<span></span>
</td>
<td class="nump">39,053<span></span>
</td>
<td class="nump">39,394<span></span>
</td>
<td class="nump">38,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">39,490<span></span>
</td>
<td class="nump">39,053<span></span>
</td>
<td class="nump">39,394<span></span>
</td>
<td class="nump">38,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Securities excluded as their inclusion would be anti-dilutive (shares)</a></td>
<td class="nump">3,793<span></span>
</td>
<td class="nump">3,510<span></span>
</td>
<td class="nump">3,793<span></span>
</td>
<td class="nump">3,510<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047617584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets | $</a></td>
<td class="nump">$ 558,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 558,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 552,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">16.20%<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="nump">15.80%<span></span>
</td>
<td class="nump">16.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Net Assets, Geographic Area | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_NetAssetsGeographicAreaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_NetAssetsGeographicAreaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042856784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Summary of Net Sales by Product Category (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 85,429<span></span>
</td>
<td class="nump">$ 78,280<span></span>
</td>
<td class="nump">$ 166,966<span></span>
</td>
<td class="nump">$ 155,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 45,078<span></span>
</td>
<td class="nump">$ 40,555<span></span>
</td>
<td class="nump">$ 87,383<span></span>
</td>
<td class="nump">$ 80,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_GrossMarginPercentage', window );">Gross margin</a></td>
<td class="nump">52.80%<span></span>
</td>
<td class="nump">51.80%<span></span>
</td>
<td class="nump">52.30%<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedTechMember', window );">Med Tech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 24,502<span></span>
</td>
<td class="nump">$ 18,886<span></span>
</td>
<td class="nump">$ 47,318<span></span>
</td>
<td class="nump">$ 36,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 15,614<span></span>
</td>
<td class="nump">$ 12,578<span></span>
</td>
<td class="nump">$ 30,043<span></span>
</td>
<td class="nump">$ 24,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_GrossMarginPercentage', window );">Gross margin</a></td>
<td class="nump">63.70%<span></span>
</td>
<td class="nump">66.60%<span></span>
</td>
<td class="nump">63.50%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_MedDeviceMember', window );">Med Device</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 60,927<span></span>
</td>
<td class="nump">$ 59,394<span></span>
</td>
<td class="nump">$ 119,648<span></span>
</td>
<td class="nump">$ 118,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 29,464<span></span>
</td>
<td class="nump">$ 27,977<span></span>
</td>
<td class="nump">$ 57,340<span></span>
</td>
<td class="nump">$ 56,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_GrossMarginPercentage', window );">Gross margin</a></td>
<td class="nump">48.40%<span></span>
</td>
<td class="nump">47.10%<span></span>
</td>
<td class="nump">47.90%<span></span>
</td>
<td class="nump">47.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_GrossMarginPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Margin, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_GrossMarginPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_MedTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_MedTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_MedDeviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_MedDeviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042774976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Summary of Net Sales by Geographic Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 85,429<span></span>
</td>
<td class="nump">$ 78,280<span></span>
</td>
<td class="nump">$ 166,966<span></span>
</td>
<td class="nump">$ 155,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">71,631<span></span>
</td>
<td class="nump">65,350<span></span>
</td>
<td class="nump">140,655<span></span>
</td>
<td class="nump">129,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 13,798<span></span>
</td>
<td class="nump">$ 12,930<span></span>
</td>
<td class="nump">$ 26,311<span></span>
</td>
<td class="nump">$ 25,437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042714000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration for acquisition earn outs</a></td>
<td class="nump">$ 18,832<span></span>
</td>
<td class="nump">$ 16,948<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">18,832<span></span>
</td>
<td class="nump">16,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration for acquisition earn outs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration for acquisition earn outs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration for acquisition earn outs</a></td>
<td class="nump">18,832<span></span>
</td>
<td class="nump">16,948<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">$ 18,832<span></span>
</td>
<td class="nump">$ 16,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047667056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Financial liabilities, beginning balance</a></td>
<td class="nump">$ 17,158<span></span>
</td>
<td class="nump">$ 16,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_ChangeInFairValueOfContingentConsideration', window );">Change in present value of contingent consideration</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement', window );">Currency gain from remeasurement</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Financial liabilities, ending balance</a></td>
<td class="nump">$ 18,832<span></span>
</td>
<td class="nump">$ 18,832<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense charged against earnings in the period resulting from remeasurement to fair value of contingent earn out liabilities related to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Gain (Loss) From Remeasurement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136043925536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability (Details) - Recurring<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liabilities</a></td>
<td class="nump">$ 18,832<span></span>
</td>
<td class="nump">$ 16,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liabilities</a></td>
<td class="nump">18,832<span></span>
</td>
<td class="nump">$ 16,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ango_RevenueBasedPaymentMember', window );">Revenue based payments | Level&#160;3 | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liabilities</a></td>
<td class="nump">$ 18,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue based payments | Level&#160;3 | Discounted cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, liability, measurement input</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=ango_MeasurementInputProbabilityofPaymentMember', window );">Probability of payment | Revenue based payments | Level&#160;3 | Discounted cash flow | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, liability, measurement input</a></td>
<td class="nump">0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=ango_MeasurementInputProbabilityofPaymentMember', window );">Probability of payment | Revenue based payments | Level&#160;3 | Discounted cash flow | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, liability, measurement input</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ango_RevenueBasedPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ango_RevenueBasedPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ango_MeasurementInputProbabilityofPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ango_MeasurementInputProbabilityofPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136052315408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_UndiscountedContingentConsiderationDisclosure', window );">Potential amount of undiscounted future contingent consideration</a></td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_UndiscountedContingentConsiderationDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted Contingent Consideration Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_UndiscountedContingentConsiderationDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047021664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU asset</a></td>
<td class="nump">$ 5,748<span></span>
</td>
<td class="nump">$ 6,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,491<span></span>
</td>
<td class="nump">2,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">3,490<span></span>
</td>
<td class="nump">4,703<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 5,981<span></span>
</td>
<td class="nump">$ 7,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating lease, right-of-use asset, statement of financial position, extensible list</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease, liability, current, statement of financial position, extensible list</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease, liability, noncurrent, statement of financial position, extensible list</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining term (in years)</a></td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047593632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Liability Maturity Schedule (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 1,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">1,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree', window );">2028 and thereafter</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">6,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed Interest</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">5,981<span></span>
</td>
<td class="nump">$ 7,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,491<span></span>
</td>
<td class="nump">2,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 3,490<span></span>
</td>
<td class="nump">$ 4,703<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136047563408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Statement of Operations Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">$ 680<span></span>
</td>
<td class="nump">$ 743<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">$ 1,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="nump">$ 764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136050337392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 1,384<span></span>
</td>
<td class="nump">$ 1,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136051514656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - patent<br></strong></div></th>
<th class="th"><div>Mar. 10, 2015</div></th>
<th class="th"><div>Jan. 11, 2012</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_CrBardIncMember', window );">C.R. Bard, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_NumberOfPatentsAssertedForReexamination', window );">Number of petitions filed for reexamination of patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_NumberOfPatentsUpheldOverPriorArtReferences', window );">Number of patents upheld over prior art references</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_TheDelawareActionMember', window );">The Delaware Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents allegedly infringed upon</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NumberOfPatentsAssertedForReexamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of patents asserted for reexamination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NumberOfPatentsAssertedForReexamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NumberOfPatentsUpheldOverPriorArtReferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Patents Upheld Over Prior Art References</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NumberOfPatentsUpheldOverPriorArtReferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ango_CrBardIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ango_CrBardIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ango_TheDelawareActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ango_TheDelawareActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136044181552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">$ 3,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,253<span></span>
</td>
<td class="nump">$ 8,640<span></span>
</td>
<td class="nump">$ 4,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPreviousAcquisition', window );">Payment for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_LegalCostsMember', window );">Legal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">2,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,072<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">4,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_MergersandAcquisitionsMember', window );">Mergers and acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_ManufacturingRelocationMember', window );">Manufacturing relocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_IsraeliInnovationAuthorityPrepaymentMember', window );">Israeli Innovation Authority Prepayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,544<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AcquisitionRestructuringAndOtherItemsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Restructuring And Other Items Net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AcquisitionRestructuringAndOtherItemsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_LegalCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_LegalCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_MergersandAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_MergersandAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_ManufacturingRelocationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_ManufacturingRelocationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_IsraeliInnovationAuthorityPrepaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_IsraeliInnovationAuthorityPrepaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136042809264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">$ 414,041<span></span>
</td>
<td class="nump">$ 435,950<span></span>
</td>
<td class="nump">$ 424,489<span></span>
</td>
<td class="nump">$ 439,457<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">407,958<span></span>
</td>
<td class="nump">$ 432,368<span></span>
</td>
<td class="nump">407,958<span></span>
</td>
<td class="nump">$ 432,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">$ (288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140136044336576">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
<td class="num">$ (550,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
<td class="nump">3,024,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
<td class="nump">1,071,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
<td class="num">(29,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
<td class="num">(550,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
<td class="nump">3,024,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
<td class="nump">1,070,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
<td class="num">(29,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_NetIncomeLoss</td>
<td class="num">(13,004,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock Issued During Period, Shares, Employee Stock Purchase Plans</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
<td class="nump">56,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
<td class="nump">6,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
<td class="num">$ (648,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
<td class="num">$ (648,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
<td class="nump">213,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
<td class="num">$ (312,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
<td class="num">$ (312,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
<td class="nump">29,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>ango-20221130_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ango="http://www.angiodynamics.com/20221130"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ango-20221130.xsd" xlink:type="simple"/>
    <context id="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i990fe285074e41ffb69712be25fba343_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i01586c4af1694483a5923523cc5adc02_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ango:PreferredStockPurchaseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="idc75a48f4c044ff4b7035f3ba66619f8_I20230105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2023-01-05</instant>
        </period>
    </context>
    <context id="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ie58c4e8650d24eb487e88de28117da2a_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i91d36c036abe435992dbd27d886b81f0_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i3787173c67d1467ea7ad2812b803a924_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i4ae2f2a17c5c4c0ab0620f6245443650_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i580a989d6bd346dea798e59360b2cf7b_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i92253b30ce7448a9b04589161b7aef74_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i0521e2ea5e8f4642ba511b1cf2257912_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ic9c3663238b141639922a3c2b6127596_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i3170daaa632a47c2864c3b1cfbeabc53_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ia78ac75b2327440aabe9a07d95648ed1_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i1d26b3b0e13245a9a8b3f331e8f3f094_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i0e978a8d0cbb4723afaecf79157faa08_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i9339830d2a2e4fda87b3402b5dc095cb_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i11e97ca8dbd54428b944767243cf21fd_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i5014bebe766c497ca5a518a9144f9fee_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="ifdc6ea670265410a9abcd9fe2ce25d89_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i0679db975f1e442f95e34936148e0ca3_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i89a2219dda3a46beaaeefb85ffdbc421_D20220301-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i4eba7ef0b2324baba133dce806849e01_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i358df3908685483ba68ef5ce671cb276_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i0773232166fe4bdfa46507e1fa96456b_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i23a1dadd2d8248f4a335ef455a4782f3_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i5e61a52d34bf4a7fa61bbf80ff3eef08_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i605f35cad602428b8143074fa8c31ba8_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i761e3ac346f34f59b5db2c93ec5cd804_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i00c8c3dc240b49d1aa14a8e2c554f67d_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="if0436957f2064843bb33c8674690b54b_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ib6493fdf5e73404cb9c65ebd100d37ef_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i21b34f1c2e1346eb854653a87b2ad11f_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i46d7e5ff2d9d47c2aca189c481fd4cb8_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i39078c2a8d3949c8b51612819ff52be6_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="ia231c271d6e74f54b40bb9f2c13d5442_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i8a4bd82406cc4389bd0da8087da40e52_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i7310c5f116f7458bbf77606953070240_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i5209e80cbf59403ba5b0127b54301190_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i71a5faedb2934ca3b6d2036bad066025_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="ib96b6c43657d45239e312ea746267dc0_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i80aa6442429842f5a354cbfbb8726ca1_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i5703543d8ed4406290fe2b3d2ebe132b_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i06eb3f7549e544fa998b0ee023503249_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i0ce7f40f7e1c4f288eaa7bdae504643a_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="icc1376a994d14170988972c24d8d1eea_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i29a2abe0d92149128c8af04916896413_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i92d7755649c74466927d4c2e158305aa_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i33519024438c43d7a67b370d508001cc_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i0fe451085baf4ea09c68e462c55b946d_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i6eaf8bf186364608810a8c124dd74a94_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i3190940009fb48f29de007d763ca8a27_D20210601-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i24b58b5cab854792a4cd67d56850fb81_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i08aee044abc04167ab7b46d2b3434e1f_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i4134390d562f48ff9f977c2e6b84a29f_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="if20cde87f3f1438582de0a6be9bfb0f0_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i31a8b6318460497bae9c739e5328a31b_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i46394e9b402e418b9d3d6c693d0247ce_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i4675e13c50964ba0a48938de3e2ae4a4_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i13178785dc1843d99d2ccce16ace2e65_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ideddd48e387b42c2b942816100384d6a_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i12da52958cc5404e98473dd0097af478_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i1dc3ec9fcfa545bd8484b6f100236204_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i96f83ef275904264810bf98c69aa89aa_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ia984848d280248bfbcb8e31640f1e39d_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i155c045358b34383ac3295044d6c9a6b_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="ifdec94434c4945059845c818633407fb_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i2a2dd77d8826427fb397445192c0bc76_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="ic9770758c2964b64b48d180cbdf84531_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="iaf6811aafe4e4669a27e18cdda0c54ef_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i22e896b21e924dea8f58a482a45a6580_D20210727-20210727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-27</startDate>
            <endDate>2021-07-27</endDate>
        </period>
    </context>
    <context id="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-27</instant>
        </period>
    </context>
    <context id="ie6ddfbc23984498e818686d27ec8ab38_D20210727-20210727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-27</startDate>
            <endDate>2021-07-27</endDate>
        </period>
    </context>
    <context id="i4932000aa21a49cda2393c4098bd3848_D20191217-20191217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ango:QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-17</startDate>
            <endDate>2019-12-17</endDate>
        </period>
    </context>
    <context id="i3b1ac96c05c4496cbe867dec215b61da_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ibff045fe7c34428eabb45c34bd46a77b_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia05af3963048441980e5da6c628ad99e_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i97cc578ba1c14c2790275846f3e88b4f_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i9da7d71470d046839e99da599e632e18_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i03b89bf280264af8b946c348ba6191a5_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i608ce6e6291c48db9671f8baa53df352_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i6552b74e0da8424b8b3f0a28d099316d_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i69edc35bb61e4b13864a2034b42aa17e_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="id4c2fd9d28c04a93ae03769f99f5b982_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia84b2cc1c77648d59e643ea5bca9cd40_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i69be4f7a7d4e429f9786923e58bb233a_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i3e5207d4b6e44c3bb870e98f47ae464f_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i0fe0ea1cdf9b43cba1dc89583cfa12f4_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i1f3b790c7408444aa2438a6d74ccf219_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ifa5895dff1504af8b53362954d42a835_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i9782032ec849455f9eb55bcd5238506f_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i730d6d555ca8411db383a11b9f16a087_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ifcdba87c68b44670aa983d442909c8c8_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i2f175e8bc06e4516859a922825203ed1_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i109b126be6684609964e1d738004a5f0_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i4b9577aad3e743eaab5f2db73438ff22_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i1532603b5d5344d2b521ebca95510e2d_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i102e00650df64160ab95f91283be5671_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia6fa11be4a974f91a8f83c64c4b79d43_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i6bbd65f28780439d8d4b3739c60451f2_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ia2cfe7c548c8479c9c72cfb258097cbf_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ibc7c9d9ebcb04ddca80d41fba203d212_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i96f682ba85b44a3598400d9868b15c05_D20220601-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="id1e9f928ee4349a68577d07adcc3b26f_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c31b0a2ffcb46a09974a5fc03fcb07e_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="i1e8bf515dc504d2e93a4cef1b15e47ed_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="ic64f7b15ed9b474995bee41f47ae8270_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="if5cf0bee2d60494bb2779598e5ddb3eb_D20220602-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-02</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="ia0e0ea76bcf04919ab502a0c59748fb9_D20220602-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-02</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i3a1d991006824083b8178abc9d11b0d5_D20220602-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2022-06-02</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i3a86996ae3f64984bc0a4ecc7bd4af54_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="iac2d1378a1f24161b87c458f35456450_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i0e064f90d3da49b9a66c4ac18aad1d0d_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia41e9cc6df0e4df7ac811956f8aff5e4_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i4026512e869c44a08831de2435fa433a_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i0933abd0902b4939a41c2a553e06b97d_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ango:MedDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:ProductTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i03538be72f0c479d88269196fae7627d_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i9a63b72365594c83ac835e0622876350_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i481617886ccd437181a9534ee467fcaa_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i232cbe1e1fc44360a597810368435c6e_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:ProductTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="id17cfc417d92464bbedc0236cf2219c3_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ib38c064a30b74d81851783f9a22c7991_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i51440fe9937d4880a24b852c727c72bc_I20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="i40a6ca8a1a2a47948d181c2ddd57b60e_I20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="ie93908ff9fa24ce8a539c1afc8be059d_I20190603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-03</instant>
        </period>
    </context>
    <context id="idd47ebcb2afe4eab9e20c68e5a784838_D20220830-20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-30</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="iac18782ad5a1446b96f8bacea0595e03_D20190603-20190603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-03</startDate>
            <endDate>2019-06-03</endDate>
        </period>
    </context>
    <context id="ie66d2669acf841099e3090e565eb8955_D20220830-20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-30</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="i6651e0f87eed4540b11c234da6d13537_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i65b19051a3bf4afba6d1ee320c49fadb_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i2a200b6474a84a51a5841bde35741a37_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i48b85744365f40d9883440cec0fe503a_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i0ec7dba98bb64aa7b30c01f66cec9680_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i9c7dabef1a2548fc9b252f702944e5c6_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="ia7eb5c10613d48cb9ebc0fe8c4cf3a93_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="idc15638543e04c98b695a64a354303c6_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ifa54aec1d4754ab481509765d96d5677_D20221103-20221103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:A2020StockAndIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="i72ea6dcaec304dba8c28be69f4cd1398_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:A2020StockAndIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i5d63329084d44df394d886d4d1bb5ee2_D20221103-20221103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="ieefdf4931e024fcbba5c7e8746fb00ff_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="id088a0af0c2d43b9ad0bda298d1ff754_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="ibc69fb0bea484528bc57184c81e8345b_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i731c9ba446ab4192a1491d1c6f27c373_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i636ddb4bd5b74d3f8a431176bd1d93e5_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ibbe2c52f725c437ab009d57429836a32_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:NetAssetsGeographicAreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i85a313731ab245768b6c5d3dfb85c22a_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="ie3ad2ccb7c6b41e89084e3b945f40e64_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="ia25b0cac0e4a4dac8864feacd65915ec_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i4b1288467e0d4c2b98b2092131400cc2_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="id5eebdc1dda64c488bf0ee527902d32d_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i48bf28259a0f48979d1480adb13bf9ec_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i63e7d990beb04157bf2af35e180e5437_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i50932b29e3234e39be7fd89538f9ae51_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="icd9433e4df6a4d73bdb71c139f61a75a_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i360405dac2ac408196db947950f5fcdd_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i8d7862e7cad34bfd8d2c83decfca3201_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ango:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i86ec9e06fac9486392729b869d82f434_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ango:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i254de9e531fb4e0c9d03f1d1943e752e_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i544584d510904231bd6fd4ad6edaceed_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i91d99785b1194e778010f6582bcc0573_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i412326f7f86f49389bc84bbcd7b983b4_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ib58f23a0eada416e97df8f458b27fbb9_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i8b7c661bc93a4242beb5a3453d1917a2_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i404cfafae04d4964a4bf5b13fba7cb2a_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i6c51f234e672471b8e71d406f6c8a7e7_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i27add22ce5d243fab019d5956cd78ed3_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i6aa1f09bc0264f0faa5e3f247394dddd_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ie222d4925bad48388ddbb56ee9bec5a3_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="idac9f367db484179bc46e4196b143896_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="iaf3a056055ed471eb130b5c3aa8d0761_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i5ea95b9fd5b84377910bba4663837245_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i4307997465a748938dd80b54c9b60cf4_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="icb6fe7fe11684c62858764a7d401b9f1_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:CrBardIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-11</startDate>
            <endDate>2012-01-11</endDate>
        </period>
    </context>
    <context id="i274e4b0db3ab4da292cee7a42340b2fd_D20150310-20150310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheDelawareActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-03-10</startDate>
            <endDate>2015-03-10</endDate>
        </period>
    </context>
    <context id="i3bd57db09d954401a970450cb332edc2_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="iee3cc03838394279b14c503789157f07_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i47bbc169a6da4a36952422f9fd58300c_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i31c5d45239404a43ada7157497ae9c3e_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:LegalCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i1113d3caab5d408faab5a5f245311b15_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i0ee2fde770274d08a3b8af0bb66c465b_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i3f83e0c893cb4e7fb69e22ed93dc6a55_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i61bc7936712144249aa26ca9905b3c8e_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:MergersandAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i5ef1be6232914c8490f870666a771ffa_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i1ab1f2674fe04183b7df7f14ea9f167c_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="ica1aa84fb02d4395a39a7bf23b044eab_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i06523c7cb754445ab38517c2cb05ce7d_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ManufacturingRelocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i6cec44cbde2244a9a355ca544f33885f_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i7706a0f7dae740418007c9381795d2bd_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="if4dd796fd591465c8eb9c1eb60615285_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i47789d4315de4707952ba298e204a6ed_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:IsraeliInnovationAuthorityPrepaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i044eeedb625141a788d4e6c857cff53e_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i94bdb9b48a8f461b95594363296e37f6_D20210901-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="i9266e9d5e54f4e03aa9bff8df03159b5_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i59f28e909af74b0abe3ae31344d25373_D20210601-20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="id7fe5b4172864faa8f8941f2d91a82a5_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="id8e6825fbb074aa89f3481933a0524ff_D20220901-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="iadc3c6dba44947808123f698ace071df_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="ibd649e5bedd943d9a3a7267d44a89998_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="iec41db309d8b4a96899fae9d890284b7_D20220601-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="unit">
        <measure>ango:unit</measure>
    </unit>
    <unit id="segment">
        <measure>ango:segment</measure>
    </unit>
    <unit id="covenant">
        <measure>ango:covenant</measure>
    </unit>
    <unit id="patent">
        <measure>ango:patent</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl80LTEtMS0xLTUzOTA2_c668e397-a872-40e3-b742-420b9e3add8e">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl82LTEtMS0xLTUzOTA2_3a4f3682-0c73-4695-b73c-b7c9b6732392">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl83LTEtMS0xLTUzOTA2_ea15df07-1296-4f91-8c0b-4062a88907eb">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl8xMC0xLTEtMS01MzkwNg_14e3453f-5546-4f46-a2fd-5034a3f23eda">0001275187</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl8xMS0xLTEtMS01MzkwNg_3b3c21a5-6564-48cc-a73f-c036be79b077">--05-31</dei:CurrentFiscalYearEndDate>
    <dei:NoTradingSymbolFlag
      contextRef="i01586c4af1694483a5923523cc5adc02_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180L2ZyYWc6Njk5ZjNlZTY0MGZhNDNjOThmNWIzOTUwOThmODM3YTcvdGFibGU6ODBmMWNhZmM2YTEwNDA5ZGE5NGM0OGQ1OTE2NmU3ZmYvdGFibGVyYW5nZTo4MGYxY2FmYzZhMTA0MDlkYTk0YzQ4ZDU5MTY2ZTdmZl8xMi0xLTEtMS01MzkwNg_f9a4ce2b-1e24-4c8c-af3c-89b69fad9ceb">true</dei:NoTradingSymbolFlag>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia2cfe7c548c8479c9c72cfb258097cbf_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0Mg_fc669142-82c7-49b8-a7a9-e8917629543b">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV84Nw_22ac79d6-b9fc-4cbe-8228-03e7cb013f7c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6YWI5MjQ4MTVkZWI0NDFiZTljMmJhNTFjODY2Yzc3NGYvdGFibGVyYW5nZTphYjkyNDgxNWRlYjQ0MWJlOWMyYmE1MWM4NjZjNzc0Zl8wLTAtMS0xLTUzOTA2_b46ef638-7bc7-4d1d-a00b-48f4d7174a14">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8xMjY_d87088c8-e7df-4cd3-9758-2ba2a47d1e6f">2022-11-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NzM5OWNkMDM2MzRlNDY5NDg0MjQ5YmJiZmU0ZjViNzcvdGFibGVyYW5nZTo3Mzk5Y2QwMzYzNGU0Njk0ODQyNDliYmJmZTRmNWI3N18wLTAtMS0xLTUzOTA2_1d422969-d736-42d3-a087-7fe467a2570e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8yMjc_867f1581-9055-491c-b2f0-07390bc7e959">0-50761</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8yMzM_c3be1ee6-beea-44b3-84c8-59daf385501b">AngioDynamics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6ODQ4N2E4ZTZiMjJkNDI1Nzk1N2ZjMzhjODUzMTNiMWYvdGFibGVyYW5nZTo4NDg3YThlNmIyMmQ0MjU3OTU3ZmMzOGM4NTMxM2IxZl8wLTAtMS0xLTUzOTA2_19b75ec9-3972-40d0-bd66-4071e0474e39">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6ODQ4N2E4ZTZiMjJkNDI1Nzk1N2ZjMzhjODUzMTNiMWYvdGFibGVyYW5nZTo4NDg3YThlNmIyMmQ0MjU3OTU3ZmMzOGM4NTMxM2IxZl8wLTItMS0xLTUzOTA2_2f4ba706-f37b-4c9a-a775-5d9ddc0af047">11-3146460</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMDA_a1eeb92b-f618-4def-abdb-ff1d0aa0f2cd">14 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMDQ_f652e6ee-03bd-45bf-8060-d00316311930">Latham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMDg_bf5b93a7-47c1-49d3-ba68-029373aaaffe">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zMTE_caae5c2d-be5e-4b31-9e34-5a729c078339">12110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zNzA_4c5580c8-e4d4-481c-9d51-bf87403a3bb0">518</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8zNzQ_73a9931a-e49e-45ef-a083-38e4a28b22c5">795-1400</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i990fe285074e41ffb69712be25fba343_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8xLTAtMS0xLTUzOTA2_995f778b-2a71-48b2-a71f-8c0be30cf3db">Common Stock, par value $.01</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i990fe285074e41ffb69712be25fba343_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8xLTItMS0xLTUzOTA2_06f05599-dc51-416d-b467-cdd54ed302b6">ANGO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i990fe285074e41ffb69712be25fba343_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8xLTQtMS0xLTUzOTA2_4629f88c-050a-4f38-b553-76c19fb38889">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i01586c4af1694483a5923523cc5adc02_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8yLTAtMS0xLTUzOTA2_430e4317-f3b6-46b8-b657-2b901ba961d5">Preferred Stock Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="i01586c4af1694483a5923523cc5adc02_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MDc1MjMwZTE5ZTM5NDFlYzkzNTQ4OGY4ZTUzZmYxYTkvdGFibGVyYW5nZTowNzUyMzBlMTllMzk0MWVjOTM1NDg4ZjhlNTNmZjFhOV8yLTQtMS0xLTUzOTA2_a14c9e88-8fe5-4ac8-93a3-466058a0556b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8xMjAw_3947b501-bc09-48a4-b239-49a3a9b8398f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8xNTAw_ec14863b-9b6a-4eb0-8225-9bd8d7d8ca69">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NDdlMDQ2ZWMwNGI1NGJjMDlkODNlNTNiNGUzYmU3MWYvdGFibGVyYW5nZTo0N2UwNDZlYzA0YjU0YmMwOWQ4M2U1M2I0ZTNiZTcxZl8wLTAtMS0xLTUzOTA2_268263f1-7448-4730-b5d0-617859b6a67f">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NDdlMDQ2ZWMwNGI1NGJjMDlkODNlNTNiNGUzYmU3MWYvdGFibGVyYW5nZTo0N2UwNDZlYzA0YjU0YmMwOWQ4M2U1M2I0ZTNiZTcxZl8yLTYtMS0xLTUzOTA2_9793b4f0-8916-4f18-83e7-86285881c2ff">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6NDdlMDQ2ZWMwNGI1NGJjMDlkODNlNTNiNGUzYmU3MWYvdGFibGVyYW5nZTo0N2UwNDZlYzA0YjU0YmMwOWQ4M2U1M2I0ZTNiZTcxZl80LTItMS0xLTUzOTA2_aede6ef4-9c03-47f4-a786-faf65bb7ee63">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGV4dHJlZ2lvbjo2ZGQ0ZWFhM2E5MWM0MGI4ODRiMzkxNzJmN2M2ZGFlYV8yMTk5MDIzMjU3NjQ5_ee951776-4c76-47a0-acb2-510bad06dc21">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="idc75a48f4c044ff4b7035f3ba66619f8_I20230105"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xL2ZyYWc6NmRkNGVhYTNhOTFjNDBiODg0YjM5MTcyZjdjNmRhZWEvdGFibGU6MzY0YmJkNDY3ZTkzNDlhMjkyOTUxYWM0M2Q3OGRkMzAvdGFibGVyYW5nZTozNjRiYmQ0NjdlOTM0OWEyOTI5NTFhYzQzZDc4ZGQzMF8xLTItMS0xLTUzOTA2_df31ac1b-7836-4cb6-b917-a59d350594f7"
      unitRef="shares">39134144</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi0yLTEtMS01MzkwNg_e76aeabf-9609-4c1f-8b91-39778da3e808"
      unitRef="usd">85429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi00LTEtMS01MzkwNg_d019def7-96d4-4f43-b3f1-3f08cf62466c"
      unitRef="usd">78280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi02LTEtMS01MzkwNg_b74b0f19-518d-415e-87c1-eb224791bf5c"
      unitRef="usd">166966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMi04LTEtMS01MzkwNg_274b3030-ec88-4c2e-aa7d-0c9e900f5892"
      unitRef="usd">155251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy0yLTEtMS01MzkwNg_ccb6c641-8fdb-4898-b3b9-5bf6fcd3f5e1"
      unitRef="usd">40351000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy00LTEtMS01MzkwNg_15a80b9b-96c3-470f-8471-4f5192b6faf1"
      unitRef="usd">37725000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy02LTEtMS01MzkwNg_5f95993a-ed9f-472a-89c5-a119924ddd8c"
      unitRef="usd">79583000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMy04LTEtMS01MzkwNg_2e396363-6d41-4968-a125-92b321e0613e"
      unitRef="usd">74557000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC0yLTEtMS01MzkwNg_2cad9c61-a447-4b05-8ff4-85d8724a8fc8"
      unitRef="usd">45078000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC00LTEtMS01MzkwNg_95143556-45ef-4e72-9849-e52bb2361b83"
      unitRef="usd">40555000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC02LTEtMS01MzkwNg_4ecac4b3-60a1-48b3-8062-d9e2eede05e6"
      unitRef="usd">87383000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNC04LTEtMS01MzkwNg_6ee88004-ef50-43a4-a956-1951eb07900a"
      unitRef="usd">80694000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi0yLTEtMS01MzkwNg_6379ed13-3abb-4077-a4e9-2749d0feb02f"
      unitRef="usd">6838000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi00LTEtMS01MzkwNg_68446df7-d477-428d-af18-08d89de2393a"
      unitRef="usd">8199000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi02LTEtMS01MzkwNg_c59f98a7-e80a-42e7-a4e8-d4c198e3d784"
      unitRef="usd">15171000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNi04LTEtMS01MzkwNg_43c332cb-4df9-43cc-ab5a-78c8a6af026a"
      unitRef="usd">15593000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy0yLTEtMS01MzkwNg_ee3a35cb-3fa3-4d96-b7fc-4f7552fd5df0"
      unitRef="usd">26007000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy00LTEtMS01MzkwNg_ff4af208-b1b7-4e55-bfc6-bbb26577ee47"
      unitRef="usd">23606000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy02LTEtMS01MzkwNg_960158ae-5043-43b8-adf1-e66106031a97"
      unitRef="usd">52550000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfNy04LTEtMS01MzkwNg_ee711dd6-359b-4262-8d54-e759c94a1006"
      unitRef="usd">48052000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC0yLTEtMS01MzkwNg_b837b415-71b8-4ec2-99ea-986c4ca520b5"
      unitRef="usd">10835000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC00LTEtMS01MzkwNg_b53e6c15-760b-4693-a45a-4291f104ea68"
      unitRef="usd">9678000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC02LTEtMS01MzkwNg_f5efd05a-8a78-44e3-b058-40b6b9bcffd5"
      unitRef="usd">20936000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOC04LTEtMS01MzkwNg_44daa6ca-60f0-433f-b0a1-7321fd7a0be1"
      unitRef="usd">18621000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS0yLTEtMS01MzkwNg_b278868c-5113-457a-b5f9-2e4ee03db4f7"
      unitRef="usd">4808000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS00LTEtMS01MzkwNg_387984ef-5783-4ed9-a04d-c5cc99908017"
      unitRef="usd">4889000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS02LTEtMS01MzkwNg_3ae5795c-90d7-49bc-bece-804d09f5b2ec"
      unitRef="usd">9645000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfOS04LTEtMS01MzkwNg_2c2f4f9d-1d93-4e71-bf47-a35388357e52"
      unitRef="usd">9710000</us-gaap:AmortizationOfIntangibleAssets>
    <ango:ChangeInFairValueOfContingentConsiderationOne
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtMi0xLTEtNTM5MDY_9766e4ef-a252-4e2c-893e-a583f8c23913"
      unitRef="usd">1646000</ango:ChangeInFairValueOfContingentConsiderationOne>
    <ango:ChangeInFairValueOfContingentConsiderationOne
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtNC0xLTEtNTM5MDY_5a874f81-c78e-4f98-9337-d61b81a7d766"
      unitRef="usd">609000</ango:ChangeInFairValueOfContingentConsiderationOne>
    <ango:ChangeInFairValueOfContingentConsiderationOne
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtNi0xLTEtNTM5MDY_16e1e8d0-0ed5-455e-bcd5-74d20b6c5807"
      unitRef="usd">1857000</ango:ChangeInFairValueOfContingentConsiderationOne>
    <ango:ChangeInFairValueOfContingentConsiderationOne
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTAtOC0xLTEtNTM5MDY_b1928fdc-4f25-41c2-b668-0692bd5bb9c6"
      unitRef="usd">804000</ango:ChangeInFairValueOfContingentConsiderationOne>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtMi0xLTEtNTM5MDY_c40ded54-0dec-4f16-9112-9a51f0a7b47e"
      unitRef="usd">3059000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtNC0xLTEtNTM5MDY_379f9ad9-9ab8-47a1-bd86-d7bab0c3dfac"
      unitRef="usd">2253000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtNi0xLTEtNTM5MDY_e2edbcfa-eb82-4c09-83e9-6378abaa5ac7"
      unitRef="usd">8640000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTEtOC0xLTEtNTM5MDY_41fb4f56-0890-493d-b55e-3ce002429098"
      unitRef="usd">4693000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <us-gaap:OperatingExpenses
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItMi0xLTEtNTM5MDY_32ad411f-00ca-4ad5-8490-9e1b7a65d79a"
      unitRef="usd">53193000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItNC0xLTEtNTM5MDY_10a26a3c-e2af-4df7-aec0-28da10738bd5"
      unitRef="usd">49234000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItNi0xLTEtNTM5MDY_2ae915fc-d876-4076-ad0c-8a1d27ab8e1e"
      unitRef="usd">108799000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTItOC0xLTEtNTM5MDY_76e30ee8-46d5-4dd6-b11e-f3efbc84be5f"
      unitRef="usd">97473000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtMi0xLTEtNTM5MDY_963239ea-a880-468b-99fc-a99d6e6a08b4"
      unitRef="usd">-8115000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtNC0xLTEtNTM5MDY_04497419-7659-4817-a3ad-a5394e656b7e"
      unitRef="usd">-8679000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtNi0xLTEtNTM5MDY_b94899f4-ced3-4185-a3cd-3f230cfacec8"
      unitRef="usd">-21416000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTMtOC0xLTEtNTM5MDY_d357b137-8f4f-417c-b738-0466809e4e19"
      unitRef="usd">-16779000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtMi0xLTEtNTM5MDY_f81cff14-f6ce-4b4d-b92c-c39a84d67ba8"
      unitRef="usd">684000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtNC0xLTEtNTM5MDY_af6f3414-2549-42f0-b4c8-45349c7e04b5"
      unitRef="usd">174000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtNi0xLTEtNTM5MDY_5e30383b-6a54-41f7-8756-33d486e2f03f"
      unitRef="usd">1065000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTUtOC0xLTEtNTM5MDY_73575cfd-d8ec-4abf-815f-c37cc0337df2"
      unitRef="usd">330000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtMi0xLTEtNTM5MDY_b8a2e51e-f8f1-4981-b17e-4d4019e8c487"
      unitRef="usd">-252000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtNC0xLTEtNTM5MDY_e514c2f5-1cc9-447c-b3a0-b7f5de3c90cc"
      unitRef="usd">-10000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtNi0xLTEtNTM5MDY_1c744637-c55b-403e-8c38-dbfc7ad447c0"
      unitRef="usd">-427000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTYtOC0xLTEtNTM5MDY_9a52c4fc-d65b-4d01-821d-79625e058fa5"
      unitRef="usd">-362000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctMi0xLTEtNTM5MDY_4f61ccaf-638d-4b99-b139-41d533d35079"
      unitRef="usd">-936000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctNC0xLTEtNTM5MDY_c807e39e-65f1-4df3-b3c4-d2cc384da59e"
      unitRef="usd">-184000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctNi0xLTEtNTM5MDY_36f689ef-e172-4768-8cf5-7e51cd32f8e7"
      unitRef="usd">-1492000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTctOC0xLTEtNTM5MDY_d1027d8e-69e3-4999-a36a-ce893a2204c5"
      unitRef="usd">-692000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtMi0xLTEtNTM5MDY_dbe17c10-22d7-4f10-84cf-afe8536795a7"
      unitRef="usd">-9051000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtNC0xLTEtNTM5MDY_fabed2f7-5662-43db-8a58-d02f2ed4e8b0"
      unitRef="usd">-8863000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtNi0xLTEtNTM5MDY_b0c911e8-1b20-4a36-aa45-4ab9bff3ae3f"
      unitRef="usd">-22908000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTgtOC0xLTEtNTM5MDY_84a4b4b9-3d89-4b02-9db2-1684d274755d"
      unitRef="usd">-17471000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktMi0xLTEtNTM5MDY_4a1e206b-842a-419c-91ce-7eec5ba2429b"
      unitRef="usd">-565000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktNC0xLTEtNTM5MDY_200d1cbf-f6e5-4adc-bfb5-a5d68fdab587"
      unitRef="usd">-512000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktNi0xLTEtNTM5MDY_5d13416b-223e-411d-b911-90c71665a47c"
      unitRef="usd">-1418000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMTktOC0xLTEtNTM5MDY_ba8c3e68-0730-48e9-811f-a353f12a7da9"
      unitRef="usd">-2148000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ie58c4e8650d24eb487e88de28117da2a_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtMi0xLTEtNTM5MDY_bb4c2bd7-7b57-408a-b00b-9dfcc27517e3"
      unitRef="usd">-8486000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtNC0xLTEtNTM5MDY_a0109334-db1f-4a3a-b147-618cad0bf83f"
      unitRef="usd">-8351000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtNi0xLTEtNTM5MDY_db0cc0bc-305f-45c9-af03-671e7d3273b4"
      unitRef="usd">-21490000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjAtOC0xLTEtNTM5MDY_b1916cfb-e2c1-4dca-bda0-780cb42b2fa0"
      unitRef="usd">-15323000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtMi0xLTEtNTM5MDY_7d6611f3-3e7f-4884-9391-d8d16fd3080b"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtNC0xLTEtNTM5MDY_73389934-e843-4dc0-a480-7558e17ff531"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtNi0xLTEtNTM5MDY_c762e8f7-1e02-46a1-a83e-2de0bc43bb03"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjQtOC0xLTEtNTM5MDY_3a230e47-7389-48c4-b26b-d1ed143a9295"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtMi0xLTEtNTM5MDY_6320648c-deaf-40d2-aa5d-96a6ece4d117"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtNC0xLTEtNTM5MDY_3e4d4a84-2f57-4f61-9854-3d1154d24bce"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtNi0xLTEtNTM5MDY_707a7d24-2340-40e5-8532-159a647d6732"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMjUtOC0xLTEtNTM5MDY_ee6ae28d-2d4f-489e-a233-2a2d90d942be"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtMi0xLTEtNTM5MDY_ca1c7a5a-fd5d-473c-9e81-7211891f1eee"
      unitRef="shares">39490000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtNC0xLTEtNTM5MDY_5e9c3d3c-b349-4aa8-abba-8cd2cee29bd4"
      unitRef="shares">39053000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtNi0xLTEtNTM5MDY_06d81fe5-c2da-4e64-9253-f5bc1e135d0b"
      unitRef="shares">39394000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzMtOC0xLTEtNTM5MDY_c52ffd01-390b-4df4-bb10-22e23bc48194"
      unitRef="shares">38893000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtMi0xLTEtNTM5MDY_bb4e8c79-a9cd-4837-b149-4d08bfd56373"
      unitRef="shares">39490000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtNC0xLTEtNTM5MDY_811628e4-352f-474c-93bf-ecd266e39220"
      unitRef="shares">39053000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtNi0xLTEtNTM5MDY_a2a81865-3206-4123-b3a4-958c0fe35f75"
      unitRef="shares">39394000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xNi9mcmFnOmI1ODE4Y2ZlYjdkMDRlZjRhMDk0MGZiZmJiMjE2ZTA4L3RhYmxlOmE2MDQ3MDY3NjdkZDRkODZhMjk4MmVmYWViNzFiODdhL3RhYmxlcmFuZ2U6YTYwNDcwNjc2N2RkNGQ4NmEyOTgyZWZhZWI3MWI4N2FfMzQtOC0xLTEtNTM5MDY_8f9614f4-9f11-48db-be8b-060fbd3c0373"
      unitRef="shares">38893000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi0yLTEtMS01MzkwNg_fd9282e8-88c1-4358-8949-5b77fd72e3e3"
      unitRef="usd">-8486000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi00LTEtMS01MzkwNg_dd74716b-a576-483f-b754-ac52b0ca7968"
      unitRef="usd">-8351000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi02LTEtMS01MzkwNg_73392432-b88b-419b-b436-6a52e581635d"
      unitRef="usd">-21490000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfMi04LTEtMS01MzkwNg_5fbd26f9-e3a7-4308-aa5e-6c0293c46ea4"
      unitRef="usd">-15323000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS0yLTEtMS01MzkwNg_6e75fe10-46f1-4173-95fa-7e4c8e3165d2"
      unitRef="usd">-1095000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS00LTEtMS01MzkwNg_84131fb2-2a7e-4eee-9452-6755ab8b4a41"
      unitRef="usd">819000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS02LTEtMS01MzkwNg_f112e4c7-096f-4ba6-b37b-fa3249ff8986"
      unitRef="usd">-1645000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNS04LTEtMS01MzkwNg_5c7420bf-aad2-4d1b-9914-2f05b8717cd2"
      unitRef="usd">1409000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi0yLTEtMS01MzkwNg_ccc04caf-c555-4519-ab72-21548f0143b0"
      unitRef="usd">-1095000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi00LTEtMS01MzkwNg_58d8d8fc-238d-4044-99b7-68533b73f82a"
      unitRef="usd">819000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi02LTEtMS01MzkwNg_0d52001e-009b-43b6-bb44-0c3af88b7d25"
      unitRef="usd">-1645000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNi04LTEtMS01MzkwNg_56ec17c5-e423-4165-92c1-76b8bccb5d97"
      unitRef="usd">1409000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy0yLTEtMS01MzkwNg_69f2018d-bdbe-4c88-8108-259840843042"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy00LTEtMS01MzkwNg_7484b918-74e6-46f7-9e08-5a621438d180"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy02LTEtMS01MzkwNg_1236796d-eb9f-41af-b343-0433331f7c34"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfNy04LTEtMS01MzkwNg_478ca0c2-a99e-450e-95ba-42ef055c5b8e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC0yLTEtMS01MzkwNg_f4c6c180-a6af-449f-994b-a4853e8f6c81"
      unitRef="usd">-1095000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC00LTEtMS01MzkwNg_a926a994-bee3-4768-b58c-83b1767d2b61"
      unitRef="usd">819000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC02LTEtMS01MzkwNg_3f4f1023-ed80-48af-8e47-d8b9563a970a"
      unitRef="usd">-1645000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOC04LTEtMS01MzkwNg_0a6b28b8-da6c-4a71-bc10-b67175d9c620"
      unitRef="usd">1409000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS0yLTEtMS01MzkwNg_1fa197a7-ff5f-4ae0-bf6b-421676cf38d8"
      unitRef="usd">-9581000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS00LTEtMS01MzkwNg_44a19771-6d6d-45fa-bb7d-a75cc5f5885f"
      unitRef="usd">-7532000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS02LTEtMS01MzkwNg_e304289f-49a0-4212-84ed-4450438f3606"
      unitRef="usd">-23135000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18xOS9mcmFnOjU0MDRiMzBjYjEzYjRiYTg5YTA4ZWY1MDdmYzU5YzE0L3RhYmxlOjc2MTRhNzE2MmM5NDRjNjFiMWYxZDVjOGQyNmIwZDAxL3RhYmxlcmFuZ2U6NzYxNGE3MTYyYzk0NGM2MWIxZjFkNWM4ZDI2YjBkMDFfOS04LTEtMS01MzkwNg_146eeb95-4dbc-47b2-b585-40351e74e0a0"
      unitRef="usd">-13914000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMy0xLTEtMS01MzkwNg_b4ebe1d1-ecd1-4549-9548-6301d7df8076"
      unitRef="usd">29857000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMy0zLTEtMS01MzkwNg_7aa4e167-89e2-49d0-9656-cdf98b8d67bb"
      unitRef="usd">28825000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0wLTEtMS01MzkwNi90ZXh0cmVnaW9uOjQ0YTEwYjE0OWVlNTRmZGRhODZkYTlkMzcyZjJlNjA0XzQ2_19871434-4b8c-4a74-bd4a-ced2897e8b7e"
      unitRef="usd">2110000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0wLTEtMS01MzkwNi90ZXh0cmVnaW9uOjQ0YTEwYjE0OWVlNTRmZGRhODZkYTlkMzcyZjJlNjA0XzUz_73128291-b962-4f93-b149-23c997f22b88"
      unitRef="usd">1939000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0xLTEtMS01MzkwNg_f6f1ea24-376f-49a1-83c6-02e49515741e"
      unitRef="usd">52852000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNS0zLTEtMS01MzkwNg_9aa9d18f-7f4a-4b29-8775-1aa704159064"
      unitRef="usd">52304000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNi0xLTEtMS01MzkwNg_f858bdd1-5fc2-42f1-b9dc-20dbc53d0bc4"
      unitRef="usd">63177000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNi0zLTEtMS01MzkwNg_6b52b462-b15f-46f9-99f1-af2e8b2164c3"
      unitRef="usd">51392000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfOS0xLTEtMS01MzkwNg_7b3a045f-ec37-4a7c-ba13-391ec5158593"
      unitRef="usd">12944000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfOS0zLTEtMS01MzkwNg_b940a930-2895-4a9d-9197-a9896f910fff"
      unitRef="usd">10824000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTAtMS0xLTEtNTM5MDY_6041be9f-ce7c-435e-ac9d-76255723954e"
      unitRef="usd">158830000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTAtMy0xLTEtNTM5MDY_0b26d473-a6a6-4824-b692-0efc12cf50a4"
      unitRef="usd">143345000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTEtMS0xLTEtNTM5MDY_6e51ba80-9e32-4522-98fc-ac99ffc18ce7"
      unitRef="usd">45957000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTEtMy0xLTEtNTM5MDY_e2717c30-7083-4916-ac63-108d5eaf4291"
      unitRef="usd">45005000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTItMS0xLTEtNTM5MDY_d84401f2-1a22-4f99-8ad2-72055870f231"
      unitRef="usd">141943000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTItMy0xLTEtNTM5MDY_b9ff41c3-2773-4539-815d-8baaaed1f2a8"
      unitRef="usd">152380000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTMtMS0xLTEtNTM5MDY_3f1a03e4-ec00-4eca-bd1c-a7de104a5bd0"
      unitRef="usd">200755000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTMtMy0xLTEtNTM5MDY_d2b39859-f223-46b2-9366-e1e967181c9d"
      unitRef="usd">201058000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTQtMS0xLTEtNTM5MDY_842ebb5f-9554-4052-8714-03bb00fba4d5"
      unitRef="usd">10722000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTQtMy0xLTEtNTM5MDY_c18895b6-e7e6-4923-b1f4-139dfa7d2150"
      unitRef="usd">10963000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTYtMS0xLTEtNTM5MDY_c7a0922b-f2a6-4266-9a8b-f50b5a346ca3"
      unitRef="usd">558207000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTYtMy0xLTEtNTM5MDY_2c77c90b-612b-4e1b-9e79-8650170edf36"
      unitRef="usd">552751000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTktMS0xLTEtNTM5MDY_011d1fb5-5860-49cc-b804-fd849b125d34"
      unitRef="usd">34688000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMTktMy0xLTEtNTM5MDY_8dfe37ae-f03e-4ac8-ac34-2fa0797cb94a"
      unitRef="usd">28047000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjAtMS0xLTEtNTM5MDY_74efb189-2c46-4882-86a3-ff84fce1ffe6"
      unitRef="usd">26533000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjAtMy0xLTEtNTM5MDY_654ce83b-2155-4490-9464-76c776d4f0bf"
      unitRef="usd">34842000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjMtMS0xLTEtNTM5MDY_eec3e595-cc8e-4f0c-a6ab-f856591f5db6"
      unitRef="usd">9760000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjMtMy0xLTEtNTM5MDY_0bca1875-073f-4a15-8695-fc6a32dfcefe"
      unitRef="usd">8783000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjQtMS0xLTEtNTM5MDY_594aef96-2f7b-430c-ae47-b3f78097f979"
      unitRef="usd">2586000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjQtMy0xLTEtNTM5MDY_b83e0a1e-5a14-4697-8681-7866239c08ba"
      unitRef="usd">2652000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjUtMS0xLTEtNTM5MDY_7b1aa0a3-24aa-48ea-a906-d4a0236113c8"
      unitRef="usd">73567000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjUtMy0xLTEtNTM5MDY_7c273930-8d49-4da2-95b8-ad0fd2ddd8c8"
      unitRef="usd">74324000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjYtMS0xLTEtNTM5MDY_3d76ff87-d47f-4281-bc7e-5629ea081104"
      unitRef="usd">49796000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjYtMy0xLTEtNTM5MDY_fd627d7d-9574-435b-a87c-040fc3dc5781"
      unitRef="usd">25000000</us-gaap:LongTermLoansPayable>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjctMS0xLTEtNTM5MDY_cdf308f0-cdb7-4338-9a22-bd4f1a0728df"
      unitRef="usd">14290000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjctMy0xLTEtNTM5MDY_9bd81101-8f6f-4fcb-a637-0f4141fc9a40"
      unitRef="usd">16037000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjgtMS0xLTEtNTM5MDY_2c45ef13-b3d0-4ec3-a5c2-19c95b198954"
      unitRef="usd">9072000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjgtMy0xLTEtNTM5MDY_9aedc4bd-3676-48b3-9393-40f595f2b8a4"
      unitRef="usd">8165000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjktMS0xLTEtNTM5MDY_6efdbb4a-3744-4aea-8d97-0a3ef8e2e4a1"
      unitRef="usd">3524000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMjktMy0xLTEtNTM5MDY_832801ef-bc08-4a15-b73d-6e22893fff96"
      unitRef="usd">4736000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzAtMS0xLTEtNTM5MDY_1b2eebee-b70b-495f-9a6e-94b8d72b588d"
      unitRef="usd">150249000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzAtMy0xLTEtNTM5MDY_ca4c2b7a-7804-424c-8a87-45f76952f829"
      unitRef="usd">128262000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzEtMS0xLTEtNTM5MDY_1bb9800e-0455-42b7-b25b-212958f530a4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzEtMy0xLTEtNTM5MDY_e1dc0785-3657-455b-8fc0-e944b3d7ed5f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl8zMg_053d1353-59d0-4964-85a9-1683e40ad9f0"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl8zMg_5c948fc7-a292-4116-9504-39074dcb3638"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl80Ng_3902bffa-84b1-46a7-8d8b-7b951e6ce80f"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl80Ng_74f2dc7b-151b-4688-a0a9-5e1be71dee99"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_06def87c-6c48-44bb-8217-276c39a05484"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_0a544cb0-37d3-416d-ace5-ac28ef8b1ef9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_14c2046d-45f3-4b18-84f1-e646a454601e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjpiYTY5YWI3ZWIwZDA0OGJmYTJlYmJlMjY3OGQxZmFkMl82OA_ae141732-a1be-45e4-bc3b-a6f32f67de28"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMS0xLTEtNTM5MDY_b1693f3b-fef4-4bf8-8da4-6ea3b45f2839"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzMtMy0xLTEtNTM5MDY_f90bb372-7275-4cac-aa19-4e6dfb1b63ee"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl8yOQ_492d283e-42c5-4fce-b30d-f805c38ec007"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl8yOQ_e422992f-4496-4e32-8a4e-5db717715383"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl80Mw_2dc1857b-1854-4997-94d2-50922351cf9a"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl80Mw_a4f8950e-42f3-469c-a1cd-17705baf66d3"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl82NQ_a7a2e758-fd3c-4a26-9bde-8f58dfc23fd8"
      unitRef="shares">39874144</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl83Mg_b3a99c19-4962-4f82-b9b2-8668ceab8303"
      unitRef="shares">39541173</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl85Mw_1aa59863-a8b8-4293-b7db-10d6ea2ee16f"
      unitRef="shares">39504144</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjozMGE3ZDNkYmIwN2I0OWI2Yjg1MzcxMTUzOTA5M2M3Nl8xMDA_4114c132-9edf-46b6-ac52-61ba2e4b045b"
      unitRef="shares">39171173</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMS0xLTEtNTM5MDY_2dcc1cae-8497-4223-8d22-2bab707e0774"
      unitRef="usd">381000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzQtMy0xLTEtNTM5MDY_25408268-f44e-4b5d-a886-c0f3dc570f66"
      unitRef="usd">380000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzUtMS0xLTEtNTM5MDY_366f1f92-7f6f-465f-a563-73da00fa0e96"
      unitRef="usd">593482000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzUtMy0xLTEtNTM5MDY_d5be9788-6b98-4857-8a50-892f32738ffe"
      unitRef="usd">586879000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzYtMS0xLTEtNTM5MDY_cd1b899e-6d55-4d55-ac17-fa6af00bff11"
      unitRef="usd">-179903000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzYtMy0xLTEtNTM5MDY_93d5e1f6-3299-4759-9509-d8406ff9d840"
      unitRef="usd">-158413000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjphOGJhODdkYTIwMzY0Mjk3OTc5ODExNmE1NDg0ZmRhOV8yMA_0baf64f2-4197-4017-b906-da05263352df"
      unitRef="shares">370000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMC0xLTEtNTM5MDYvdGV4dHJlZ2lvbjphOGJhODdkYTIwMzY0Mjk3OTc5ODExNmE1NDg0ZmRhOV8yMA_de4afea2-f5d4-4ac3-a1f9-2cc3217ce167"
      unitRef="shares">370000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMS0xLTEtNTM5MDY_6f2716d1-76f8-4427-a062-16742edbb842"
      unitRef="usd">5714000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzctMy0xLTEtNTM5MDY_fa832bea-9ed4-41a6-b3b2-0dd0ff303b64"
      unitRef="usd">5714000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzgtMS0xLTEtNTM5MDY_da972606-a8c0-4736-8431-18b154af90b4"
      unitRef="usd">-288000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzgtMy0xLTEtNTM5MDY_fbf008c8-cf8a-43a5-98e7-f59031383239"
      unitRef="usd">1357000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzktMS0xLTEtNTM5MDY_c7279d03-ee03-45ca-95d5-ae307bf2fd87"
      unitRef="usd">407958000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfMzktMy0xLTEtNTM5MDY_afce0b94-0937-4d28-b1f4-258bd1a81ace"
      unitRef="usd">424489000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNDAtMS0xLTEtNTM5MDY_f33cb188-974a-42d4-b176-b743e9969a43"
      unitRef="usd">558207000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yMi9mcmFnOjYxMGE1YjY3NGRiYzQyOWFhNDI1MmI1Yjg4ZDM4OGJkL3RhYmxlOmU4NjNkOTJhMGE3ZDQ3MDViODBmNmEyNjcwODk1ZDJiL3RhYmxlcmFuZ2U6ZTg2M2Q5MmEwYTdkNDcwNWI4MGY2YTI2NzA4OTVkMmJfNDAtMy0xLTEtNTM5MDY_ad39ec15-e319-427a-a5a9-0424cb1073dc"
      unitRef="usd">552751000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMy0xLTEtMS01MzkwNg_3e8c0de3-d4bc-42d2-b017-ff711a5a9ac2"
      unitRef="usd">-21490000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMy0zLTEtMS01MzkwNg_435e1458-aad8-4e0b-9c00-267c9d7c0ff0"
      unitRef="usd">-15323000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNS0xLTEtMS01MzkwNg_fb203048-b6c1-4308-881a-2fc3db4e9fe2"
      unitRef="usd">15478000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNS0zLTEtMS01MzkwNg_3558e592-d7cd-4ba7-9d6e-41eb67e44d3b"
      unitRef="usd">14276000</us-gaap:DepreciationAndAmortization>
    <ango:NonCashLeaseExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNi0xLTEtMS01MzkwNg_e93e5b78-5e1c-4c86-8721-ca3212962a25"
      unitRef="usd">1248000</ango:NonCashLeaseExpense>
    <ango:NonCashLeaseExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNi0zLTEtMS01MzkwNg_8f7d9545-c348-4cfb-a6b6-a1958ef83837"
      unitRef="usd">1209000</ango:NonCashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNy0xLTEtMS01MzkwNg_b50a4180-4fdc-46a4-8c5d-c39ebc72520d"
      unitRef="usd">6374000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNy0zLTEtMS01MzkwNg_936e13b6-9464-403d-96b4-3481114cec7c"
      unitRef="usd">5437000</us-gaap:ShareBasedCompensation>
    <ango:ChangeInFairValueOfContingentConsiderationOne
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfOC0xLTEtMS01MzkwNg_8b71b52b-e0f2-4e19-8372-d9698c09092e"
      unitRef="usd">1857000</ango:ChangeInFairValueOfContingentConsiderationOne>
    <ango:ChangeInFairValueOfContingentConsiderationOne
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfOC0zLTEtMS01MzkwNg_2859a0c2-713b-4d5c-b719-beb5377ee5a1"
      unitRef="usd">804000</ango:ChangeInFairValueOfContingentConsiderationOne>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTEtMS0xLTEtNTM5MDY_dfc088d4-06b5-466c-8340-fe8c372dce51"
      unitRef="usd">-1525000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTEtMy0xLTEtNTM5MDY_f2bf3548-ed33-4d17-b264-1cfde5dd261c"
      unitRef="usd">-2259000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTItMS0xLTEtNTM5MDY_46826e44-7c0f-425f-8f2c-30d100f762de"
      unitRef="usd">392000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTItMy0xLTEtNTM5MDY_9923afb7-bca7-4b8d-90cd-7ad48694cc2c"
      unitRef="usd">16000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTMtMS0xLTEtNTM5MDY_4074fc85-dba4-470c-a08c-ccddfa392d51"
      unitRef="usd">87000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTMtMy0xLTEtNTM5MDY_df392295-98f3-4aa5-bde2-990594575b7e"
      unitRef="usd">97000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTYtMS0xLTEtNTM5MDY_b283739f-fa44-47d3-858c-73cecb596a6a"
      unitRef="usd">43000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTYtMy0xLTEtNTM5MDY_1faa2ef6-68d4-4d09-b2fc-ea7159f1cdd2"
      unitRef="usd">78000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTgtMS0xLTEtNTM5MDY_3c723ef2-5dc7-4f13-88d8-66f15656fe5a"
      unitRef="usd">1019000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTgtMy0xLTEtNTM5MDY_73e109db-340a-4749-9ddb-2ba145f03fca"
      unitRef="usd">2922000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTktMS0xLTEtNTM5MDY_b4250841-a938-4c2d-9013-ff5cbf8c34cf"
      unitRef="usd">11831000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMTktMy0xLTEtNTM5MDY_0e85bef5-b6a8-46fa-a40a-e60d35940ae8"
      unitRef="usd">-478000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjAtMS0xLTEtNTM5MDY_6c91b030-1a6b-4220-95f9-154340f756c3"
      unitRef="usd">3931000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjAtMy0xLTEtNTM5MDY_c7a224a0-5b81-4852-9f9e-d8442ec327aa"
      unitRef="usd">4184000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjEtMS0xLTEtNTM5MDY_441be31f-c58a-459c-89c2-03604f9e4858"
      unitRef="usd">-2843000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjEtMy0xLTEtNTM5MDY_cab67503-72d0-4023-a661-a26383e61f8e"
      unitRef="usd">-4514000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjItMS0xLTEtNTM5MDY_f6402a4c-7e3b-4ccd-a050-77d4302b0fbd"
      unitRef="usd">-17246000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjItMy0xLTEtNTM5MDY_3c92a917-3647-4281-af5a-cd67e5027afa"
      unitRef="usd">-6963000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjQtMS0xLTEtNTM5MDY_6c2c9a7c-eb82-42e2-95ed-d5c203458de5"
      unitRef="usd">2090000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjQtMy0xLTEtNTM5MDY_73ab1c86-0aa0-4e3d-9900-0c90fd0bc2d8"
      unitRef="usd">2152000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireEquipmentOnLease
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjYtMS0xLTEtNTM5MDY_553780f0-097f-4b26-944f-8ba2e3c6293b"
      unitRef="usd">3442000</us-gaap:PaymentsToAcquireEquipmentOnLease>
    <us-gaap:PaymentsToAcquireEquipmentOnLease
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjYtMy0xLTEtNTM5MDY_b73a976b-7996-46f1-b06f-0c82618467f4"
      unitRef="usd">7189000</us-gaap:PaymentsToAcquireEquipmentOnLease>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjctMS0xLTEtNTM5MDY_35d66c48-64a9-4abf-be59-5def1ed542b6"
      unitRef="usd">540000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMjctMy0xLTEtNTM5MDY_bde00d50-8d85-4889-892e-7930ba7b8f3a"
      unitRef="usd">3600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzAtMS0xLTEtNTM5MDY_1979a616-8029-410c-ac2e-1eeebba7c07e"
      unitRef="usd">-6072000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzAtMy0xLTEtNTM5MDY_ba31066a-9939-4346-ba2a-6379b5617ba5"
      unitRef="usd">-12941000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzItMS0xLTEtNTM5MDY_9a25f111-0734-4bfb-992c-5ee8186f370a"
      unitRef="usd">70000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzItMy0xLTEtNTM5MDY_b5b97af0-7b16-407c-8852-0949840591dc"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzMtMS0xLTEtNTM5MDY_a286d276-65a5-4c5c-a33d-310317b80715"
      unitRef="usd">45000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzMtMy0xLTEtNTM5MDY_b469b275-3230-4c1e-bbeb-2845645683a6"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzQtMS0xLTEtNTM5MDY_42ca7e96-549a-4508-b651-67b295a28aa8"
      unitRef="usd">751000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzQtMy0xLTEtNTM5MDY_2210669c-bb12-47c6-b38a-0ec82c883db4"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <ango:ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzctMS0xLTEtNTM5MDY_9895ed78-7eb2-426d-9760-a40edf9215f1"
      unitRef="usd">230000</ango:ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised>
    <ango:ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzctMy0xLTEtNTM5MDY_df16d995-d9c0-49ca-8911-c07c8bf4093d"
      unitRef="usd">1388000</ango:ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzgtMS0xLTEtNTM5MDY_bb79969c-0855-4df4-95d1-ff1ee9a59e2d"
      unitRef="usd">24479000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzgtMy0xLTEtNTM5MDY_5afdd73e-1f6b-4dc9-ad68-849129cebf9c"
      unitRef="usd">6388000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzktMS0xLTEtNTM5MDY_7aa40871-d728-43f5-8460-10a03dd92aa1"
      unitRef="usd">-129000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfMzktMy0xLTEtNTM5MDY_bbff0b14-1543-4b23-8f6c-c3a894feb4c1"
      unitRef="usd">-354000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDAtMS0xLTEtNTM5MDY_13db8054-ab17-473e-9651-19518a0032a7"
      unitRef="usd">1032000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDAtMy0xLTEtNTM5MDY_f2d73151-ef96-455e-9022-a15a2d10ad82"
      unitRef="usd">-13870000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDEtMS0xLTEtNTM5MDY_7d9372e1-3532-4258-937f-4bef4d63038e"
      unitRef="usd">28825000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4ae2f2a17c5c4c0ab0620f6245443650_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDEtMy0xLTEtNTM5MDY_9ae2182a-a0bb-45ae-a7ca-392d4dae2043"
      unitRef="usd">48161000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDItMS0xLTEtNTM5MDY_a7d2e5c8-a19f-4351-870b-341206dcc5d3"
      unitRef="usd">29857000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i580a989d6bd346dea798e59360b2cf7b_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDItMy0xLTEtNTM5MDY_4772a3d2-cd75-465d-9200-0e6fce6feea2"
      unitRef="usd">34291000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDYtMS0xLTEtNTM5MDY_e370413e-33f0-4722-8f92-2a6c58a2ffde"
      unitRef="usd">113000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yNS9mcmFnOjdjYzZiYjJiZDIyNjQzOGNiMzM5NGZiNTg1ZDBhYWQ5L3RhYmxlOmM3MGY1OWM4NzA0NDRlMjU5NDNiMzJlOTFlOWY0NGE0L3RhYmxlcmFuZ2U6YzcwZjU5Yzg3MDQ0NGUyNTk0M2IzMmU5MWU5ZjQ0YTRfNDYtMy0xLTEtNTM5MDY_6a864849-03a2-4753-9075-fae3b816083c"
      unitRef="usd">65000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i92253b30ce7448a9b04589161b7aef74_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xLTEtMS01MzkwNg_bdd59844-51d4-45c6-891f-097b293d8166"
      unitRef="shares">39541173</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i92253b30ce7448a9b04589161b7aef74_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0zLTEtMS01MzkwNg_3d3d0c46-252a-4124-8ecb-ae686e0984a7"
      unitRef="usd">380000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0521e2ea5e8f4642ba511b1cf2257912_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi01LTEtMS01MzkwNg_bf9e4cae-2c21-46a2-8d79-e097bcdb1778"
      unitRef="usd">586879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9c3663238b141639922a3c2b6127596_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi03LTEtMS01MzkwNg_b1241af7-2d49-4d39-9371-2540b9955817"
      unitRef="usd">-158413000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3170daaa632a47c2864c3b1cfbeabc53_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi05LTEtMS01MzkwNg_776a405b-45bb-4acb-989f-f48c5875084e"
      unitRef="usd">1357000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia78ac75b2327440aabe9a07d95648ed1_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xMS0xLTEtNTM5MDY_0adda0c6-b5de-4e9a-afeb-6efe99316276"
      unitRef="shares">370000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ia78ac75b2327440aabe9a07d95648ed1_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xMy0xLTEtNTM5MDY_dc052105-17b9-4aef-b8fe-15b325f14a8e"
      unitRef="usd">-5714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMi0xNS0xLTEtNTM5MDY_6faa018c-fd90-4090-b5de-3dfbb4581145"
      unitRef="usd">424489000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1d26b3b0e13245a9a8b3f331e8f3f094_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMy03LTEtMS01MzkwNg_f28d5535-bb24-4458-b11c-8fae4b0c04b7"
      unitRef="usd">-13004000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMy0xNS0xLTEtNTM5MDY_c1d42dae-8c08-4a13-9f42-3dc5e325be8c"
      unitRef="usd">-13004000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNC0xLTEtMS01MzkwNg_b99c376b-a6c8-429f-8047-ebb5967b00c5"
      unitRef="shares">6617</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNC01LTEtMS01MzkwNg_28cfedb6-3ef0-4878-858f-eb9c6bf605f1"
      unitRef="usd">-29000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNC0xNS0xLTEtNTM5MDY_e0e5ba9e-d383-4da2-bf19-fd591abd9393"
      unitRef="usd">-29000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0e978a8d0cbb4723afaecf79157faa08_D20220301-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNS0xLTEtMS01MzkwNg_e9114ce7-6372-45a3-ab2f-6d5ce39692e4"
      unitRef="shares">213241</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9339830d2a2e4fda87b3402b5dc095cb_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNS01LTEtMS01MzkwNg_ebdbddc7-887b-4b39-b6f1-cb17ef3a241c"
      unitRef="usd">-648000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i11e97ca8dbd54428b944767243cf21fd_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNS0xNS0xLTEtNTM5MDY_fadc6241-e39c-44c5-9465-eb7a8e6cc35b"
      unitRef="usd">-648000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5014bebe766c497ca5a518a9144f9fee_D20220301-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNi0xLTEtMS01MzkwNg_4a8fae02-c2b1-43ae-a426-21d08d74c023"
      unitRef="shares">29826</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifdc6ea670265410a9abcd9fe2ce25d89_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNi01LTEtMS01OTQ3Nw_91e956b9-c10c-4444-9adf-e64d82aaa4db"
      unitRef="usd">-312000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0679db975f1e442f95e34936148e0ca3_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNi0xNS0xLTEtNTk1MDQ_160586ed-c93f-4e10-829a-a1d7e58e07b4"
      unitRef="usd">-312000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy0xLTEtMS01MzkwNg_7842756c-13a2-423e-86ec-1c09ba2d2982"
      unitRef="shares">56894</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ief1ff8adb100415b882bbcd12444aeb1_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy0zLTEtMS01MzkwNg_e368d74d-039a-4499-88be-f41568f9733a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy01LTEtMS01MzkwNg_8fddfbce-e90f-48c9-9875-47b5afe49b04"
      unitRef="usd">1070000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfNy0xNS0xLTEtNTM5MDY_3c626883-93b1-44bf-8510-8831ae250226"
      unitRef="usd">1071000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i13227d07610a4f9a9e8ddb4a1d1ed0b8_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfOC01LTEtMS01MzkwNg_18126138-fdb8-4a47-898c-459c10982076"
      unitRef="usd">3024000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfOC0xNS0xLTEtNTM5MDY_6484319b-308d-4731-86ba-c3deabaccc6c"
      unitRef="usd">3024000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i89a2219dda3a46beaaeefb85ffdbc421_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTEtOS0xLTEtNTM5MDY_abe421cd-c712-4e67-9430-ff47ade4e30d"
      unitRef="usd">-550000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTEtMTUtMS0xLTUzOTA2_1fcae9f6-8317-4f0d-ad96-055265dfa5f6"
      unitRef="usd">-550000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4eba7ef0b2324baba133dce806849e01_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMS0xLTEtNTM5MDY_1101a58b-1e13-431c-b6db-d61fc331913a"
      unitRef="shares">39847751</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4eba7ef0b2324baba133dce806849e01_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMy0xLTEtNTM5MDY_dec5de86-7e35-48f8-b395-7f018ad13a25"
      unitRef="usd">381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i358df3908685483ba68ef5ce671cb276_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItNS0xLTEtNTM5MDY_3dc1cd88-d9ec-4e53-82a9-33160179d761"
      unitRef="usd">589984000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0773232166fe4bdfa46507e1fa96456b_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItNy0xLTEtNTM5MDY_73fc8ea4-f587-4b0b-8ecd-5dbfb560721a"
      unitRef="usd">-171417000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23a1dadd2d8248f4a335ef455a4782f3_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItOS0xLTEtNTM5MDY_7322e98f-e7b2-4b93-8dc7-aa5daa2d1742"
      unitRef="usd">807000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i5e61a52d34bf4a7fa61bbf80ff3eef08_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMTEtMS0xLTUzOTA2_895e9a74-f749-42cb-a19c-302c84015ad0"
      unitRef="shares">-370000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i5e61a52d34bf4a7fa61bbf80ff3eef08_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMTMtMS0xLTUzOTA2_5eef293d-2fb0-4d59-a8fe-d2dcf610a698"
      unitRef="usd">-5714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i605f35cad602428b8143074fa8c31ba8_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMTItMTUtMS0xLTUzOTA2_04aa8c69-b2b6-4e80-9792-6c0dcd4c112a"
      unitRef="usd">414041000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie58c4e8650d24eb487e88de28117da2a_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjMtNy0xLTEtNTM5MDY_bb4c2bd7-7b57-408a-b00b-9dfcc27517e3"
      unitRef="usd">-8486000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjMtMTUtMS0xLTUzOTA2_94535150-0623-458d-b6bb-2ffa9b5b9736"
      unitRef="usd">-8486000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i761e3ac346f34f59b5db2c93ec5cd804_D20220901-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjQtMS0xLTEtNTM5MDY_c2b6ee91-cc86-4a0a-adc1-89f9259f50d3"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i00c8c3dc240b49d1aa14a8e2c554f67d_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjQtNS0xLTEtNTM5MDY_b24c1132-5700-44cd-a7b3-ef6eabc99ecf"
      unitRef="usd">184000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjQtMTUtMS0xLTUzOTA2_9933092e-14ad-4e53-805e-b1fa59a5a2a8"
      unitRef="usd">184000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if0436957f2064843bb33c8674690b54b_D20220901-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjUtMS0xLTEtNTM5MDY_96a12ff9-c37f-4880-b749-651b1cff6735"
      unitRef="shares">11393</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib6493fdf5e73404cb9c65ebd100d37ef_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjUtNS0xLTEtNTM5MDY_378aa9a7-b9c8-4adb-9d7d-05cfd7ab87dd"
      unitRef="usd">-36000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i21b34f1c2e1346eb854653a87b2ad11f_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjUtMTUtMS0xLTUzOTA2_22141868-ca61-4c86-91cd-7f8bd29d4ff7"
      unitRef="usd">-36000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i00c8c3dc240b49d1aa14a8e2c554f67d_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjgtNS0xLTEtNTM5MDY_382fe771-fb87-41df-9a10-95c4746ddf54"
      unitRef="usd">3350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMjgtMTUtMS0xLTUzOTA2_fbd74a68-4de6-4d8d-94f4-d04ab83c7f26"
      unitRef="usd">3350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46d7e5ff2d9d47c2aca189c481fd4cb8_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzEtOS0xLTEtNTM5MDY_051a7a89-865d-49e9-be48-7fe051061f4e"
      unitRef="usd">-1095000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzEtMTUtMS0xLTUzOTA2_6066a235-22d0-48f0-9bbc-0d2e1eb763b5"
      unitRef="usd">-1095000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i39078c2a8d3949c8b51612819ff52be6_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMS0xLTEtNTM5MDY_5bec5821-bc53-4aed-a3ca-907a371a181f"
      unitRef="shares">39874144</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i39078c2a8d3949c8b51612819ff52be6_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMy0xLTEtNTM5MDY_d4a8325b-32b1-4ef9-add6-dc5d181622bd"
      unitRef="usd">381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia231c271d6e74f54b40bb9f2c13d5442_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItNS0xLTEtNTM5MDY_e1b0ea28-7cc8-45fe-be14-181c7d349d38"
      unitRef="usd">593482000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a4bd82406cc4389bd0da8087da40e52_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItNy0xLTEtNTM5MDY_fc9fcc68-403b-48da-a0ce-d6dc8aa08272"
      unitRef="usd">-179903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7310c5f116f7458bbf77606953070240_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItOS0xLTEtNTM5MDY_b7c52293-7d95-48b1-b52e-8ab1027884db"
      unitRef="usd">-288000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i5209e80cbf59403ba5b0127b54301190_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMTEtMS0xLTUzOTA2_4ce3c009-aca3-40c6-9281-8c99c412a028"
      unitRef="shares">370000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i5209e80cbf59403ba5b0127b54301190_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMTMtMS0xLTUzOTA2_feb5d5a5-a371-445a-b585-069ac0dbba5b"
      unitRef="usd">-5714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOmM1MGZiZmEzMjAxZTQ0NzViZDRjNmU4ZTU1ZGI5OTY3L3RhYmxlcmFuZ2U6YzUwZmJmYTMyMDFlNDQ3NWJkNGM2ZThlNTVkYjk5NjdfMzItMTUtMS0xLTUzOTA2_07e7272c-4b57-476c-bdd9-84c14764cc03"
      unitRef="usd">407958000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i71a5faedb2934ca3b6d2036bad066025_I20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xLTEtMS01MzkwNg_22861526-4d3e-4898-a93a-3207c813ee9f"
      unitRef="shares">38920951000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i71a5faedb2934ca3b6d2036bad066025_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0zLTEtMS01MzkwNg_337be325-7dfb-4fa0-98e4-ed069409f8a1"
      unitRef="usd">377000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib96b6c43657d45239e312ea746267dc0_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi01LTEtMS01MzkwNg_97a4763e-818e-4635-bd44-7833aefa6749"
      unitRef="usd">573507000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i80aa6442429842f5a354cbfbb8726ca1_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi03LTEtMS01MzkwNg_676e6885-1b91-4885-86a8-65e6398b0739"
      unitRef="usd">-131866000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5703543d8ed4406290fe2b3d2ebe132b_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi05LTEtMS01MzkwNg_dd2a8352-cf41-47f5-a183-189fa8b94ec8"
      unitRef="usd">3153000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i06eb3f7549e544fa998b0ee023503249_I20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xMS0xLTEtNTM5MDY_9ac294d5-58a0-4c86-af51-5707ed894d16"
      unitRef="shares">370000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i06eb3f7549e544fa998b0ee023503249_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xMy0xLTEtNTM5MDY_cb4c401a-babf-4911-bbb3-5bdaa58e7fab"
      unitRef="usd">-5714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ae2f2a17c5c4c0ab0620f6245443650_I20210531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMi0xNS0xLTEtNTM5MDY_ab7b2962-f1fc-4fc8-83cd-97a17e91fab6"
      unitRef="usd">439457000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0ce7f40f7e1c4f288eaa7bdae504643a_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMy03LTEtMS01MzkwNg_0cf4dc11-deb3-4df0-bf58-849f403a898a"
      unitRef="usd">-6972000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMy0xNS0xLTEtNTM5MDY_26476b64-0c52-4cde-a0ef-83122646ae23"
      unitRef="usd">-6972000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC0xLTEtMS01MzkwNg_cfaa4483-8814-4b66-a2d2-78162abf6409"
      unitRef="shares">80635000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC0zLTEtMS01MzkwNg_6bf7691a-0814-478c-8f65-c51ed46fa356"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i29a2abe0d92149128c8af04916896413_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC01LTEtMS01MzkwNg_26250505-a379-4c78-9dae-904188b65b59"
      unitRef="usd">1279000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNC0xNS0xLTEtNTM5MDY_09850380-f937-4834-bd22-002c3775ec73"
      unitRef="usd">1280000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i92d7755649c74466927d4c2e158305aa_D20210601-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNS0xLTEtMS01MzkwNg_202080c0-bd4e-4cd4-aedd-e7f63c7e8f45"
      unitRef="shares">279495000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i33519024438c43d7a67b370d508001cc_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNS01LTEtMS01MzkwNg_8e703106-9854-48e2-9906-ac5132987c49"
      unitRef="usd">-1734000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0fe451085baf4ea09c68e462c55b946d_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNS0xNS0xLTEtNTM5MDY_3cbcb3ed-f194-4935-8f1b-bd58f3d15a23"
      unitRef="usd">-1734000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6eaf8bf186364608810a8c124dd74a94_D20210601-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNi0xLTEtMS01MzkwNg_89f6ad25-3893-4680-9939-40145e7a36fc"
      unitRef="shares">59371000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy0xLTEtMS01MzkwNg_8772615c-c737-40d5-bb5e-145205a34064"
      unitRef="shares">49789000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i1d15768f3347479dbff38c4f802fe18f_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy0zLTEtMS01MzkwNg_256565e8-044f-4b04-91c5-18b3d9f20ff2"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i29a2abe0d92149128c8af04916896413_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy01LTEtMS01MzkwNg_751ac514-6a24-45fd-9a84-9a6c480198aa"
      unitRef="usd">899000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfNy0xNS0xLTEtNTM5MDY_07a8a0c5-3b2e-4e6d-9796-5057bc2f9fed"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i29a2abe0d92149128c8af04916896413_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfOC01LTEtMS01MzkwNg_24677ee3-106f-4ac7-a079-dfb3c1fa20ef"
      unitRef="usd">2429000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfOC0xNS0xLTEtNTM5MDY_19fcfa80-1331-4dc2-a61f-34f257298b08"
      unitRef="usd">2429000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3190940009fb48f29de007d763ca8a27_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTEtOS0xLTEtNTM5MDY_57ffdad4-705a-4eef-967d-999caba584df"
      unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icc1376a994d14170988972c24d8d1eea_D20210601-20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTEtMTUtMS0xLTUzOTA2_fe883335-867e-4d1e-8cd3-4fb06af7ab17"
      unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i24b58b5cab854792a4cd67d56850fb81_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMS0xLTEtNTM5MDY_0a0fd9a9-7608-448e-a5df-646a6e7cacb1"
      unitRef="shares">39390241000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i24b58b5cab854792a4cd67d56850fb81_I20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMy0xLTEtNTM5MDY_dc12fb51-3391-4426-bc1f-e53345e69c1e"
      unitRef="usd">379000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i08aee044abc04167ab7b46d2b3434e1f_I20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItNS0xLTEtNTM5MDY_c2bdc072-e23c-4c50-af82-c1beac614c57"
      unitRef="usd">576380000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4134390d562f48ff9f977c2e6b84a29f_I20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItNy0xLTEtNTM5MDY_85b66748-0c9a-4936-9036-c9490f0c38ee"
      unitRef="usd">-138838000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if20cde87f3f1438582de0a6be9bfb0f0_I20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItOS0xLTEtNTM5MDY_3da03c0b-9f27-48b1-940f-f68dca15ac17"
      unitRef="usd">3743000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i31a8b6318460497bae9c739e5328a31b_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMTEtMS0xLTUzOTA2_0d47ea93-c786-4995-bd74-2f3de650aa16"
      unitRef="shares">370000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i31a8b6318460497bae9c739e5328a31b_I20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMTMtMS0xLTUzOTA2_e53fc1c2-3db3-493b-8dad-46add3fc9ba3"
      unitRef="usd">-5714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46394e9b402e418b9d3d6c693d0247ce_I20210831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTItMTUtMS0xLTUzOTA2_1b03c718-339d-43e9-a63b-0f9191dc0f1a"
      unitRef="usd">435950000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i4675e13c50964ba0a48938de3e2ae4a4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTMtNy0xLTEtNTM5MDY_64979225-dfd9-487a-b97f-f3e37fbc0aa9"
      unitRef="usd">-8351000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTMtMTUtMS0xLTUzOTA2_0ae69c06-19c2-43a8-84c8-ecaf94b1d766"
      unitRef="usd">-8351000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i13178785dc1843d99d2ccce16ace2e65_D20210901-20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTQtMS0xLTEtNTk0OTc_7ce4f985-66d9-484b-b09d-879b48dba774"
      unitRef="shares">56064000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ideddd48e387b42c2b942816100384d6a_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTQtNS0xLTEtNTk0OTc_cd03c384-469a-459f-bf65-0a808de81445"
      unitRef="usd">1022000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTQtMTUtMS0xLTU5NDk3_286cf3e0-1297-47bb-b1a1-87d37143f54e"
      unitRef="usd">1022000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i12da52958cc5404e98473dd0097af478_D20210901-20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTUtMS0xLTEtNTM5MDY_ffc069d0-a4b2-4a21-b356-7ac462f728ed"
      unitRef="shares">8695000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1dc3ec9fcfa545bd8484b6f100236204_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTUtNS0xLTEtNTM5MDY_6d5e86d3-e648-4730-bf56-e88c4418b49b"
      unitRef="usd">-83000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i96f83ef275904264810bf98c69aa89aa_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTUtMTUtMS0xLTUzOTA2_f0a63c0f-a3bb-491b-9fb0-51fb653e14ae"
      unitRef="usd">-83000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i13178785dc1843d99d2ccce16ace2e65_D20210901-20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTctMS0xLTEtNTk0OTk_402472a4-37d4-454e-b887-3d6848212546"
      unitRef="shares">193000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ideddd48e387b42c2b942816100384d6a_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTctNS0xLTEtNTk0OTk_429638a2-855f-4e28-afa3-ad6c752e712b"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTctMTUtMS0xLTU5NDk5_c4f78486-804a-49c3-a9a4-3a7db7067753"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ideddd48e387b42c2b942816100384d6a_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTgtNS0xLTEtNTM5MDY_4d323967-1382-49c6-931c-157686c806a1"
      unitRef="usd">3008000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMTgtMTUtMS0xLTUzOTA2_8d3df3b3-d11e-462a-8263-433941809e13"
      unitRef="usd">3008000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia984848d280248bfbcb8e31640f1e39d_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjEtOS0xLTEtNTM5MDY_a577fe7d-0ade-49d9-939e-3b74ac0ed12d"
      unitRef="usd">819000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjEtMTUtMS0xLTUzOTA2_40cacce8-25e3-4edf-9c7c-f198f57ee4d7"
      unitRef="usd">819000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i155c045358b34383ac3295044d6c9a6b_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMS0xLTEtNTM5MDY_41ad0368-c98d-40ff-b1ab-e51702e8ac96"
      unitRef="shares">39455193000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i155c045358b34383ac3295044d6c9a6b_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMy0xLTEtNTM5MDY_9e3e6dec-c8a9-415d-b1ef-74847f764021"
      unitRef="usd">379000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifdec94434c4945059845c818633407fb_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItNS0xLTEtNTM5MDY_08e781b6-0416-46e4-a16d-7542bebf3f3f"
      unitRef="usd">580330000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a2dd77d8826427fb397445192c0bc76_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItNy0xLTEtNTM5MDY_4c98bf49-ca69-462a-a021-88f279bd23df"
      unitRef="usd">-147189000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9770758c2964b64b48d180cbdf84531_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItOS0xLTEtNTM5MDY_8158c5e0-6663-4ba9-ac4e-70c967184bd5"
      unitRef="usd">4562000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iaf6811aafe4e4669a27e18cdda0c54ef_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMTEtMS0xLTUzOTA2_dddab86c-aadf-4964-b59d-481c1cb39087"
      unitRef="shares">370000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="iaf6811aafe4e4669a27e18cdda0c54ef_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMTMtMS0xLTUzOTA2_ab9d275c-1635-4125-ac6e-9f6206f2014d"
      unitRef="usd">-5714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i580a989d6bd346dea798e59360b2cf7b_I20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18yOC9mcmFnOjA2YzA1YjgyYTMyMjQyNGQ5Y2M1ZGRlNDU3MzhkZTY0L3RhYmxlOjEzYzYxYzgwMTI0NDQwODM5MTM2NjgyMjc2M2E5ZmU5L3RhYmxlcmFuZ2U6MTNjNjFjODAxMjQ0NDA4MzkxMzY2ODIyNzYzYTlmZTlfMjItMTUtMS0xLTUzOTA2_f2535523-6e78-42de-a0ae-7c871be308d2"
      unitRef="usd">432368000</us-gaap:StockholdersEquity>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNC9mcmFnOmI0YzAxYTZhZmM4ZTQzMDBiOTM3N2RkNTcwYzVlY2FkL3RleHRyZWdpb246YjRjMDFhNmFmYzhlNDMwMGI5Mzc3ZGQ1NzBjNWVjYWRfMTI2MA_a7cc4234-ad2f-4fd7-81a9-67dba4e8dd7f">CONSOLIDATED FINANCIAL STATEMENTS&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Loss for the three and six months ended November&#160;30, 2022 and 2021, the Consolidated Balance Sheet as of November&#160;30, 2022, the Consolidated Statements of Cash Flows for the six months ended November&#160;30, 2022 and 2021, and the Consolidated Statements of Stockholders&#x2019; Equity for the six months ended November&#160;30, 2022 and 2021 have been prepared by the Company and are unaudited. The Consolidated Balance Sheet as of May&#160;31, 2022 was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to state fairly the financial position, changes in stockholders&#x2019; equity and comprehensive income, results of operations and cash flows as of and for the period ended November&#160;30, 2022 (and for all periods presented) have been made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim consolidated financial statements for the three and six months ended November&#160;30, 2022 and 2021 include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries (collectively, the "Company", "we", "our" or "us").  All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfODg2_cadbc739-5fe3-4cea-b769-d6ef31ed034c">ACQUISITIONSCamaro Support Catheter Asset AcquisitionOn July 27, 2021, the Company acquired the Camaro support catheter (rebranded as Syntrax) from QX Medical, LLC for an aggregate purchase price of $4.0&#160;million, which included an upfront payment of $3.6&#160;million and $0.4&#160;million in purchase price holdbacks, along with $1.0&#160;million of potential future contingent consideration related to revenue milestones. This acquisition supports the Auryon product family and the Company's strategic plan.  The Company accounted for this acquisition as an asset purchase.  The Company recorded the amount paid at closing as inventory and fixed assets of $0.1&#160;million and an intangible asset product technology of $3.9&#160;million.  The intangible asset will be amortized over 15 years.  The contingent consideration is comprised of revenue milestones and will be accounted for when the contingency is resolved or becomes probable and reasonably estimable.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="i22e896b21e924dea8f58a482a45a6580_D20210727-20210727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMjEw_ee0592af-17f4-4928-b413-46d730940fa5"
      unitRef="usd">4000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMjUx_2e42278b-9982-46b0-a1e2-65ad93fbe3f6"
      unitRef="usd">3600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMjU4_6b2dda06-98e6-4c1d-a31b-8bc29c967d49"
      unitRef="usd">400000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <ango:RevenueRemainingPerformanceObligationVariableConsiderationAmount
      contextRef="i64a04e2cf0dd4f329b46465d2bfa98d8_I20210727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfMzAx_0101cdca-6d53-4f3d-afd2-04ef4a51744a"
      unitRef="usd">1000000</ango:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <ango:AssetAcquisitionInventoryAndFixedAssets
      contextRef="i22e896b21e924dea8f58a482a45a6580_D20210727-20210727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfNjE0_0dc7aedf-df01-4cc3-9403-b1f498d48465"
      unitRef="usd">100000</ango:AssetAcquisitionInventoryAndFixedAssets>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ie6ddfbc23984498e818686d27ec8ab38_D20210727-20210727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfNjYz_56d4701d-1717-4934-9584-6f57110b5a82"
      unitRef="usd">3900000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i4932000aa21a49cda2393c4098bd3848_D20191217-20191217"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY18zNy9mcmFnOmE4MWNiNmVlYjhkZDQ5ZTk4NjMwMDFjNTJkNTUyMDM4L3RleHRyZWdpb246YTgxY2I2ZWViOGRkNDllOTg2MzAwMWM1MmQ1NTIwMzhfNzEy_7d6d373a-61cb-4e9c-90a5-e952a02244a7">P15Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMzNg_180c5915-a874-484a-bcfa-45363704718c">REVENUE FROM CONTRACTS WITH CUSTOMERS&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has one primary revenue stream which is the sales of its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company has previously announced, the Company is focused on its ongoing transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company that delivers unique and innovative health care solutions. The Company believes that this transformation will enable the Company to shift the portfolio from the mature, lower-growth markets where we have competed in the past by investing in technology and products that provide access to larger and faster growing markets. As such, we believe the growth in the near to mid-term will be driven by our Med Tech segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes net sales by Med Tech, Med Device and by geography:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended November 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended November 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Tech &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Device&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended November 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended November 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Tech &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Device&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Product Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's products consist of a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's products are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be implanted for short or long term use. The Company sells its products to its distributors and to end users, such as interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists and critical care nurses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contracts with its customers based on customer purchase orders, which in many cases are governed by master purchasing agreements. The Company&#x2019;s contracts with customers are generally for product only, and do not include other performance obligations such as services or other material rights. As part of its assessment of each contract, the Company evaluates certain factors including the customer&#x2019;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price and Allocation to Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction prices of products are typically based on contracted rates. Product revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to a customer, net of any variable consideration as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products underlying each performance obligation. The Company has standard pricing for its products and determines standalone selling prices based on the price at which the performance obligation is sold separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company&#x2019;s performance obligation is satisfied), which occurs at a point in time, and may be upon shipment from the Company&#x2019;s manufacturing site or delivery to the customer&#x2019;s named location, based on the shipping terms of a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining whether control has transferred, the Company considers if there is a present right to payment from the customer and when physical possession, legal title and risks and rewards of ownership have transferred to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically invoices customers upon satisfaction of identified performance obligations.  As the Company&#x2019;s standard payment terms are 30 to 90 days from invoicing, the Company does not provide any significant financing to its customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into agreements to place placement and evaluation units (&#x201c;units&#x201d;) at customer sites, but the Company retains title to the units. For the duration of these agreements the customer has the right to use the unit at no upfront charge in connection with the customer&#x2019;s ongoing purchase of disposables. These types of agreements include an embedded operating lease for the right to use the units. In these arrangements, revenue recognized for the sale of the disposables is not allocated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;between the disposal revenue and lease revenue due to the insignificant value of the units in relation to the total agreement value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves: Revenue from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established for discounts, returns, rebates and allowances that are offered within contracts between the Company and its customers.  These reserves are based on the amounts earned or to be claimed on the related sales and are classified as a contra asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rebates and Allowances: The Company provides certain customers with rebates and allowances that are explicitly stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. The Company establishes reserves for such amounts, which is included in accrued expenses in the accompanying Consolidated Balance Sheets. These rebates and allowances result from performance-based offers that are primarily based on attaining contractually specified sales volumes.  The Company is also required to pay administrative fees to group purchasing organizations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product Returns: The Company generally offers customers a limited right of return.  Product returns after 30 days must be pre-approved by the Company and customers may be subject to a 20% restocking charge.  To be accepted, a returned product must be unadulterated, undamaged and have at least twelve months remaining prior to its expiration date.  The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized.  The Company currently estimates product return liabilities using its historical product return information and considers other factors that it believes could significantly impact its expected returns, including product recalls.  During the six months ended November&#160;30, 2022, such product returns were not material.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances with Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A receivable is generally recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer and generally coincide with revenue recognition. Accordingly, the Company does not have any contract assets associated with the future right to invoice its customers. In some cases, if control of the product has not yet transferred to the customer or the timing of the payments made by the customer precedes the Company&#x2019;s fulfillment of the performance obligation, the Company recognizes a contract liability that is included in deferred revenue in the accompanying Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the Company&#x2019;s receivables, contract assets and contract liabilities with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended November&#160;30, 2022, the Company had additions to contract liabilities of $0.5 million.  This was offset by $0.5 million in revenue that was recognized during the six months ended November&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Costs to Obtain or Fulfill a Customer Contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 606, the Company may recognize an asset for incremental costs of obtaining a contract with a customer if it expects to recover those costs. The Company&#x2019;s sales incentive compensation plans qualify for capitalization since these plans are directly related to sales achieved during a period of time. However, the Company has elected the practical expedient under ASC 340-40-25-4 to expense the costs as they are incurred within selling and marketing expenses since the amortization period is less than one year.&lt;/span&gt;&lt;/div&gt;The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping and handling are recorded in net sales.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMyOQ_b13ed108-dff0-4f07-84e6-b1f912a4b59e">Revenue Recognition&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company&#x2019;s performance obligation is satisfied), which occurs at a point in time, and may be upon shipment from the Company&#x2019;s manufacturing site or delivery to the customer&#x2019;s named location, based on the shipping terms of a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining whether control has transferred, the Company considers if there is a present right to payment from the customer and when physical possession, legal title and risks and rewards of ownership have transferred to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically invoices customers upon satisfaction of identified performance obligations.  As the Company&#x2019;s standard payment terms are 30 to 90 days from invoicing, the Company does not provide any significant financing to its customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into agreements to place placement and evaluation units (&#x201c;units&#x201d;) at customer sites, but the Company retains title to the units. For the duration of these agreements the customer has the right to use the unit at no upfront charge in connection with the customer&#x2019;s ongoing purchase of disposables. These types of agreements include an embedded operating lease for the right to use the units. In these arrangements, revenue recognized for the sale of the disposables is not allocated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;between the disposal revenue and lease revenue due to the insignificant value of the units in relation to the total agreement value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves: Revenue from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established for discounts, returns, rebates and allowances that are offered within contracts between the Company and its customers.  These reserves are based on the amounts earned or to be claimed on the related sales and are classified as a contra asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rebates and Allowances: The Company provides certain customers with rebates and allowances that are explicitly stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. The Company establishes reserves for such amounts, which is included in accrued expenses in the accompanying Consolidated Balance Sheets. These rebates and allowances result from performance-based offers that are primarily based on attaining contractually specified sales volumes.  The Company is also required to pay administrative fees to group purchasing organizations.&lt;/span&gt;&lt;/div&gt;Product Returns: The Company generally offers customers a limited right of return.  Product returns after 30 days must be pre-approved by the Company and customers may be subject to a 20% restocking charge.  To be accepted, a returned product must be unadulterated, undamaged and have at least twelve months remaining prior to its expiration date.  The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized.  The Company currently estimates product return liabilities using its historical product return information and considers other factors that it believes could significantly impact its expected returns, including product recalls.  &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances with Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A receivable is generally recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer and generally coincide with revenue recognition. Accordingly, the Company does not have any contract assets associated with the future right to invoice its customers. In some cases, if control of the product has not yet transferred to the customer or the timing of the payments made by the customer precedes the Company&#x2019;s fulfillment of the performance obligation, the Company recognizes a contract liability that is included in deferred revenue in the accompanying Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Costs to Obtain or Fulfill a Customer Contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 606, the Company may recognize an asset for incremental costs of obtaining a contract with a customer if it expects to recover those costs. The Company&#x2019;s sales incentive compensation plans qualify for capitalization since these plans are directly related to sales achieved during a period of time. However, the Company has elected the practical expedient under ASC 340-40-25-4 to expense the costs as they are incurred within selling and marketing expenses since the amortization period is less than one year.&lt;/span&gt;&lt;/div&gt;The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping and handling are recorded in net sales.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMzNw_77d34daa-c544-41a7-ab28-409c5dfc6253">The following table summarizes net sales by Med Tech, Med Device and by geography:&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended November 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended November 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Tech &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Device&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended November 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended November 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Tech &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Device&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b1ac96c05c4496cbe867dec215b61da_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy0xLTEtMS01MzkwNg_0a20d937-fcbc-4a28-a024-cdfe46286f94"
      unitRef="usd">20550000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibff045fe7c34428eabb45c34bd46a77b_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy0zLTEtMS01MzkwNg_3c86f3c4-50db-4972-be22-42584ff72a76"
      unitRef="usd">3952000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy01LTEtMS01MzkwNg_d77c45c9-a5f3-4e95-ba3b-90f5a0b6b042"
      unitRef="usd">24502000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia05af3963048441980e5da6c628ad99e_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy03LTEtMS01MzkwNg_2789fc9c-f441-410a-884a-c7b3c28e2852"
      unitRef="usd">16243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97cc578ba1c14c2790275846f3e88b4f_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy05LTEtMS01MzkwNg_f65f2537-af38-48dc-b52f-092d0b3aaa37"
      unitRef="usd">2643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfMy0xMS0xLTEtNTM5MDY_7ba568d6-5dc8-4b9b-a76e-8b82cf822aef"
      unitRef="usd">18886000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03b89bf280264af8b946c348ba6191a5_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC0xLTEtMS01MzkwNg_2eecf2d3-3ad3-482a-824b-73e6a8a24d8a"
      unitRef="usd">51081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i608ce6e6291c48db9671f8baa53df352_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC0zLTEtMS01MzkwNg_637b729b-570a-4493-b84e-36d1aa3187be"
      unitRef="usd">9846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC01LTEtMS01MzkwNg_d84427aa-a5e9-463b-88f9-d7be95afe708"
      unitRef="usd">60927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6552b74e0da8424b8b3f0a28d099316d_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC03LTEtMS01MzkwNg_ecd75c9b-8b4d-4f0b-acc5-abc1a5bdee16"
      unitRef="usd">49107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69edc35bb61e4b13864a2034b42aa17e_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC05LTEtMS01MzkwNg_24c4fde0-aa17-4193-b887-4aac814cce2b"
      unitRef="usd">10287000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNC0xMS0xLTEtNTM5MDY_d3784a98-ea69-4584-9727-c208bfef77ad"
      unitRef="usd">59394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4c2fd9d28c04a93ae03769f99f5b982_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS0xLTEtMS01MzkwNg_b4757919-967e-4de5-9e3e-383dbb401f5f"
      unitRef="usd">71631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia84b2cc1c77648d59e643ea5bca9cd40_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS0zLTEtMS01MzkwNg_c8ecf6f5-d16a-4f69-9037-c5ca173c50a1"
      unitRef="usd">13798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS01LTEtMS01MzkwNg_2484b603-f3ac-4e68-b5f4-121d4784d72c"
      unitRef="usd">85429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69be4f7a7d4e429f9786923e58bb233a_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS03LTEtMS01MzkwNg_26b2c048-ffb6-4fed-9554-65e5a45b5be5"
      unitRef="usd">65350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e5207d4b6e44c3bb870e98f47ae464f_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS05LTEtMS01MzkwNg_66386942-c97b-4dec-913a-ccbf86c3d88a"
      unitRef="usd">12930000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmU1MTljODRiOWEyNTRjMjBhYTQzNmQ3NjA3ZDQ3Y2FjL3RhYmxlcmFuZ2U6ZTUxOWM4NGI5YTI1NGMyMGFhNDM2ZDc2MDdkNDdjYWNfNS0xMS0xLTEtNTM5MDY_c943e4c1-7658-4135-be16-b141f959718c"
      unitRef="usd">78280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fe0ea1cdf9b43cba1dc89583cfa12f4_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy0xLTEtMS01OTI1Nw_0f4b6aaa-6625-4bf7-8fe9-dd822c9271cf"
      unitRef="usd">40991000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f3b790c7408444aa2438a6d74ccf219_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy0zLTEtMS01OTI2NA_bab93aab-c423-4ba5-a18f-1a47b2c1d342"
      unitRef="usd">6327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy01LTEtMS01OTUyMQ_620a206d-bbfb-480f-bd59-ae0e840ec637"
      unitRef="usd">47318000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9782032ec849455f9eb55bcd5238506f_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy03LTEtMS01OTI3MQ_eb53b0c0-260b-481d-8b5e-fec52a54f952"
      unitRef="usd">31467000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i730d6d555ca8411db383a11b9f16a087_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy05LTEtMS01OTI3OA_bc5ece26-7564-43f6-ab4c-5a92730f79be"
      unitRef="usd">5026000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfMy0xMS0xLTEtNTk1MjE_be8eeae0-8783-4481-8640-dadeab73690b"
      unitRef="usd">36493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcdba87c68b44670aa983d442909c8c8_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC0xLTEtMS01OTI1Nw_7c66cf5f-890a-482a-8ff5-37b71cd7e1b7"
      unitRef="usd">99664000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f175e8bc06e4516859a922825203ed1_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC0zLTEtMS01OTI2NA_1853bc87-388e-4ead-b2d2-bb6050c1a217"
      unitRef="usd">19984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC01LTEtMS01OTUyMQ_c282b4e7-a4aa-4e88-b2e4-0bb11871fa54"
      unitRef="usd">119648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i109b126be6684609964e1d738004a5f0_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC03LTEtMS01OTI3MQ_d56d7c73-0b56-48f6-ad09-001a3e29aa18"
      unitRef="usd">98347000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b9577aad3e743eaab5f2db73438ff22_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC05LTEtMS01OTI3OA_03c4d41b-fba7-4772-bcdd-592b92d6145f"
      unitRef="usd">20411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNC0xMS0xLTEtNTk1MjE_45dd374c-aea1-4879-bfa8-f2bf60882c11"
      unitRef="usd">118758000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1532603b5d5344d2b521ebca95510e2d_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS0xLTEtMS01OTUyMQ_511f2d90-f8ce-4902-8ac7-0165f74c8236"
      unitRef="usd">140655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i102e00650df64160ab95f91283be5671_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS0zLTEtMS01OTUyMQ_c771e252-1a77-48de-88db-b031d166393a"
      unitRef="usd">26311000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS01LTEtMS01OTUyMQ_d29e4755-fd21-4458-bd98-b558af155f86"
      unitRef="usd">166966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6fa11be4a974f91a8f83c64c4b79d43_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS03LTEtMS01OTUyMQ_bfdc547f-5cab-4828-9c64-f00902c981b4"
      unitRef="usd">129814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bbd65f28780439d8d4b3739c60451f2_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS05LTEtMS01OTUyMQ_71810640-db07-42e1-8df2-2af7daafba33"
      unitRef="usd">25437000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOjQ0YmI0NDgzMzIxODQ1OWQ5ZjI5OGVlYTgxYmM1NmMzL3RhYmxlcmFuZ2U6NDRiYjQ0ODMzMjE4NDU5ZDlmMjk4ZWVhODFiYzU2YzNfNS0xMS0xLTEtNTk1MjE_9c83d98b-486b-4d26-9149-7fe55ca20769"
      unitRef="usd">155251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ango:RevenuePerformanceObligationPaymentTerm
      contextRef="ia2cfe7c548c8479c9c72cfb258097cbf_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNDU2Ng_46f0df4e-c51d-422d-87f5-b531e0448a37">P30D</ango:RevenuePerformanceObligationPaymentTerm>
    <ango:RevenuePerformanceObligationPaymentTerm
      contextRef="ibc7c9d9ebcb04ddca80d41fba203d212_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNDU3Mg_67d61237-b07c-49f9-a4c2-06f4103c6933">P90D</ango:RevenuePerformanceObligationPaymentTerm>
    <ango:ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNjU2Nw_14fbb069-108e-4354-a1fc-b7f7cd4c9294">P30D</ango:ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval>
    <ango:ContractWithCustomerRightOfReturnRestockingCharge
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNjY0MA_8e2a9fec-c8cc-49ef-90ef-5388fc28cc0a"
      unitRef="number">0.20</ango:ContractWithCustomerRightOfReturnRestockingCharge>
    <ango:ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfNjc0OQ_ab29667d-6ca7-4278-b40a-969fdf192b18">P12M</ango:ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfOTMzNA_2b0a5960-4a98-40bc-9afd-ed424a2db255">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the Company&#x2019;s receivables, contract assets and contract liabilities with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMS0xLTEtMS01MzkwNg_f6f1ea24-376f-49a1-83c6-02e49515741e"
      unitRef="usd">52852000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMS0zLTEtMS01MzkwNg_9aa9d18f-7f4a-4b29-8775-1aa704159064"
      unitRef="usd">52304000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMi0xLTEtMS01MzkwNg_8c5ae61a-20cd-492b-9558-7a1fb63a1e47"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMi0zLTEtMS01MzkwNg_43e0f340-3883-4908-90bf-53f9afe65321"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMy0xLTEtMS01MzkwNg_8b0e011c-2e55-4786-87ba-bbfcf17a5798"
      unitRef="usd">522000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RhYmxlOmEyN2Q4YTRhYmVhZDQ2MGY4YWQ5N2Y2Y2E5NzExNTkwL3RhYmxlcmFuZ2U6YTI3ZDhhNGFiZWFkNDYwZjhhZDk3ZjZjYTk3MTE1OTBfMy0zLTEtMS01MzkwNg_8e6c1554-2137-449f-b74b-b89f96c15452"
      unitRef="usd">526000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfODIwMQ_04119730-60e7-4363-b4c7-52fdfcc6b064"
      unitRef="usd">500000</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <ango:CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180MC9mcmFnOjA5ZDMwYjg0YzY0ZjQ4NjNhMjNkYzVkZDU2OWRlZTZkL3RleHRyZWdpb246MDlkMzBiODRjNjRmNDg2M2EyM2RjNWRkNTY5ZGVlNmRfODIyNQ_b0a597cb-f1d1-4d51-9079-fd0f9ff20906"
      unitRef="usd">500000</ango:CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTM4_bbf695e4-955e-43b3-aeb5-397041703de7">INVENTORIES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at lower of cost and net realizable value (using the first-in, first-out method).  Inventories consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The Company periodically reviews inventory for both obsolescence and loss of value.  The Company makes assumptions about the future demand for and market value of the inventory.  Based on these assumptions, the Company estimates the amount of obsolete, expiring and slow-moving inventory.  The total inventory reserve at November&#160;30, 2022 and May&#160;31, 2022 was $3.9 million and $3.7 million, respectively.</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTM3_b29c98bb-0266-4b63-bff9-e06c6209a326">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at lower of cost and net realizable value (using the first-in, first-out method).  Inventories consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMS0xLTEtMS01MzkwNg_8de16f1e-0da0-4611-87cd-220bbe2aeef5"
      unitRef="usd">33732000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMS0zLTEtMS01MzkwNg_750da56d-d692-4505-b633-d8a33a2ade78"
      unitRef="usd">28251000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMi0xLTEtMS01MzkwNg_e939df1f-b62a-4f6e-a54b-ef48bcd67cc2"
      unitRef="usd">8201000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMi0zLTEtMS01MzkwNg_a3c3171f-ff3e-440b-93cf-517295e9d258"
      unitRef="usd">7186000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMy0xLTEtMS01MzkwNg_72ab024b-17af-461d-93aa-0f6f4f5eab5f"
      unitRef="usd">21244000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfMy0zLTEtMS01MzkwNg_68b775ec-c825-4c9a-964e-918b00533f73"
      unitRef="usd">15955000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfNC0xLTEtMS01MzkwNg_adf7523a-9e1e-43ea-ab0d-44a452e8bd77"
      unitRef="usd">63177000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RhYmxlOmNjYzBjNjIxZGYyYjRiYWZhMzUwYmFmYTAxYzI0NjZhL3RhYmxlcmFuZ2U6Y2NjMGM2MjFkZjJiNGJhZmEzNTBiYWZhMDFjMjQ2NmFfNC0zLTEtMS01MzkwNg_3fbf5444-5fe3-4c5a-a8e5-e511584cbfae"
      unitRef="usd">51392000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTAz_52551c1f-d2a9-4a33-8b7f-008af05c3a0f"
      unitRef="usd">3900000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180My9mcmFnOjExOTYzMGM3MjNmODQ5YmE4YTAwZTZkZWYyNzM1Y2YxL3RleHRyZWdpb246MTE5NjMwYzcyM2Y4NDliYThhMDBlNmRlZjI3MzVjZjFfNTEw_8345171e-fa2e-4f5b-9b75-7372f5d91c4f"
      unitRef="usd">3700000</us-gaap:InventoryValuationReserves>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDYwNA_a4918cb1-ce8f-4c27-80eb-9c7da4118b0d">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is not amortized, but rather, is tested for impairment annually or more frequently if impairment indicators arise. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in each business combination. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically performed its annual goodwill assessment during the third quarter of each fiscal year.  During the fourth quarter of fiscal year 2022, the Company changed its annual impairment assessment date from December 31 to April 30 to more closely align the impairment assessment date with the Company's long term planning and forecasting process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's annual testing for impairment of goodwill was completed as of April 30, 2022.  Prior to the first quarter of fiscal year 2023, the Company managed its operations as one reporting unit.  At the beginning of the first quarter of fiscal year 2023, the Company began to manage its operations as two operating segments and two reporting units, namely Med Tech and Med Device (see Note 11 "Segment and Geographic Information" set forth in the Notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q).  As a result of this change, goodwill was required to be allocated to each reporting unit and an interim goodwill impairment assessment was performed at the Company and reporting unit levels.  To determine the fair value of the individual reporting units and the entire company as of June 1, 2022, the Company utilized the income approach.  The income approach is based on the projected cash flows discounted to their present value using discount rates, that in the Company's judgment, consider the timing and risk of the forecasted cash flows using internally developed forecasts and assumptions.  Under the income approach, the discount rate used is the average estimated value of a market participant&#x2019;s cost of capital and debt, derived using customary market metrics.  Other significant assumptions include revenue growth rates, profitability projections, and terminal value growth rates.  The market approach was also considered; however, the income approach was chosen as the Company determined it is a better representation of both the Med Tech and Med Device reporting units' projected long-term performance. The fair value of each reporting unit and the Company as a whole was assessed to determine if there was any impairment.  The Company compared each reporting unit's fair value to the adjusted carrying value to conclude that there was no impairment for either reporting unit or the Company as a whole.  The adjusted carrying value of each reporting unit was used to calculate the Company's book value to compare to its market capitalization at the assessment date.  Based on the results of this evaluation, there were no adjustments to goodwill for either reporting unit or the Company as a whole as of August 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adjustments to goodwill for the six months ended November&#160;30, 2022 other than foreign currency translation adjustments.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Even though the Company determined that there was no goodwill impairment at November&#160;30, 2022, the future occurrence of a potential indicator of impairment, such as a significant adverse change in legal, regulatory, business or economic conditions or a more-likely-than-not expectation that one of the reporting units or a significant portion of either of the reporting units will be sold or disposed of, would require an interim assessment for the reporting units prior to the next required annual assessment as of April 30, 2023.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill for each reporting unit is allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Med Tech &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Med Device &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adjustments to goodwill for the six months ended November&#160;30, 2022 other than foreign currency translation adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Definite Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill are amortized over their estimated useful lives on a straight-line basis. Useful lives range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0Mg_fc669142-82c7-49b8-a7a9-e8917629543b"&gt;two&lt;/span&gt; to eighteen years.  The Company periodically reviews, and adjusts, if necessary, the estimated useful lives of its intangible assets and reviews such assets or asset groups for impairment whenever events or changes in circumstances indicate that the carrying value of the assets or asset groups may not be recoverable. If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&#160;carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&#160;carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three months ended November&#160;30, 2022 and 2021 was $4.8 million and $4.9 million, respectively.  Amortization expense for the six months ended November&#160;30, 2022 and 2021 was $9.6 million and $9.7 million, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected future amortization expense related to the intangible assets for each of the following fiscal years is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i96f682ba85b44a3598400d9868b15c05_D20220601-20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfODg3_82d53026-c381-401e-9cfb-e6c138fd8026"
      unitRef="unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTAxMg_5b665c83-3829-44d5-8ed5-9332d13e6ccc"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportingUnits
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTAzOA_197333f1-dfcd-4b7c-8cc4-95f3ec1591ac"
      unitRef="unit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id1e9f928ee4349a68577d07adcc3b26f_D20201231-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzAyMw_6dcc70c8-699b-4c1b-b9d8-55e746d9c2a4"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDU5NQ_ab0f9aed-64ca-4200-b684-a94cb7799c33">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill for each reporting unit is allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Med Tech &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Med Device &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3c31b0a2ffcb46a09974a5fc03fcb07e_I20220601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMi0xLTEtMS01OTQ5MQ_3375956e-408d-492f-bd47-ce48e554c0e4"
      unitRef="usd">160529000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1e8bf515dc504d2e93a4cef1b15e47ed_I20220601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMi0zLTEtMS01OTQ5MQ_4bfc9507-0165-46b3-a599-07195cfb9199"
      unitRef="usd">40529000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic64f7b15ed9b474995bee41f47ae8270_I20220601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMi01LTEtMS01OTQ5MQ_e584d6e0-e0bd-4019-9e58-779bfd24bd45"
      unitRef="usd">201058000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if5cf0bee2d60494bb2779598e5ddb3eb_D20220602-20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMy0xLTEtMS01OTQ5MQ_7f0c09f5-f678-4a4c-9837-381d7f747fc4"
      unitRef="usd">-20000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia0e0ea76bcf04919ab502a0c59748fb9_D20220602-20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMy0zLTEtMS01OTQ5MQ_943c53a0-ebc8-45c9-aa0b-dfe5c456085c"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3a1d991006824083b8178abc9d11b0d5_D20220602-20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfMy01LTEtMS01OTQ5MQ_ea014423-8148-432c-b5f5-244388ab29b2"
      unitRef="usd">-20000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i3a86996ae3f64984bc0a4ecc7bd4af54_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNC0xLTEtMS01OTQ5MQ_9a1411d8-9d49-4c1c-97be-a99842158131"
      unitRef="usd">160509000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iac2d1378a1f24161b87c458f35456450_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNC0zLTEtMS01OTQ5MQ_ef672902-e901-43c1-af30-c520653173c8"
      unitRef="usd">40529000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i605f35cad602428b8143074fa8c31ba8_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNC01LTEtMS01OTQ5MQ_73a54436-258e-4caa-893a-476a730ee786"
      unitRef="usd">201038000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0e064f90d3da49b9a66c4ac18aad1d0d_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNS0xLTEtMS01OTQ5Mw_3afb3d62-13c8-414c-95ed-93f92286a5ed"
      unitRef="usd">-283000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia41e9cc6df0e4df7ac811956f8aff5e4_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNS0zLTEtMS01OTQ5Mw_e09a7f8c-e4b9-41be-b041-5c4249662894"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNS01LTEtMS01OTQ5Mw_4b328902-b3b4-48db-b01b-69f54b9bced1"
      unitRef="usd">-283000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i4026512e869c44a08831de2435fa433a_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNi0xLTEtMS01OTQ5Mw_cbb65a79-3076-49f5-9f31-d02ee0bdb47d"
      unitRef="usd">160226000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0933abd0902b4939a41c2a553e06b97d_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNi0zLTEtMS01OTQ5Mw_6aa8dd09-b511-43e0-87a1-1c94dc5335e2"
      unitRef="usd">40529000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjUzNGQ1OTc2ZGZjNjQ2MmQ4OTQwMTFhM2Q0ODk2M2I5L3RhYmxlcmFuZ2U6NTM0ZDU5NzZkZmM2NDYyZDg5NDAxMWEzZDQ4OTYzYjlfNi01LTEtMS01OTQ5Mw_ff226151-9c91-4d0f-952f-1dfe89832325"
      unitRef="usd">200755000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibc7c9d9ebcb04ddca80d41fba203d212_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMzg0OA_0a58229e-be64-47e5-ba0e-f0058153c34c">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <ango:ScheduleOfIntangibleAssetsTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDU5Ng_d7c9e348-ee8b-4236-ae3b-6fa8cc00fe2d">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&#160;carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&#160;carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ango:ScheduleOfIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMi0xLTEtMS01MzkwNg_328a6eda-f500-42a0-8251-0d816bafa62e"
      unitRef="usd">237863000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMi0zLTEtMS01MzkwNg_e46de334-d82b-43bd-8e7b-1f067d6ba4a9"
      unitRef="usd">119301000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie8d16252a7e34aca9dd4edaa9b487b30_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMi01LTEtMS01MzkwNg_3c48ca26-be1d-41f3-9df4-89233e83dd1c"
      unitRef="usd">118562000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i03538be72f0c479d88269196fae7627d_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMy0xLTEtMS01MzkwNg_c5699adb-fc1b-4128-a9f3-2d2bb3b89a63"
      unitRef="usd">60076000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i03538be72f0c479d88269196fae7627d_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMy0zLTEtMS01MzkwNg_d4cf3780-197f-4817-b706-0d89fae50369"
      unitRef="usd">39972000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i03538be72f0c479d88269196fae7627d_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfMy01LTEtMS01MzkwNg_95bdb756-8d03-46cc-84af-0407f1b7db7d"
      unitRef="usd">20104000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9a63b72365594c83ac835e0622876350_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNC0xLTEtMS01MzkwNg_d24fd28f-5bf7-4a48-a21b-960c00de3999"
      unitRef="usd">9950000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9a63b72365594c83ac835e0622876350_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNC0zLTEtMS01MzkwNg_79e302c7-f5f4-4c55-85b7-6066ce841360"
      unitRef="usd">7326000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9a63b72365594c83ac835e0622876350_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNC01LTEtMS01MzkwNg_b3380c1a-e001-4685-a5ff-afe7e69aa535"
      unitRef="usd">2624000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i481617886ccd437181a9534ee467fcaa_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNS0xLTEtMS01MzkwNg_f3556d74-55be-471e-986d-3ae65479c66b"
      unitRef="usd">5377000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i481617886ccd437181a9534ee467fcaa_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNS0zLTEtMS01MzkwNg_7760b179-6e21-4ce8-93f8-6890c4b659bf"
      unitRef="usd">4724000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i481617886ccd437181a9534ee467fcaa_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfNS01LTEtMS01MzkwNg_395f5bfd-83ba-4628-b3a7-014722ef0e9d"
      unitRef="usd">653000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfOC0xLTEtMS01MzkwNg_8aac24f4-b7d8-4d37-94ab-beffcb21e1e4"
      unitRef="usd">313266000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfOC0zLTEtMS01MzkwNg_b4e50061-835d-4a81-b25a-113e4cde3557"
      unitRef="usd">171323000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjQzOWIzMDdiMDg3ZjRiZDU4Nzk3ZmY2ZTZiNTE0YTBhL3RhYmxlcmFuZ2U6NDM5YjMwN2IwODdmNGJkNTg3OTdmZjZlNmI1MTRhMGFfOC01LTEtMS01MzkwNg_9c54a36a-55cd-47b9-86ba-e3679ab0483b"
      unitRef="usd">141943000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i232cbe1e1fc44360a597810368435c6e_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMi0xLTEtMS01MzkwNg_9c21af61-19b9-4e62-930c-ca6675fccc6b"
      unitRef="usd">239467000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i232cbe1e1fc44360a597810368435c6e_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMi0zLTEtMS01MzkwNg_283b9de8-3f91-4ac3-a3ef-02fb5ed82ad0"
      unitRef="usd">112141000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i232cbe1e1fc44360a597810368435c6e_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMi01LTEtMS01MzkwNg_62f64995-e0d2-4e74-a01e-bab55be6809b"
      unitRef="usd">127326000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id17cfc417d92464bbedc0236cf2219c3_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMy0xLTEtMS01MzkwNg_d7a20b69-3598-4ebb-a636-a9b14cc0701c"
      unitRef="usd">60115000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id17cfc417d92464bbedc0236cf2219c3_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMy0zLTEtMS01MzkwNg_092a7622-28a4-4680-af59-65a728646e37"
      unitRef="usd">38003000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id17cfc417d92464bbedc0236cf2219c3_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfMy01LTEtMS01MzkwNg_eb14bfe1-dd06-4724-ab7b-3f6e07050106"
      unitRef="usd">22112000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib38c064a30b74d81851783f9a22c7991_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNC0xLTEtMS01MzkwNg_612b682e-9454-4466-a767-6e05d8786a78"
      unitRef="usd">9950000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib38c064a30b74d81851783f9a22c7991_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNC0zLTEtMS01MzkwNg_ad6eda95-0256-42f2-9f45-64a5eb0d0fce"
      unitRef="usd">7185000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib38c064a30b74d81851783f9a22c7991_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNC01LTEtMS01MzkwNg_45561e45-f79b-428a-8548-907bfb2a3f92"
      unitRef="usd">2765000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNS0xLTEtMS01MzkwNg_61c806fb-00a4-49d9-a79a-ee1e3f89385e"
      unitRef="usd">4837000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNS0zLTEtMS01MzkwNg_c562e18b-3fe8-4aa7-98de-f74e4bebe489"
      unitRef="usd">4660000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifa0e928a6c7f475aa085c1aa3e5f3ff5_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfNS01LTEtMS01MzkwNg_985d4e22-1e08-4309-bd3a-bceedf1e9304"
      unitRef="usd">177000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfOC0xLTEtMS01MzkwNg_37ab8985-eada-4a40-962a-aed9929b21b3"
      unitRef="usd">314369000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfOC0zLTEtMS01MzkwNg_66b09770-1bea-4e46-80a2-3d764c27dd74"
      unitRef="usd">161989000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOmZlYTZlNWE2YzMxYzQwZDRhMjJhOTRkOWRmZjU2OWIwL3RhYmxlcmFuZ2U6ZmVhNmU1YTZjMzFjNDBkNGEyMmE5NGQ5ZGZmNTY5YjBfOC01LTEtMS01MzkwNg_db310b38-3929-4b1f-92e7-835f9fa638fb"
      unitRef="usd">152380000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTA5OTUxMTYzMjQ3Mg_5604a7e6-243b-43fb-9a66-16ba850ba637"
      unitRef="usd">4800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTA5OTUxMTYzMjU0Mw_ce2ab24a-e58d-4563-9715-7e7c75efe616"
      unitRef="usd">4900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMjc0ODc3OTA3NDE4MQ_d4791fb7-b9ab-464b-9761-bfa89bb921ea"
      unitRef="usd">9600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfMTA5OTUxMTYzMjU0OQ_e769e9a3-9c91-4af4-a4dc-9cd079faaf70"
      unitRef="usd">9700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RleHRyZWdpb246MTNiMDMzZjBkYmI4NDRkMmI3OTc1ZjQ0OGY1NWM2YjFfNDYwMg_057ec237-c244-4607-b03c-7c5bf78a27df">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected future amortization expense related to the intangible assets for each of the following fiscal years is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfMS0xLTEtMS01MzkwNg_844dd914-05a0-4e81-9444-44cfc59751e7"
      unitRef="usd">9229000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfMi0xLTEtMS01MzkwNg_3b12aaaa-b773-405e-b803-05742fffb6a1"
      unitRef="usd">16680000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfMy0xLTEtMS01MzkwNg_2da17c2b-904c-4849-93e7-de9b63c54cc9"
      unitRef="usd">16662000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNC0xLTEtMS01MzkwNg_6671a414-6a05-4096-8797-f6f12ec57ef9"
      unitRef="usd">16481000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNS0xLTEtMS01MzkwNg_168ae14d-a70d-40d9-b581-7a35d95ac1b1"
      unitRef="usd">16310000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <ango:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNi0xLTEtMS01MzkwNg_65240a97-b584-4c26-be89-368e7c9dd626"
      unitRef="usd">66581000</ango:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180Ni9mcmFnOjEzYjAzM2YwZGJiODQ0ZDJiNzk3NWY0NDhmNTVjNmIxL3RhYmxlOjAwMTY1ZWQ2YTA0ODQ1M2M4MWFkMjVhNWJiZmE2Y2RmL3RhYmxlcmFuZ2U6MDAxNjVlZDZhMDQ4NDUzYzgxYWQyNWE1YmJmYTZjZGZfNy0xLTEtMS01MzkwNg_2678e7f9-f330-40d7-b4ae-3c0e8157bd3e"
      unitRef="usd">141943000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RleHRyZWdpb246YTM2ZGI2ZGMwZWY5NDZiYmEzZjE4MTM0ZGNjMzM3ZDVfODI_bcde7d59-d894-4fb8-8a9d-ed55ea23e9cf">ACCRUED LIABILITIES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and franchise taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RleHRyZWdpb246YTM2ZGI2ZGMwZWY5NDZiYmEzZjE4MTM0ZGNjMzM3ZDVfNzg_b2d62a52-cf02-4592-b21b-e18984517a51">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and franchise taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMS0xLTEtMS01MzkwNg_40bdf9c3-c1d8-4760-915e-fcc9782b396d"
      unitRef="usd">10185000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMS0zLTEtMS01MzkwNg_de72a7c6-1cdd-407c-ba30-b7dd032d2c6c"
      unitRef="usd">20232000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMi0xLTEtMS01MzkwNg_cfd2bfcc-cec9-490a-b9cd-8c747e87c8f3"
      unitRef="usd">1967000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMi0zLTEtMS01MzkwNg_94bc2c2b-c1a7-4948-9294-a42d249e8647"
      unitRef="usd">2986000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMy0xLTEtMS01MzkwNg_7357ceba-8a48-41b3-b104-18487af7d2d1"
      unitRef="usd">6739000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMy0zLTEtMS01MzkwNg_0346cab4-4e3d-4a97-8aad-4b07b6bd0874"
      unitRef="usd">3731000</us-gaap:AccruedProfessionalFeesCurrent>
    <ango:AccruedResearchAndDevelopmentCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNC0xLTEtMS01MzkwNg_a4c17ccb-8d2c-4bbf-aea4-e6846dbd563e"
      unitRef="usd">1084000</ango:AccruedResearchAndDevelopmentCurrent>
    <ango:AccruedResearchAndDevelopmentCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNC0zLTEtMS01MzkwNg_13476d62-2258-4c93-98c8-432ab0909ecc"
      unitRef="usd">1279000</ango:AccruedResearchAndDevelopmentCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNS0xLTEtMS01MzkwNg_0bf751e7-8ed6-4d7a-8c3f-4e5cfec22d4c"
      unitRef="usd">815000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNS0zLTEtMS01MzkwNg_96b51dda-199c-43a3-ae9b-362ccae3f4d1"
      unitRef="usd">750000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNy0xLTEtMS01MzkwNg_a6df9e66-13a3-409f-814b-94bb5ce560e7"
      unitRef="usd">421000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfNy0zLTEtMS01MzkwNg_488a9191-f1e6-4219-b021-686cde71fe1f"
      unitRef="usd">511000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfOC0xLTEtMS01MzkwNg_f526e9ea-2eeb-4575-8ba4-5cf83bc9c9af"
      unitRef="usd">5322000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfOC0zLTEtMS01MzkwNg_d02ed941-22cb-446e-b375-0d29dd312368"
      unitRef="usd">5353000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMTAtMS0xLTEtNTM5MDY_3a6c1461-c200-4f24-a2a8-2aec812acfc4"
      unitRef="usd">26533000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY180OS9mcmFnOmEzNmRiNmRjMGVmOTQ2YmJhM2YxODEzNGRjYzMzN2Q1L3RhYmxlOmIwZWZmMjBiZTdmZjQ1M2Q4ZjMzYmFlYTZjNDQwNTRkL3RhYmxlcmFuZ2U6YjBlZmYyMGJlN2ZmNDUzZDhmMzNiYWVhNmM0NDA1NGRfMTAtMy0xLTEtNTM5MDY_dbbfeb35-c846-4486-8158-d9278994641c"
      unitRef="usd">34842000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc2Ng_e39d09ef-5041-4e9d-b87a-44a3a1414632">LONG-TERM DEBT&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 30, 2022, the Company repaid all amounts outstanding under its then existing credit agreement and entered into a new Credit Agreement (the "Credit Agreement") with its lenders, JPMorgan Chase Bank, N.A., as Administrative Agent, sole bookrunner, and sole lead arranger, and Bank of America, N.A. and KeyBank National Association, as Syndication Agents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement provides for a $75.0&#160;million secured revolving credit facility (the "Revolving Facility") and a $30.0&#160;million delayed draw term loan (the "Delayed Draw Term Loan"), and also includes an uncommitted expansion feature that allows the Company to increase the total revolving commitments and/or add new tranches of term loans in an aggregate amount not to exceed $75.0 million.&#160; Each exercise of such expansion feature must be drawn in $5.0&#160;million increments.  The proceeds of the Revolving Facility may be used for general corporate purposes, including permitted acquisitions.  The proceeds of the Delayed Draw Term Loan may be used for general corporate purposes, including primarily to finance the manufacturing costs of the Auryon laser capital equipment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement has a five-year maturity.  Interest on the Revolving Facility and  Delayed Draw Term Loan will be based, at the Company's option, on a rate equal to (i) the Secured Overnight Financing Rate ("SOFR") plus 0.10% (subject to a floor of 0%), or (ii) if the Company elects to treat a borrowing as an ABR Borrowing, an alternate base rate based on SOFR, plus, in each case, an applicable margin of 1.25%, 1.50% or 1.75%, depending on the leverage ratio.  If any amounts are not paid when due, such overdue amounts will bear interest at an amount generally equal to 2.0% plus the existing loan rate.  The Credit Agreement also carries a commitment fee in the case of the Revolving Facility, and a ticking fee, in the case of the Delayed Draw Term Loans of 0.20% to 0.25% per annum on the unused portion.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's obligations under the Credit Agreement are unconditionally guaranteed, jointly and severally, by the Company's material direct and indirect domestic subsidiaries (the &#x201c;Guarantors&#x201d;). All obligations of the Company and the Guarantors under the Credit Agreement are secured by first priority security interests in substantially all of the assets of the Company and the Guarantors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, two quarterly financial covenants as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Maximum leverage ratio of consolidated total indebtedness* to consolidated EBITDA* of not greater than 3.00 to 1.00 (during certain periods following material acquisitions the ratio shall be increased to 3.50 to 1.00). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Fixed charge coverage ratio of consolidated EBITDA minus consolidated capital expenditures* to&#160;consolidated interest expense* paid or payable in cash plus scheduled principal payments in respect of indebtedness under the Credit Agreement of not less than 1.25 to 1.00. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* The definitions of consolidated total indebtedness, consolidated EBITDA, consolidated capital expenditures and consolidated interest expense are specifically defined in the Credit Agreement included as an exhibit to Form 8-K filed on August 31, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of November&#160;30, 2022, there was $25.0&#160;million outstanding on the Revolving Facility and $25.0&#160;million outstanding on the Delayed Draw Term Loan and the interest rate at November&#160;30, 2022 applicable to each was 5.59%.  As of November&#160;30, 2022 and May&#160;31, 2022, the carrying value of long-term debt approximated its fair market value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delayed Draw Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments of approximately 3.57% on the Delayed Draw Term Loan will amortize in equal quarterly installments over a five year period beginning on the earlier of a full draw or the expiry of the draw period (March 1, 2024).&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i51440fe9937d4880a24b852c727c72bc_I20220830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfNDI0_c2163e0d-0421-4390-8247-b4746a03607d"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i40a6ca8a1a2a47948d181c2ddd57b60e_I20220830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfNDk0_73ad811c-72a8-4ebd-a8a7-004407d79679"
      unitRef="usd">30000000</us-gaap:DebtInstrumentFaceAmount>
    <ango:LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature
      contextRef="ie93908ff9fa24ce8a539c1afc8be059d_I20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfNzQ2_f1d59a11-3d4b-4d56-87dc-8044616513c0"
      unitRef="usd">75000000</ango:LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="idd47ebcb2afe4eab9e20c68e5a784838_D20220830-20220830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfODA4_54e6d0e5-ed8b-4de7-850f-a5399cc9be20"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="iac18782ad5a1446b96f8bacea0595e03_D20190603-20190603"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc3MA_80fa0d18-f092-45a6-a9a7-6c4249aa0741">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie66d2669acf841099e3090e565eb8955_D20220830-20220830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTM0OA_b0bc2479-92a9-47dd-9486-6506968574c4"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ango:DebtInstrumentFloorInterestRate
      contextRef="ie66d2669acf841099e3090e565eb8955_D20220830-20220830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTM3NA_239bcc8d-64df-4a07-9ae1-ef2528315200"
      unitRef="number">0</ango:DebtInstrumentFloorInterestRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6651e0f87eed4540b11c234da6d13537_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTUzMw_39c87266-8665-42f4-b46d-499dbb880cd2"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i65b19051a3bf4afba6d1ee320c49fadb_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTUzNw_b5f81dcb-9336-4b6b-9b65-3a0a5e8c53be"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2a200b6474a84a51a5841bde35741a37_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTU0Mw_ead48383-1ad5-4b97-a8fa-104e3e6a92d3"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ango:DebtInstrumentDebtDefaultInterestRateIncrease
      contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTY5MQ_1fd396df-b030-40dc-9341-f3141967cddd"
      unitRef="number">0.020</ango:DebtInstrumentDebtDefaultInterestRateIncrease>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i48b85744365f40d9883440cec0fe503a_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTg3OQ_15162074-d5d3-4ca3-ad4d-6cec89fc62ca"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i0ec7dba98bb64aa7b30c01f66cec9680_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMTg4NQ_bdea048f-aaff-4df7-ae7f-19591011d198"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <ango:LineOfCreditFacilityNumberOfCovenants
      contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMjQ5MQ_fe492766-a53e-43cd-88cf-2f6546214f76"
      unitRef="covenant">2</ango:LineOfCreditFacilityNumberOfCovenants>
    <ango:DebtInstrumentCovenantTermsMaximumTotalLeverageRatio
      contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMjY0MA_84b52950-e444-4970-a984-483a00e46e8e"
      unitRef="number">3.00</ango:DebtInstrumentCovenantTermsMaximumTotalLeverageRatio>
    <ango:DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions
      contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMjczOQ_0f756da2-1241-4d7a-a17e-da4c38f53edf"
      unitRef="number">3.50</ango:DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions>
    <ango:DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio
      contextRef="ia4c0f690ce4a44ff9d65f33f53eef8a9_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzAwOA_6c62e79b-d14e-48b8-9ad1-94c500f09d11"
      unitRef="number">1.25</ango:DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio>
    <us-gaap:LineOfCredit
      contextRef="i9c7dabef1a2548fc9b252f702944e5c6_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzI5Ng_397b09de-efdb-48dc-98ed-666c2d204d57"
      unitRef="usd">25000000</us-gaap:LineOfCredit>
    <us-gaap:LongTermDebt
      contextRef="ia7eb5c10613d48cb9ebc0fe8c4cf3a93_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzM0MQ_1af3ebb8-d2f2-4ac0-8d08-b5c2481586e4"
      unitRef="usd">25000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i9c7dabef1a2548fc9b252f702944e5c6_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzQzNw_e5959d32-c8ea-49bf-b54e-549b97c5dbde"
      unitRef="number">0.0559</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc3MQ_10fcb119-2d23-4b98-b2fb-4edf318855e0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delayed Draw Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9c7dabef1a2548fc9b252f702944e5c6_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfMS0xLTEtMS01MzkwNg_1a5a0e4c-1bb8-48b3-b3c3-b78ebcfb9212"
      unitRef="usd">25000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7eb5c10613d48cb9ebc0fe8c4cf3a93_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfMi0xLTEtMS01MzkwNg_aad732e7-9d65-4cc9-bc41-bf864544e3f5"
      unitRef="usd">25000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfMy0xLTEtMS01MzkwNg_f45024f9-1814-46a9-8def-79e7edd2409e"
      unitRef="usd">204000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RhYmxlOjMxMTg1MTZlZTNkNDQwOWJhZGI5ZjVhYjI0ZjY4OTUyL3RhYmxlcmFuZ2U6MzExODUxNmVlM2Q0NDA5YmFkYjlmNWFiMjRmNjg5NTJfNC0xLTEtMS01MzkwNg_bfd95022-09d7-424b-ab6c-9e76115869a6"
      unitRef="usd">49796000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="idc15638543e04c98b695a64a354303c6_D20220601-20221130"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzU3Mw_7eabf6e9-9a3b-4693-9518-6237fe67019c"
      unitRef="number">0.0357</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="idc15638543e04c98b695a64a354303c6_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181Mi9mcmFnOjUyZWFjZTQ0YTA2NzRlYjM5MzlhYzU4MjA2YTBhNzg4L3RleHRyZWdpb246NTJlYWNlNDRhMDY3NGViMzkzOWFjNTgyMDZhMGE3ODhfMzc3Mg_ea403f4c-887a-41e5-99b3-440913cfc562">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181NS9mcmFnOjYxZjkzMzViOGUyMjRmNzZhNzg5MjU4NzQ0MDU5ODU3L3RleHRyZWdpb246NjFmOTMzNWI4ZTIyNGY3NmE3ODkyNTg3NDQwNTk4NTdfMTk1MA_dcfbf529-b237-421d-8c37-5aa9d5516ea2">INCOME TAXES&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year adjusted for any discrete events, which are recorded in the period that they occur. &#160;The estimated annual effective tax rate prior to discrete items was 5.8% as of the second quarter of fiscal year 2023, as compared to 12.3% for the same period in fiscal year 2022.  In fiscal year 2023, the Company&#x2019;s effective tax rate differs from the U.S. statutory rate primarily due to the impact of the valuation allowance, foreign taxes, and other non-deductible permanent items (such as non-deductible meals and entertainment, Section 162(m) excess compensation and non-deductible share-based compensation). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence.  Therefore, the Company has provided a valuation allowance on its federal and state net operating loss carryforwards, federal and state R&amp;amp;D credit carryforwards and other net deferred tax assets that have a limited life and are not supportable by the naked credit deferred tax liability sourced income as of November&#160;30, 2022.  The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&#x2019;s results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181NS9mcmFnOjYxZjkzMzViOGUyMjRmNzZhNzg5MjU4NzQ0MDU5ODU3L3RleHRyZWdpb246NjFmOTMzNWI4ZTIyNGY3NmE3ODkyNTg3NDQwNTk4NTdfMzE0_cd53e6dc-5522-43e1-b1db-fcaea84d10eb"
      unitRef="number">0.058</ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent>
    <ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181NS9mcmFnOjYxZjkzMzViOGUyMjRmNzZhNzg5MjU4NzQ0MDU5ODU3L3RleHRyZWdpb246NjFmOTMzNWI4ZTIyNGY3NmE3ODkyNTg3NDQwNTk4NTdfMzcy_64811a32-a830-4abd-9aae-66516c851658"
      unitRef="number">0.123</ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjU3MQ_d9444894-4b93-4d20-83ef-c3516341e319">SHARE-BASED COMPENSATION&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 13, 2020, the Company's shareholders approved the 2020 Stock and Incentive Award Plan (the &#x201c;2020 Plan&#x201d;).  The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance share units, performance shares and other incentive awards to the Company's employees, directors and other service providers.  On November 3, 2022 the Company's shareholders approved an amendment to the 2020 Plan to increase the reserve of shares of common stock available for future grants by 1,950,000 shares.  As of November&#160;30, 2022, there was a maximum of 2.8&#160;million shares of common stock available for future grant under the 2020 Plan.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the adoption of the 2020 Plan, equity awards were issued under the 2004 Stock and Incentive Award Plan (the &#x201c;2004 Plan&#x201d;).  The adoption of the 2020 Plan did not impact the administration of equity awards issued under the 2004 Plan but following the adoption of the 2020 Plan, equity award grants are no longer made under the 2004 Plan.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has an employee stock purchase plan.  On November 3, 2022 the Company's shareholders approved an amendment to the employee stock purchase plan to increase the reserve of shares of common stock available for future grants by 1,000,000 shares.  As of November&#160;30, 2022, there was a maximum of 3.3&#160;million shares of common stock available for future grant under the employee stock purchase plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended November&#160;30, 2022 and 2021, share-based compensation expense was $3.4 million and $3.0 million, respectively.  For the six months ended November&#160;30, 2022 and 2021, share-based compensation expense was $6.4&#160;million and $5.4&#160;million, respectively.    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended November&#160;30, 2022 and 2021, the Company granted stock options and restricted stock units under the 2020 Plan to certain employees and members of the Board of Directors.  Stock option awards are valued using the Black-Scholes option-pricing model and then amortized on a straight-line basis over the requisite service period of the award.  Restricted stock unit awards are valued based on the closing trading value of the Company&#x2019;s common stock on the date of grant and then amortized on a straight-line basis over the requisite service period of the award.  &lt;/span&gt;&lt;/div&gt;During the six months ended November&#160;30, 2022 and 2021, the Company granted performance share units under the 2020 Plan to certain employees.  The awards may be earned by achieving performance levels over the requisite service period.  The performance criteria are based on achieving certain performance targets and the total shareholder return (&#x201c;TSR&#x201d;) of the Company&#x2019;s common stock relative to the TSR of the common stock of a pre-defined industry peer-group.  The fair value of these awards is based on a Monte Carlo simulation model.  As of November&#160;30, 2022, there was $24.4 million of unrecognized compensation expense related to share-based payment arrangements.  These costs are expected to be recognized over a weighted-average period of approximately two years.  The Company has sufficient shares to satisfy expected share-based payment arrangements.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="ifa54aec1d4754ab481509765d96d5677_D20221103-20221103"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjE5OTAyMzI1ODc5Mg_0965d44d-e6a1-470e-ac05-a6048451155b"
      unitRef="shares">1950000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i72ea6dcaec304dba8c28be69f4cd1398_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfNDg2_7a8735a6-d3a6-4c5b-bb10-b96bd2b8824a"
      unitRef="shares">2800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="i5d63329084d44df394d886d4d1bb5ee2_D20221103-20221103"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjE5OTAyMzI1ODgwMw_69bcdae2-aa1a-4e61-b0e0-e518228a0324"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ieefdf4931e024fcbba5c7e8746fb00ff_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfOTk3_834498cf-e8a4-4f69-b893-f801ecc13b8c"
      unitRef="shares">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTE2NQ_aeb2283c-b147-48bd-8b6c-5685239d42b6"
      unitRef="usd">3400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTE3Mg_6d8f5100-8322-4514-a9d2-98d2ebbae2e1"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTA5OTUxMTYzMDQ5Ng_07f82682-d945-4b2f-aa91-5409c635b19d"
      unitRef="usd">6400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMTA5OTUxMTYzMDUxMA_1958f165-2d9b-4acf-ac51-b9a6e0314543"
      unitRef="usd">5400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjMwMg_e3dc5ac7-7f7a-4cdb-a492-59e33c74d0d5"
      unitRef="usd">24400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY181OC9mcmFnOjAyNzI1NjQzYzM5MjQ5ZTg4YmViYzdmNWU2YWYwM2JhL3RleHRyZWdpb246MDI3MjU2NDNjMzkyNDllODhiZWJjN2Y1ZTZhZjAzYmFfMjQ3OA_7258dea1-d34c-4181-b9f2-5722001c9eba">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RleHRyZWdpb246ZDBjMmYxMTU1NGQ4NGNjZDllZDIxZDZmNTg1MDFiNWNfNjY2_5e0af118-28a7-4c89-8d7f-2005095724d2">EARNINGS PER SHARE&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is based on the weighted average number of common shares outstanding without consideration of potential common stock. Diluted earnings per share includes the dilutive effect of potential common stock consisting of stock options, restricted stock units and performance stock units, provided that the inclusion of such securities is not anti-dilutive. In periods with a net loss, stock options and restricted stock units are not included in the computation of diluted loss per share as the impact would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles basic to diluted weighted-average shares outstanding: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three&#160;Months&#160;Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities excluded as their inclusion would be anti-dilutive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RleHRyZWdpb246ZDBjMmYxMTU1NGQ4NGNjZDllZDIxZDZmNTg1MDFiNWNfNjcw_3fc2584a-e515-496c-b4a4-f0c95e65197b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles basic to diluted weighted-average shares outstanding: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three&#160;Months&#160;Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities excluded as their inclusion would be anti-dilutive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi0xLTEtMS01MzkwNg_f615353c-1191-4da3-887c-4e98c29a95ea"
      unitRef="shares">39490000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi0zLTEtMS01MzkwNg_47c07c99-8c43-4006-bf16-7ddc2111cc1b"
      unitRef="shares">39053000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi01LTEtMS01MzkwNg_9dd29ac2-6eec-4683-a6bb-9cf6f29902d3"
      unitRef="shares">39394000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMi03LTEtMS01MzkwNg_8789302c-af5a-4d05-9e4b-bb64c550a8d4"
      unitRef="shares">38893000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy0xLTEtMS01MzkwNg_ee554fe5-6907-4320-91a0-8a7a0107d6c6"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy0zLTEtMS01MzkwNg_0b2b81ae-ed2f-4732-8d53-23fc5fd1a2b7"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy01LTEtMS01MzkwNg_495264f5-9dc0-4e67-8d45-4198ba82cb3f"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfMy03LTEtMS01MzkwNg_2434913b-770f-4580-862f-8b855bc926a3"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC0xLTEtMS01MzkwNg_e9526fa6-2079-4a70-ba6f-746a432d86f7"
      unitRef="shares">39490000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC0zLTEtMS01MzkwNg_8ce5950c-b156-4a1f-9385-141012ccd453"
      unitRef="shares">39053000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC01LTEtMS01MzkwNg_4b1c84ee-9372-45b2-975f-790a3c3cb56f"
      unitRef="shares">39394000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNC03LTEtMS01MzkwNg_080fdce4-a27c-4681-a497-7ddc3f0a15c6"
      unitRef="shares">38893000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi0xLTEtMS01MzkwNg_9f020193-cf5f-4e4b-bba6-8fce9c254498"
      unitRef="shares">3793000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi0zLTEtMS01MzkwNg_e0f55cff-8621-4a02-8e2f-214b0a6f204c"
      unitRef="shares">3510000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi01LTEtMS01MzkwNg_243fd853-0b0c-48e9-9750-0ce8e68c5259"
      unitRef="shares">3793000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182MS9mcmFnOmQwYzJmMTE1NTRkODRjY2Q5ZWQyMWQ2ZjU4NTAxYjVjL3RhYmxlOjE0OTBlODM5NGQ2MjRkYjdiYjI2M2EwYTYzMGI5Y2Q0L3RhYmxlcmFuZ2U6MTQ5MGU4Mzk0ZDYyNGRiN2JiMjYzYTBhNjMwYjljZDRfNi03LTEtMS01MzkwNg_ffe9852f-f28a-4a41-ab05-39104841b5e4"
      unitRef="shares">3510000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjQyMw_7a01208a-b995-4db6-b471-bacd37e5ab14">SEGMENT AND GEOGRAPHIC INFORMATION&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:21.6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly reviews its segments and the approach used by the chief operating decision maker, the President and Chief Executive Officer ("CEO"), and management to evaluate performance and allocate resources.  Prior to the first quarter of fiscal year 2023, the Company considered the business to be a single operating segment engaged in the development, manufacture and sale of medical devices for vascular access, peripheral vascular disease and oncology on a global basis.  Commencing with the first quarter of fiscal year 2023, the Company began to manage its operations through two segments, Med Tech and Med Device to align with the transformation from a company with a broad portfolio of largely undifferentiated products to a more focused medical technology company.  The Company's chief operating decision maker evaluates these two segments based on net sales and gross margin to, among other items, allocate resources and assess performance.  Executives reporting to the CEO include those responsible for commercial operations, manufacturing operations, regulatory and quality and certain corporate functions.  The CEO evaluates all other elements of profitability, investment and cash flow metrics on a consolidated global basis due to shared infrastructure and resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company manages its assets on a total company basis, not by operating segment; therefore, the CEO does not review any asset information by operating segment and, accordingly, asset information is not reported or evaluated by operating segment.  Total assets were $558.2 million as of November&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes net sales and gross margin by Med Tech and Med Device including prior periods during which the Company considered the business to be a single operating segment, in order to conform to the current period presentation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Tech Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gross margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Device Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gross margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gross margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Geographic information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes net sales by geographic area based on external customer location:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;For the three months ended November&#160;30, 2022 and 2021, international sales as a percentage of total net sales were 16.2% and 16.5%, respectively.  For the six months ended November&#160;30, 2022 and 2021, international sales as a percentage of total net sales were 15.8% and 16.4%, respectively.  Sales to any one country outside the U.S., as determined by shipment destination, did not comprise a material portion of net sales in any of the last three fiscal years. In addition, no one customer represents more than 10% of consolidated net sales and 96% of long-lived assets are located within the United States.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfNjA1_db02c173-ff67-4450-92c8-6ce358c07543"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfOTA4_db02c173-ff67-4450-92c8-6ce358c07543"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:Assets
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMTA5OTUxMTYzMDU2NA_a4a725c5-0124-4a7e-b4d9-134d75f97b8d"
      unitRef="usd">558200000</us-gaap:Assets>
    <ango:ScheduleOfNetRevenueByProductGroupTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjQzMg_07c8334e-074f-44cb-b756-abd3d2a2e761">The table below summarizes net sales and gross margin by Med Tech and Med Device including prior periods during which the Company considered the business to be a single operating segment, in order to conform to the current period presentation:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Tech Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gross margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Med Device Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gross margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gross margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ango:ScheduleOfNetRevenueByProductGroupTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy0xLTEtMS01MzkwNg_d9a8703e-453f-4da9-8a06-7ed2ef7ab704"
      unitRef="usd">24502000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy0zLTEtMS01MzkwNg_77852287-4531-41c6-9c56-3eed676e9f45"
      unitRef="usd">18886000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy01LTEtMS01MzkwNg_3fa52ca4-e4df-4247-9a59-4837d0f4a3e2"
      unitRef="usd">47318000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMy03LTEtMS01MzkwNg_ff72aad4-bc50-4183-b6b7-6dd25669d3ba"
      unitRef="usd">36493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC0xLTEtMS01MzkwNg_4472d82a-c9d0-4b29-9e42-68f728424aa3"
      unitRef="usd">15614000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC0zLTEtMS01MzkwNg_09a8dd1e-4d72-492d-923a-6b6181e7aa80"
      unitRef="usd">12578000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC01LTEtMS01Nzg0Mw_9519998a-f3b8-4309-b3db-f11ebb4d05d9"
      unitRef="usd">30043000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNC03LTEtMS01Nzg1Mg_831f6697-2c85-4cc5-8e2c-bebdd293e8e0"
      unitRef="usd">24095000</us-gaap:GrossProfit>
    <ango:GrossMarginPercentage
      contextRef="ia7cf2371beb243ac809deef0d5f399dd_D20220901-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS0xLTEtMS01MzkwNg_3a89d169-7fec-43a4-ae1e-7ab4662c8d96"
      unitRef="number">0.637</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="i9da7d71470d046839e99da599e632e18_D20210901-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS0zLTEtMS01MzkwNg_c9de2a44-850f-4511-bee3-611cf87b78b7"
      unitRef="number">0.666</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="ifa5895dff1504af8b53362954d42a835_D20220601-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS01LTEtMS01ODkyNA_b5c8d42d-1609-4b64-a31c-fe7aa087ad47"
      unitRef="number">0.635</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="i02b33e4b49cc4c5a8b45c84f4885d21e_D20210601-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNS03LTEtMS01ODkyNA_8259a8a7-3d38-44da-b61b-afd8021f28fb"
      unitRef="number">0.660</ango:GrossMarginPercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy0xLTEtMS01MzkwNg_7f45a9e8-b306-48d2-bed1-1352156e6e54"
      unitRef="usd">60927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy0zLTEtMS01MzkwNg_47ad14d6-8f4a-46ce-bc7b-c3445d6b6c01"
      unitRef="usd">59394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy01LTEtMS01MzkwNg_2fd19173-6fef-4a90-9222-4b313d49b26a"
      unitRef="usd">119648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfNy03LTEtMS01MzkwNg_8c9b0aad-5ce8-41aa-9e53-9118f334a89d"
      unitRef="usd">118758000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC0xLTEtMS01MzkwNg_879c1573-156d-4451-b41d-b1b1684dc01d"
      unitRef="usd">29464000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC0zLTEtMS01MzkwNg_66f0b9da-c007-44a4-b245-e19f721b66fa"
      unitRef="usd">27977000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC01LTEtMS01Nzg2MQ_5ebb625d-11ae-480b-9b37-8d3d97bef438"
      unitRef="usd">57340000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOC03LTEtMS01Nzg3MQ_09726aa9-808b-4560-bd98-44311ccc31e2"
      unitRef="usd">56599000</us-gaap:GrossProfit>
    <ango:GrossMarginPercentage
      contextRef="i180ed0c523f540d4909ecf60ee05277a_D20220901-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS0xLTEtMS01MzkwNg_09c62cbe-2d02-4198-92bc-c7b3fab59bf0"
      unitRef="number">0.484</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="ia4f0a61f5f28442fa51956d277ea9e1b_D20210901-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS0zLTEtMS01MzkwNg_67759b88-01b6-4f1a-bbc9-0dd566c29d9d"
      unitRef="number">0.471</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="ia42c8b6418cf42f9909602d7756471f2_D20220601-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS01LTEtMS01ODk0OA_36061b02-1061-4cb0-9f0c-86f0519ef910"
      unitRef="number">0.479</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="ia8ba2b15f70842f8abdfdf2f5299c5be_D20210601-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfOS03LTEtMS01ODk0OA_64e41b8a-a0a8-43fe-ad21-29d81a11f018"
      unitRef="number">0.477</ango:GrossMarginPercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtMS0xLTEtNTM5MDY_7c52205f-fc99-4e2a-82d4-e7704fc86d7b"
      unitRef="usd">85429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtMy0xLTEtNTM5MDY_46f110a4-5beb-4705-87df-b9da8e7dc5ef"
      unitRef="usd">78280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtNS0xLTEtNTM5MDY_af9164c3-0c8a-408c-b6fd-6506febff56e"
      unitRef="usd">166966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTEtNy0xLTEtNTM5MDY_ff02c581-8415-4db4-8f0a-1b213acd82b5"
      unitRef="usd">155251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItMS0xLTEtNTM5MDY_914daaef-a00a-4508-bb9a-a258124df269"
      unitRef="usd">45078000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItMy0xLTEtNTM5MDY_58da206b-4a06-4174-8247-3947721f9a82"
      unitRef="usd">40555000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItNS0xLTEtNTk1MzE_6cbe8d10-4d00-4115-acad-9f9f18c8de58"
      unitRef="usd">87383000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTItNy0xLTEtNTk1MzE_83f51b05-c9c1-4026-9827-651450496a69"
      unitRef="usd">80694000</us-gaap:GrossProfit>
    <ango:GrossMarginPercentage
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtMS0xLTEtNTM5MDY_e53f5b6e-47a1-4389-9092-a90ec2b2c0fd"
      unitRef="number">0.528</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtMy0xLTEtNTM5MDY_fd52b4e2-1f20-40f1-9ab9-c66a7aaa042d"
      unitRef="number">0.518</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtNS0xLTEtNTg0NDc_4abb22d2-4726-4fea-94f3-30183582d22c"
      unitRef="number">0.523</ango:GrossMarginPercentage>
    <ango:GrossMarginPercentage
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjYxNGFkYzdlODdmMzQ5N2VhY2I4YjNhZjQxODQwYWU2L3RhYmxlcmFuZ2U6NjE0YWRjN2U4N2YzNDk3ZWFjYjhiM2FmNDE4NDBhZTZfMTMtNy0xLTEtNTg0NTM_45506ef5-0157-4696-a53e-70e9e43ac5ea"
      unitRef="number">0.520</ango:GrossMarginPercentage>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjQyOA_198dc25e-377c-46d6-b519-fa36323b61dc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes net sales by geographic area based on external customer location:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4c2fd9d28c04a93ae03769f99f5b982_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy0xLTEtMS01MzkwNg_f074a8cd-2832-48b4-8b49-1d6f7c115b3d"
      unitRef="usd">71631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69be4f7a7d4e429f9786923e58bb233a_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy0zLTEtMS01MzkwNg_7d7a3981-f992-4a7e-9cfb-2743507f9c8b"
      unitRef="usd">65350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1532603b5d5344d2b521ebca95510e2d_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy01LTEtMS01MzkwNg_db2b3ea3-efd3-42d2-be49-9150e9119493"
      unitRef="usd">140655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6fa11be4a974f91a8f83c64c4b79d43_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfMy03LTEtMS01MzkwNg_1f6d24d1-d77f-4f19-a59b-a502d6cdf56a"
      unitRef="usd">129814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia84b2cc1c77648d59e643ea5bca9cd40_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC0xLTEtMS01MzkwNg_1d5732a3-c1bd-4f83-b57c-08f8f3812519"
      unitRef="usd">13798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e5207d4b6e44c3bb870e98f47ae464f_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC0zLTEtMS01MzkwNg_8966f00a-2f99-4f65-a96d-ead0a8fc8b20"
      unitRef="usd">12930000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i102e00650df64160ab95f91283be5671_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC01LTEtMS01MzkwNg_371d4b92-b8e6-456d-8102-9b3f915c3d00"
      unitRef="usd">26311000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bbd65f28780439d8d4b3739c60451f2_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNC03LTEtMS01MzkwNg_5d382f78-3607-4c19-958b-b694ee51f93b"
      unitRef="usd">25437000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi0xLTEtMS01MzkwNg_83e67bc4-6ae5-4d3e-a12b-55b94f5aa8d3"
      unitRef="usd">85429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi0zLTEtMS01MzkwNg_89963319-09c3-4503-b342-0101faf11fc9"
      unitRef="usd">78280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi01LTEtMS01MzkwNg_336655da-e0f3-4309-94c6-50c0dacf1243"
      unitRef="usd">166966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RhYmxlOjkwMDM2NWY5ZTQyYzQ5Y2JiMDA5MjkyZGQ1NmIxZmYwL3RhYmxlcmFuZ2U6OTAwMzY1ZjllNDJjNDljYmIwMDkyOTJkZDU2YjFmZjBfNi03LTEtMS01MzkwNg_9a3dbde0-44b0-4949-bab2-a8626d85cd5d"
      unitRef="usd">155251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id088a0af0c2d43b9ad0bda298d1ff754_D20220901-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjA3Ng_cdba627e-1b74-4136-be13-5b658ae5e915"
      unitRef="number">0.162</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibc69fb0bea484528bc57184c81e8345b_D20210901-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjA4Mw_5dc947b8-b83c-4b3b-9e48-1a1e28ab4329"
      unitRef="number">0.165</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i731c9ba446ab4192a1491d1c6f27c373_D20220601-20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMTA5OTUxMTYzMDI3MA_39245c7b-e248-41f9-8225-8ca2ddfebe91"
      unitRef="number">0.158</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i636ddb4bd5b74d3f8a431176bd1d93e5_D20210601-20211130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMTA5OTUxMTYzMDI3Mw_11a3b41d-5602-4c78-9a31-690569536208"
      unitRef="number">0.164</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibbe2c52f725c437ab009d57429836a32_D20220601-20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182NC9mcmFnOjIzZGE3YTlkMWIwYTQ2ZDhiOWIzZmVmNzJjNDJiMzlkL3RleHRyZWdpb246MjNkYTdhOWQxYjBhNDZkOGI5YjNmZWY3MmM0MmIzOWRfMjM1Ng_103e71cd-354c-42b9-9963-23e50000799b"
      unitRef="number">0.96</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI2Ng_9f49d865-0cc9-4bbc-b9e1-6a3c432df5fe">FAIR VALUE&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, the Company measures certain financial assets and financial liabilities at fair value based upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, the Company applies valuation techniques to estimate fair value. FASB ASC Topic 820,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of financial assets and financial liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.  The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - Inputs to the valuation methodology are significant unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's financial instruments include cash and cash equivalents, accounts receivable, accounts payable and contingent consideration. The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities.  The recurring fair value measurements using significant unobservable inputs (Level 3) relate to contingent consideration liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements using inputs considered as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value at Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration for acquisition earn outs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements using inputs considered as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value at May&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration for acquisition earn outs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between Level 1, 2 and 3 for the three and six months ended November&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the changes in fair value components of Level 3 instruments:     &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in present value of contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency gain from remeasurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in present value of contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency gain from remeasurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Liability for Acquisition Earn Outs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company's business combinations involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones or various other performance conditions. Payment of the additional consideration is generally contingent on the acquired company reaching certain performance milestones, including attaining specified revenue levels or product development targets. Contingent consideration is recorded at the estimated fair value of the contingent payments on the acquisition date. The fair value of the contingent consideration is remeasured at the estimated fair value at each reporting period with the change in fair value recognized as income or expense within change in fair value of contingent consideration in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the initial liability and remeasures the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements, which is determined using a discounted cash flow model applied to projected net sales, using probabilities of achieving projected net sales and projected payment dates. Projected net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sales are based on internal projections and extensive analysis of the target market and the sales potential. Increases or decreases in any valuation inputs in isolation may result in a significantly lower or higher fair value measurement in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of November&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue based payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;At November&#160;30, 2022, the amount of undiscounted future contingent consideration that the Company expects to pay as a result of all completed acquisitions is approximately $20.0&#160;million.  The milestones, including revenue projections and technical milestones associated with the contingent consideration, must be reached in future periods ranging from fiscal years 2023 to 2029 in order for the associated consideration to be paid.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI4Mw_7cbbae31-d962-48db-96b9-ed4db0f7a7a8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements using inputs considered as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value at Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration for acquisition earn outs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements using inputs considered as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value at May&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration for acquisition earn outs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i85a313731ab245768b6c5d3dfb85c22a_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItMS0xLTEtNTM5MDY_b9378f24-03e1-4826-a88c-a9a28653cbab"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie3ad2ccb7c6b41e89084e3b945f40e64_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItMy0xLTEtNTM5MDY_c7379fb5-750a-4e5b-9b86-ef99ea61f3c0"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia25b0cac0e4a4dac8864feacd65915ec_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItNS0xLTEtNTM5MDY_decc177b-8dcb-4d99-afd1-1d9e74fd7fce"
      unitRef="usd">18832000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4b1288467e0d4c2b98b2092131400cc2_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTItNy0xLTEtNTM5MDY_03390c5b-1efc-4a16-9bf9-847f5a2b431c"
      unitRef="usd">18832000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i85a313731ab245768b6c5d3dfb85c22a_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtMS0xLTEtNTM5MDY_a38d22cc-837e-44fe-b191-ddd15d1b94d6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie3ad2ccb7c6b41e89084e3b945f40e64_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtMy0xLTEtNTM5MDY_e18fa073-8df0-40e9-ada0-4c76bb857cbb"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia25b0cac0e4a4dac8864feacd65915ec_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtNS0xLTEtNTM5MDY_0d8b7a22-c58a-42fb-87c5-44fe131e3f58"
      unitRef="usd">18832000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4b1288467e0d4c2b98b2092131400cc2_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMTMtNy0xLTEtNTM5MDY_7b58bc9b-e690-4dd3-837c-43a485ed40cf"
      unitRef="usd">18832000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id5eebdc1dda64c488bf0ee527902d32d_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtMS0xLTEtNTM5MDY_9d716292-f2d0-4e71-b91c-f952161ad64e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i48bf28259a0f48979d1480adb13bf9ec_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtMy0xLTEtNTM5MDY_c3f74931-bf92-48e6-84e4-2e340a9ef5c0"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i63e7d990beb04157bf2af35e180e5437_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtNS0xLTEtNTM5MDY_0bd3d69e-6481-4046-bfae-3fcf62019a36"
      unitRef="usd">16948000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i50932b29e3234e39be7fd89538f9ae51_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjUtNy0xLTEtNTM5MDY_ecd88f5a-e315-4616-bf84-ea119394b658"
      unitRef="usd">16948000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id5eebdc1dda64c488bf0ee527902d32d_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtMS0xLTEtNTM5MDY_e1120ef0-3c60-4255-b39d-406436735842"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i48bf28259a0f48979d1480adb13bf9ec_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtMy0xLTEtNTM5MDY_e26e7508-e93b-48cd-8568-0a3a3d21a2a6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i63e7d990beb04157bf2af35e180e5437_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtNS0xLTEtNTM5MDY_f1e29948-ebe5-421e-9738-4aaffa3be1e0"
      unitRef="usd">16948000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i50932b29e3234e39be7fd89538f9ae51_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjVhMDZhYTk2NzQwMTRlM2U5NmQ2M2ZkYWJiOTQ4ODI1L3RhYmxlcmFuZ2U6NWEwNmFhOTY3NDAxNGUzZTk2ZDYzZmRhYmI5NDg4MjVfMjYtNy0xLTEtNTM5MDY_3986d5b6-58e8-4b6a-97ad-74074236385d"
      unitRef="usd">16948000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI3OA_5bc9350b-24f3-404a-b8de-dbf7ac6d62b9">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the changes in fair value components of Level 3 instruments:     &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in present value of contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency gain from remeasurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&#160;Measurements Using Significant Unobservable Inputs (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in present value of contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency gain from remeasurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount.</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i605f35cad602428b8143074fa8c31ba8_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfMi0xLTEtMS01MzkwNg_bc72942d-bd30-4827-bde1-18228f8d895d"
      unitRef="usd">17158000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <ango:ChangeInFairValueOfContingentConsideration
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfNC0xLTEtMS01MzkwNg_7f656501-471b-4384-9b3f-1511a9f61728"
      unitRef="usd">1646000</ango:ChangeInFairValueOfContingentConsideration>
    <ango:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfNS0xLTEtMS01MzkwNg_fe275d81-80ea-46ba-88e3-2f7138d4c9c1"
      unitRef="usd">28000</ango:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjA4MmE1NGRkODJhZjQzNzVhYTkzNWNjMjM5ZDUwZmMyL3RhYmxlcmFuZ2U6MDgyYTU0ZGQ4MmFmNDM3NWFhOTM1Y2MyMzlkNTBmYzJfNi0xLTEtMS01MzkwNg_54c46098-e0c7-43a4-8cb1-6b3c395f3dba"
      unitRef="usd">18832000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfMi0xLTEtMS01OTUzMw_578df072-83b4-437a-96c4-b1cb1c9f833d"
      unitRef="usd">16948000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <ango:ChangeInFairValueOfContingentConsideration
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfNC0xLTEtMS01OTUzMw_0645bec6-395e-4498-adac-300bc751d684"
      unitRef="usd">1857000</ango:ChangeInFairValueOfContingentConsideration>
    <ango:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfNS0xLTEtMS01OTUzMw_fac96de5-75f8-470c-8e61-9ad704f53416"
      unitRef="usd">27000</ango:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjUyYjQ4MGRiZjliYzQ2M2JiYTY4MWRlNmEwNDA2NmZhL3RhYmxlcmFuZ2U6NTJiNDgwZGJmOWJjNDYzYmJhNjgxZGU2YTA0MDY2ZmFfNi0xLTEtMS01OTUzMw_1dadfff9-f020-42f2-be16-2364de922c9a"
      unitRef="usd">18832000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDI4MQ_d3bd66e1-030b-491b-809d-bc3c9a338924">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of November&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue based payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icd9433e4df6a4d73bdb71c139f61a75a_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMS0xLTEtMS01MzkwNg_15cb867f-97da-48af-b3e0-6c1db608d7d6"
      unitRef="usd">18832000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i360405dac2ac408196db947950f5fcdd_I20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMS03LTEtMS01MzkwNg_87c71ead-038b-48fe-ab17-14a346e8e10f"
      unitRef="number">5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8d7862e7cad34bfd8d2c83decfca3201_I20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMi03LTEtMS01MzkwNi90ZXh0cmVnaW9uOmFmMjIzOWU0ZThiZDRjYjc4NmIyOTMxNjQ2MGEwZDJjXzQ_fb80494f-a656-4838-8b4e-249774f750cd"
      unitRef="number">0.90</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i86ec9e06fac9486392729b869d82f434_I20221130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RhYmxlOjY2NjBkMTVmYmMzNzRjNmY5MzM0MjZhMTM2MTM4ZDE3L3RhYmxlcmFuZ2U6NjY2MGQxNWZiYzM3NGM2ZjkzMzQyNmExMzYxMzhkMTdfMi03LTEtMS01MzkwNi90ZXh0cmVnaW9uOmFmMjIzOWU0ZThiZDRjYjc4NmIyOTMxNjQ2MGEwZDJjXzk_8c44aff4-49c5-4e4e-8fde-e02f477b44fd"
      unitRef="number">1</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <ango:UndiscountedContingentConsiderationDisclosure
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY182Ny9mcmFnOjhiM2U2M2U3YjgyMTQ1ZDI5MTFiZmFhMTc0ODRiZDBlL3RleHRyZWdpb246OGIzZTYzZTdiODIxNDVkMjkxMWJmYWExNzQ4NGJkMGVfNDAxNg_0d4b6271-343f-4d10-b1f5-a91e5bf8ee7f"
      unitRef="usd">20000000</ango:UndiscountedContingentConsiderationDisclosure>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc1Nw_4a99ba60-3d71-4c58-b7fb-5083752257a6">LEASES&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception of the contract.  The Company has operating leases for buildings, primarily for office space, R&amp;amp;D, manufacturing and warehousing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date.  Many of the lease agreements contain renewal or termination clauses that are factored into the determination of the lease term if it is reasonably certain that these options would be exercised.  The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to leases:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate implicit in lease agreements is typically not readily determinable, and as such the Company used the incremental borrowing rate based on the information available at commencement date in determining the present value of future payments.  The incremental borrowing rate is defined as the interest the Company would pay to borrow on a collateralized basis, considering factors such as length of lease term.  The following table presents the weighted average remaining lease term and discount rate:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturities of the lease liabilities for each of the following fiscal years is:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended November&#160;30, 2022 and 2021, the Company recognized $0.7 million and $0.7 million of operating lease expense, respectively, which includes immaterial short-term leases.  During the six months ended November 20, 2022 and 2021, the Company recognized $1.4&#160;million and $1.4&#160;million of operating leases expense, respectively, which includes immaterial short-term leases.  The expenses on the Consolidated Statement of Operations were classified as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow and other information related to leases for the six months ended:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <ango:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc2Mg_36aaf87b-0397-4b45-8aea-8f021985c524">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to leases:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e4c0de31-95ac-4ee7-b36d-7b0c79dc61f9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0xLTEtMS01MzkwNg_e56e909f-8d01-459c-a7d6-1ae2d5b84bee"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_bc18ab03-3ff5-42b8-98f6-d74ad5a9a830"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0xLTEtMS01MzkwNg_cad03038-efd8-4da1-b669-ac6f5a9b6662"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_38146802-b068-43e9-98a3-6489dd0f05bd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0xLTEtMS01MzkwNg_86cf5c09-8431-46c8-9f01-beb913076e56"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The following table presents the weighted average remaining lease term and discount rate:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ango:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi0zLTEtMS01MzkwNg_a2a64b55-11c5-4fc7-b948-c7cd37fa6645"
      unitRef="usd">5748000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfMi01LTEtMS01MzkwNg_ce44080e-5ecd-4a00-b43a-2a1cdfe672f5"
      unitRef="usd">6974000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC0zLTEtMS01MzkwNg_b4a93ba2-6920-4f3f-966b-c9923a8a473d"
      unitRef="usd">2491000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNC01LTEtMS01MzkwNg_ac1f3d95-8180-4854-afa6-d89f25ee0f5b"
      unitRef="usd">2560000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS0zLTEtMS01MzkwNg_00efdbfc-3316-47cd-aa51-72764316bace"
      unitRef="usd">3490000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNS01LTEtMS01MzkwNg_0e5c0b0a-fc76-4c86-bd68-4e82956058b8"
      unitRef="usd">4703000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNi0zLTEtMS01MzkwNg_1df79834-dd53-4da5-971a-358a8bcea398"
      unitRef="usd">5981000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i3787173c67d1467ea7ad2812b803a924_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjk5NzE1N2IxNzExYjRmZDQ4N2ZlMTlhZjcxNzdmNTAwL3RhYmxlcmFuZ2U6OTk3MTU3YjE3MTFiNGZkNDg3ZmUxOWFmNzE3N2Y1MDBfNi01LTEtMS01MzkwNg_3954571b-09a2-43d2-811a-572e23594ed7"
      unitRef="usd">7263000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjA5ZjdjMTdjYWRlMTQwYjhiM2IyNGE3MjRjZTBmMDAyL3RhYmxlcmFuZ2U6MDlmN2MxN2NhZGUxNDBiOGIzYjI0YTcyNGNlMGYwMDJfMS0xLTEtMS01MzkwNg_b0ff33da-9561-40fd-8e54-65cfb65921bd">P2Y10M17D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjA5ZjdjMTdjYWRlMTQwYjhiM2IyNGE3MjRjZTBmMDAyL3RhYmxlcmFuZ2U6MDlmN2MxN2NhZGUxNDBiOGIzYjI0YTcyNGNlMGYwMDJfMi0xLTEtMS01MzkwNg_f8b57457-ff21-451e-811d-249dbf3d1499"
      unitRef="number">0.038</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc2MA_52721dc0-feeb-4ccc-9e1a-f59339955a4a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturities of the lease liabilities for each of the following fiscal years is:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMS0xLTEtMS01MzkwNg_70aaf878-205e-42bf-a656-66cd21aca37a"
      unitRef="usd">1392000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMi0xLTEtMS01MzkwNg_994be80c-51aa-4b37-bcd5-07f51c3ffab9"
      unitRef="usd">2189000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMy0xLTEtMS01MzkwNg_5678f50a-983d-4f8a-b058-cd647773fe5f"
      unitRef="usd">1425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfNC0xLTEtMS01MzkwNg_fc15dc67-b03b-43c9-9ed5-9f265f9292ef"
      unitRef="usd">1129000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <ango:LesseeOperatingLeaseLiabilityToBePaidAfterYearThree
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfNS0xLTEtMS01MzkwNg_38b6eab6-afec-4961-99cd-be63ae069942"
      unitRef="usd">171000</ango:LesseeOperatingLeaseLiabilityToBePaidAfterYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfNy0xLTEtMS01MzkwNg_1f6a3420-5861-4a6a-8b07-90a0a7f83cbb"
      unitRef="usd">6306000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfOC0xLTEtMS01MzkwNg_16c24534-b627-4b63-9ed4-e63a3a0fe3ba"
      unitRef="usd">325000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfOS0xLTEtMS01MzkwNg_1df79834-dd53-4da5-971a-358a8bcea398"
      unitRef="usd">5981000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMTAtMS0xLTEtNTM5MDY_b4a93ba2-6920-4f3f-966b-c9923a8a473d"
      unitRef="usd">2491000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i91d36c036abe435992dbd27d886b81f0_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjc5YjkwNmY0ZTFiMTQ4YzNhOTg2NzYxNjFhZWJhMjYzL3RhYmxlcmFuZ2U6NzliOTA2ZjRlMWIxNDhjM2E5ODY3NjE2MWFlYmEyNjNfMTEtMS0xLTEtNTM5MDY_2a958529-db65-4132-8bb3-08b066bd359f"
      unitRef="usd">3490000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTQ1NQ_87384461-b096-4271-85bd-4e779af0dc58"
      unitRef="usd">700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTQ2Mg_223da7c5-f841-438b-9906-5f48346a79de"
      unitRef="usd">700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTA5OTUxMTYyOTc3NQ_d94f4ee1-a253-4f3b-b03c-08fa91a96fbd"
      unitRef="usd">1400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTA5OTUxMTYyOTc3Mw_27b8e45a-a41c-4a00-9008-9f1bf29e6f9e"
      unitRef="usd">1400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RleHRyZWdpb246NzU2MjQwZGJkOWE1NDliNzkwODJkZTJhNGNiNTg4YThfMTc2Mw_f2ee50e1-2f37-4248-aee5-1df9b1d3fd32">The expenses on the Consolidated Statement of Operations were classified as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow and other information related to leases for the six months ended:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="i254de9e531fb4e0c9d03f1d1943e752e_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi0xLTEtMS01MzkwNg_28a3203b-5c53-4c60-9804-9f89c0debfa6"
      unitRef="usd">221000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i544584d510904231bd6fd4ad6edaceed_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi0zLTEtMS01MzkwNg_9ac55a68-b97c-41e2-992a-6d41db30a66c"
      unitRef="usd">218000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i91d99785b1194e778010f6582bcc0573_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi01LTEtMS01MzkwNg_7178464f-1134-44cf-be8e-b174f40e61a7"
      unitRef="usd">440000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i412326f7f86f49389bc84bbcd7b983b4_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMi03LTEtMS01MzkwNg_05c561b0-f7ec-4025-9101-ac380d99955a"
      unitRef="usd">437000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib58f23a0eada416e97df8f458b27fbb9_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy0xLTEtMS01MzkwNg_eea6990b-98b3-435c-a389-106bb3f63142"
      unitRef="usd">53000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i8b7c661bc93a4242beb5a3453d1917a2_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy0zLTEtMS01MzkwNg_f0c1ac21-75c0-4f00-a9a7-858d7a07b0ef"
      unitRef="usd">52000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i404cfafae04d4964a4bf5b13fba7cb2a_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy01LTEtMS01MzkwNg_39c09e59-1c95-42c7-a307-b01a8e982d4b"
      unitRef="usd">104000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i6c51f234e672471b8e71d406f6c8a7e7_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfMy03LTEtMS01MzkwNg_3b21bb5e-ac77-464f-b78b-4b5419c593b8"
      unitRef="usd">150000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i27add22ce5d243fab019d5956cd78ed3_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC0xLTEtMS01MzkwNg_8084dceb-99b6-4131-9923-4f2d534bb014"
      unitRef="usd">41000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i6aa1f09bc0264f0faa5e3f247394dddd_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC0zLTEtMS01MzkwNg_945087de-bb20-4c12-a3d4-505bf7f6f4fe"
      unitRef="usd">39000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ie222d4925bad48388ddbb56ee9bec5a3_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC01LTEtMS01MzkwNg_f7a347d5-0b7c-4727-a189-6426c8b24d9d"
      unitRef="usd">81000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="idac9f367db484179bc46e4196b143896_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNC03LTEtMS01MzkwNg_1c3a8198-cba6-47e8-a310-24c3c2aaee8a"
      unitRef="usd">79000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="iaf3a056055ed471eb130b5c3aa8d0761_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS0xLTEtMS01MzkwNg_a62ee5b4-afdf-43e2-aad1-1d19bcc0e1eb"
      unitRef="usd">365000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i5ea95b9fd5b84377910bba4663837245_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS0zLTEtMS01MzkwNg_2e78c726-156d-4df8-b679-c3b92292e0ad"
      unitRef="usd">434000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i4307997465a748938dd80b54c9b60cf4_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS01LTEtMS01MzkwNg_e2ef7e14-8619-46ae-ba53-59756b9a6505"
      unitRef="usd">725000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="icb6fe7fe11684c62858764a7d401b9f1_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNS03LTEtMS01MzkwNg_f4699843-d696-443d-b7bf-6de4f35d474e"
      unitRef="usd">764000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi0xLTEtMS01MzkwNg_a60d506c-2b04-4896-bd14-8188e9733783"
      unitRef="usd">680000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi0zLTEtMS01MzkwNg_2e8acef0-46fc-44f7-803f-be0d30f51aae"
      unitRef="usd">743000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi01LTEtMS01MzkwNg_f561e847-ce7a-4954-9756-9f63e579ee62"
      unitRef="usd">1350000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOjU1YjRjYjE2MmNiODRhMzA4MmI2MGJkMWNiZGM0MDUwL3RhYmxlcmFuZ2U6NTViNGNiMTYyY2I4NGEzMDgyYjYwYmQxY2JkYzQwNTBfNi03LTEtMS01MzkwNg_5c7c62ed-a405-4641-b969-455bbed0128d"
      unitRef="usd">1430000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfMi0xLTEtMS01MzkwNg_270068f1-1f09-4a41-a7c6-121f23b71fa5"
      unitRef="usd">1384000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfMi0zLTEtMS01MzkwNg_572a902c-92ee-498a-ad10-7b573543fb0a"
      unitRef="usd">1359000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfNC0xLTEtMS01MzkwNg_3d69da25-a39a-4c85-907e-224a78d3e9b9"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183MC9mcmFnOjc1NjI0MGRiZDlhNTQ5Yjc5MDgyZGUyYTRjYjU4OGE4L3RhYmxlOmYwNzlhNGZkNjczMjRmZGY5MzI5OGFmNGQ4YzdhOGU5L3RhYmxlcmFuZ2U6ZjA3OWE0ZmQ2NzMyNGZkZjkzMjk4YWY0ZDhjN2E4ZTlfNC0zLTEtMS01MzkwNg_4757c4e6-7e39-4349-8314-bc00110b6906"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfNjg2NA_b7203ec3-75df-47af-b00a-5be876a59abc">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various legal proceedings, including commercial, intellectual property, product liability, and regulatory matters of a nature considered normal for its business.  The Company accrues for amounts related to these matters if it is probable that a liability has been incurred, and an amount can be reasonably estimated.  The Company discloses such matters when there is at least a reasonable possibility that a material loss may have been incurred.  However, the Company cannot predict the outcome of any litigation or the potential for future litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;C.R. Bard, Inc. v. AngioDynamics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 11, 2012, C.R. Bard, Inc. (&#x201c;Bard&#x201d;) filed a suit in the United States District Court of Utah claiming certain of the Company's implantable port products infringe on three U.S. patents held by Bard (US Patent Nos. 7,785,302 ("302"), 7,959,615 (&#x201c;615&#x201d;) and 7,947,022 ("022")).  The case was stayed pending reexamination in the US Patent and Trademark Office ("USPTO").  Following the reexamination proceedings, and the parties&#x2019; related appeals to the Federal Circuit which resulted in further proceedings at the USPTO, certain claims of the 615 patent were held invalid, while the remaining claims of the 615 patent and the other two patents were upheld over the prior art references considered in the reexamination proceedings.  Thereafter, the case was transferred from the District of Utah to the United States District Court for the District of Delaware (&#x201c;District of Delaware&#x201d;).  A scheduling order was entered on March 23, 2021.  On July 22, 2021, in another case against a different defendant, the District of Utah invalidated multiple claims of the &#x2018;302, &#x2018;022, and &#x2018;615 Patents under 35 USC &#xa7;101, including claims asserted against the Company.  Following the Utah court&#x2019;s decision, the Company filed a Motion for Judgment on the Pleadings based on collateral estoppel on August 9, 2021. Bard filed its opposition brief on September 2, 2021 and the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Company filed a reply on September 9, 2021. Following a hearing on the Motion for Judgment on the Pleadings on December 21, 2021, the District of Delaware stayed the case pending the Federal Circuit's resolution of Bard's appeal from the Utah Decision. Previously, the Company had filed a Motion for Leave to Amend its Answer and Counterclaims on April 14, 2021. This motion sought to add counterclaims for infringement of U.S. Patent Nos. 9,168,365; 9,895,523; and 10,632,295, as well as a counterclaim of inequitable conduct. On November 5, 2021, the Company notified the District of Delaware that the Utah decision was certified for appeal to the Court of Appeals for the Federal Circuit. Contemporaneously, the Company withdrew its Motion for Leave to Amend its Answer and Counterclaims without prejudice to refile. Oral argument has been scheduled for February 10, 2023, and the appeal remains pending. The Company believes these claims are without merit and intends to defend them vigorously. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2015, Bard and Bard Peripheral Vascular filed suit in the District of Delaware claiming certain of the Company's implantable port products infringe on three U.S. patents held by Bard (US Patent Nos. 8,475,417, 8,545,460, 8,805,478).  The case proceeded through trial which began on March 4, 2019.  At the close of Bard&#x2019;s case, the Court granted the Company's oral motion for judgment as a matter of law as well as its motions for summary judgment on the grounds that the asserted patents are invalid, ineligible, not infringed and not willfully infringed. On May 10, 2019, the Company filed a motion for attorney fees and non-taxable expenses under 35 USC Sec. 285. Bard appealed the judgment to the Federal Circuit and on November 10, 2020, the Federal Circuit reversed the judgment in part with respect to Section 101 (subject matter eligibility), and vacated and remanded the trial court&#x2019;s invalidity and non-infringement judgments.  Following remand from the Federal Circuit, a jury trial commenced in the District of Delaware beginning November 14, 2022.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 22, 2022, a jury entered a verdict finding that certain of the Company&#x2019;s implantable port products infringe certain claims of U.S. patents held by Bard. The issue of damages was bifurcated by the Court during trial, was not determined by the jury and will be subject to a separate proceeding. The Company strongly disagrees with the claims and the verdict. The issues presented to the jury do not comprise all of the issues to be determined in the case. Equitable issues and patent eligibility issues remain to be decided by the judge, and damages remain to be decided by a jury. The Company believes it has meritorious defenses and positions with respect to the matters remaining to be decided and the jury decision, and intends to vigorously pursue all available remedies and defenses, including post-trial motions and appeals. The parties proposed a post-trial briefing schedule with opening briefs to be filed January 20, 2023. The Company maintains its belief that Bard&#x2019;s claims are without merit. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2021, Bard filed suit in the District of Delaware asserting certain of the Company&#x2019;s port products (including certain related infusion sets) infringe U.S. Patent Nos. 8,025,639, 9,603,992 (&#x201c;992&#x201d;) and 9,603,993 (&#x201c;993&#x201d;).  On May 20, 2021, the Company filed a Motion to Dismiss Bard&#x2019;s claims with respect to the &#x2019;992 and &#x2019;993 patents. On July 22, 2021, the Company submitted the Utah court&#x2019;s decision invalidating claims of the related &#x2018;302, &#x2018;022, and &#x2018;615 Patents as supplemental authority in support of its Motion to Dismiss. The parties agreed to submit supplemental briefing to address the Utah court&#x2019;s decision. Bard submitted its brief on August 12, 2021, and the Company submitted its reply on September 2, 2021. On December 21, 2021, the District of Delaware stayed the case pending the Federal Circuit's resolution of Bard's appeal of the Utah decision invalidating multiple claims of the &#x2018;302, &#x2018;022, and &#x2018;615 patents under 35 USC &#xa7;101. The Company maintains its belief that Bard's claims are without merit. The Company has not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;AngioDynamics, Inc. v. C.R. Bard, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 30, 2017, the Company commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&#x201c;Bard&#x201d;).  In this action, the Company alleged that Bard had illegally tied the sales of its tip location systems to the sales of its PICCs in violation of federal antitrust laws and this practice had an anti-competitive effect in the US market for PICCs.  The Company sought both monetary damages and injunctive relief.  On October 6, 2022, a jury verdict was rendered finding Bard did not restrain competition in violation of federal antitrust laws.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <ango:NumberOfPatentsAssertedForReexamination
      contextRef="i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfODM1_b37ac397-ce21-47f8-b2c6-538163e3da29"
      unitRef="patent">3</ango:NumberOfPatentsAssertedForReexamination>
    <ango:NumberOfPatentsUpheldOverPriorArtReferences
      contextRef="i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfMTI5NA_fc26534b-1c09-46c4-8573-8d14d7e5f071"
      unitRef="patent">2</ango:NumberOfPatentsUpheldOverPriorArtReferences>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i274e4b0db3ab4da292cee7a42340b2fd_D20150310-20150310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183My9mcmFnOmMzMWRiMWVlYjZmMTRkODI5YTJkODgwZmY3YTAyY2RhL3RleHRyZWdpb246YzMxZGIxZWViNmYxNGQ4MjlhMmQ4ODBmZjdhMDJjZGFfMzQxMA_465d1611-bf69-4dc0-b3b2-ba862ee81e52"
      unitRef="patent">3</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RleHRyZWdpb246NTdlNzg3NGI2Y2QwNGMwOWIxMDU0ZTdiNmQ4MTRmYTRfNjM3_c15bd6a7-df51-4921-94fe-edcb31cce488">ACQUISITION, RESTRUCTURING, AND OTHER ITEMS, NET&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisition, Restructuring and Other Items&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition, restructuring and other items, net, consisted of:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mergers and acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing relocation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli Innovation Authority prepayment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Legal expenses related to litigation that is outside the normal course of business. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Legal and due diligence expenses related to mergers and acquisitions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Expenses to relocate certain manufacturing lines from Queensbury, NY to Costa Rica.  &lt;/span&gt;&lt;/div&gt;(4) In the first quarter of fiscal year 2023, a $3.5&#160;million payment was made to the Israeli Innovation Authority to fully satisfy the obligation related to grant funds that were provided to Eximo for development of the Auryon laser prior to the acquisition in the second quarter of fiscal year 2020.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RleHRyZWdpb246NTdlNzg3NGI2Y2QwNGMwOWIxMDU0ZTdiNmQ4MTRmYTRfNjM4_c1877d7d-c6a7-4f46-8107-9d9086f6b727">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition, restructuring and other items, net, consisted of:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nov 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mergers and acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing relocation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli Innovation Authority prepayment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Legal expenses related to litigation that is outside the normal course of business. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Legal and due diligence expenses related to mergers and acquisitions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Expenses to relocate certain manufacturing lines from Queensbury, NY to Costa Rica.  &lt;/span&gt;&lt;/div&gt;(4) In the first quarter of fiscal year 2023, a $3.5&#160;million payment was made to the Israeli Innovation Authority to fully satisfy the obligation related to grant funds that were provided to Eximo for development of the Auryon laser prior to the acquisition in the second quarter of fiscal year 2020.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i3bd57db09d954401a970450cb332edc2_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi0xLTEtMS01MzkwNg_7b2b790f-9093-4e99-82bf-5ab37b8646d1"
      unitRef="usd">2422000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="iee3cc03838394279b14c503789157f07_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi0zLTEtMS01MzkwNg_1180f4ab-de14-442c-a30a-57ade3dac7db"
      unitRef="usd">2072000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i47bbc169a6da4a36952422f9fd58300c_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi01LTEtMS01MzkwNg_1afd0129-6b22-427f-98ca-1566c26483d4"
      unitRef="usd">4285000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i31c5d45239404a43ada7157497ae9c3e_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMi03LTEtMS01MzkwNg_c5cb418b-2901-4fcf-a431-007102b79c60"
      unitRef="usd">4156000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i1113d3caab5d408faab5a5f245311b15_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy0xLTEtMS01MzkwNg_5263c34d-8d87-40db-9f66-c7f22e9fc826"
      unitRef="usd">0</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i0ee2fde770274d08a3b8af0bb66c465b_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy0zLTEtMS01MzkwNg_8d090fa2-d838-423d-bcbf-a49f6fdac028"
      unitRef="usd">59000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i3f83e0c893cb4e7fb69e22ed93dc6a55_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy01LTEtMS01MzkwNg_28214fc5-fd57-4329-b50f-f94f9b535728"
      unitRef="usd">0</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i61bc7936712144249aa26ca9905b3c8e_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMy03LTEtMS01MzkwNg_3ff9d80d-2ca3-4d4f-965b-4d9e542cd18a"
      unitRef="usd">59000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i5ef1be6232914c8490f870666a771ffa_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi0xLTEtMS01MzkwNg_3a2107cb-c4bf-473f-95ac-616e0e1706d6"
      unitRef="usd">602000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i1ab1f2674fe04183b7df7f14ea9f167c_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi0zLTEtMS01MzkwNg_dbaf7edf-8133-4497-8125-7e15a2efed7a"
      unitRef="usd">59000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="ica1aa84fb02d4395a39a7bf23b044eab_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi01LTEtMS01MzkwNg_0c6fb6a8-c020-4eff-8d21-c047c3a64364"
      unitRef="usd">738000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i06523c7cb754445ab38517c2cb05ce7d_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfNi03LTEtMS01MzkwNg_2d9900dc-8ec6-42e9-894a-cb058d9236d2"
      unitRef="usd">59000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i6cec44cbde2244a9a355ca544f33885f_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC0xLTEtMS01MzkwNg_51bbab92-b91c-4e78-a83e-c2fd45d9c63d"
      unitRef="usd">0</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i7706a0f7dae740418007c9381795d2bd_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC0zLTEtMS01MzkwNg_2dd86cdb-03a5-4aed-85ec-708131a04d99"
      unitRef="usd">0</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="if4dd796fd591465c8eb9c1eb60615285_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC01LTEtMS01NjM4Nw_32f9b55b-c75f-4691-99ee-bd6a61d318a9"
      unitRef="usd">3544000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i47789d4315de4707952ba298e204a6ed_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOC03LTEtMS01NjQxOQ_603acd35-5d42-4bfe-b112-4276267a224b"
      unitRef="usd">0</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i044eeedb625141a788d4e6c857cff53e_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS0xLTEtMS01MzkwNg_d3604b76-6f3c-4ed2-a3c7-66fdef36bedd"
      unitRef="usd">35000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i94bdb9b48a8f461b95594363296e37f6_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS0zLTEtMS01MzkwNg_eb3c67ab-7907-4b9a-a0fa-66ab660173ec"
      unitRef="usd">63000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i9266e9d5e54f4e03aa9bff8df03159b5_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS01LTEtMS01MzkwNg_e1c506ee-bc62-49bf-835e-058b6dcfb6d1"
      unitRef="usd">73000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i59f28e909af74b0abe3ae31344d25373_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfOS03LTEtMS01MzkwNg_cca0ad6b-3dda-494a-83fb-0023a83b8682"
      unitRef="usd">419000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i957682acc89b4e82b461dd18e66b5886_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtMS0xLTEtNTM5MDY_5028f118-c848-4d6a-a044-46dfac1b65d2"
      unitRef="usd">3059000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i48d32dc48642430588a84c812aa9d3e4_D20210901-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtMy0xLTEtNTM5MDY_1b70997f-f932-4517-a8c4-dbe75eb18899"
      unitRef="usd">2253000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtNS0xLTEtNTM5MDY_bdb9a7c0-b025-4bff-8fdf-65720537e327"
      unitRef="usd">8640000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <ango:AcquisitionRestructuringAndOtherItemsNet
      contextRef="ic0b36681ab9341ff8f89ac0adda8a7a8_D20210601-20211130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RhYmxlOmRhMGE0ZThjMWFkZDQ2NzZiZjQ3NmVlZDFlNzE1OTQxL3RhYmxlcmFuZ2U6ZGEwYTRlOGMxYWRkNDY3NmJmNDc2ZWVkMWU3MTU5NDFfMTAtNy0xLTEtNTM5MDY_7a077e7c-9284-4739-8c47-e8363999e639"
      unitRef="usd">4693000</ango:AcquisitionRestructuringAndOtherItemsNet>
    <us-gaap:PaymentsForPreviousAcquisition
      contextRef="i96f682ba85b44a3598400d9868b15c05_D20220601-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183Ni9mcmFnOjU3ZTc4NzRiNmNkMDRjMDliMTA1NGU3YjZkODE0ZmE0L3RleHRyZWdpb246NTdlNzg3NGI2Y2QwNGMwOWIxMDU0ZTdiNmQ4MTRmYTRfMzkz_c50a00ad-f0bb-4379-a884-26a3b2cd20d7"
      unitRef="usd">3500000</us-gaap:PaymentsForPreviousAcquisition>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RleHRyZWdpb246MjhiOWM3ODhhMzI1NDE1NGE3ZmMzNGMxZDgyYTZmY2FfMTQ4_7f6fdd77-ace3-44ce-8fb1-c3e8138e0f09">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in each component of accumulated other comprehensive income, net of tax, are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RleHRyZWdpb246MjhiOWM3ODhhMzI1NDE1NGE3ZmMzNGMxZDgyYTZmY2FfMTUw_bceba231-6638-4a40-8879-778a864e8b15">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in each component of accumulated other comprehensive income, net of tax, are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Six Months Ended Nov&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="id7fe5b4172864faa8f8941f2d91a82a5_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfMi0xLTEtMS01MzkwNg_0547be53-4f1a-4fa8-b227-ac7df004e958"
      unitRef="usd">807000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="id8e6825fbb074aa89f3481933a0524ff_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfMy0xLTEtMS01MzkwNg_a3b96977-7f29-4e41-bd15-5ab2b5cc04dd"
      unitRef="usd">-1095000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id8e6825fbb074aa89f3481933a0524ff_D20220901-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfNS0xLTEtMS01MzkwNg_fca7a4d9-c23e-4602-b90a-18fc611b740f"
      unitRef="usd">-1095000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="iadc3c6dba44947808123f698ace071df_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOmJjZDhjMjIzYTgyODQwMTNhNDkyYTYyMmJhMWU1MjZhL3RhYmxlcmFuZ2U6YmNkOGMyMjNhODI4NDAxM2E0OTJhNjIyYmExZTUyNmFfNi0xLTEtMS01MzkwNg_63ecc589-8f8c-4ab5-90da-859ca3f90719"
      unitRef="usd">-288000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd649e5bedd943d9a3a7267d44a89998_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfMi0xLTEtMS01OTU0MQ_face1f4d-8e41-452e-8a3d-a9238cc03a22"
      unitRef="usd">1357000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="iec41db309d8b4a96899fae9d890284b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfMy0xLTEtMS01NzYxNQ_f3a4119d-0904-458f-bc28-c7fed3792542"
      unitRef="usd">-1645000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iec41db309d8b4a96899fae9d890284b7_D20220601-20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfNS0xLTEtMS01OTU0MQ_2203dc9c-06a3-4ede-a95a-a27786104a16"
      unitRef="usd">-1645000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="iadc3c6dba44947808123f698ace071df_I20221130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY183OS9mcmFnOjI4YjljNzg4YTMyNTQxNTRhN2ZjMzRjMWQ4MmE2ZmNhL3RhYmxlOjY3OTViZTExMjlmZjRhNTdiOTk1ZTRhN2I0MDI2YzkwL3RhYmxlcmFuZ2U6Njc5NWJlMTEyOWZmNGE1N2I5OTVlNGE3YjQwMjZjOTBfNi0xLTEtMS01OTU0MQ_2997060f-6b0d-417f-b95d-498f8ce7d580"
      unitRef="usd">-288000</us-gaap:StockholdersEquity>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY184Mi9mcmFnOjI3YWQzNTk4YjQ1MzQyZjBhYWQ5MjhhN2M0M2I3OTgwL3RleHRyZWdpb246MjdhZDM1OThiNDUzNDJmMGFhZDkyOGE3YzQzYjc5ODBfNTg_5e64c8e2-d31b-4565-9847-6d2a4ea037b8">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recently Issued Accounting Pronouncements - Adopted&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Consolidated Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;ASU 2021-10,&#160; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;This ASU increases the transparency of government assistance to include the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The Company adopted the new standard in the first quarter of fiscal year 2023 and it did not have an impact on the Company's consolidated financial statements. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Consolidated Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2021-08,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;This ASU&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The Company plans to adopt the new standard in the first quarter of fiscal year 2024 and does not expect there to be a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130"
      id="id3VybDovL2RvY3MudjEvZG9jOjg5N2MyNGVmMjA2ODRjOTM4MDFlNjg2YTk1ZTZhYmNjL3NlYzo4OTdjMjRlZjIwNjg0YzkzODAxZTY4NmE5NWU2YWJjY184Mi9mcmFnOjI3YWQzNTk4YjQ1MzQyZjBhYWQ5MjhhN2M0M2I3OTgwL3RleHRyZWdpb246MjdhZDM1OThiNDUzNDJmMGFhZDkyOGE3YzQzYjc5ODBfNjg_952431a6-d6e9-4089-b811-2b9ad516b1d3">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recently Issued Accounting Pronouncements - Adopted&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Consolidated Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;ASU 2021-10,&#160; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;This ASU increases the transparency of government assistance to include the disclosure of (1) the types of assistance, (2) an entity's accounting for the assistance, and (3) the effect of the assistance on an entity's financial statements. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The Company adopted the new standard in the first quarter of fiscal year 2023 and it did not have an impact on the Company's consolidated financial statements. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Consolidated Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2021-08,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;This ASU&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The Company plans to adopt the new standard in the first quarter of fiscal year 2024 and does not expect there to be a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>80
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>%1OB[&\=9>B%;IX4+VI?;5DNO"\KD9_G0GL9*"A9V8@@,*!=<-!*(=:_0>
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M4;:'*\X MC: ^TL!ZF5_HK^I=-_0YO\!4$L#!!0    ( /F&)E9&4-006 ,
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M!^1G@O;(ARWY\#+RBE$35II4*OXOWK .ZJN]Z+7^L$,U]*K? ?WYN#T#H];
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MJK[.P-/7&;QV93"/2/''=U'0L@$H+872&)3&#Q_:#"HHH+0<2I,HVM >?;&
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MG!KMC!0%\UC A=!,<\$DS#QM4.R]&^6>S 3AG#>0)PER\ KD(5P;[4L'Y[K
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M_$!+V;U_M-4+6]F,-^".&I;N90R&F;9K/\U;3ZH@*'38CA_N9XG,A(8(\*^
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ML5 ;;%$5P1B$]6B#P.=R*#)Y<$%%@2'8HZ_OS%#':CJ--E5Z&O&PAB2D7UV
M([:UZ1<Y?=$5E6!<XYE.D<*6RB4DXO^93=)US.RDA*H@JH])K/'P.=_Q]>CY
M$XJ QJSDN4BWJ#)[ E@5T#U8-%J'J80L3[>HJ+L82E5^A\.N[VQCDFO<C-J
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M'M["EUL%<+:T +^OC?'U#6W0?!G[ZC]02P,$%     @ ^88F5FQV&1NY @
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M)Q:TE5%9![I?2VF.BDW0[OGQ7U!+ P04    " #YAB96%@.YL7L(  !P%
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M@GI::?T8E6MQAH!-#1R$OAYZMW.;D5; V3.&&,>@L<%[QI!.9*V6EB\EF0V
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M)>QVQ+^;5FLBQ3&.>F5IMW+\)9HF)R%^%\L UM9OTA_65JIZ^\8Q8?PMAKZ
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M6%/QVS::4QQ';)^,^45,U^[DU_#15L*B%'/[7J8@1-8*8H1%4Q)XQL(XUA'
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MQ?=_X@W@D5YK(M-)P[?QI(5 SX@\1.F3V2>Z:3I]<3H\$;\1S T7D0FH#AT
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M- &_+ZP-]0MMT'SKNOX/4$L#!!0    ( /F&)E;<LI+8X0,  (X)   9
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MT<KVF">#)&Q#;KQ[Z WY\"CF+9B/D]"B3V<95CO\ZP$__@$^)[<(VACRBUK
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M:,R"%C!J=X'.5TK9G>,*]"L]_0M02P,$%     @ ^88F5E@*&IU]!   ( L
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MO,@",.T;T"I6;_W<76G+4]S_EOQLHG$&O+_6VAX4%Z![B.?_ U!+ P04
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MG+.\")#?+[),'"Z*!NICBI/_ %!+ P04    " #YAB963_%+O5X#   )"P
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MXK1#>SI1?%=L<CYRI5<:Q>&6:!LA<H"^O^9</9_D^Z;5/OGB/U!+ P04
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M5W?O]]Z_SB+ZB.ZW9%UNT&D4:$X&I6%06@!%,_W4D=J=@*8Y%S1A@](P*"V
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MU0;R_25CXOF)ZF!W0YO9_U!+ P04    " #YAB96>6_[_,T"    "0  &0
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M@NF:2_-$06D7F/FY$/JQ8ZMF_>B)?P)02P,$%     @ ^88F5B.]:71/ @
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MQ!N]^P2]GR/'5VII_2_;A=S9+&)E9U$W/9@4-$*%+[_OZW  ()YQ0-H#TJ>
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M:Z),)N^I>4V8!R% W?J66FFD!O7+FD8H&)= YVNM<1^X"X:A7/P&4$L#!!0
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M0ZBLV[7W*G$AECB8<+9%7*.5FGZILE^Q5;X(U?OD7G+UE2B>#"+,*:$K@1;
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MHS80Q[^*15?5G72W/"20;)I$V@1H5[I=K9)N^Z+J"R], EJP4]M)[J1^^-K
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MA7LV=P?V$S5#ZS'M)WT]@'_";%T0CDI825?.Z4B*&JMGVGHAZ$8/;?=4R"=
M7^: ,V#*0-Y?42H>%\I!^\]"_!]02P,$%     @ ^88F5D1Q,#%- P  U@\
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M0EV\@>L U3]C3+XW]-6NNLJ'_P!02P,$%     @ ^88F5E4_N*$: P  B0@
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M]E*M/^,FGZ'C2Y4P_A?6F]AN &EEK"HW8%)0<EG_L[N-#SL XFD'1!M ]+>
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M-<%. >O^DN S])YSD(3)-&M2"/ #FR&29#6T**O/-&7UQ!7FA*._;^0"Z).
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M)[R.I#[+KF\8KN1A[2-F#!?R,D4P0408\.\W&+.7&S% ^Q^%Y;]02P,$%
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M_6- !(X3_@G]@KX^!NCCAT_H XHS],>&YER:\+$I9%P%W5S4,=Q6,3BOQ#!
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MF" 8(RH-Q/L5(?QY( F:ZZ/9OU!+ P04    " #YAB96/!%^(VT%  "%'@
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MH3Y<$NP1IFZ0W\\I%9L3]28R>_,\^!]02P,$%     @ ^88F5G([XU0P P
MZA(   T   !X;"]S='EL97,N>&ULW5AM:]LP$/XK1EU'"Z-.XL6-UR2P!0J#
M;13:#_M6E%A.!++DR4J7[-=/)SG.2W6EZX<MG4-JW3VZYQ[ISK7(L#9KP6X7
MC)EH50I9C\C"F.I#'->S!2MI?:$J)BU2*%U28TT]C^M*,YK7$%2*N-?II'%)
MN23CH5R6UZ6IHYE:2C,B_=85^=OG?$2ZZ7L2>;J)RMF(W)^]_;%4YNI-Y.\G
M[TY..O?G5X?^,P><DSA(VG\&Z44'Y[481IWN4[OIIY;(!YYB89?/4O2$((QX
M$-!CY6\E@>&"XZ8@XV&AY+8N"?$.RTY+%CU0,2(3*OA4<X@J:,G%VKM[X)@I
MH71D;$/8=%WPU+\\W/46]$K#4W*IM,OM,_B_TV;Z ;"Q0" 7HA78(]XQ'E;4
M&*;EM37<9.=\!$7-^&Y=685S3=?=7I]L ]S-)IDJG3/=INF2C6L\%*P .9K/
M%W WJHH!-$:5=I!S.E>2.@V;B&9@:6=,B%MXD+X7>]RK8J=N':B:;(=64#/T
M--X _ETVS[U+VWL1;U3Q!V4^+>URI+.AT=B-9@5?.7M5M (P]B[.3JM*K#\*
M/I<E\XM_=L+QD&[BHH72_)?-!JTRLPZF2?3 M.&S7<]/3:L[MC*;=EH5N.;>
M*]3\=_=YSB335.R*MKU_S+O\8L7)Y;^2[/ZK' H.:FS>CL<NLO\:1*:O0>0K
MZ,DD.WZ-S:GHZ$3&S?M[YY"P=T1HO1$<Q4;D&QSLQ#9I-%UR8;ALK 7/<R8?
MG10LO:%3>Y#?X[?S<U;0I3!W+3@BV_%7EO-EF;6S;F CFEG;\1=87C=MSX$V
M%Y<Y6[%\TIAZ/G7#R YLUN:"@$/DVEUA!(OQ6!@!#,N#*<!B?!26YW]:SP!=
MC\<P;8,@,D!C!FB,CPHA$_?!\H1C,GN%5YIE29*FV(Y.)D$%$VS?TA2^839,
M&T1@>2#3G^TU7FV\0Y[N ZRF3W4(ME*\$[&5XGL-2'C?("++PM7&\D $5@6L
M=R!_. _T5#@F2:"JF#;L"<:1+,,0Z,5PCZ8ILCLI?,+UP9Z2),FR, )86$&2
M8 @\C3B"*0 -&)(D[CUX\#Z*-^^I>/OKUO@W4$L#!!0    ( /F&)E:7BKL<
MP    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$
M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E
MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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MEIUM^K=\-OXC;O$"4$L! A0#%     @ ^88F5@=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #YAB96
M7/'U8.X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #YAB96F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( /F&)E83JV'C7@8
M '<E   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " #YAB96DAQ*DN0&  #.(0  &               @(&A
M#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ^88F5KK#
MF6*N P  E0X  !@              ("!NQ4  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( /F&)E:GB5B?FP8  $\;   8
M  " @9\9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #Y
MAB961E#4$%@#  "Y"P  &               @(%P(   >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ ^88F5J+X$VTT!P  <!X  !@
M         ("!_B,  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( /F&)E9]TO+2.@\  "[+   8              " @6@K  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #YAB96H"8D(R8$   @"@
M&               @('8.@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ ^88F5N.KQ]?. P  90@  !@              ("!-#\  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( /F&)E84)CWE^@\
M "4K   9              " @3A#  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ ^88F5FQV&1NY @  U04  !D              ("!
M:5,  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #YAB96
M03MEA?<)   J&@  &0              @(%95@  >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( /F&)E:A9'3\TP(  /,%   9
M      " @8=@  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ ^88F5A8#N;%["   <!0  !D              ("!D6,  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #YAB96X^/-U$L%   _#
M&0              @(%#;   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( /F&)E9%ZW8$WP0  !@.   9              " @<5Q  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ ^88F5D\0;[N!
M P  ;0@  !D              ("!VW8  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " #YAB96B!TF:)D&  "<#P  &0
M@(&3>@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( /F&
M)E8GI-MLC @  #09   9              " @6.!  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ ^88F5J-\1]'2!@  +Q$  !D
M         ("!)HH  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " #YAB96VY)DW <,  !#(@  &0              @($OD0  >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( /F&)E9$_[Y>B0,  /<'
M   9              " @6V=  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ ^88F5M@17TW@ @  "0<  !D              ("!+:$
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #YAB96#Z^7
M[V$$  "="@  &0              @(%$I   >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( /F&)E:A5<).2 H  /<:   9
M  " @=RH  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
M^88F5MRRDMCA P  C@D  !D              ("!6[,  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " #YAB96=A7-_+X"  #>!0  &0
M            @(%SMP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( /F&)E98"AJ=?00  " +   9              " @6BZ  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ ^88F5JIYE$S& @
MZ 4  !D              ("!'+\  'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " #YAB96I,Z+/X$"  !5!0  &0              @($9
MP@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( /F&)E9:
MCI=;S (  '<&   9              " @='$  !X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ ^88F5A1+U,0<!   O@D  !D
M     ("!U,<  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /F&)E;&-.!P)00  . 7   9              "
M@6[<  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ ^88F
M5E=%T;:%!0  LB@  !D              ("!RN   'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " #YAB963_%+O5X#   )"P  &0
M        @(&&Y@  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( /F&)E:>5NU.9@(  '$&   9              " @1OJ  !X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ ^88F5MO\W]V4 @  WP8
M !D              ("!N.P  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    " #YAB96860/C"8"   (!0  &0              @(&#[P
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( /F&)E8F/^V/
M8@0  "@=   9              " @>#Q  !X;"]W;W)K<VAE971S+W-H965T
M-#,N>&UL4$L! A0#%     @ ^88F5EXT1ZU\ P  P@X  !D
M ("!>?8  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #Y
MAB96M6(QK4H$   S%P  &0              @($L^@  >&PO=V]R:W-H965T
M<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( /F&)E;:P:;']P(  -@)   9
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M970U,"YX;6Q02P$"% ,4    " #YAB96WU$^&Y($  #A&P  &0
M    @('F$@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (
M /F&)E;K?3J&#@,  +@*   9              " @:\7 0!X;"]W;W)K<VAE
M971S+W-H965T-3(N>&UL4$L! A0#%     @ ^88F5CM7U=,+!   XA4  !D
M             ("!]!H! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"
M% ,4    " #YAB96OX' K%8$  "I%0  &0              @($V'P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( /F&)E:NH;,SEP,
M &40   9              " @<,C 0!X;"]W;W)K<VAE971S+W-H965T-34N
M>&UL4$L! A0#%     @ ^88F5D1Q,#%- P  U@\  !D              ("!
MD2<! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " #YAB96
M53^XH1H#  ")"   &0              @($5*P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4W+GAM;%!+ 0(4 Q0    ( /F&)E;)$J+]X@,  .D5   9
M      " @68N 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%
M  @ ^88F5MR06% F @  5P0  !D              ("!?S(! 'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #YAB96F]7@7'\#  !T#
M&0              @('<- $ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+
M 0(4 Q0    ( /F&)E;(C4,\. ,  ,$+   9              " @9(X 0!X
M;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ ^88F5H72G7LT
M!   71@  !D              ("! 3P! 'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6Q02P$"% ,4    " #YAB969Q@?,9X"  " !@  &0
M@(%L0 $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( /F&
M)E:0ON-IQ (  -D)   9              " @4%# 0!X;"]W;W)K<VAE971S
M+W-H965T-C0N>&UL4$L! A0#%     @ ^88F5M?K8"7I!   ;20  !D
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M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #YAB96EXJ[',     3 @  "P
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52P4&     $L 2P"$%   36,!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>216</ContextCount>
  <ElementCount>265</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>53</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Consolidated Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedFinancialStatements</Role>
      <ShortName>Consolidated Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Revenue from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RevenuefromContractswithCustomers</Role>
      <ShortName>Revenue from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Acquisition, Restructuring and Other Items, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet</Role>
      <ShortName>Acquisition, Restructuring and Other Items, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Recently Issued Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements</Role>
      <ShortName>Recently Issued Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Recently Issued Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies</Role>
      <ShortName>Recently Issued Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Revenue from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables</Role>
      <ShortName>Revenue from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/RevenuefromContractswithCustomers</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/Inventories</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AccruedLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/LongTermDebt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/EarningsPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentandGeographicInformationTables</Role>
      <ShortName>Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/FairValue</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/Leases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Acquisition, Restructuring and Other Items, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables</Role>
      <ShortName>Acquisition, Restructuring and Other Items, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionsDetails</Role>
      <ShortName>Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Revenue from Contracts with Customers - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue from Contracts with Customers - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Revenue from Contracts with Customers - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenue from Contracts with Customers - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Revenue from Contracts with Customers - Contract Balances with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails</Role>
      <ShortName>Revenue from Contracts with Customers - Contract Balances with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Inventories - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails</Role>
      <ShortName>Inventories - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Inventories - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/InventoriesNarrativeDetails</Role>
      <ShortName>Inventories - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Goodwill and Intangible Assets - Change in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Change in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Goodwill and Intangible Assets - Expected Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Expected Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/IncomeTaxes</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ShareBasedCompensationDetails</Role>
      <ShortName>Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/ShareBasedCompensation</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/EarningsPerShareTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails</Role>
      <ShortName>Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Segment and Geographic Information - Summary of Net Sales by Product Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails</Role>
      <ShortName>Segment and Geographic Information - Summary of Net Sales by Product Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Segment and Geographic Information - Summary of Net Sales by Geographic Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails</Role>
      <ShortName>Segment and Geographic Information - Summary of Net Sales by Geographic Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Fair Value - Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>Fair Value - Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails</Role>
      <ShortName>Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Fair Value - Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails</Role>
      <ShortName>Fair Value - Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Fair Value - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueAdditionalInformationDetails</Role>
      <ShortName>Fair Value - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Leases - Liability Maturity Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails</Role>
      <ShortName>Leases - Liability Maturity Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Leases - Supplemental Statement of Operations Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails</Role>
      <ShortName>Leases - Supplemental Statement of Operations Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/CommitmentsandContingencies</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Acquisition, Restructuring and Other Items, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails</Role>
      <ShortName>Acquisition, Restructuring and Other Items, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="ango-20221130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - ango-20221130.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - ango-20221130.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:FiniteLivedIntangibleAssetUsefulLife -  ango-20221130.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="ango-20221130.htm">ango-20221130.htm</File>
    <File>a11302022-exx311.htm</File>
    <File>a11302022-exx312.htm</File>
    <File>a11302022-exx321.htm</File>
    <File>a11302022-exx322.htm</File>
    <File>ango-20221130.xsd</File>
    <File>ango-20221130_cal.xml</File>
    <File>ango-20221130_def.xml</File>
    <File>ango-20221130_lab.xml</File>
    <File>ango-20221130_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ango-20221130_g1.gif</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="684">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ango-20221130.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2021-01-31": 684,
    "http://xbrl.sec.gov/dei/2021q4": 32
   },
   "contextCount": 216,
   "dts": {
    "calculationLink": {
     "local": [
      "ango-20221130_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ango-20221130_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ango-20221130.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ango-20221130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ango-20221130_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ango-20221130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 433,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 13
   },
   "keyCustom": 31,
   "keyStandard": 234,
   "memberCustom": 15,
   "memberStandard": 35,
   "nsprefix": "ango",
   "nsuri": "http://www.angiodynamics.com/20221130",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.angiodynamics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Revenue from Contracts with Customers",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.angiodynamics.com/role/RevenuefromContractswithCustomers",
     "shortName": "Revenue from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.angiodynamics.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.angiodynamics.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Accrued Liabilities",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.angiodynamics.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.angiodynamics.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.angiodynamics.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Share-Based Compensation",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.angiodynamics.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.angiodynamics.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Segment and Geographic Information",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.angiodynamics.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.angiodynamics.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.angiodynamics.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.angiodynamics.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Acquisition, Restructuring and Other Items, Net",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet",
     "shortName": "Acquisition, Restructuring and Other Items, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accumulated Other Comprehensive Income",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome",
     "shortName": "Accumulated Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Recently Issued Accounting Pronouncements",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements",
     "shortName": "Recently Issued Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Recently Issued Accounting Pronouncements (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies",
     "shortName": "Recently Issued Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Revenue from Contracts with Customers (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables",
     "shortName": "Revenue from Contracts with Customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.angiodynamics.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:ScheduleOfIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:ScheduleOfIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Accrued Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.angiodynamics.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.angiodynamics.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.angiodynamics.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:ScheduleOfNetRevenueByProductGroupTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Segment and Geographic Information (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.angiodynamics.com/role/SegmentandGeographicInformationTables",
     "shortName": "Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:ScheduleOfNetRevenueByProductGroupTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.angiodynamics.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.angiodynamics.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Acquisition, Restructuring and Other Items, Net (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables",
     "shortName": "Acquisition, Restructuring and Other Items, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Accumulated Other Comprehensive Income (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables",
     "shortName": "Accumulated Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Acquisitions (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.angiodynamics.com/role/AcquisitionsDetails",
     "shortName": "Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i22e896b21e924dea8f58a482a45a6580_D20210727-20210727",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Revenue from Contracts with Customers - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
     "shortName": "Revenue from Contracts with Customers - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i3b1ac96c05c4496cbe867dec215b61da_D20220901-20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Revenue from Contracts with Customers - Narrative (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails",
     "shortName": "Revenue from Contracts with Customers - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ango:ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Revenue from Contracts with Customers - Contract Balances with Customers (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails",
     "shortName": "Revenue from Contracts with Customers - Contract Balances with Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Inventories - Schedule of Inventories (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails",
     "shortName": "Inventories - Schedule of Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Inventories - Narrative (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.angiodynamics.com/role/InventoriesNarrativeDetails",
     "shortName": "Inventories - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "unit",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i605f35cad602428b8143074fa8c31ba8_I20220831",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Goodwill and Intangible Assets - Change in Goodwill (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Change in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "ic64f7b15ed9b474995bee41f47ae8270_I20220601",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ango:ScheduleOfIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ango:ScheduleOfIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Goodwill and Intangible Assets - Expected Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets - Expected Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Long-Term Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "idd47ebcb2afe4eab9e20c68e5a784838_D20220830-20220830",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Long-Term Debt - Schedule of Debt (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.angiodynamics.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ango:EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Share-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.angiodynamics.com/role/ShareBasedCompensationDetails",
     "shortName": "Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.angiodynamics.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Segment and Geographic Information - Narrative (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
     "shortName": "Segment and Geographic Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "id088a0af0c2d43b9ad0bda298d1ff754_D20220901-20221130",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Segment and Geographic Information - Summary of Net Sales by Product Category (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails",
     "shortName": "Segment and Geographic Information - Summary of Net Sales by Product Category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "3",
      "lang": "en-US",
      "name": "ango:GrossMarginPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Segment and Geographic Information - Summary of Net Sales by Geographic Area (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails",
     "shortName": "Segment and Geographic Information - Summary of Net Sales by Geographic Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i4b1288467e0d4c2b98b2092131400cc2_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Fair Value - Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "Fair Value - Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i4b1288467e0d4c2b98b2092131400cc2_I20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i605f35cad602428b8143074fa8c31ba8_I20220831",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails",
     "shortName": "Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i605f35cad602428b8143074fa8c31ba8_I20220831",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i4b1288467e0d4c2b98b2092131400cc2_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Fair Value - Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails",
     "shortName": "Fair Value - Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "icd9433e4df6a4d73bdb71c139f61a75a_I20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ango:UndiscountedContingentConsiderationDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Fair Value - Additional Information (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.angiodynamics.com/role/FairValueAdditionalInformationDetails",
     "shortName": "Fair Value - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ango:UndiscountedContingentConsiderationDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ango:AssetsAndLiabilitiesLesseeTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ango:AssetsAndLiabilitiesLesseeTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Leases - Liability Maturity Schedule (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails",
     "shortName": "Leases - Liability Maturity Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i91d36c036abe435992dbd27d886b81f0_I20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Leases - Supplemental Statement of Operations Information (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails",
     "shortName": "Leases - Supplemental Statement of Operations Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ango:NumberOfPatentsAssertedForReexamination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i6ba6837ddda449578aa0ade2e92ba3cd_D20120111-20120111",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ango:NumberOfPatentsAssertedForReexamination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i957682acc89b4e82b461dd18e66b5886_D20220901-20221130",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ango:AcquisitionRestructuringAndOtherItemsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Acquisition, Restructuring and Other Items, Net (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails",
     "shortName": "Acquisition, Restructuring and Other Items, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i96f682ba85b44a3598400d9868b15c05_D20220601-20220831",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForPreviousAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i605f35cad602428b8143074fa8c31ba8_I20220831",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Accumulated Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "id7fe5b4172864faa8f8941f2d91a82a5_I20220831",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i71a5faedb2934ca3b6d2036bad066025_I20210531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i0ce7f40f7e1c4f288eaa7bdae504643a_D20210601-20210831",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Consolidated Financial Statements",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.angiodynamics.com/role/ConsolidatedFinancialStatements",
     "shortName": "Consolidated Financial Statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Acquisitions",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.angiodynamics.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i834a5e79304d40b58d1a73a37aa215b7_D20220601-20221130",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ango-20221130.htm",
      "contextRef": "i67b2c477cc4a49a0b3b3b75f4faee17b_D20220301-20220531",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - ango-20221130.htm",
     "menuCat": "Cover",
     "order": "67",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - ango-20221130.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 53,
   "tag": {
    "ango_A2020StockAndIncentiveAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Stock And Incentive Award Plan",
        "label": "2020 Stock And Incentive Award Plan [Member]",
        "terseLabel": "2020 Stock And Incentive Award Plan"
       }
      }
     },
     "localname": "A2020StockAndIncentiveAwardPlanMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_AccruedResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Research And Development, Current",
        "label": "Accrued Research And Development, Current",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_AcquisitionRestructuringAndOtherItemsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Restructuring And Other Items Net.",
        "label": "Acquisition Restructuring and Other Items Net",
        "terseLabel": "Acquisition, restructuring and other items, net"
       }
      }
     },
     "localname": "AcquisitionRestructuringAndOtherItemsNet",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_AssetAcquisitionInventoryAndFixedAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Inventory And Fixed Assets",
        "label": "Asset Acquisition, Inventory And Fixed Assets",
        "terseLabel": "Inventory and fixed assets"
       }
      }
     },
     "localname": "AssetAcquisitionInventoryAndFixedAssets",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ango_ChangeInFairValueOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense charged against earnings in the period resulting from remeasurement to fair value of contingent earn out liabilities related to acquisitions.",
        "label": "Change in Fair Value of Contingent Consideration",
        "terseLabel": "Change in present value of contingent consideration"
       }
      }
     },
     "localname": "ChangeInFairValueOfContingentConsideration",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_ChangeInFairValueOfContingentConsiderationOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Fair Value Of Contingent Consideration",
        "label": "Change In Fair Value Of Contingent Consideration One",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "ChangeInFairValueOfContingentConsiderationOne",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Right Of Return, Minimum Remaining Product Life Prior To Return",
        "label": "Contract With Customer, Right Of Return, Minimum Remaining Product Life Prior To Return",
        "terseLabel": "Minimum remaining period prior to product expiration"
       }
      }
     },
     "localname": "ContractWithCustomerRightOfReturnMinimumRemainingProductLifePriorToReturn",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ango_ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Right Of Return, Product Return Period After Purchase Date Requiring Pre-Approval",
        "label": "Contract With Customer, Right Of Return, Product Return Period After Purchase Date Requiring Pre-Approval",
        "terseLabel": "Days after purchase after which pre-approval is required for product return"
       }
      }
     },
     "localname": "ContractWithCustomerRightOfReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ango_ContractWithCustomerRightOfReturnRestockingCharge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Right Of Return, Restocking Charge",
        "label": "Contract With Customer, Right Of Return, Restocking Charge",
        "terseLabel": "Restocking charge (as percent)"
       }
      }
     },
     "localname": "ContractWithCustomerRightOfReturnRestockingCharge",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ango_CrBardIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C.R. Bard, Inc. [Member]",
        "label": "Cr Bard Inc [Member]",
        "terseLabel": "C.R. Bard, Inc."
       }
      }
     },
     "localname": "CrBardIncMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer With Customer, Liability, Revenue Recognized, Including Current Period",
        "label": "Customer With Customer, Liability, Revenue Recognized, Including Current Period",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "CustomerWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriod",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio",
        "label": "Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio",
        "terseLabel": "Maximum total leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTermsMaximumTotalLeverageRatio",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ango_DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio, Subsequent To Material Acquisitions",
        "label": "Debt Instrument, Covenant Terms, Maximum Total Leverage Ratio, Subsequent To Material Acquisitions",
        "terseLabel": "Maximum total leverage ratio subsequent to material acquisitions"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTermsMaximumTotalLeverageRatioSubsequentToMaterialAcquisitions",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ango_DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Terms, Minimum Fixed Charge Coverage Ratio",
        "label": "Debt Instrument, Covenant Terms, Minimum Fixed Charge Coverage Ratio",
        "terseLabel": "Minimum fixed charge coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTermsMinimumFixedChargeCoverageRatio",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ango_DebtInstrumentDebtDefaultInterestRateIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Debt Default, Interest Rate Increase",
        "label": "Debt Instrument, Debt Default, Interest Rate Increase",
        "terseLabel": "Debt default interest rate increase (percentage)"
       }
      }
     },
     "localname": "DebtInstrumentDebtDefaultInterestRateIncrease",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ango_DebtInstrumentFloorInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Floor Interest Rate",
        "label": "Debt Instrument, Floor Interest Rate",
        "terseLabel": "Floor interest rate"
       }
      }
     },
     "localname": "DebtInstrumentFloorInterestRate",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ango_EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Before Discreet Items, Percent",
        "label": "Effective Income Tax Rate Reconciliation Before Discreet Items, Percent",
        "terseLabel": "Estimated federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationBeforeDiscreetItemsPercent",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ango_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Gain (Loss) From Remeasurement",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Currency Gain (Loss) From Remeasurement",
        "terseLabel": "Currency gain from remeasurement"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "2028 and thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_GrossMarginPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Margin, Percentage",
        "label": "Gross Margin, Percentage",
        "terseLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossMarginPercentage",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ango_IsraeliInnovationAuthorityPrepaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israeli Innovation Authority Prepayment",
        "label": "Israeli Innovation Authority Prepayment [Member]",
        "terseLabel": "Israeli Innovation Authority Prepayment"
       }
      }
     },
     "localname": "IsraeliInnovationAuthorityPrepaymentMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_LegalCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Costs [Member]",
        "label": "Legal Costs [Member]",
        "terseLabel": "Legal"
       }
      }
     },
     "localname": "LegalCostsMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Three",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Three",
        "terseLabel": "2028 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearThree",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Accordion Feature",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Accordion Feature",
        "terseLabel": "Line of credit accordion feature"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityAccordionFeature",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_LineOfCreditFacilityNumberOfCovenants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Number Of Covenants",
        "label": "Line Of Credit Facility, Number Of Covenants",
        "terseLabel": "Number of covenants"
       }
      }
     },
     "localname": "LineOfCreditFacilityNumberOfCovenants",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ango_ManufacturingRelocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Relocation",
        "label": "Manufacturing Relocation [Member]",
        "terseLabel": "Manufacturing relocation"
       }
      }
     },
     "localname": "ManufacturingRelocationMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_MeasurementInputProbabilityofPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability of Payment [Member]",
        "label": "Measurement Input, Probability of Payment [Member]",
        "terseLabel": "Probability of payment"
       }
      }
     },
     "localname": "MeasurementInputProbabilityofPaymentMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_MedDeviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Med Device",
        "label": "Med Device [Member]",
        "terseLabel": "Med Device"
       }
      }
     },
     "localname": "MedDeviceMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_MedTechMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Med Tech",
        "label": "Med Tech [Member]",
        "terseLabel": "Med Tech"
       }
      }
     },
     "localname": "MedTechMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_MergersandAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mergers and Acquisitions [Member]",
        "label": "Mergers and Acquisitions [Member]",
        "terseLabel": "Mergers and acquisitions"
       }
      }
     },
     "localname": "MergersandAcquisitionsMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_NonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Lease Expense",
        "label": "Non-Cash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NonCashLeaseExpense",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_NumberOfPatentsAssertedForReexamination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of patents asserted for reexamination.",
        "label": "Number Of Patents Asserted For Reexamination",
        "terseLabel": "Number of petitions filed for reexamination of patents"
       }
      }
     },
     "localname": "NumberOfPatentsAssertedForReexamination",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ango_NumberOfPatentsUpheldOverPriorArtReferences": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Patents Upheld Over Prior Art References",
        "label": "Number Of Patents Upheld Over Prior Art References",
        "terseLabel": "Number of patents upheld over prior art references"
       }
      }
     },
     "localname": "NumberOfPatentsUpheldOverPriorArtReferences",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ango_PreferredStockPurchaseRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock Purchase Rights [Member]",
        "label": "Preferred Stock Purchase Rights [Member]",
        "terseLabel": "Preferred Stock Purchase Rights"
       }
      }
     },
     "localname": "PreferredStockPurchaseRightsMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds (Outlays), Issuance Of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "label": "Proceeds (Outlays), Issuance Of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercise of stock options and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsOutlaysIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_ProductTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product technologies.",
        "label": "Product Technologies [Member]",
        "terseLabel": "Product technologies"
       }
      }
     },
     "localname": "ProductTechnologiesMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "QX Medical, LLC Camaro Support Catheter Asset Acquisition",
        "label": "QX Medical, LLC Camaro Support Catheter Asset Acquisition [Member]",
        "terseLabel": "QX Medical, LLC Camaro Support Catheter Asset Acquisition"
       }
      }
     },
     "localname": "QXMedicalLLCCamaroSupportCatheterAssetAcquisitionMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_RevenueBasedPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Based Payment [Member]",
        "label": "Revenue Based Payment [Member]",
        "terseLabel": "Revenue based payments"
       }
      }
     },
     "localname": "RevenueBasedPaymentMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_RevenuePerformanceObligationPaymentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Payment Term",
        "label": "Revenue, Performance Obligation, Payment Term",
        "terseLabel": "Payment term"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPaymentTerm",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ango_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "terseLabel": "Potential future contingent consideration"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_ScheduleOfIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of intangible assets.",
        "label": "Schedule of Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ango_ScheduleOfNetRevenueByProductGroupTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of net revenue by product group.",
        "label": "Schedule of Net Revenue by Product Group [Table Text Block]",
        "terseLabel": "Summary of Net Sales by Product Category"
       }
      }
     },
     "localname": "ScheduleOfNetRevenueByProductGroupTableTextBlock",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ango_TheDelawareActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Delaware Action",
        "label": "The Delaware Action [Member]",
        "terseLabel": "The Delaware Action"
       }
      }
     },
     "localname": "TheDelawareActionMember",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ango_UndiscountedContingentConsiderationDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted Contingent Consideration Disclosure",
        "label": "Undiscounted Contingent Consideration Disclosure",
        "terseLabel": "Potential amount of undiscounted future contingent consideration"
       }
      }
     },
     "localname": "UndiscountedContingentConsiderationDisclosure",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ango_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Number Of Shares Outstanding, Basic And Diluted",
        "label": "Weighted Average Number Of Shares Outstanding, Basic And Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract",
     "nsuri": "http://www.angiodynamics.com/20221130",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag",
        "terseLabel": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r385",
      "r457",
      "r475",
      "r496",
      "r497",
      "r511",
      "r523",
      "r529",
      "r556",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r385",
      "r457",
      "r475",
      "r496",
      "r497",
      "r511",
      "r523",
      "r529",
      "r556",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r280",
      "r458",
      "r513",
      "r527",
      "r559",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r280",
      "r458",
      "r513",
      "r527",
      "r559",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r378",
      "r385",
      "r456",
      "r457",
      "r475",
      "r496",
      "r497",
      "r511",
      "r523",
      "r529",
      "r556",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r378",
      "r385",
      "r456",
      "r457",
      "r475",
      "r496",
      "r497",
      "r511",
      "r523",
      "r529",
      "r556",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r281",
      "r282",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r514",
      "r528",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r281",
      "r282",
      "r485",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r514",
      "r528",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r28",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r203",
      "r286",
      "r287",
      "r501"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances of $2,110 and $1,939 respectively",
        "verboseLabel": "Receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails",
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r32"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Outside services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r32"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r204",
      "r470",
      "r480",
      "r483"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r211",
      "r212",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r46",
      "r49",
      "r164",
      "r476",
      "r477",
      "r499",
      "r537",
      "r538",
      "r539",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r45",
      "r49",
      "r164",
      "r212",
      "r213",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation income"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r546",
      "r547",
      "r548",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r131",
      "r133",
      "r145",
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r133",
      "r141",
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Charges against income for share-based payment arrangements"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r205",
      "r288",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r71",
      "r97",
      "r102"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Securities excluded as their inclusion would be anti-dilutive (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r524",
      "r561",
      "r562",
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r181",
      "r191",
      "r220",
      "r267",
      "r271",
      "r276",
      "r291",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r411",
      "r413",
      "r427",
      "r526",
      "r554",
      "r555",
      "r573"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r43",
      "r220",
      "r291",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r411",
      "r413",
      "r427",
      "r526",
      "r554",
      "r555",
      "r573"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r135",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r157",
      "r158",
      "r410"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration for acquisition earn outs",
        "verboseLabel": "Contingent consideration, liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r157",
      "r159"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Current portion of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration, liability, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r157",
      "r159"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent consideration, net of current portion"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r26",
      "r73"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r68",
      "r73",
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r68",
      "r175"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r220",
      "r246",
      "r247",
      "r249",
      "r251",
      "r258",
      "r259",
      "r291",
      "r317",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r345",
      "r346",
      "r347",
      "r348",
      "r427",
      "r498",
      "r536",
      "r541",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r36",
      "r111",
      "r184",
      "r196"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r546",
      "r547",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share, 75,000,000 shares authorized; 39,874,144 and 39,541,173 shares issued and 39,504,144 and 39,171,173 shares outstanding at November\u00a030, 2022 and May 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r208",
      "r210",
      "r216",
      "r466",
      "r472"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r62",
      "r215",
      "r465",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r80",
      "r81",
      "r173",
      "r174",
      "r284",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r80",
      "r81",
      "r173",
      "r174",
      "r284",
      "r484",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r80",
      "r81",
      "r173",
      "r174",
      "r284",
      "r486",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r80",
      "r81",
      "r173",
      "r174",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r80",
      "r81",
      "r173",
      "r174",
      "r284",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract Balances with Customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r350",
      "r352",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r350",
      "r351",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersContractBalanceswithCustomersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r350",
      "r351",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Purchase price holdbacks"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Additions to contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r58",
      "r458"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales (exclusive of intangible amortization)"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.",
        "label": "Customer Refund Liability, Current",
        "terseLabel": "Rebates"
       }
      }
     },
     "localname": "CustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (percentage)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r12",
      "r182",
      "r190",
      "r343"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r177",
      "r179",
      "r326",
      "r440",
      "r507",
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Principal payment percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r34",
      "r124",
      "r125",
      "r126",
      "r127",
      "r176",
      "r177",
      "r179",
      "r189",
      "r223",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r440",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term (years)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r27",
      "r178",
      "r557"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r71",
      "r151",
      "r395",
      "r403",
      "r404",
      "r544"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Gain on contingent consideration for IPR&amp;D Write-off"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r71",
      "r106"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r370",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r217",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r244",
      "r246",
      "r249",
      "r250",
      "r251",
      "r255",
      "r417",
      "r418",
      "r467",
      "r473",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Loss per share, basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r217",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r246",
      "r249",
      "r250",
      "r251",
      "r255",
      "r417",
      "r418",
      "r467",
      "r473",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Loss per share, diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expenses related to share-based payment arrangements"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r123",
      "r200",
      "r211",
      "r212",
      "r213",
      "r224",
      "r225",
      "r226",
      "r230",
      "r238",
      "r240",
      "r257",
      "r292",
      "r349",
      "r386",
      "r387",
      "r388",
      "r396",
      "r397",
      "r416",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r476",
      "r477",
      "r478",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r169",
      "r419",
      "r420",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r334",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r420",
      "r453",
      "r454",
      "r455",
      "r507",
      "r508",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r419",
      "r420",
      "r422",
      "r423",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r334",
      "r379",
      "r384",
      "r420",
      "r453",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r334",
      "r379",
      "r384",
      "r420",
      "r454",
      "r507",
      "r508",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r334",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r420",
      "r455",
      "r507",
      "r508",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary Showing the Recurring Fair Value Measurements of the Contingent Consideration Liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value Measurements Using Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Financial liabilities, ending balance",
        "periodStartLabel": "Financial liabilities, beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueMeasurementsUsingSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r334",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r453",
      "r454",
      "r455",
      "r507",
      "r508",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r424",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Estimated useful life of intangible assets other than goodwill"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r300",
      "r302",
      "r303",
      "r304",
      "r459",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r101",
      "r463"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross carrying value, finite intangible items"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r98",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r101",
      "r459"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net carrying value, finite intangible items"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsExpectedFutureAmortizationExpenseDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Intangible asset amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Intangible asset acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r79",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r88",
      "r90",
      "r464",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r71",
      "r89",
      "r91",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r57",
      "r220",
      "r267",
      "r270",
      "r275",
      "r278",
      "r291",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r427",
      "r505",
      "r554"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r71",
      "r105"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Fixed and intangible asset impairments and disposals"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r180",
      "r185",
      "r198",
      "r267",
      "r270",
      "r275",
      "r278",
      "r468",
      "r505"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income tax benefit"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r305",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails",
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails",
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r392",
      "r393",
      "r394",
      "r401",
      "r405",
      "r407",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r222",
      "r239",
      "r240",
      "r266",
      "r391",
      "r402",
      "r406",
      "r474"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r96",
      "r99"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r178",
      "r187",
      "r214",
      "r265",
      "r439"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r42",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets",
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r42",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lease Liability Schedule"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r572"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r31",
      "r220",
      "r291",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r412",
      "r413",
      "r414",
      "r427",
      "r504",
      "r554",
      "r573",
      "r574"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r183",
      "r194",
      "r526",
      "r543",
      "r553",
      "r567"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r33",
      "r220",
      "r291",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r412",
      "r413",
      "r414",
      "r427",
      "r526",
      "r554",
      "r573",
      "r574"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total Financial Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseAgreementTermsMember": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terms of the license agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "License Agreement Terms [Member]",
        "terseLabel": "Licenses"
       }
      }
     },
     "localname": "LicenseAgreementTermsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r12",
      "r182",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee (percentage)"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at period end (percentage)"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r12",
      "r182",
      "r192",
      "r333",
      "r344",
      "r507",
      "r508"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Outstanding draw term loan",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermLoansPayable": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans Payable, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r34",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Number of patents allegedly infringed upon"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetAssetsGeographicAreaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the total assets less the total liabilities of a designated geographic area ( such as a state, country, continent, or market) when it serves as a benchmark in a concentration of risk calculation.",
        "label": "Net Assets, Geographic Area [Member]",
        "terseLabel": "Net Assets, Geographic Area"
       }
      }
     },
     "localname": "NetAssetsGeographicAreaMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r68",
      "r69",
      "r72"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r54",
      "r72",
      "r186",
      "r197",
      "r202",
      "r206",
      "r209",
      "r213",
      "r220",
      "r229",
      "r233",
      "r234",
      "r235",
      "r236",
      "r239",
      "r240",
      "r248",
      "r267",
      "r270",
      "r275",
      "r278",
      "r291",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r418",
      "r427",
      "r505",
      "r554"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r201",
      "r227",
      "r228",
      "r231",
      "r232",
      "r241",
      "r242",
      "r243",
      "r289",
      "r290",
      "r293",
      "r294",
      "r373",
      "r374",
      "r375",
      "r376",
      "r389",
      "r398",
      "r399",
      "r400",
      "r415",
      "r428",
      "r429",
      "r430",
      "r452",
      "r460",
      "r461",
      "r462",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1": {
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.",
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)",
        "terseLabel": "Accrual for capital expenditures incurred during the period"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r49",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r267",
      "r270",
      "r275",
      "r278",
      "r505"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails",
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails",
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease, liability, current, statement of financial position, extensible list"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesLiabilityMaturityScheduleDetails",
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease, liability, noncurrent, statement of financial position, extensible list"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r444",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease ROU asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease, right-of-use asset, statement of financial position, extensible list"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r449",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r448",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Consolidated Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r32"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r161",
      "r162",
      "r163"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss), before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r44",
      "r47"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r51",
      "r123",
      "r207",
      "r210",
      "r215",
      "r432",
      "r437",
      "r438",
      "r465",
      "r471",
      "r537",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r207",
      "r210"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r161",
      "r162",
      "r163"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "negatedLabel": "Income tax expense related to items of other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r32",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense:"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForPreviousAcquisition": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow representing an adjustment to the purchase price of a previous acquisition.",
        "label": "Payments for Previous Acquisition",
        "terseLabel": "Payment for acquisition"
       }
      }
     },
     "localname": "PaymentsForPreviousAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Deferred financing costs on long-term debt"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquipmentOnLease": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for payments to acquire rented equipment which is recorded as an asset.",
        "label": "Payments to Acquire Equipment on Lease",
        "negatedTerseLabel": "Additions to placement and evaluation units"
       }
      }
     },
     "localname": "PaymentsToAcquireEquipmentOnLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance share units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r135",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r14",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r14",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r3",
      "r24",
      "r25"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from borrowings on long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r107",
      "r195",
      "r469",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r218",
      "r296"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Change in accounts receivable allowances"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r148",
      "r199",
      "r581"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r306",
      "r308",
      "r311",
      "r315",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Acquisition, Restructuring and Other Items, Net"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r128",
      "r193",
      "r390",
      "r479",
      "r483",
      "r526"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r200",
      "r224",
      "r225",
      "r226",
      "r230",
      "r238",
      "r240",
      "r292",
      "r386",
      "r387",
      "r388",
      "r396",
      "r397",
      "r416",
      "r476",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r263",
      "r264",
      "r269",
      "r273",
      "r274",
      "r280",
      "r281",
      "r284",
      "r369",
      "r370",
      "r458"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomersDisaggregationofRevenueDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r284",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r377",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RecentlyIssuedAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r372",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/RevenuefromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r447",
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r7",
      "r28"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Sales and franchise taxes"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r49",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r34",
      "r124",
      "r125",
      "r126",
      "r127",
      "r176",
      "r177",
      "r179",
      "r189",
      "r507",
      "r509",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Principal Obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value of Assets and Liabilities Measured on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r98",
      "r100",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r93",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsChangeinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r93",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Goodwill for Each Reporting Unit"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r21",
      "r22",
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r108",
      "r109",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionRestructuringandOtherItemsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r56",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Summary of Net Sales by Geographic Area"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r52",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r82",
      "r83",
      "r84",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r135",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Basic to Diluted Weighted-Average Shares Outstanding"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Delayed Draw Term Loan"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails",
      "http://www.angiodynamics.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r267",
      "r268",
      "r272",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationNarrativeDetails",
      "http://www.angiodynamics.com/role/SegmentandGeographicInformationSummaryofNetSalesbyProductCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LeasesSupplementalStatementofOperationsInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Amount of shares issuable through two stock-based compensation plans (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease)",
        "terseLabel": "Approved increase of common stock reserve (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r132",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r123",
      "r220",
      "r246",
      "r247",
      "r249",
      "r251",
      "r258",
      "r259",
      "r291",
      "r317",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r345",
      "r346",
      "r347",
      "r348",
      "r427",
      "r498",
      "r536",
      "r541",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r38",
      "r123",
      "r200",
      "r211",
      "r212",
      "r213",
      "r224",
      "r225",
      "r226",
      "r230",
      "r238",
      "r240",
      "r257",
      "r292",
      "r349",
      "r386",
      "r387",
      "r388",
      "r396",
      "r397",
      "r416",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r476",
      "r477",
      "r478",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r257",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r14",
      "r15",
      "r123",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchase of common stock under ESPP, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r123",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance/Cancellation of performance share units and restricted stock units, net, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r123",
      "r128",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r14",
      "r15",
      "r123",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Purchases of common stock under ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r128",
      "r134",
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance/Cancellation of performance share units and restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r38",
      "r123",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r18",
      "r19",
      "r86",
      "r526",
      "r543",
      "r553",
      "r567"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets",
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending Balance, Treasury Shares",
        "negatedPeriodStartLabel": "Beginning Balance, Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r37",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r37",
      "r129",
      "r130"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, 370,000 shares at November\u00a030, 2022 and May 31, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Discounted cash flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/FairValueSummaryShowingtheRecurringFairValueMeasurementsoftheContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive securities (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r245",
      "r251"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted average shares outstanding (in shares)",
        "totalLabel": "Diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
      "http://www.angiodynamics.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r244",
      "r251"
     ],
     "calculation": {
      "http://www.angiodynamics.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.angiodynamics.com/role/ConsolidatedStatementsofOperations",
      "http://www.angiodynamics.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r531": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r532": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r533": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r534": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r535": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0001275187-23-000005-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001275187-23-000005-xbrl.zip
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MI\5$ZK-Y@1XE-F+G1=)"ZAX>W9K$;<'&[F/%QH_<(B+PV>=S=EGHF0(Q@2A
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M,(P+QKT7-GC"OH-RH]?LV]#J'NR>=URO73E:CP.X=0_@9"SXR%Q!(T. O4:
M$UIB#(.E2388GWEZV#_](4_+,I^B\@(%1H,RWGB%OS@F-,&(V:5OH'L9MJR\
M:G5;P_BF]2F&K>XP1QRN'=<&@SA\/XCIM/VFE::MTXV6Z?C.J^[VT>;%WM':
M!8+W>?_UWZWMC7=D?^/O5N/BF#<^[)'&!L+?_.>HT=DZ>\-WVO&_=L[W/X03
MQT#6FXU6?:-^L7_TU_%>9PL:&SO']<X6WVYZNG_T#N'?HXT/>.>C5ZE^<4#J
M"!FZQX:B.ZR95P48IU$GK2FB-E1)9@1PA.PMV_L1Q+C2BJ(+)E6@(%7$.P:F
M*7.:<&L8?-PJ$1,YBKP-U/9)[-LAJN*;: =Q)Z=>MA-B5&*U.T3JS4[5=D)
M,:ALH6?5&[1RYF#S#".^08;U36LPG"Z6O+Y^A:6GC:,M5-V=UOY&^[#1?"?V
MCKRH;QR<[[]^?[[7W#G:.WH/VZ\W ;'$YYVUMU'E&Q>;M,&VSO#?L[VCG<[^
MQCMHL/UVO=D^W#_R^'M &5C[?'4-/NMTGZ'J-X]YO?F>[QUMXK^O6HW7^\>-
MC0-4]?=GVQ]>=?!^O,'V:'WCK_2 ^D;P)$1."R.L+R!&53@N0Z$<>M8F>$F3
M65K]?FK@/[>'A[%?0C9H]+I^9$1_1( ,#5QFLV!=!"Z,8<$%IH+6TFF:R$B
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M$ED8?&9@$&9<RWVIU4YRJM%W!:.<C<8K;J+@3%M.W<) -H5!F'&QGN0&4(6
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MY_M'X0C/.=S_L/DIO/X'PG_]W=YG[4_NJ,?V7[\C^Q]>'=;9IJA_J)/ZZRW
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MWNJ.F3!>_?GXO_7 7!'M]H1G.V<G-@P/8N6-&1U\9=O+.+!RU+\FI\W%_DR
M@3/82<,-1,\],$D=Z* PR#2,2N.(0T@"@.H;$YK\GW]A@7XIR8-7 ^8U9&$K
M,&\(S*?WV'G0COH$;DN9!F:, F.M >4\23J#:.M9!7/$9S-Z%)BO$LQKR$-6
M8-X4F$^MYDAXA6/@X(@WP()@H FG$+EU.&#*?3Z*FV!.-2LP7VF8UY"(J\"\
M(3"?WFEUG,3HT\A1C2PP'QE86U50#X3:I."PSJNY:BO=I-5\?9*?/.: 1XV%
M5U>>Y!;EF;@<SQFN*S17'\W-)A:Q>4R=U&"T\\ 4E3FC=#)?/%(V>BZHI'7Y
M)IIWGK8 _0E\$P7HBP#ZM'="82R("@QH$C; )'.@J8T0G"="!*H3A]?EG2A
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MYVJY*6M*;6O*; (;' W6TDB(D<>TIH2TG$1A@1$LI'"1*J\VMG2;J_K25->
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M%JNDRR*&()(R8YP)A$.C**I,IR9/)Q,P2T-/P"31E>948& =S0?'(B4Q38A
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M8L0A:,-U((G8"&LS.7NR^F$V<F.2F2XB?'WUJ:%V7UFAAB>BABG-PTWT7M(
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M(THJE<22.B$]9D*&1(Z>*$S2^DN-)NSM7J7#.,5SE%^%Y>ICN=DBS-)K*DG
M0#G-X4Q<07HAYTD/D7E!$<TU68EJ*\(;%,M0(IIJACHS@41BL'3<L:2%+!($
M14$89XP*CBJHXP+U98+Z^716CD"P(@8,LC8)&A/ 2&> :N*93V\B1C>VF&IC
M,7N2I80M/;%P">GU6R7+?*V]FWKI27GM?^;W_"M#Z!I[*ARBPMC *-<)Y-83
MZ9425N$X(?1YN\X*H=='Z+-IEHST)'"GDDFJDV*CR59-MJ@%RC!!PCO'?2)T
MHMN*RS5SA15"+(0X18A<(:.5]L)ZRH1/QJQ6@6LJD"4N2CM1N(40EXD0IQ0N
MDY(8Z@DX+SDPP3UHDFL3!A%=^G\(AFQL4=8F^M$*=\%^NZN&7,U^7M'=TR8#
MI>F1_.#,]D*34Y;>M94K7]7\]=GI::\Z-61Z+=\=N=Y@=#:LCG\F'$!E=%S+
M\-_W-::[O>O.U5/>XQ:DD:="6J/OL3Y6^;9SP[.$F%S/S)G3;D9/^'R:[/'N
M.,%GE##CSJJ$./YLF+$R/@X/--/70'BNIK:L_T#4H)_Y^&#XP@S'E__8_EI,
MKQ/RBR>#?AB;X?GV:!3&HZN"4']VC>WV*JY.;YR=!(^+L+R7L)RM(1NH1 S3
M )1&!$P2 BIJ L0(QY4A,?JPL96&M4&)0Q9D21?.:M*S/>E)K<)93\I94\:P
M,$HPQ30@:G+"(TY!HV061Q.H58F5%,T'MAZ]JUMR'2U;@W\>FV0-I]^^^W'K
M/^G'U2=.S/!=MS]Q9I!O6=PELS$,%\]J)+/:85+4QKG!2?KN\RRQ^X-QNKM)
MQJO)5>G&X=TPJ?+3Q#O9FDT"?!0RV57>&#/^FJLR730:IQ>J[&N;7Z;X=#]<
M?CG%FSD<_70P(;!GP] SR0P.OWSJ^O'Q%>->^]QD-C]#7S]B;&K#V?CVCS2E
MB\6WG7']9VYMQ<!*2T=8B$G(*N8T50@'H831/ ACG7M+U,;5AXZ_V-&GYET
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MM+%%)6JG^5?T2]$O*Z!?[F.@/8SIBH'VA RW_RW#\31.1%,/)%H$S',-1L4
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M)6>V:!!%L"P;1!&L[RP6 T]<=(2J[XR%W1EG<]X-[!,/'L3@ )H-XB%AY)*
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M1',6C G4P]*)M#[2*,4M6'3OWD]U#_C'!:KW4^D57_'NGO^B?.3):(&D+.1
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MW(%?M9D[]JQZ*:E>>@H?P-SA7$%*[_>.&]6 M\OO#3?*$7] LJ .Y,K3G5$
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M>L<,A_%_2Y_-N2ZWLZ]P=9?;,IJ9/?!Q2+MA(OI3C-VSS;H+%?FKIN_>VPT
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MLG?6E[/&EOW1Z1WW_N@/!H6.\ZT]@D]&I[<SG^0K0^?V^@>\ZRF1+.* ,*>
MS<Q@I"G/G/:*2XN9Q"KD?*@W5R5$@<AU\Y(/HS_.JCV(W_O=[U,(D,:+,U;L
M3^>?3U8-5#MKU-W$B&-P@JVV!#Q?K@R''5H33T,(0CF)XVW%*&_/'PX!)(ZS
M8,.0XEH!N5ID%HO,-[P+AE#0A'BD<M"!1Q<0+(1"&(-FJZ",5 ;,97RCR(38
MM:<@,F%@3QJP,?0:W3X 7"4GZ^,/U_.'V9!J_ L^7/E[!<RPFGW817SW.)2D
M<A 5W^_U.J,QS2, 7GY"BG8$4@E;DQWE':Q_,KRTMXW*308Q[Q[Y[Z/^"*!\
M2H3+/;-DE,SU?V2T"Z'L6Z.2Q X/SQS D[$/X79Y-'8/H'+/CN)XRVP<]D?Y
M8?&'CS# NPAZ-*"3.B63 "E]U%8PXXE-7KN(A0E9T(D!4Y0M%O12DW(7L,ST
MZ8, HWI735ZM"0LUX>PCW4TD"&,)02QPAW@0N<=D\$B#)D@B!=B&^ KP;(R5
MX$VE$HT-Z_=!/.(@9_UFF1H>ES_,2G(O&VHN%ITYS-)V%UD*@:OHO*,V11ZM
M,Y%B+W445FFNF1Z[-0":Z';H^=>@GP5Z^&[0[WT8#H]!)4#.IEV?6GH620^,
M@^\*'F7 42#P&++TY ("@1/*&FZ\!X>"@O3<O/,6!.M5%F8CFVM'XU69T)//
M;[F-GCW-4G0\!#3*-AP8J'$ T >J?Y2;6L!-CN&G800KNX+9_/4C6-0*8JW_
MW^-.U5CEJJ<N!O"???( Y&4 UFU&T=0YS()6G@+V[3%8&* ;%5X/1^<#6#L>
MG,+T= '<!PWP%3L9VR.,NU3BY0C 2S''P?L!\^FZ@(;U1"M-;1#@<'/IC$S:
M@;%C80L1$;.L^=4N@BZVD^LLI;R@EW0;7LC_'HX')[!Y#./A*U/HUIEGK;5=
MC9/%8(FBA$UN:V EL@9,(^DYY<9:K#A964W@CJ+3: >S80J0YBS(HU,0S@_%
M50:P[Q]>I<39$+I*S4X '+*>.9#^ #;3:-KN^4_0D:/*4X6[VT91.] ,T ]0
MK]\Z?R\7?QY;])O?X^ PBV#C75&\/(9/^1N_K7S>?/<)S/>C[O&P<>4^!*#O
MXF#6K)$R4"F-]4ES@HV)#!L 0RFBTT:(&[:B#^UWU\OG'W;8&7X^ M,N;![^
M&Z C!SKSJ,GYIH/H:Q/2K1;>7-MUV'EP\0PRU!K$50C(Y)BW%%@:J87B^?@0
MOUG0@_9OC=^&Q^X@^F+-VD;J]@'" 6]_U>(7ZW;&A\MCFFA/7O%7O>"LO;9+
MF7'>ZX D#PEQ0"%D;"0H)BJH9D10#(;&@M4&9PN6][<. $(G77*<8A=D8)B%
M8 0J!KY5PTW\B!S\ @!:^^-3X]RW:!:GJ MK<IB!(X-2!3H%GC((921I%B#)
MVWXC9G/8PX?5-X^.NAU?.JI46_/=14Z"-1YQT@I,%"XX=N# 4L:#E8$PP19'
M]&N\N:?X?3EKG>R"OZH5J#O2L B(T\21XS(@;DQP3FOL UU9)6_H?'WLWYIW
M76;AP'H1Q#*7N$TN+V^,#-P<#@YT</4R/\XRMT]VG4B:!.^084PB[B3\Y&#!
MF<561.T%<YE#Y<V"TLJ_99BYVT)3"Z#E)%?<:FYAP07L)"Y$!ML7K'ZMSX^S
MT!CT&:8D!PL8(N!.P$(;A:Q.%A',(XO2&AHRF>\;M5"?0SR*U<G1V+#M1K O
M[5[9$#K];/FF1MYB)H=-=A!+^*R<0IWD,Z9P#-M"B8_TX:OPV_FU8ZO7#O()
M4V4^Y\WI<!*&&SN;X$:>6[MW$SO+/4[28!^YY3PE$Z1(C"7!8DS:FMN+W0++
M)?^V'I,][HZF[9</XPCE:Q:\;='ZN$M2R T[$G*X:KWK 6LX08D13HQ4/N1C
M5[H@8/*WRD7)XG9^0%EBS=D(&<<OYKSJ$F/V=C#(/=_L5"RXD6)L="KIS3;*
MU7&6<;"Z,>KX;_GO\,7FHF\N=N*&=S=SN';9@.<,Q!(FR&C-. =I!:F- C-[
M=UA<%#I^>SX5[V+\*PYRWRO0X-<LH'ML$P14$$G!QT=!!(:XS^0"@8/=#0N@
M3?*2>IL]*[I(0N^,13AZ%9PUVL$^:*UR#'M,DLQ/ S\.UVO]6&O-VQ]WP=:P
MF.N$K$W@5(4$NV!4"1$C#,&$!&)T6>L%NV .I (RP*I.-L'CPQ(0/>H/\A7/
M.39Y$6%RW<Y>R7\8CI-$1@M1=A#+X1W8!%4F!6S.>\=V8$'2<^3JH ];>;<*
M=@V+J0!7-!ON=":@U0,D!RNMVPB=08Y/Y.MA4JI?0A]>$T 8K 8W[(2.+9A>
M#AK_[__1H"3_?%\]LC\8EC^0?_[]36,-C(GIM^A?]H'S$_+O%U^]Z3TG9^0P
M^-09#',>1:>?XWW5)_F'B=U23A+S:$=PZTZ9E9R!,QZ"'0[CZ!8#>O-LQ6AV
M^L[/>GTI,[>#DI@$,Y7AJ"Q/LW%2DG=*B]8\%1ZLPT/X?3C>A;V/W3@89^CD
M%^T=3J*H(%>'U7R&ROZJ,ER&U7W/CR&:V8[,EFLN8X.IAC\-K_%0)P-X7!MR
M$6BWRWX!?YU,P7RH'L#G/%0_AG+\VI#\X&,V*U/DABHI\\%;1)SEOB3:)T23
M%%Q2PI.2*ZNCD_[\(2XX$0/0U^[I^$RJ4PZRQG.> V%59^#A[S-9PC=KXSC%
M%^6"@=^9G-%/1-@O5-""D/+\;9Y^")=G)W\E=SHMZ0PS[F16Z=RN.:=/EQ:@
M589'GD8'OQ[&X?"_LN5UZ9J-/SYLK:_]5_YN=CSW<H2SZ#N\YQ*YBQ/ESO["
M</SZ6_GU_C6>@D]Y!EZQ=F_C?"3'G:!&8!0YYX@;A1&8S/"39A;CR&74<665
MO<$+<C1 , A\T/@MC(^7XV!D85\&\ZW3#\.+OM\7UL?TP7C9C"LQ'.[;ZCQN
MDFX4EBSV<#MA^@P&2?S?XWS^VV^-7WEMZHU?L;#Y,W  <5)"!DL1H3G3/3-!
M6J(B"K!V3.>5"BD+VX(8Z$38_GZG-.%ZF[CC-O&N\P-TS^_#3,:R55^S5U3[
M0*/7 >?L\B?GV20_2C S9V:5?:3:YB]=>AZ('#>?_J\JD-D?P/\78L=LZ'L[
MW*]"5$._'\-Q-_N" #F^<P1/@0NK%$2X$FYUE#T:&.OT)G:=YS'>QKKYLN7>
MPSJ'&7;*$KTM*_2V7^]D.;ED[61S;5=Z2:,R#@7"P4[53B-C T&&>X%QPB80
M<L4YV@1<[H(M3]ZPOH#&?Y58+'AA( OG7O<-%EQSD=HV;];8L9=XC;)67CLH
M7"?E0CJP\\O(RI6+E6WLIX;Q*7C\L=]QG9(M\0X<L(9&_P]<A6YUYCTINR%5
MV<TSC?JLE25J@Z9F\*@0\%(E$4SA"<S&71)5C5?!NIB(I8+KY(VC@B:%J>&9
M5%E>05!P;9%(G8FZ&%L^B/;>+C/* 8!$%%-P@"WY:$7'@*24G@:*>1"YN]_-
MR:C3I6'79Z[=11ZLBDYX@B5A@6OO3'3Y1$-[[A.SAMV6L*+.3+Y9'EHX'[79
MQ**#'2;01!&W'B,=L$:P"I3GXF@9^<_*PQ49BY/HY3D&EP0A.[H"6J:3@G)E
M14X8RC!S-^/FYX#FED<GTX>X:Z._BM.X<1A>\=')V<><*1*%$28PBKR.%EQR
MET"NP*01\*-17@078DY\%_/].?X&F^1U&TZ1HI8]'?^53!>TYJ/<TRR'WVWW
MN!R]=@$.4"G>R<9$EJA!'SS?RA0 >SO9SB!GG'V+H^I+<UOT?*'\U*8]WB8Y
M?:-$]M7ZE9?\^P 4()>D_O.D$T;[$[J)J2^.MWE\\17KP$@Y'EW]E:GB?U^J
M;'^1-4#XS 1-_;L_F(SF"&QZY ;1?D,VP6!_M]T3>SI<^<=EHP<LGIDYG'W]
M*U\RI<>R42O+"\"@7YTE_%Y<KWP5#,DNRU :^X,,</_G9J8&V->W"HJ"0KS-
MV B>YG__PZXN6L?%E?.WJH1??62^A<]CQWDS7?8PAZ^8?('EG1PG[P@Q",PX
MEK.U8!.G"6R\&!(C6@L1\2R9PG\76I +-"I4)"#177LTC+]/?OCGA/^N<U@$
MLWSIGY<]E:RSLW2]66:KCR_4&7S3HM)CYKSQD\<?ORD?S5"K5)]I^8;HJS_&
M;\B5GUUW6T+>2'J[V]Y ^'='+N/'83RZ$4O*Y/]6?-K^,=PB#/]^):WQK=ZM
MVH.6Z>W 7C@GN+CT;B^>I7K>_[HKD^>KY3R[\_N_&$JSGXS W% U^'9L@M^%
M8^$7LYK][+Y=L9H=M'ZTMO9(:VNGN[/5_I89S#:__KF_\_Z#V#GX]_[VP0>\
M<[ -X_ER.LMJUCK;^+&Y_N5'N_?O;HM^S QF8KOW[MOV0;?7_OJN ^.'-X)W
MW_HSM>:;DA$K+([<(Y+=>*YSKW3FX1^EH_/)&4IH]N";>,')Y\\1_CX-9]E+
M[BNT.#12MQEZ[+A@C5)/@E*=^0Y$-BA&HT+Y5!%Q[PURGA/DDI9<P%;#DG@H
ME*H[F]Q>!_\5A\/?0?-L+V<DGV62GAPAZXPY/BJBA5?6^>2W7\"PO1Y3' QB
MJ"KOX]L\[>VX--V4G@?LS#<^2UQ@RI-!\ H<<6D-TB$FI$Q4,03*L8D .WB^
MV_N<7[P$71">O]U3(?GU_Y9LM)F0_8/2[EYMO[YH'_<AIV:Y ?P7X/?=#YQK
M1+\9T=OSC:I<"@8PG2)L@D*<<H>LDQX!H$N2SZN-E2NKW#25D4_!X7U+C7D<
M]N[9[*$K<X56_]L-_K%Z9=;1TN08_36?"]E/T^>UW=,['OP'3X1D6G 6,?=&
M.VF$E=PR^ MF7MZ0U<BO]R _Q1![A6$)1N[KLLER'/6%M4YV5;0NR6B0L<R!
MY648,H)H)"E3*4J%B?$E0UHM8HFX-H&D%/]/')9"(E-J_"]J=#JP/K;;'<O/
M]UR#>2UIVD_)2$V:=K<3RKW=:#EFB7ND"RD\B0(9XQCB8(43YI,7DE:D:8V%
MI&E5-4;#Q;W.X>%4GA%<V^W$0D]E&^D8A*,0S?8'8QZ H\[@=%)"63X9W^BW
MEAWX_4:5.\+__N8.&1]W!MI;-E,0R]Q,03]^,X4/F=TW;MD?ZYVA[_:'QX.X
M+,?Z[4G3DX/M'SL'W\Y:9__N;+[_<EKLE;.=K"2B=?"%M\\^XM;Z%P$V#IM3
MFH-W/1C36?OK![ZS]0'&"HK3RTKR[124AE6-3[[Q]E9(+1AO:VTW^.22H 8Y
M ,[<#S@@[>$G8:T)0A 9[5Q/!9"EX+4AVEG,&:<NT2BE3%91'@33LVD ']IO
M-UL;C:VU_V_C\T]T5+CQ<<\EPWFJKOTR\WVGB&5C9'_D9/**8C$>A@PJ)1^Q
MI#)V>N<(-2$[*]<-1^-,LYA2]*5% =RHRGI,8Y JJ)4ZV68HV->PX>!X.!I3
MI^;Q!/AP$#-]8REA;C9.]COPY)RW/LAY0>$B5WT\BL*%#;\#]GE_/'C3&+O7
ME\:4R0ERMOS\T$K)>LZX/']R9Q1[PY_)O11*:FH]R(CC45/')0F!:! 2  D]
MV5[-%288NU16LC$9Z3E4Y*S+3S %A_G,NXCE'Q%F+:Z7<<?1ASSLL66V/&;9
MD\/)V0;>]:".40:/A  /"LP=@AP)#B5OH]4\$!Q=3LC4"VPR>TY#,,R3'2;V
M5O[KM.3"$K+2&,-G31K\3 $DUX'1X+F6X-\Q##("@RL=[P#S6.1%8,A$8$@M
M,(\C,/YT5W)-B&44V<S1R:T+8,_;B#++HO0:_A$ [X2^F>\_^+=S<!O"8DQ
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MO0;Y)U 0WF26RN%Q C#HE(98LXM8\0R6DNUT7#IW3$@CX(GC=\[,Z[$;QSR
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MLI3'W;,61.75@=]+6Z 7@_'+\E_5F7^/@.3[UUQ5D1"*8\*(>8D1IT(@QTP
M_5!R)A43FM,'ROQ; AL]CT29&E!K0'U\1UX-J(\#J/.J,951":Q1-,PAKGU
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M?]EKJFJSV!XW/6Y=+\]^EZ5:6LW_'P[L?Y!!+BFFN3*:Z 85JTQ%E_KYE:(
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M"0^/]WX!G7^79!<QR,+ CN\/?':B)+#<5LLK 7\*Z1WVBDAI@W724^S7OC?
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M:'[<*!N-9_'6=?!K_'LJ_)MOX.Z%=YQHAVC6VGGR"<'&$H2Q(CB;QE[BC'^
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MW1$,O%0 %L3$,&3P= <(+Q)R\9Z'7)F$P1U(1KKB_+L[#O"@ 5'N@$E/:#V
MK/C0$^#"\$"/ =G!72Y<)1=8D#F**] ]XH"L]AI\UYJ;\(]Y%@__I&QDS,*A
MZZ?Z4)_,.''I('S[8?$VPLM>OVL9)G> +GHFEC1J.N_T.JS?YATVL*R_NOU7
M6[SKZ8R.[E+6I7=0Z,V(N3VX<V;9P&DPGH1\!&+7O>,7OA6,^540\UMXQT\@
MMK\=F,*O;U(*OS#_^.I]!4HU_[B%]X&2?W7[971E_/GU\F^@]M^!2L?GQI_C
MJ]$\A5]^';G7OU^VKL]&H\N_+_2KLW/@"N>M/\>7?P.U?__S;#C]X_;/\1\&
M*O^_F']UL=F\W>TVF,6QEY;%&SUGH#>L%N_IK1[7'*V_($5!G'<L9C+@O*9E
MZP/@S0.[-= ZCM7O6^8KA0-!3 #R8,/Q5Q].3D]_O?SUT\GM^9ER??OO\R_*
MZ?7EYR_G_SZ_NKGX[5RYN(+/YXM*3A'/ETNHAQ;RX8DQZL8:<3OQ^+5S8EG)
M."&&1+;J$ES[%$31+9H8+Q?A?KW_:V#Q 3-:>J/3P;D'S-0:O1[(E6ZWQWH=
MDZ.,GT>@M0Q+F'JN;P-#?V<8V/GB^1TGQ,-.1\P?PN- 4'!FC0#;QI/ EW*&
MY0BB!(@A]'.&(G 3XHBJ^%R()?8=U"808B QG<#S@OOH74H19*=F.J>PC6&/
M'IM$_%WZQ_NT<8OKTTKIIO>ST%O2)(2 *7Y^?^_:\0B=0DU-.(9DII5\L_RY
M23_-V?KBMY[>!.U\Y<]:4U_YV[K'@JS0M,Y&CWT@0>S!7,[%2[?U;190MW"+
M!5C!PWWC:6^S5+)1R+ER"=>-(N7<1P7I*K@3"EM+4U&%,9:TA]D0E ?U_6X&
M@->DR8$1P$!??+.RZJW@;-_"__1^X93+M'6P@."CKUA)&'+? IT:-.?(DS*5
M6- ,/)ZI\/&@_NZ?F,?0_P1FPTDR3,"6;>ES5%!/,ZVGF2[W5=A=A[<'IMXU
M0'EQ&,,(B*D[AMW76<]@[;\NEKHH6@N:9 SZX"CP '[1.=B<\;0T@8P=U409
MR/C/US_/1O"NB[__N!U.K\]^N;^\O1I=G7T#M?"/Z>7X/Z/+WW_5+[_^.9H/
M9,!ZOUW_?#F]_'HUNCZ[,*]@?9?&N79]^Y_1U=>+Z1_C<UCOK].K,0TEG:_^
MU-IF=\#;8-0X.H-_6*\Q, PT=+JVHVDF[[=[KS[TM.X+&TE:@63WZR7ZL0?6
M4U$[WJE8O;HM,UYOPY-ZO-,SVLY@H'5-8$E]IV7V]'ZKQ;2V83J;]*Z+8,/P
MUSR7NK;<G[@#.L07;GDLBES'%9,M,"Q[[=RR[R=Q'+J#A*R-V^ S6#!^1>*U
ME6!SBV- 66O0[_2[W4;7,?H-DYMZ8V#K[4:;#8Q!V[(T$XO<=57K+SII%W3?
M$O32J,1\F8.R@BOD@2LXY-Z$UHM65ZNDJY9$,*SQ>::BX7,0X@)K"?&4$N)J
ML0V*8[$N,^U^PS):O&%V-&R#JK&&WG.LCJX/NJ;F/%Y";$53!U:!MW'>'=PG
M<17<\?& AP\ZZ!Z;:?5"A<$^07,\HH+95LOJV -FFGVSV]-ZNM%R.OT>L[C6
MU6U'^#6VD!"U@^-Q?'W1P=%I<<MJ]_J-GM.S&B8;M!M]S6:-7KMOL9;3AW/"
M@J/>XC"5K?7^?1#'?G,SU^4OU/&Q.C[VB!C)C?N]CH[5T;$Z.C:OB5ZR:1T:
MJT-CFZJ0 [MC]GD;NVSVS9;=9RW6-3I=VS19K]_O]V1HK+U+:.SHW05?_VA=
MW_[F_GE[_OWRJS?^\RM<?VN[U[0FO/="NSR[,.#]]_-JY=57"];Q'^_R]GQZ
M_3L\]>=S':YOP_,\3,WZXRNHJ%__A+W^-!,WN[[]5;O\Y2\'5'S=,>U&#WW)
M9MO@C1YKV0W6-UH]R]):S##07=!JUY&S.G)V7)$S;IFZ/6AI?;LW,%F_ WS*
M81P^]36C9VY4,UY'SLK)Z J1LZN___A^!8RNQ4Q=[]L-K:^9P.AZ3F-@&;V&
MU76XW>KVC;9)C*YCUI&SX]!EZ\A9'3DKG6"H(V?ED!#%R)E4A>%$6[;5MQI:
MA[5P@  '+;C-&LSH=GL=73.9WGF\A*@C9W7DK$1LL8Z<U9&SH^+KBRX.H]_O
M@JQV&MBCH&'J7=#\^VWXJX^A--ZUVSWM."-G&S626!F/65UJ][C29&PL7N+2
MY.[3ER;#4D\L"_ '3F+X.0Q\^-/BU+3@Q+=E8>&%7[S&]2UWXO&H)-6DYF76
MH."B]<?OO_Q]=?L->,(O^N7?OTS__/K3"+YK7WX= 5U?:I?&!=#^\'ZQFM0>
M_7EV"70Z<J_.?OW[ZNP_X\N?/\)WWZ;72-=___+W'T#[UV= U[?#OP"!3*O'
MC8;=T@=@PG?:C7[/[#8ZML%,SK16=]";KUXVG;;>[9@#T.V8V>-MUK/Y8-#J
M=KMVB\/_%HI/#W;RGX$=6%/Q[XL]Y:_#O_IMPVSIK-.P.[S?,+5>OS'HZ0#2
M09_9;;TST.V%3B^==FO0=33'ZCA=LVN!$M]R^K;>LO5!M]_3!_.G_.7\]/SJ
M]M,?RL7-S:_G9\K)Z>GUKU>W%U<_*Y^_7%_!WZ?GEW#%S5(6NK)L_0%VMK2J
M_6$$G=UJK\U[IMGFH&!T3)QM[G2XTP-E \?GM#2VZCT/@VB^28\Y@"=J=D^S
MS1Y<8S!FM^RV@^/PJ"G8,V=>]/O-7KNU2^*%H35-P]A[XD6KU=3T)\CGT)J:
MT=W_:HVFWMKLL4NM1]TH5WK#P^*<=/DO')49;ZI<1!&@MI)S7V66_2H-Y<0.
M)C&WMPGZ/\X+>P#/;KW@_2PX4[0WZ1TV+QPDAII&LXNL;Q*(GD/OJ,>1>\?S
M7+,?9W.F)+_4\EO8 ,R()%Y]RY.G66W8+F/!%5/X=Q3FK&7(&X.0LV\-YL!B
MWS'OGDVC5V]GA2N(CCD8SF]_Y28=YTDRBF"/@@^"D1^$=/#OP#[D(5X%2V)E
M68HR"E&9_<<&+:1>?: &-AA(/D4]&+CDO]ZR#\O.<:G*L:NJLH'J4:J<4-!,
M3+V]HV8"T'@:S63_*H3^1*LUFJ#P[S.!M63IA\LUDYN8^38+[0UR+BNUKS,P
MM4)W@N1\;%L[=QQNH8!6SEC,CW-W2B :'P+')P<EM;#ZZ/K,MUSF*8"UL5"8
MM\J-G?&++J9][9I4O#H=ZR 1*62Y)S>_8N!);^B:*D)16>O')UH./?&=&\/V
MK0T6^',  /.I(>9)%+E13 &TU[?!Q+647LMX\TXY<R/+"Z(DA'4,ILI/LJVT
M<@Z2.G;A2S8(DEA9^J3E ;?=<0*/^%DPYA#(<CMR(P4QQO4M4'JIK330'B6B
M3YC(2@?M:Y@#FN5'%@=XFY?(;N!V=FAX"S86IT=-)_!0[$B7W:@JV)<;-LOQ
M.*?_C+!;76H48\]4:H5:N!S;<6/K:_R>2R;AS%V%;*/X2"?C&%'&,0IMO,N&
M%LNY\>$R._^3^%Q9D7R_)=".GI!$ESN46&-X\U1APHTC6N3#XR.I:*4M?1_L
M8$T([\9 4;;B![$R8B#Q84\N/+\H(.EU@.M6451N@/A;UK@MXFEMX;PL"^<%
M^%ZO@,[^X*!(3":@Q@BW0[B+1[92*G=M U9N:[4-^ 0VX+$8@%K1 -1ZZFR%
MU.'M/TJ93*TY4& &<*94EI+9?UH;[+^367L G;^8$H56'H_%>)[LNT\N&[B>
M, MIU$WZ2Z3<N_%(.4TB.&\>1@NA\M6Y1%71= _F9$CMQN<=2[/AXE!/#L%B
MC>1,C1E<HA$;(;"3D-]Q/^&4=5! %RM%%]3663;1"DLX4F1%EP2<5@A?XU/A
M$.!R'"$"=TPH=0\3@E&%]U$S!P.5[.C" )&06\'0%W,^T#3V\V6ERU$\B==3
M>E0ZT@38]5@0 .S-#3-S&*"?#"+^WP0O2K<F7_,W/'8PS0>,A#R<'VA5+H0O
ML3'<.I Q7$U+&&P_GP:5D4F\LT%LBO%M 2P2S6&<W&;1TT)R0@T KY4QT%:(
MRH$TDN5$G8=-XX<LXTT"[!L/C-![#^:PON00?6MUB'Z+]-YVEMY;Q_6K'M<O
M88(VSH55C*9RR7Q *F0B_XPH8I& /D!>:%LY\9DWC5QR?.=V"VS6%D(?K_G"
MH\2+Z9+K"1?P++"C#=UR99A$@RQ?3(U!?<CU18T@[C,:!8EG(X<&TD/59\BI
M()94K8WX<ZKK(.<7&EW(4:#XZ5R;XNMD.,)6N!?Q>Y(/)&+@(*1T\5 /FP0A
MJ4P?X49%UQJ_-!5E=@]V?IQS6X#GP9J_)KZHS,DVDGMCT64." #"P8,SGG_7
M_ZK9CC;;^^R^5^V0SVQFZUEOSTU#>8 /0#0$50"!#CNXAS\;GX+@&WY>8N97
MBB@>PCI5GB;N58[Z$[8P!;$\..3_]X^>86CO<TZ#7^C=]_OC-RJ]0G]/=@=S
M?1S_)$[!DZ=00$=$=HEM8\Y\_%7&X3Z'[AW.H;WA5A(*6_Q3/COX"[:B&(-5
M3W$[O=]O XZ>>#.H'F9H<.(/W>!LZL.A6-$_I;:'%)+$B"\YH:0*C@HW9UL+
M\JTI%HM&BH/#K-3<D(O O(KY<(I?V<".X#>P%K^*=UA!%-.-$W1GB!G! $(,
M1--E=F+1[T#L'$/1=SQ;!7P-5N\]L(-@@D>--7LNW49*,#&LP5?ANJ.5CK-3
M)<-4;J^X?@8@YP F%A4A)28Q%P*O]V TP!6)-<(K7PF 1>HKY15P+ >4ZS%]
M<%'2VO0G P2SW D\DC[2"O&/ ?=<L!WI[XCS;_0'CV)WG%TJ0$5_@TKOCL&Z
M=2WX!#NX8Z" "PR&[=%ZQ-)P[Q%<ZH$Z#ZLCPUEL$,]S);XUD2E'ZZZ@!Z!)
M, 0Z@TUQ 5D)2H DB09?FN-X,5C)7[DP#T(W^B;6AG$ FI^,!]94+GP 01R$
MXO$62W!/%,\#P.-P9<2,.WH_[#K%O3&;@M@ <SS,;!$@>_)(+<7H]) E0'!.
M6XC&"YR W50^PGMP!?1.?#03AKXPXFD)Z8N9-<)#(QM_YDTIDJA$N)@PX<$A
MB!>K@N-@7:<X'@L0+Z7FT^O?+LX:>E\9>L$ "0VNX/!$<5/JEH"+9U\',)73
M3A47UL6_(V[ >9$4 Z::TT_,K9$/?'B(%BL8AW=X1I%T=,3B9&,\$+&KE-P
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M(K,\CC('^18RF@FZG&&?<#,ROYS7B>G.*'R'M(?,TYMJ)"AR1".U%1(IY^.
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M;397NLJK3^BZH1_/^"!^A<XIA -:,.(I5R)7=M/2CYV156]V#H:L&(W']!X
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MH;+V"JZRH'B)+7WXUR!\^V&E5K80*WHZ4XR>^,Z-F>=:,[#ISL-&;_](^1[
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M0AYQ'P?887?V,4W:@"6RXI+3EO'QB,74X#IFWSCLQ"_N!)NV<WC.B'LV#A[
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M;JMT2$WE8D-KGD0/,0.PJD4KS;6&TZRZ8X=PR8:-YN:8$"D-J^]?X41X'L>
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M9);1Z\W.X?H/I&79NJF\.IVM^R)RHUGBF .PI$S;3\NT-TW8S+,]/X/$5BZ
M'A"X%T(MWR&7<S-T WY<.7P[:5(\#,,VZ)*M9%RF$,@0-8>Y>32'2P5+>QHD
M2C2BW"R+@9!(4/%*1]D+K4^ A)3[))*]TJBP5WM?Q"NA ,Y#DB[4WZ?&,?/]
M)-/6BNCVOZ1EXB7%F@*A8EZRJ=0N]30@2[&1XJZ*IJ GF@PC#,;X'BK3@S4)
M,L.4Z!!C5F3S%7+3BIJG#=IEQ#,=E!:69M2K,V6 OH0XKC[K;RQSVYK*'SEX
M0W[G8H8VF7 2OE$"VRB""V$[9M0#$%WHA<!2:G@MQ$ H=2DS8IO*B5^\32K[
M^06D0+M^(E@)1@.P<) I(\ D> D&O?"P$%XB7A'*I*8!YYBSE($IRS&2L161
M82BW,<'=!DF$%F-FB\NUK,:!O9#=*MU]4^;5VHAY'9);&4WE5Q_,;VP7CF;W
M#9-]&<_!#H^G19<&8MNO$9VH%*75Y&VWQ8;H"G6$S].3BM2_$"%$G^&(A3SS
M2\V'S]"?@BR2JOH!*64,$..&65]W$9?=()TR:Q@DEIB9?=0HW\+$PTG$WZ5_
MO ?:F'AL^L[U:<MTT_O98T [9WZR"YZ*^#DW@9J:,(/D8!GYYH?GV+<[S;ZY
M^N?B'/MM'MMK=OKMG9ZZ_K=V:_]K[39[>J\B:^TUC7:G(FO5M69'VVQ!#\Q$
M>GA$E;YP;24&P%]$40)ZP.=B*><"%]]F,OPV\\FW&-]1;BC>8HX%B?VK).?)
M@4-?W1#WIS\_9[S]]>*<T%TA]*(@?2*21P4T0]?B M2?F6O3=Z !*P3P&KI[
MP&-E#0K3)Q8)TUY>]SD9>*[E3>G#B2_*/VUY6,$P9.-(>;TXP[@^FPW.YI)]
M=\?)6( V+YFAS[*BY#?F)>(+X.*%,R,;$XQ8Y0\>TQ<_\25G^2N%)#][L$3Q
MC%!9>6A'/V;TAD]B4J^5U.1O*/EWJ;;]F(&BCQM_5KXI7V3/&.^WG(JW+3 .
M/)+T:0^UPC/MMMY_N9'9T)M&Z[A1N>95-:^J>=41\*IR(_/1#YN^MN)@5D],
MOTFC13MIB4O 4!'FJJO=?F^WX<@5&F]\S QRV19+CG/MIMZI/,X=.6/835"5
M[YAJUE EUG!PK#MZ7UD:B2ZH0-E7^_"459#5==O]W?3Q"MF/Q\SFEFVQW!BG
MMYH]O?(X=^1LX5&F>HF.J68-56(-!\>Z/?F !"+URZP*B0#Z(_P]TA\G<^]:
ML&D[2#"3+UW[L;GB#;7=[NZFG.\/5B4W*)\8*2K,C/</H')3BVXVNSOZN8Z&
M6FIV^E3>CAI%:A0I/8J0,OF6*A66E)#,CJ+4L6+DZ8=1]C<J(2FD_#[[VV?'
M4':;;2HOOJ76A;(ZA;J@Y,4GU*N-CR=>,.6BQBIBL1LY4R5FWZG*911XQ>X;
MHNA3-CS#\B\YR@?[FX8NMEV0;WHK1P'1"RC5O"&ZSK)[%JXK#RKSV1KE/-MT
M5B;VXL-.>(7.O6QV2&3>(R]KFR=:B8M3*Q0F8=T39H526V"J3GQ$I6ZG:I6Z
MK:9R)L9($K+?<-\-PD*MQ,[5;0<=Z',5^,M:YFQZBOVJG:+95"[A%^6&.3R>
M%J>+[%CE/S_TN,K'J1M5.\YV4PX3* RF>O @*W-L<A4OLNF/N8^F/[K>?LJN
M/^FE.&>B 8 +F16_$QW9IJOA=NB60#.KY=]'[L"-WQ]Z?4_>)VC9&;TO57%]
MIW(5W+VFKN^_>->$&XW=JJ+7U@2WFZ;Q!*7&3_A8XUDJF!<O/7!9W,-$0^AZ
M_G__OOCIXE:YN#H[_[^5H9=^Z7>WHC[;!RXY"<1XV 'V27(X3FF:K6_=\.S+
MMN7E!WH5-%<>8U7W=,8C*W1I$M!CBE_+4K&Z(?)B7YT7M-USH40I+VC+'UT/
MW7QG6(B\A"'-F2ZZ,*UV!<ECRKU?Q$-V%P/ERJ)HZ4W]<2)@]7[VWZ5UHTT=
MTB9[[ *E4<9TO:5A+B^L\'M+UYNC&-C.*0(9YZA0]ZOEC>7-U^P-C81KV_!A
M\][G2^RYA[%A"P5WUTMWX&[/N+HGW?,Q\);5R>@U;RD';S%JWE+SE@KR%J/6
M6\K.6XRE>@LZD5<,*RFRG5LW1K[34Y5??1KM=X/MKB/E-+"YBAR''J:WVIJ8
M8V('$[RJ^(CTHK[6R6;ML'# ?!XUKK][?)HR*4/3C)I)E>?2(V)2M0)4=B:U
M5 '*F-3BK*R:2=5,ZIB8E*[IS8NKFZ?B4X?8TNU(3$>F&7)V8"6BJWZ:;,<F
M$QPX($=MT+0I)N;1V2QF-#5.&7"+)1&GZ;?_]].73TK,AB*W#XNM;7MVX)N(
M"(L+T_=M =":0FL*?8!";T[_?4P42I1R8XWXF"EG-<&4Y-)C(IC3DT]'1S"G
MS+-P.BCJBY]<_QOF\F?D$]7T<^A+CXE^SLX_'AW]W++O@1^,I\KY]YC[-&'I
MC#NN[RZGJ)J@#GWI,1'4IY.?CHZ@/K$!]Z):%I7PTF,BG<]?SH^.=#Z'/ )*
MJ9 RMU (7+KYV4LK#DI37]/>3WU-[]6'IZNO*6T)S:&7\F*F:M]<_'QU<OOK
ME_.;E20]-SN[1%5]GPN!%9I3.E,O[VR2K*+*&W'B9HB/&K%(L1.<E(L.8;LX
M4A=?,^!*!(<&/P ?1V_Q@(^8YV ! 3Z(,$A>@&63//'A)GH>2^)1$,+N[,5"
MQ'V#S]@(?+-]*IZW**K?:VK]_BXU46;3U,VG&)-H[C;4<FV14:>I][I[?ZS1
M[!C[7VQ7A\?V#U01=?!+2Z]&GES]?'%]]L?5R>7%Z8VJ7%R=-G>I5#HXH(_I
M3%Y_R03'TBENM0E:P4/%DIMW3V.0E7[O_V%^ E:4TJ'>XJV#0B$KORI7]P2"
MTUOE1GDK]*?%?_]S<GE^HYPVE=-/YY>7YU^>I'_19J,M5RVQ^.^2#*,CDB6[
MCBDM+T8NKX/]#\.'(=)Y?#SFH4HN)Q>M-'6E:5>6Q:_($"[]NE]_#EW?<B?,
M6US\F]5TM5>UH+.W2VL!7@OP7:&PO(+Z<'!8*Z!O;L\___O\2CEI*K=?KG__
MZ<O%V<_G2[IVUF*PC!T?;F(^&7&?3B\,[@>A:P^Y6F# OP'[+4H_#%BL2.^F
MWPI</+^ ^;9R8EG8Y!% L\C4*Q0G*8'2+$(BG=4AD;>#P)["?T;QV/OP_P%0
M2P,$%     @ ^88F5BMG_4 .$   GZT  !$   !A;F=O+3(P,C(Q,3,P+GAS
M9.U=VW+;.!)]SU=@];+9JE%L^9+$KCA;LA.G7"5?5G8FLT]3$-F44*$(!01M
M:[Y^&R ID8)(D)2=:(?.2RP)?=#HT[@U;A_^_3CUR3V(D/'@I--[L]LA$#C<
M9<'XI//U[KS[OO/OCZ]>??A'M_O'Z7! /G$GFD(@R9D *L$E#TQ.R#<7PN_$
M$WQ*OG'QG=W3;O>C%CKCL[E@XXDD>[M[^ZN_BN/#=^#U  Z[[XX.H'L NV^[
M(_==K[N''_?V/.?H_='HM_'QZ-!]ARF\[D$/WG</WCF][NC@\+![M'<PZNV_
M/]AUWA]JT,?P.'0F,*4$"Q:$QX_A26<BY>QX9^?AX>'-P_X;+L8[>[N[O9T_
M+@>W.FDG2>NSX'LN]>-(^&GZ_1WU\XB&D":GP9CGDN,7C+OS@$Z9$[YQ^!3E
M]O9ZO?W=5$0!LI(L6!!*&CB++%PING(^@W"]#/Z\HWY6^>QV=]%JO0ZA4@HV
MBB2<<S']!!Z-?'G2B8(?$?69Q\!%AGU0'.829'Z65(Q!7M$IA#/J0-4R?GQ%
MB+(_F\ZXD"0PY#T:CK3>H9!*K*=4WD>58\8&W*%2NZ%*'Z* +J@AM0.^#-6G
M[A+CS6/H=G:J:Q"%W3&ELP9:9"5C39)OZFN3<<C>T='1SJ/RL/5ZK/46G;ZK
M_NSV]NIE6^1VU?/&3]U4[BET6-:N>CJD<AOJL+8J%7F$35)_#BNJH8%"<-Z,
M^?V.PZ- BKGV+HM'KA-)/VA?;)*_"TP#_3BHF/M20/W9C?_,YTR#@$N-H;Y)
MOIO-6.#Q^ O\2K%XG%(Y!"]M+XTF>4U]T?\=4^$([ELJU\Y,\!D(R2#,-N<:
M8"+ .^FH1KV;-FE_^G3T!C5)DQ@9Y/U1_;R#(N /EB5)995+G'1"I,&'V#;;
M7/"9@+H%1Y$0.Q5-]/]]^1WJURT_BCB1__<HO@M>W>*C" M8@](KZ3O\G3#W
MI'/&<2QZ0\>HG?K^Z_#",OK0>2^E4N@4?*G5QUW]KT>ZRS%LEVA)HD0_[*P*
MK$!%(;C7P4?]]ZJO)\))DA+!%2>I+)>W[EJQY,O4G*5&#D+N,U>-WV^Q$'HP
M&'+O&EU$JQ;6M+X5SDK+'G*QD-6\+#&7/X2$>V0)^T*9=\:G6+ )!"&[AP$/
MGX8Y$]5*X'YU G/H1,&WE,A3ZJO1\^T$0#8G+H]B)>J@C*@$B\1@+[3(\(8*
M+-4$)$,]GX:C/*25L,/JA)'7.>Q_M93 7%-&P\FYSQ^>J&%<H%EI>UNC0414
MHF%?"/-N)7>^3[CO@@@__XB8G#\)<VM@K12^JTYA%OZ?),Z@I62>LP";)$;]
MI84:,[@.RTK;>S7$9Z'C\S 2L,K; C+#8(N8ZCOHFR&K/\K/"5HY.%KE("O>
M(G,/X1Z""-3*"'JA%-21H5HQ.8M"R:?86-3BP(YF(Z:WNTI,@ADOWBQ0XV6=
M!6Z+&+L(T!Z2"P;UN,G*65GHK;*0D6Z1K;]P[CXP'X>P[@46 @T[\J$?AG6G
M0V4X5B[V5KE(T0C"D24>B0%;1$_?<40$[H#1$?.9K%LCUHA;R=@W^PT-0C(H
M+6)@P(/Q':A5VI&L9?N<H-7J!ZM65^)=)4\40(L,?A&@">&./M9N_9=R5G,?
MFJV_DB9:O$7&OIU0 :<4I55($()0ZU/+[@405@K>KE*@@;H:B62A6D3'9RH"
M%HS#&Q#:&K6(,(2M%+Q;I2"%((@1\]$BX]_"6$U%<<CQ!?A8T-F$.1>!Q\6T
M0:6P8%FI,6;0":(>$2TQ20:T152=4R9^IWY4KX(LI:SF-R;/2I9HX1:9>0#8
M&-?KA1,1FX'WC$EP+-@BXV(7-V52![^P3JMI/[:\$#AUQ_AE.%8:C%EP!DTW
M-3F\%K&3"98-(90B<F0DT!!HDVLY 7$A81I>0;TI0650*V_&C#D#_1O)@6L:
M-3S1^+\1S*%53#K15&D!L9%S:]_QL+_NG-J*9^5OW20[14W(RJ_1Q\ MHFT(
M#BKOSR_", (7S:.V5:([WP@>X)].@V6-BI!6\HRY>@I,8F2RA"9Y[!?^5HQ]
MPWU6N\>K"6WETP@&5.:3O$YS:=-"OW4-Y(Z._-J<5L.TDFF$%2JMKI#7,7Z;
M:,PL>#0@S)2V4F.$&S(8;22@9,VD 2%V-"M!1M"A?!VFC9R9*RH-J"H$L3*T
M9E'?6)QI(RW9Q98&A*P1MU&Q;T8P<BLV;61A-0+=@(D"""L;1B###&6WD1%+
M'+H!0=40K7P9 0Q[?+N-_"U"U@V86I6U<F($)99![S;:/HY(-^E-LH)6JYLK
M_UJ\C1:O&A]M-.2J!6UES8@9U S MI->:^2TV6"Z(JJ55"-V4"TJVTXNEYN)
M/X&DS&^^ESF5M_)C!!"R*.1U@M,F&JQA,S07'8\%C+6BW$L$FE"V:5Y6>HWP
M0[70G1;*9*P.@Z22+SZQAJ<K*M3QW?OG\0(#W<J[$=2HROLBJQ>>US&1?IN<
M4%RIK,_!?:4<;?YPT.R 1'S*2/^4GLDTH_PM=)-,D%W=M>5&/G O\V431ZB*
M::6Z[!2&"@HDX*I)SRT6M)O'C1KP,APK7T;8)L]7NQODDA68C1BK@VMET CR
M6-9X7D@M-/[9!#\""](D3\QM$;R58B.B9*4XSHJP8)GTA>L<&:N?GYCK(G@K
MUT8<RLKUFF7<%ZJSMO_\. -'G7R/))JT/^5"LK^TNNJ7('SJ-KQR?E9G,.)7
M5F=(\R9QYB2;.TFR;Z5_F$OTS:)<12A6+M?$NM:L]+>0F>Q:_4;#JE(@*S]&
ML&IE^;_MXZ:L=9=S1/5I4Z[6HUD),Z),!F'9V6:\A:.%O&6.T3:;71KB-F8.
MC7A/]C!N*TE8?Z:V"1_E2%9JC/A,T2'=5M*TNEFI"4%%&%9JC%#,NAU/+23%
MLD%IHR%#76PKB48TIL(VJ+:/+"PDW$;3*15S[EV!O*4^A*/YC>!NY,@S*F',
MQ?P9F*^>J=4EC.A-)9=(%%!#%[6[1.M 1G.2:$%2-5X\IA)YRW1] ?3G.,SZ
M/*W^8D2 -O*7C(#2HI7NLM@XN?B#>W'$!$V:F7Y? E4F=WE A^!$0FWVPI$1
M:S1P?K),K0YC1(DRVSQS'] WDD"1<J5LW"%5@J O4;+0@VA%7GQ&_Y'82)\3
M_!JB=6[9.& ><V@@OP9\%(*X5]O&+H)9U"R>_%1Y6CW&B$45>4PV?Z(5(!D-
M2%8%$NO0;F=)6N';"7] 6\D)+*K26DJYATD6-S)(=:DJ<Y.K^-/JV6AT\U,4
MLKJ9$5++N5G:8R6Z$<PYT_(4.2&V82KA4D>24W+1JK5S8+0@M>^Z&I/ZF6'"
M1IY4BFAUA9+[=U0H?(&=/Q_20@;CPP*WT6P6/RA'_>Q%]QN261O<QNO;@FM_
M=/5>YI*_4_^%8VVC14MU2=6Y CE/P]7-F;5"6ODTXH,+/I<-:PJ^C*^_D%AD
M\3][ST C@KX0^8PM[N(6^^R#2T_>]%;-Q4JU$3A>WP8OGUW(O?CTTAH;S*1/
MDCPYY27 5I:-R/)ZEA</G[2>UY)[])JP60'.RJ$1"BZ]G:^5K%4]U[GA&;5*
MV%8^-S\TVDJ&K><[&V[-J@IKY;7QN=&_-YT?=O+/#,>?<T\1JX>(DZ?0-=GJ
M#=0_TV,\WS*GAX;J ?MK;PA8/71MY,YWK"9G$_50>H?04:A%3CH>]=7#JNJ1
M9?TH4EVD0&W2'*G'5K$RJA=:U7OQQSC\02=213OIN%$\%.J0,,)LF8S4IR^"
M1[.33IR<897M$!DG3Q^05R#J7CE5GQ72\GEFPP)J]]%%H)H#_4B\S[FX""0@
M\7*(3E587JO<5I1.+RIDFK[T#,F\'[CG[!'<]/V1@E)6EJ]3VOBW41QXP!]@
MQ&1%&\3?3'F M5G,*QC ZI;)JFWR0>O;]Y#'FT@X$QS&?4(RAX &$/K:0^C/
M9H+?J]<1FU:$YCD^N4O%WZ1"5<R9%"A;N,6L-3D[. 2'CP/V%[C8]OJ1JVI\
M)-1+C7%ABRWW). ;>*(CP'T^5[R*IB,0U]X-\JL6C683\-UK]98SJB;Z CW"
MP_9#':8L-%$MC&=R%X;-W#@>DM5J6]7KTP$-I-H'&E[21S:-IG?80?D#I%;0
M,0R5+A4;W*I@SV2#&0X^-C0 ]O.HLVY$XPY1O\Z]D1ELD+_6&-] M8+89<0Z
MI:ZLM\^%UY$,U0Z.9(G=P?[E$_,CE3RQ0]8BL?JQ03:&?2:K(#SF6L$NEX!,
M"35US=ZQ<0FJ'$6%+I=YQJ&'RZ>45>DI+L&] V=B*T8NT3;H_7DZ\_D<0+]Q
MFG;)-]A!E)?$*K8-9?O/'VAP]5;R8'!V1J=4<!6@XD+MG)L #D%6AWOE96X,
MMPVV.!.G5*A!1'D9C63;H'N^#XB/9G@T\F5V!H(Z"Q6'K-B36%&V8CXS '0I
M2$+DP5@'6A=#Q#M^"C>4Q:/I_P(5=Q,!Q>5OA&6W @M4CR-_\N#RL^>!(S/7
M<#T.]33"X8&#!=*\G(+'!:CHB5!KRBK6=1-;OM!&F\)NA=/$<]1^;F]?3+Z^
M3.P.'N6IC\UV^2RX$L SEE>FN50I<4$XM6\\J5)4XLH VSKQ1Z00)P9BS(+$
M&VE)]*H@]5:X[XU0<SJA7GC/C"UT2,$R2JPBN0W]V;H-;RH(8.ZCS+<\^5VY
MB[8[#@@X\R^8^P!Y/1=\.D30!7:A&_Q\1;8V6I'$6_3QLQLZ5S^6.UN)P#;X
MV #&U#_CH:W.F.FV0?N,/VK_NQ%\E#@9]RK14P=A&TI\-X%/X-,'G,7W'?M<
MI##Y-I0EW<1S[:U]+L(^ *D.L"4#$/0N!\!5\1>?SD/UN(]JM-*PS/*H;.)Y
M?2'4M3BQ=R9QW>N94NSS(W:4#%,6&N=9\MK68<U%*"CX["((^+W.OA_)"5=;
MQ;"SGU5I".H@;$/E&;  N3S3G=TY=9+==SK@>\J%T#O4S^@,?Y%S]7J4<%&!
M<U ;Z$KF?AN!;NLD,+Y;ZB)8#&.PB.M/#!2OP=2 V-8ZTF2EX!8U@1\1IK_C
MESC%%8SZV=#JDRY+V#/[M9'Z_M[NWJZ>,_35'4IJGL+NH8^=JVN/A%84WH:F
MI;JS7P<E.Q_JH6QKK;&N6R?+2SB!0>O&;P"J=>P!\T"O/M[Q.%WSE?'J.?SZ
ME?#%>G2J*PB]J5.-/$8^B^_'_IUBU48U<U[0GZH7#@NMM#GPMG9/ES2(/)I$
MDH: 0TEJ']A;A+:A&4G<5*UD!=SG8WUTN#PN4RBP#>5)KC\;0@A4.!.U9HH^
MZ?.9[N'BW18ED<,JPMOJHE\#EX7Z!5)P"QKQY>[#0AO41-E68YRKK8@PP-Y[
M]2+%]"[#[!V&BY62<QZ)X@C;)IC-#?6L/><5#]3>?KV E%SD6+R!9UW:;1T2
M+,,.5R#3^%YZVXK.IG;\HBK0EL0Q+D$U7\P!ZSZ&?+)M:,;7S7'3W3'I/*5X
M7E-1^I?O,5O9$:>:$J%N>.5B"/!(IRPHG_!6EO_E)4WJS=KQ8!+:4M-.V\#2
M+O\3!]=ZGWJ(K<.4?GSU/U!+ P04    " #YAB96'K *((D=  "/' $ %0
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M/%>3]-L./OMQNMA\6B? 7A]AIHPJP16AZ)>C<1,<"9XGPJ7QH(Q'I&T<WAW
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M=@42'#_E%5,!KI=.0QI>'FDOA1.^CB>3D2G'(&5)7XFEG!HKO/0.?[.RG*
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M>N>__N;GT(W]!!='RW6F@A.?3*FK )$$%#D1FBNK#;/<MFE;LA'.D';7#V;
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MQ@_BMQ[#H1J"V5$G7GQ>7@+>ZQ]_^S]02P,$%     @ ^88F5N(_:Q"310
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MB*:9_SWIPR$B[^4" )?4XSZ*BU_,0"1#^]>5;/4DM$B(3SHXV0L '5#TZ!V
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M"7B,9O=1-*LFL>TQ796->!3B1GT(3VT,67H#*DLGLY7*H9\=T>O6/DLYV/;
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M!+7X)J?,E4LFLSJWZ(X V_\"VZDN/<S=KDM7!3]NASS6U]!PX_$<")<,S9#
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M^1+6BJY^M[WMG<@;P*T:VST0\-/$?:LI0'-%ZXR]9Z!T1B!(=.>)2D*4L[5
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M:]U\V,32OPG9!4M[?(\C1%SCHMP]/VBAV9$#[FW@"02.FAV9Q&W/9@(^()H
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MZ?O-X#^(L2;YV\>(NZ\,?L@A27"><*=P4^/H(WG%&.%2TF0S$U9^?QG\G6O
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M0O@RT2JJO O1RX^A'J0?DPH\55@[M^%:]X%J@*QJO'0WMJ<)DW;#80/%:$%
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M.<$#&A<2 TB7/[TNX?'9$#?3U^.KRU4EZW?#V;S!N< !JE(&G&WJ2@%PV/E
M!Q.Y.0]H^?XMN[2$4@DHUMEL-X;H(O2P?.1ODW'I&E,,VVJQ@@<C]1\!V,K0
M5O]]EU@.O3NU^G7Y$OP,_NU?_B]02P,$%     @ ^88F5N6^AY8<+0  (BX
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M_X2T$%F:"7(GIWGKFH>I8":MIB(+QA,DM/51=D;7&U?2+75AK^2#(VT!V(P
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M,?!HZ)S,DR5DS3+!%1)"!&F? J_DK%Q-+!*[=S\;'P%*SQP3?)6,7-376F&
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M.5^-U?#^861U^FSJK8Y@7,JN?QG*9)JBL#W=#Q%5SB9&,(NY2!B*<$JL>,I
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M+$V5RR2R5&1Q% 9&-5![9$R-LK;IAW78W UXHA7X5I^Y_[?@ER#43A)8-E6
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M&C("!D=ZGG'UO?0RZ)/VM02ONCYIM2$FW=+<X&]QNN=Y'$8ZX/,V'G;G?E>
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MA> T"T,1!=@J'KQ'UM2(L=;MO_]CF ;_%%NV<.P!U(SH','DF<1V"S\TBMZ
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M1:,/Z>;R#0-K0,E*?4<?=3.6INIM^R*G!",<1 Q2*F*(A P@85&F/N"!%)'
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M0?<;?:+L\X4;KHIXU\&?ITY\W_[@\[50;J=F>O7_0E=3QUS1;X(H#",<:>[
M$..,P2053&\<X)R+ <'N-CI,C:EU1?4EG=NRR!#TS?C%,Z:>F:?5O@E1WT2Z
M?-^/=-G8 #HCW%:TOP)"'V'I5GJ\1$3Z$*#.!*,/>I1]JMV;=J/E_:+N6Z:7
MTU]U/=D90IAG3(>2R""%Z@?E'448PR"7..2,9(PQTZR[<T*F1F&=GF!'4?!'
MK:IA,$DOI/VTY0HHS[PT"".KG+U+( Q.WSO[X-$R^2Z9MIO4=_':8=[..UI4
M_T[G:_GJ>?//_U7(2CWHX5DG\,[KF"=,19(S%L",)CJ2+$LA1D1"$B<4LSS&
M>695OMY,[-0(0:L*:EW!1MEZN^;C[;\/"C(S1-_,P7&/J6?NN 9.:]_%#AVG
M[HJAZ%$]%#LX#IT2R[N'4=/;OZ^+U?,FEYTD41C(B,& T@RB2"VO:*P66HQP
M1B4.@I08);R<?OS4J*;1SB0!W@0[,P(9CHAGHC 'PYH63MOL=/H?B!AUFI\V
M[W ZG[EJ^/+AW]:T4K-D_GPGG\IJ-4-YF$LB=.0Y3B *8@E9$B=0I"A+":-9
MF!B5J^N1,;4)O'&,-WJ"1E'[E<,AFN8+ARLP&FO=8 S/H$7#&0"N7C,</G?T
M)<,9PTZM&,Y=.NRK_%L=LBJ;I<C3>O55/>9-J;LES'B>BR20"<RBF.MNP1DD
M,@E@*G/$.,T(B2.;+_1Y45.;[#N:@EI5H'4%?S3:6GZ[>Q V^XZ[P<TS 0R%
MS/H+?QD-IU_['G&C?ODOFWWH!1C<,8PR="/S<E$'N;<E2(,XUDWO0L@3+'5A
M"PHQ(P(BF::YY$'$ ZO"%D<2ID80C8)-;H4=&QR#9T8"5T'B>>[OHN&P:.M%
MTYU.]&,IH\[OLT8>3NOS%PZ;S?].JT)O/-[1E:QWIY)<)BQ,)4P"P=1DYB$D
M+%$. ,8)5=_]A%*K8)1# 5.;RYU^NB:E'+3M=P2AV92^!AC/,]H*$^L)?<YP
MI_/Y2,BHT_F<B8>S^>QUPR9S';/VL5R471)&TR^["VK;U-R,9)A&E$$FI/I>
M,QE!@F4.HTRH^4UXA+G5]K^9V*E-_"8HLPUS_;/=E#<$VHP(W,/GF1X:Y'8U
M!HW*X*=6Z9^][.[9 >643@Q%CTHR=G <4H_EW0,)B1>O9%Y6\DYRG0]?Y 6O
M#SN7'^7J4_Z5_KA=K:J"K5>:!;^6GVD=8ACE4200XS#.F3X<0!+BG,20($%)
M+F.!B%4 UC UIDE8:I">*OF@!JGX)L&\;OR\D'42UZHG.LCE\!C2FG?0?=/<
MZ_<W@-4F@",;;L#'!G1EQPW8M41WHFUL<<A\5V'IE@F'J3(N,UX%UQ%37O>T
M@66 Y+W>NFDV>14[GVIZBG6U#Q1D,$BU'Q>P"-((4TAX&/" A)1@JVPE YE3
MX\16Y3K.X"^RO*_HTT/!=\.7+.L$&<!N1G^.P?3,=1V.&W7]=YFU ,AM92$#
MN>/6&#('XJC:D,6M SVX???P@_(W9LHWBQ,1Y3 .0@)1%BK>B06%@B5!(L-<
M)CRRR:TY(<.*9T;(JMF6M= >EZ67=0)"0Q?J.F!\^T='JS^MX/D"3/9>SWGS
MW;HT)^2,ZZ^<-_3(&>FY],H9OE^QHTOW2D7(TB1((<G5,@S%4DWV+&60$\&3
M"%'$S4+%S<1-S;]HU0+;G8ZY5GMX7MT%M"UYX6H,1Z.(XVI SA/MS%#QPQRG
M1;X,B?2:?Y9/^N\:&(Y>+(J5K)LKO%^LU(M1J 52DU-]^Z@]EO^J7?1VS^D_
M):V^?B]G.-+]I*F /$08(AG$D& 4PY3G+!=Q$.# :O=GD!93(R+U B:6T>B#
MP#<C(.^0>N:E1O^V <S6@J9$PTU=NX'KJC&[QMP ;0=0AC@,8[\&1[=1[8,T
M&3?(_1JPCF+>KWJ8@QJN[4%^4W*4,K5T(C2">:Z/VI,D@#B0&8P31B5)*8^S
M?+:0]U2]E$TIZB\K6JW,^.^L6*,)29H)>4:XORGZ2MX7BX5V'5Y1]0>NG(=M
M4=/^:J:6X$O"8ZQ\7!CIF&9$]&D#Q2&4D<PD4R.0<[D/_MN%>"GH.]'^@%<2
MQD#=[$-S'8 O4VNW4=-SS=U36/BKO+LG[>7J[YXRNK<*[\D;AI&W6F_K)\LW
MLOG?]TT0UD,Y5\]8-CD7=^5\_JZLOM-*S&0N:"Y$")G(%:6S5$"22 I9AE#*
M:9 &>6#CQ5K*GYK_VJD/?NH,^!D4;=!@:\/_ %UFD+8#M(98!F/9#I,9#7D$
MWS,Y><#=FK@&HN>4SFQU&)7D!@)T2'U#'S,\,^Q=L>1TKKWC=^HWRQEB)(K4
M(ATF**-JZ2XQ9'%*E%,5\8#B( O#W#8S[$#&U(AMD_K4Z-DL$FM-[5/##N'L
M)R='('DFH 'X#,H-.X/ U;EAA\\=/3?LC&&G<L/.73HP!$&[3:\4CPCE1NEE
M<%,S.,.2Q)D,8!BB5+<70) 20F :D(2G)!81LXH>/2UF:M.\R6Y@6LTZ!*O3
MTS*\X#2D9D[(]4!YGNJU@K#!Z#-]KF?];56I2^HTI!L=,LKI\J&KC>HPEJ 7
M&K?A Z=%C1LQT&ON49! _]77YXVTZ8Q1QD42I1ED7.^CI,H-H)1Q*".&>1KF
M,HVM]NV/14R-% [R) ;EAYX THP.KH/',Q58(G-5#HG'],\38EXLCZ0_W;/G
MRJ&%,Y>K:LU7:]W>\'8A[N1<[T+>\E7QK3[W/A4:)UDJDS1-89IH_Y^'>K\C
MPY (FN:8(R1CJTS0(4I,C21NN5IX+8OF"&G/H)W:X'5KZCJFV+; YH!1,N,7
MW]A[9J!CI%L#P-8"_T&.UX#HN,CF $5&KK(Y'*KC,IM7/&M@>?=/K]^?B@/O
M8L1W-QUS2D66(@352RP@HCR#A&,,HYA%(68(IY%5\2L+V9-C1Z7ZF?2)W12+
MJ_:$;8;&C!L] >Z9$AUC;5\)W1XUM[71+>2/6RW='IBC^ND#'C&0Z(2HG1DZ
M_TP+\7[QFCX5*SIORUEP1B@.I,*>2PY1)AG$,4NAS'#, YJGG%OUI.V5-CDR
MVR@+ZAXPQ0+P1E]+PNJ%V)"B7 'GFY2VF&E%H<*L5=5#+1$C4-QR3J_$<5G&
MQ/@C7C&Z:6 E(;I\4,Z9_A]]./6-SA5A+6]7KVE5/2O'K2Y$.F-82,%U6^N<
M,8CR0$#,,(4BIEF>(R$PMZLN9")U:LRBM:T7,?7^J=SJ;5E^R AQ,X)QCJ-G
MHME 6/]C1^4;0%>@T[JI8.RP>I$-2FXK&AE)'K?*D0T81Y6/K&X>&*$I^<.B
MG)?WS_5^^6%D:/L!UL5.4<X5!64\A4B* &(1)##'$8\I930+K'P<(ZE38Z2M
MTK#6^BB,VC92T AZ,VIR#JAG:KJ,I0=?R HDMZ&%1I+'#3.T >,HY-#JYBM*
M.[W>K?VQ30!4R[O/.F2]7)Q: 88S$1'$DS" @B3*@Y(1ACB1.<Q#'@F&98Q1
MV 4XFS'6%=H83;O]R&?/3-9FKZ[HCZX:%*C:K>)5"0J],Z]W1LH3Y5>*-O%U
MWIOXZGQ S5C0]R"-66QJSXS]?..;I@1+:X[_4BS7H^J^,M5 ?<8O5W4=<"=K
M6%WYR&%T_*%<W"LOZ_&-9+L5G7,B!,\EA0%%'*(X"B#-200Y"UB.4II8%JXZ
M+69JKJ#6$FHU@=;SYIIJV6=P-2.\Z]'RS&7#@+*FJ'X<G++/&5&C$DN_N8><
M<>%J.SJHF]C_VW_\)D7!Z?S#A]>OZ2.MRB_K)UV0Y355_+1JNTCOA &T:YF0
MQ4P*F2J*4+X9RF@(2813* (>))@F&6-&;32N46)J5/)O_P%:.VZ L@0TIH#6
M%M 9TZR*P(XY9C1SU7CUD]!8H^"9H@8/P.45JKN1$&V\<Q,]^](CLJ?-!$?F
M^@^+"R2;SXY^DOZ61&$8!_67Y*IGC_*=<6%]]Q5R\BP?=7Z^J->WCM+^E+\K
M%G3!"SK_7#;BW_Y8:>]:N<\?BN5*?;>B&&5Y#M.,"XC2)(*$"PPE"5#(<Y[R
M#+FK"&2NV-2^99_V:P;=;(H&/=\ WAAW Y:=>7J+(>\,!$]E%S$H-S:J^Y>6
MX8'.QMQPQ^$%1M+W]L/E"D8WX,ON(&YL YUQX(^M>>#M0GTLJOI;X;(TMF/D
M1ZR29*'<A.HIV4-J5WEIP/,'+%T^5Z58\]5F [N0W4$+2H.,2HI@A%()41[%
M$&."8)A&01;+5$B>&2].SHJ9&F6WBH+_0]W;]KB-:^FB?T7 ',SM#11G))(2
MR9E/U4EZ(SCI)$C2LW%N?S#X6O&,RZYMN]*I\^LO*<GOMDS2E$H7V+M3J4A<
M:SV4'BV2ZV6]IVF /WL93H^U0Q*0>F;##3[[2L8X_I>!"G#MDP VD/-^[L'Z
MMT2.^54<.EWORW</YUQ?M># ?;Y^=1_=4R8((8J14* R% ),30DX*R0PF.9*
MTE(:%E8(LU/<V)CQH%M*W7$@9<>4))U21L23'AU2AFJ+TM^ATV61(VJ#TGET
M=/VN."9IDY]7WQ;U(GZI+659.>N7S_8I6=_/E0M@>G*73(0I)<P5 04KJ645
MC@ 3"@$-\PJ+O"1%D8>=S?L+']]1_";:=.5.;I]:O>^R)Z=Y';NG-[J'L4_
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M@ZUO'RD6L8B<HBMHW)A<=&GT@;.,KAAYFFYT[88;DP=V:0FK;5(,R6%I**6
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M#38(O4?9M^'RN)MOS"3XL$TGPJ+4'!J[XJT#QHJ*VQ6OKD#)#:($8VE$7-[
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MDRLB@70M0[#]8%COTWXY8"FHS!$FBGH=A'K(&IL+6NOVK_]25/E_PLBB:6<
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M5 ^2'_+H#Q.CWGP1_VJ-R'C;HJ>M7[38Z1]?P"ALAA#%$DE8@<)8:L8YU$!
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M8(8*P2@I-7D)'I230J X)J.@>Z.[@AUW/M]T/9]0S41!9 E4H0N H8& 8JE
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M@"%#@3%(X=QH:4Q0U:QK L?VJI^I ;/5./NST?GF\CE'F/MN6Z9#LO?-RUM
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M/TF$@&!EI5B>$Z5,2$J2O^@@FA@@&\E%E-?MO)]=5N=T;O_7ZISQK=)AWD[
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M/>@*AN7DM"M\A(@%^+GN>5]<@XY/YHM>/R_G7W0=C>C8\SM?/NB)@H54)8'
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MC420IE*%T"G&/) ,Q0%?_&CC?N5+J\8?6(^)^(/L2GPKRE*;64K4!\RVB?Z
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MMK;V/J+I\8,TC>L"M8'30!KH $M_P3D):$:<O,@GT_FZ6J_>W5VP0Q+RRKL
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MYSZ%[[AZ_9WD1SJ<SL/RQR: 7=!OYZ=$VFPMCXTYGV@MD,L*&ZP)ZQ@1(L,
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MN*U1\.$&;B\RQ]D[GQX]BZ=2Y<$X)4KBHBU2SR5XMSY;TOZBHQ=09'2@:NI
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MKU/RO:ZQ-2F%'#MI2#R"9*1"0/#<(Z!TV7I=1 J-ZLL?I6WLGBE-(#6P2CH
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ML,R?Z,/K$,3KE%FP&031"DJ8"-%'!])ZFPR/,?LV:2TWR.BD2\3QX?WAPNT
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M ZL\&7"2Y;JAC2?#UT3=^ 1\G+A.[+FA +&#ZW",=#H%W/)ZWV[/]ERD]8D
M89FIB;E>D+O%"T1MG=9,F.0;>PY/4-<)Y(:"Q"[>ZC'RZ0ES1VB/FWLMZXIC
MF6R.9#EI$"\1HHT68I(I,*ZEVZT7PBAAZ_UNQ=N;D'WH\Y/CHH--<6NI#UPD
MW.3Z%LZ3]AJBLZDV?:TU$EP!EY:CX399V\8FW8V^3@[CTP-HWER:'6#TU>62
MN+-<OIY_C=/96JPU'8!81\*A[Y;3C(OMO?)F_3\F(5BEZHAOAL: <D6 U\5
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MP@28SF=3XM5F9VIOK"X(UM4Z<*;J1 I,8"*3*3$TJ-I4;SQ,STZXTG]O#3N
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MN@3PGENP0OF(41;-1U"ECY';U35',Q .(JP.#K_'TC^B4RB8K$7/ NN]3('
M0P:1@E89(R-CM;M\FU-=3QR#JB$8WL%)]DPNHS.R")40@I5U.F4TQ"')@.R"
MI%E@KL@V$9$!4DE/=</0 $6'L+_?0^A6%J/U*)U79$VJVL8#90:'+!+7,M(/
MKJ1&J?S#I))R]G(Q=: 4_@;75),[V31#7E1-^,FOJNXNY_JRZM\&X.7MRI_K
M](]YV6)J/ENVJG#:]64M2YT.6G";N\(0;""C,]:-*4$QX2 :^B*#+-4=SRJW
M\E&'ORM</_,77*;%]-NZK=NZ"X9R+L=2#& @E::\8[38&$!834J.VRQ]R\O
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MF8YC#ZD=F%KOOC?&@N1)9F,=\()U.+KVX)%;8%$Z9I \6=&F"\4^5(ZK*H]
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M              "  7P'  !A,3$S,#(P,C(M97AX,S$R+FAT;5!+ 0(4 Q0
M   ( /F&)E9Y1LJ;Z00  /H2   4              "  0P/  !A,3$S,#(P
M,C(M97AX,S(Q+FAT;5!+ 0(4 Q0    ( /F&)E:.-UJ:] 0  !X3   4
M          "  2<4  !A,3$S,#(P,C(M97AX,S(R+FAT;5!+ 0(4 Q0    (
M /F&)E8^&<R5N]D! "&!%@ 1              "  4T9  !A;F=O+3(P,C(Q
M,3,P+FAT;5!+ 0(4 Q0    ( /F&)E8K9_U #A   )^M   1
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M &%N9V\M,C R,C$Q,S!?;&%B+GAM;%!+ 0(4 Q0    ( /F&)E8T['TV*WH
M #=9!0 5              "  1]: P!A;F=O+3(P,C(Q,3,P7W!R92YX;6Q0
52P4&      L "P#4 @  ?=0#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
